<SEC-DOCUMENT>0001104659-22-109375.txt : 20221017
<SEC-HEADER>0001104659-22-109375.hdr.sgml : 20221017
<ACCEPTANCE-DATETIME>20221017170143
ACCESSION NUMBER:		0001104659-22-109375
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		24
CONFORMED PERIOD OF REPORT:	20221012
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221017
DATE AS OF CHANGE:		20221017

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Spring Valley Acquisition Corp. II
		CENTRAL INDEX KEY:			0001843477
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41529
		FILM NUMBER:		221314210

	BUSINESS ADDRESS:	
		STREET 1:		2100 MCKINNEY AVE., SUITE 1675
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		214-308-5230

	MAIL ADDRESS:	
		STREET 1:		2100 MCKINNEY AVE., SUITE 1675
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm216731d39_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SVII="http://sv-ac.com/20221012">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_SVII_sv%2Dac.com_20221012 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20221012_20221012 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001843477 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityCentralIndexKey">0001843477</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="svii-20221012.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-10-12to2022-10-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001843477</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-12</xbrli:startDate>
        <xbrli:endDate>2022-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-122022-10-12_custom_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001843477</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SVII:UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-12</xbrli:startDate>
        <xbrli:endDate>2022-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-122022-10-12_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001843477</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-12</xbrli:startDate>
        <xbrli:endDate>2022-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-122022-10-12_custom_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001843477</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SVII:Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-12</xbrli:startDate>
        <xbrli:endDate>2022-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-122022-10-12_custom_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001843477</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SVII:RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-12</xbrli:startDate>
        <xbrli:endDate>2022-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20221012__20221012_zbCXYZ2LhB9i"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or Section&#160;15(d)<br />
of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_905_edei--DocumentPeriodEndDate_c20221012__20221012_z2Q7QLSnhVHg"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">October 12, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_907_edei--EntityRegistrantName_c20221012__20221012_zPurBvFHsIK7"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityRegistrantName">SPRING VALLEY
ACQUISITION CORP. II</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b>(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20221012__20221012_zLtSrIgqfR79"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">Cayman Islands</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of<br />
incorporation</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">or organization)</p></td>
    <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityFileNumber_c20221012__20221012_z9hHHCvFBLb1"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityFileNumber">001-41529</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission<br />
    File Number)</p></td>
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20221012__20221012_zi4Q917mg1P7"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityTaxIdentificationNumber">98-1579063</ix:nonNumeric></span><br />
</b>(I.R.S. Employer
<br />
Identification Number)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20221012__20221012_zf4gL5IvsqS"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityAddressAddressLine1">2100 McKinney Ave.</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20221012__20221012_zgc6RTMi0gb8"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityAddressAddressLine2">Suite 1675</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20221012__20221012_zuuHnLaSNjO3"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20221012__20221012_zpgPqbb5c6Zf"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityAddressStateOrProvince">TX</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20221012__20221012_zHjfAWD5IHP2"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:EntityAddressPostalZipCode">75201</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_909_edei--CityAreaCode_c20221012__20221012_zzmszqliPTib"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:CityAreaCode">214</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20221012__20221012_z2NqhhIa5gD5"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" name="dei:LocalPhoneNumber">308-5230</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b>(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_905_edei--WrittenCommunications_c20221012__20221012_zayf8OopwiOe"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span>&#8239;&#8239;&#8239;&#8239;&#8239;Written
communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_906_edei--SolicitingMaterial_c20221012__20221012_z8wH1FrqpNi"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span>&#8239;&#8239;&#8239;&#8239;&#8239;Soliciting
material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_902_edei--PreCommencementTenderOffer_c20221012__20221012_zJQSLofXqLG7"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span>&#8239;&#8239;&#8239;&#8239;&#8239;Pre-commencement
communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20221012__20221012_zdXtxSzYxOh1"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span>&#8239;&#8239;&#8239;&#8239;&#8239;Pre-commencement
communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: Black 2.5pt double; width: 40%; padding-right: 5.4pt">
    <p style="border-bottom: Black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Title of
    each class</b></p></td>
    <td style="border-top: Black 2.5pt double; width: 27%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Trading Symbols</b></p></td>
    <td style="border-top: Black 2.5pt double; width: 33%; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Name of each
    exchange on which<br />
registered</b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_900_edei--Security12bTitle_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_z5iM9jQXQbk6"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" name="dei:Security12bTitle">Units, each consisting of one Class A ordinary share,
    $0.0001 par value, one right and one-half of one redeemable public warrant</ix:nonNumeric></span></b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90A_edei--TradingSymbol_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_zz3FkbCfJEa9"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" name="dei:TradingSymbol">SVIIU</ix:nonNumeric></span></b></td>
    <td style="padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90B_edei--SecurityExchangeName_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_zxpjeg48mobi"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_908_edei--Security12bTitle_c20221012__20221012__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHfnK0Lg119j"><ix:nonNumeric contextRef="From2022-10-122022-10-12_us-gaap_CommonClassAMember" name="dei:Security12bTitle">Class A ordinary shares, par value $0.0001 per
    share</ix:nonNumeric></span></b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90B_edei--TradingSymbol_c20221012__20221012__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHV8LZPS7tef"><ix:nonNumeric contextRef="From2022-10-122022-10-12_us-gaap_CommonClassAMember" name="dei:TradingSymbol">SVII</ix:nonNumeric></span></b></td>
    <td style="padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90B_edei--SecurityExchangeName_c20221012__20221012__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOkM0raPfTfc"><ix:nonNumeric contextRef="From2022-10-122022-10-12_us-gaap_CommonClassAMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90A_edei--Security12bTitle_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_zHmkAUN1s2xe"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" name="dei:Security12bTitle">Rights included as part of the units to acquire one-tenth
    (1/10) of one share of Class A ordinary share</ix:nonNumeric></span></b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90D_edei--TradingSymbol_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_zhvwvHh0BWke"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" name="dei:TradingSymbol">SVIIR</ix:nonNumeric></span></b></td>
    <td style="padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90B_edei--SecurityExchangeName_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_zQj4NtK6vPlh"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90A_edei--Security12bTitle_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_zbZrZnlOrdm5"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" name="dei:Security12bTitle">Redeemable
    public warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise</ix:nonNumeric></span> price of
    $11.50</b></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90F_edei--TradingSymbol_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_zN4HYfQ3WNr7"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" name="dei:TradingSymbol">SVIIW</ix:nonNumeric></span></b></td>
    <td style="border-bottom: Black 2.25pt double; padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_904_edei--SecurityExchangeName_c20221012__20221012__us-gaap--StatementClassOfStockAxis__custom--RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_zeqKO9F9omvb"><ix:nonNumeric contextRef="From2022-10-122022-10-12_custom_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule&#160;405 of the Securities Act of 1933 or Rule&#160;12b-2 of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<span style="font-family: Wingdings"><span id="xdx_900_edei--EntityEmergingGrowthCompany_c20221012__20221012_zTXkXr9n9fy6"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section&#160;13(a)&#160;of the Exchange Act.&#8239;&#8239;&#8239;&#8239;&#8239;<span style="font-family: Wingdings"><span id="xdx_90A_edei--EntityExTransitionPeriod_c20221012__20221012_zQPQGVjAdLA1"><ix:nonNumeric contextRef="From2022-10-12to2022-10-12" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b></b></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 1.01</b></td><td><b>Entry into a Material Definitive Agreement.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October&#160;12, 2022, the Registration Statement
on Form&#160;S-1 (File No.&#160;333-253156) (the &#8220;Registration Statement&#8221;) relating to the initial public offering (the &#8220;IPO&#8221;)
of Spring Valley Acquisition Corp. II (the &#8220;Company&#8221;) was declared effective by the U.S. Securities and Exchange Commission.
On October&#160;17, 2022, the Company consummated the IPO of 23,000,000 units (the &#8220;Units&#8221;), including 3,000,000 Units issued
a result of the full exercise of the underwriters&#8217; over-allotment option. Each Unit consists of one Class&#160;A ordinary share,
$0.0001 par value per share (the &#8220;Class&#160;A Ordinary Shares&#8221;), one right to receive one-tenth of one Class&#160;A ordinary
share (the &#8220;Rights&#8221;) and one-half of one redeemable warrant (the &#8220;Public Warrants&#8221;), each whole Public Warrant
entitling the holder thereof to purchase one Class&#160;A Ordinary Share at an exercise price of $11.50 per share. The Units were sold
at an offering price of $10.00 per Unit, generating gross proceeds of $230,000,000. Further, in connection with the IPO, the Company entered
into the following agreements previously filed as exhibits of the Registration Statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>an Underwriting Agreement, dated October&#160;12, 2022, among the Company and Citigroup Global Markets Inc. and Guggenheim Securities,
LLC, as representatives of the several underwriters, which contains customary representations and warranties and indemnification of the
underwriters by the Company;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>a Public Warrant Agreement, dated October&#160;12, 2022, between the Company and Continental Stock Transfer&#160;&amp; Trust Company
(&#8220;CST&#8221;), as warrant agent, which sets forth the expiration and exercise price of and procedure for exercising the Public Warrants,
certain adjustment features of the terms of exercise, provisions relating to redemption and cashless exercise of the Public Warrants,
certain registration rights of the holders of Public Warrants, provision for amendments to the Public Warrant Agreement, and indemnification
of the warrant agent by the Company under the agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>a Private Warrant Agreement, dated October&#160;12, 2022, between the Company and CST, as warrant agent, which sets forth the expiration
and exercise price of and procedure for exercising the private placement warrants, each exercisable to purchase one Class&#160;A ordinary
share at $11.50 per share, at a price of $1.00 per warrant (the &#8220;Private Placement Warrants&#8221;), certain adjustment features
of the terms of exercise, provisions relating to redemption and cashless exercise of the Private Placement Warrants, certain registration
rights of the holders of Private Warrants, provision for amendments to the Private Warrant Agreement, and indemnification of the warrant
agent by the Company under the agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>a Rights Agreement, dated October&#160;12, 2022, between the Company and CST, as rights agent,&#160;which provides the terms upon
which the Rights shall be issued, and the respective rights, limitation of rights, and immunities of the Company, the rights agent, and
the holders of the Rights;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>an Investment Management Trust Agreement, dated October&#160;12, 2022, between the Company and CST, as trustee, which establishes
the trust account that will hold the net proceeds of the IPO and certain of the proceeds of the sale of the Private Placement Warrants,
and sets forth the responsibilities of the trustee, the procedures for withdrawal and direction of funds from the trust account, and indemnification
of the trustee by the Company under the agreement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>a Registration and Shareholder Rights Agreement, dated October&#160;12, 2022, among the Company and Spring Valley Acquisition Sponsor
II, LLC (the &#8220;Sponsor&#8221;), which provides for customary demand and piggy-back registration rights for the Sponsor, as well as
certain transfer restrictions applicable to the Sponsor with respect to the Company&#8217;s securities and, upon consummation of the Company&#8217;s
initial business combination, the right of the Sponsor to nominate three individual for election to the Company&#8217;s board of directors;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>a Private Placement Warrants Purchase Agreement, dated October&#160;12, 2022, between the Company and the Sponsor, pursuant to which
the Sponsor purchased 13,350,000 Private Placement Warrants;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>Indemnity Agreements, each dated October&#160;12, 2022, by and between the Company and each of the officers and directors of the Company,
pursuant to which the Company has agreed to indemnify each officer and director of the Company against certain claims that may arise in
their roles as officers and directors of the Company;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>an Administrative Services Agreement, dated October&#160;12, 2022, by and between the Company and the Sponsor, pursuant to which the
Sponsor has agreed to make available office space and certain administrative and support services, as may be required by the Company from
time to time, for $10,000 per month until the Company&#8217;s initial business combination or liquidation; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>a Letter Agreement, dated October&#160;12, 2022, by and between the Company, the Sponsor and each of the officers and directors of
the Company (together with the Sponsor, the &#8220;Insiders&#8221;), pursuant to which each Insider has agreed to vote any Class&#160;A
Ordinary Shares held by such Insider in favor of the Company&#8217;s business combination; to facilitate the liquidation and winding up
of the Company if an initial business combination is not consummated within 15 months, which is extendable at the Sponsor&#8217;s option
up to three months, as described in the Registration Statement; and to certain transfer restrictions with respect to the Company&#8217;s
securities.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The above descriptions are qualified in their
entirety by reference to the full text of the applicable agreement, each of which is incorporated by reference herein and attached hereto
as Exhibits 1.1, 4.1, 4.2, 4.3, 10.1, 10.2, 10.3, 10.4, 10.5, and 10.6, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 3.02</b></td><td><b>Unregistered Sales of Equity Securities.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Simultaneous with the consummation of the IPO and
the issuance and sale of the Units, the Company consummated the private placement of 13,350,000 Private Placement Warrants at a price
of $1.00 per Private Placement Warrant, generating total proceeds of $13,350,000 (the &#8220;Private Placement&#8221;). The Private Placement
Warrants, which were purchased by the Sponsor, are substantially similar to the Public Warrants, except that if held by the Sponsor or
its permitted transferees, they (i)&#160;may be exercised for cash or on a cashless basis, (ii)&#160;are not subject to being called for
redemption under certain redemption scenarios and (iii)&#160;subject to certain limited exceptions, will be subject to transfer restrictions
until 30 days following the consummation of the Company&#8217;s initial business combination. If the Private Placement Warrants are held
by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company under
all redemption scenarios and exercisable by holders on the same basis as the Public Warrants. The Private Placement Warrants have been
issued pursuant to and are governed by the Private Warrant Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 5.03</b></td><td><b>Amendments to Certificate of Incorporation or Bylaws.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October&#160;12, 2022, in connection with the
IPO, the Company amended and restated its Memorandum and Articles of Association. On October&#160;13, 2022, in connection with the IPO,
the Company filed its Amended and Restated Memorandum and Articles of Association with the Cayman Islands Registrar. The terms of the
Amended and Restated Memorandum and Articles of Association are set forth in the Registration Statement and are incorporated herein by
reference. A copy of the Company&#8217;s Amended and Restated Memorandum and Articles of Association is attached as Exhibit&#160;3.1 hereto
and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 8.01</b></td><td><b>Other Events.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A total of $237,750,000, comprised of proceeds
from the IPO and the sale of the Private Placement Warrants, was placed in a U.S.-based trust account at Morgan Stanley&#160;&amp; Co.
LLC. maintained by CST, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released
to the Company to pay its taxes, if any, the funds held in the trust account will not be released from the trust account until the earliest
to occur of: (1)&#160;to the Company, until the completion of its initial business combination, or (2)&#160;to the Company&#8217;s public
shareholders, until the earliest of (a)&#160;the completion of its initial business combination, and then only in connection with those
Class&#160;A ordinary shares that such shareholders properly elected to redeem, (b)&#160;the redemption of any public shares properly
tendered in connection with a shareholder vote to amend the Company&#8217;s amended and restated memorandum and articles of association
(A)&#160;to modify the substance or timing of the Company&#8217;s obligation to provide holders of the Company&#8217;s Class&#160;A ordinary
shares the right to have their shares redeemed in connection with the Company&#8217;s initial business combination or to redeem 100% of
the Company&#8217;s public shares if we do not complete the Company&#8217;s initial business combination within 15 months (or up to 18
months if the Company extends the period of time to consummate a business combination) or (B)&#160;with respect to any other provision
relating to the rights of holders of the Company&#8217;s Class&#160;A ordinary shares, and (c)&#160;the redemption of the Company&#8217;s
public shares if the Company has not consummated the Company&#8217;s business combination within 15 months (or up to 18 months if the
Company extends the period of time to consummate a business combination) from the closing of the initial public offering, subject to applicable
law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"></td><td style="width: 1in; text-align: left"><b>9.01.</b></td><td style="text-align: justify"><b>Financial Statements and Exhibits.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%; padding-left: 5.4pt"><a href="tm216731d39_ex1-1.htm">1.1</a></td>
    <td style="width: 89%"><a href="tm216731d39_ex1-1.htm">Underwriting Agreement, dated as of October&#160;12, 2022, among the Company and Citigroup Global Markets Inc. and Guggenheim Securities, LLC, as representatives of the several underwriters</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex3-1.htm">3.1</a></td>
    <td><a href="tm216731d39_ex3-1.htm">Amended and Restated Memorandum and Articles of Association of the Company</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex4-1.htm">4.1</a></td>
    <td><a href="tm216731d39_ex4-1.htm">Public Warrant Agreement, dated October&#160;12, 2022, between the Company and CST</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex4-2.htm">4.2</a></td>
    <td><a href="tm216731d39_ex4-2.htm">Private Warrant Agreement, dated October&#160;12, 2022, between the Company and CST</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex4-3.htm">4.3</a></td>
    <td><a href="tm216731d39_ex4-3.htm">Rights Agreement, dated October&#160;12, 2022, between the Company and CST</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex10-1.htm">10.1</a></td>
    <td><a href="tm216731d39_ex10-1.htm">Investment Management Trust Agreement, dated October&#160;12, 2022, between the Company and CST</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex10-2.htm">10.2</a></td>
    <td><a href="tm216731d39_ex10-2.htm">Registration and Shareholder Rights Agreement, dated October&#160;12, 2022, among the Company and the Sponsor</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex10-3.htm">10.3</a></td>
    <td><a href="tm216731d39_ex10-3.htm">Private Placement Warrants Purchase Agreement, dated October&#160;12, 2022, between the Company and the Sponsor</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex10-4.htm">10.4</a></td>
    <td><a href="tm216731d39_ex10-4.htm">Indemnity Agreement, dated October&#160;12, 2022, by and between the Company and each of the officers and directors of the Company</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex10-5.htm">10.5</a></td>
    <td><a href="tm216731d39_ex10-5.htm">Administrative Services Agreement, dated October&#160;12, 2022, by and between the Company and the Sponsor</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt"><a href="tm216731d39_ex10-6.htm">10.6</a></td>
    <td><a href="tm216731d39_ex10-6.htm">Letter Agreement, dated October&#160;12, 2022, by and between the Company, the Sponsor and each of the officers and directors of the Company</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 5.4pt">104</td>
    <td>Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: October&#160;17, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">SPRING VALLEY ACQUISITION CORP.
    II</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-size: 10pt">/s/ Robert Kaplan&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Robert Kaplan&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Chief Financial Officer and Vice President of
    Business Development</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm216731d39_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 1.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Execution Version</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Spring
Valley ACQUISITION Corp. II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">20,000,000 Units</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Underwriting Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 456pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October&nbsp;</FONT><FONT STYLE="font-size: 10pt">12,
2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Citigroup Global
Markets Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Guggenheim Securities,
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As Representatives
of the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">several Underwriters
listed</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">in Schedule 1 hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c/o Citigroup Global
Markets Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">388 Greenwich Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">New York, New York
10013</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c/o Guggenheim Securities,
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">330 Madison Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">New York, New York
10017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Ladies and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Spring Valley Acquisition
Corp. II, a Cayman Islands exempted company (the &ldquo;<U>Company</U>&rdquo;), proposes to issue and sell to the several underwriters
listed in Schedule 1 hereto (collectively, the &ldquo;<U>Underwriters</U>&rdquo;), for whom you are acting as representatives (collectively,
the &ldquo;<U>Representatives</U>&rdquo;), an aggregate of 20,000,000 units of the Company (the &ldquo;<U>Underwritten Units</U>&rdquo;)
and, at the option of the Underwriters, up to an additional 3,000,000 units of the Company (the &ldquo;<U>Option Units</U>&rdquo;). The
Underwritten Units and the Option Units are herein referred to as the &ldquo;<U>Units</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Unit consists of one Class&nbsp;A ordinary share of the Company, par value $0.0001 per share (collectively, the &ldquo;<U>Ordinary Shares</U>&rdquo;),
</FONT><FONT STYLE="font-size: 10pt">one right (the &ldquo;<U>Rights</U>&rdquo;) to receive one-tenth (1/10) of one Ordinary Share upon
the consummation of an initial Business Combination (as defined below) and one-half of one redeemable warrant, where each whole warrant
entitles the holder to purchase one Ordinary Share (the &ldquo;<U>Warrant(s)</U>&rdquo;). The Ordinary Shares, Rights and the Warrants
included in the Units will not trade separately until the 52nd day following the date of the Prospectus (as defined below) (or if such
date is not a business day (as defined below), the following business day) (unless the Representatives inform the Company of their decision
to allow earlier separate trading), subject to (a)&nbsp;the Company&rsquo;s filing of a Current Report on Form&nbsp;8-K that includes
an audited balance sheet reflecting the receipt by the Company of the proceeds of the Offering (as defined below) and the sale of the
Private Placement Warrants (as defined below) with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) and (b)&nbsp;the
Company having issued a press release announcing when such separate trading will begin. Each holder of a Right will receive one-tenth
(1/10) of one Ordinary Share upon consummation of the initial Business Combination. As a result, each holder must have 10 Rights in order
to receive one Ordinary Share at the closing of the initial Business Combination. No fractional Rights or Warrants will be issued upon
separation of the Units, and only whole Rights or Warrants will trade. Each whole Warrant entitles its holder, upon exercise, to purchase
one Ordinary Share at a price of $11.50 per share, subject to certain adjustments as described in the Public Warrant Agreement (as defined
below), during the period commencing on the later of thirty days after the completion of the Company&rsquo;s initial Business Combination
(as defined below) and twelve months from the date of the consummation of the Offering and terminating on the five-year anniversary of
the date of the completion of such initial Business Combination or earlier upon redemption or Liquidation (as defined below); <U>provided</U>,
<U>however</U>, that pursuant to the Public Warrant Agreement, a fractional Warrant may not be exercised, so that only a whole Warrant
may be exercised at any given time by a holder thereof. As used herein, the term &ldquo;Business Combination&rdquo; (as described more
fully in the Prospectus) shall mean a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination
with one or more businesses or entities involving the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into an Investment Management Trust Agreement, effective as of the date hereof (the &ldquo;<U>Trust Agreement</U>&rdquo;), with
Continental Stock Transfer&nbsp;&amp; Trust Company (&ldquo;<U>CST</U>&rdquo;), as trustee (the &ldquo;<U>Trustee</U>&rdquo;), in substantially
the form filed as Exhibit&nbsp;10.1 to the Registration Statement (as defined below), pursuant to which proceeds from the sale of the
Private Placement Warrants from time to time and proceeds of the Offering will be deposited and held in a trust account (the &ldquo;<U>Trust
Account</U>&rdquo;) for the benefit of the Company, the Underwriters and the Public Shareholders (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into a Public Warrant Agreement, effective as of the date hereof (the &ldquo;<U>Public Warrant Agreement</U>&rdquo;), with respect
to the Warrants with CST, as warrant agent, in substantially the form filed as Exhibit&nbsp;4.4 to the Registration Statement, pursuant
to which CST will act as warrant agent in connection with the issuance, registration, transfer, exchange, redemption, and exercise of
the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Company has entered into a Private Warrant Agreement, effective as of the date hereof, with respect to the Private Placement Warrants,
certain warrants that may be issued to the Company&rsquo;s executive officers or directors, the Sponsor or its affiliates upon conversion
of working capital loans made to the Company (the &ldquo;<U>Working Capital Warrants</U>&rdquo;) and certain warrants that may be issued
upon conversion of loans made in connection with extending the period of time to consummate a business combination (the &ldquo;<U>Extension
Warrants</U>&rdquo;), with CST, as warrant agent, in substantially the form filed as Exhibit&nbsp;4.5 to the Registration Statement (the
 &ldquo;<U>Private Warrant Agreement</U>&rdquo; and, together with the Public Warrant Agreement, the &ldquo;<U>Warrant Agreements</U>&rdquo;),
pursuant to which CST will act as warrant agent in connection with the issuance, registration, transfer, exchange, redemption and exercise
of the Private Placement Warrants, the Working Capital Warrants and the Extension Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into a Securities Subscription Agreement, dated as of January&nbsp;26, 2021 (the &ldquo;<U>Securities Subscription Agreement</U>&rdquo;),
with Spring Valley Acquisition Sponsor II, LLC, a Delaware limited liability company (the &ldquo;<U>Sponsor</U>&rdquo;), pursuant to
which the Sponsor purchased an aggregate of 5,750,000 shares of the Company&rsquo;s Class&nbsp;B ordinary shares, par value $0.0001 per
share, for an aggregate purchase price of $25,000 in substantially the form filed as Exhibit&nbsp;10.7 to the Registration Statement.
In March&nbsp;2022, the Company effected a share capitalization with respect to its Class&nbsp;B ordinary shares of 1,916,667 shares
thereof, so that the Sponsor owns an aggregate of 7,666,667 shares of the Company&rsquo;s Class&nbsp;B ordinary shares (the &ldquo;<U>Founder
Shares</U>&rdquo;). Up to 1,000,000 Founder Shares are subject to forfeiture depending on the extent to which the Underwriters&rsquo;
over-allotment option is exercised. The Founder Shares are substantially similar to the Ordinary Shares included in the Units, except
as described in the Registration Statement, the Pricing Disclosure Package (as defined below) and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into a Private Placement Warrants Purchase Agreement, effective as of the date hereof (the &ldquo;<U>Private Placement Warrants
Purchase Agreement</U>&rdquo;), with the Sponsor, in substantially the form filed as Exhibit&nbsp;10.3 to the Registration Statement,
pursuant to which the Sponsor agreed to purchase an aggregate of 12,000,000 warrants (or up to 13,350,000 warrants if the over-allotment
option is exercised in full), each warrant entitling its holder, upon exercise, to purchase one Ordinary Share (the &ldquo;<U>Private
Placement Warrants</U>&rdquo;), for $1.00 per Private Placement Warrant. The Private Placement Warrants are substantially similar to
the Warrants included in the Units, except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into a Registration and Shareholder Rights Agreement, dated as of the date hereof (the &ldquo;<U>Registration and Shareholder
Rights Agreement</U>&rdquo;), with the Sponsor and the other parties thereto, in substantially the form filed as Exhibit&nbsp;10.2 to
the Registration Statement, pursuant to which the Company has granted certain registration rights in respect of the Private Placement
Warrants and the Ordinary Shares underlying the Private Placement Warrants, the Founder Shares, Working Capital Warrants and Extension
Warrants, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into a letter agreement, dated as of the date hereof, in substantially the form filed as Exhibit&nbsp;10.8 to the Registration
Statement (the &ldquo;<U>Insider Letter</U>&rdquo;), with the Sponsor and each of the Company&rsquo;s officers, directors and director
nominees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into an Indemnity Agreement, dated as of the date hereof, in substantially the form filed as Exhibit&nbsp;10.4 to the Registration
Statement (the &ldquo;<U>Indemnity Agreement</U>&rdquo;) with the Company and each of the Company&rsquo;s officers, directors and director
nominees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into a Rights Agreement, dated as of the date hereof, in substantially the form filed as Exhibit&nbsp;4.6 to the Registration
Statement (the &ldquo;<U>Rights Agreement</U>&rdquo;) with CST, pursuant to which CST will act as rights agent in connection with the
issuance, registration, transfer, exchange, redemption and exercise of the Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company has
entered into an Administrative Services Agreement, dated as of the date hereof (the &ldquo;<U>Administrative Services Agreement</U>&rdquo;
and, collectively with this Agreement (as defined below), the Trust Agreement, the Warrant Agreements, the Securities Subscription Agreement,
the Private Placement Warrants Purchase Agreement, the Registration and Shareholder Rights Agreement, the Insider Letter, the Indemnity
Agreement and the Rights Agreement, the &ldquo;<U>Transaction Documents</U>&rdquo;), with the Sponsor, in substantially the form filed
as Exhibit&nbsp;10.5 to the Registration Statement, pursuant to which the Company will, subject to the terms of the Administrative Services
Agreement, pay to an affiliate of the Sponsor, an aggregate monthly fee of $10,000 for office space, utilities, administrative and support
services from the date that the Units are first listed on The Nasdaq Capital Market (&ldquo;<U>Nasdaq</U>&rdquo;) until the earlier of
(x)&nbsp;the consummation of an initial Business Combination and (y)&nbsp;the Liquidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
January&nbsp;26, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Offering
pursuant to a non-interest bearing promissory note, which was amended and restated on January&nbsp;28, 2022, and amended and restated
a second time on September&nbsp;26, 2022 (as amended, the &ldquo;<U>Promissory Note</U>&rdquo;), in substantially the form filed as Exhibit&nbsp;10.6
to the Registration Statement. The Promissory Note will be payable on the earliest to occur of the date of the consummation of the Offering
or September&nbsp;30, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Company hereby
confirms its agreement with the several Underwriters concerning the purchase and sale of the Units, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Statement</U>. The Company has prepared and filed with the Commission under the Securities Act of 1933, as amended, and the rules&nbsp;and
regulations of the Commission thereunder (collectively, the &ldquo;<U>Securities Act</U>&rdquo;), a registration statement (File No.&nbsp;333-253156),
including a prospectus, relating to the Units, the Rights and the Warrants and Ordinary Shares included therein. Such registration statement,
as amended at the time it became effective, including the information, if any, deemed pursuant to Rule&nbsp;430A under the Securities
Act to be part of the registration statement at the time of its effectiveness (&ldquo;<U>Rule&nbsp;430 Information</U>&rdquo;), is referred
to herein as the &ldquo;Registration Statement&rdquo;; and as used herein, the term &ldquo;<U>Preliminary Prospectus</U>&rdquo; means
each prospectus included in such registration statement (and any amendments thereto) before effectiveness, any prospectus filed with
the Commission pursuant to Rule&nbsp;424(a)&nbsp;under the Securities Act and the prospectus included in the Registration Statement at
the time of its effectiveness that omits Rule&nbsp;430 Information, and the term &ldquo;Prospectus&rdquo; means the prospectus in the
form first used (or made available upon request of purchasers pursuant to Rule&nbsp;173 under the Securities Act) in connection with
confirmation of sales of the Units. If the Company has filed an abbreviated registration statement pursuant to Rule&nbsp;462(b)&nbsp;under
the Securities Act (the &ldquo;<U>Rule&nbsp;462 Registration Statement</U>&rdquo;), then any reference herein to the term &ldquo;Registration
Statement&rdquo; shall be deemed to include such Rule&nbsp;462 Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">At or prior to the
Applicable Time (as defined below), the Company had prepared the following information (collectively with the pricing information set
forth on Annex A, the &ldquo;<U>Pricing Disclosure Package</U>&rdquo;): a Preliminary Prospectus dated September&nbsp;26, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;Applicable
Time&rdquo; means 4:45 P.M., New York City time, on October&nbsp;12, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchase
of the Units</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company agrees to issue and sell the Underwritten Units to the several Underwriters as provided in this underwriting agreement (this
 &ldquo;<U>Agreement</U>&rdquo;), and each Underwriter, on the basis of the representations, warranties and agreements set forth herein
and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase at a price per Unit of $9.80 (the &ldquo;<U>Purchase
Price</U>&rdquo;) from the Company the respective number of Underwritten Units set forth opposite such Underwriter&rsquo;s name in Schedule
1 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
addition, the Company agrees to issue and sell the Option Units to the several Underwriters as provided in this Agreement, and the Underwriters,
on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall
have the option to purchase, severally and not jointly, from the Company the Option Units at a price per Unit of $9.80 less an amount
per unit equal to any dividends or distributions declared by the Company and payable on the Underwritten Units but not payable on the
Option Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If any Option Units
are to be purchased, the number of Option Units to be purchased by each Underwriter shall be the number of Option Units which bears the
same ratio to the aggregate number of Option Units being purchased as the number of Underwritten Units set forth opposite the name of
such Underwriter in Schedule 1 hereto (or such number increased as set forth in Section&nbsp;10 hereof) bears to the aggregate number
of Underwritten Units being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate
any fractional Units as the Representatives in their sole discretion shall make.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The Underwriters
may exercise the option to purchase Option Units at any time in whole, or from time to time in part, on or before the 45<SUP>th</SUP>
day following the date of the Prospectus, by written notice from the Representatives to the Company. Such notice shall set forth the
aggregate number of Option Units as to which the option is being exercised and the date and time when the Option Units are to be delivered
and paid for, which may be the same date and time as the Closing Date (as defined below) but shall not be earlier than the Closing Date
nor later than the 10<SUP>th</SUP> full business day after the date of such notice (unless such time and date are postponed in accordance
with the provisions of Section&nbsp;10 hereof). Any such notice shall be given at least two business days prior to the date and time
of delivery specified therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
addition to the discount from the public offering price represented by the Purchase Price, the Company hereby agrees to pay to the Underwriters
a deferred discount of $0.350 per Unit (including both Underwritten Units and Option Units) purchased hereunder (the &ldquo;<U>Deferred
Discount</U>&rdquo;). The Deferred Discount will be paid directly to the Representatives, on behalf of the Underwriters, by the Trustee
from amounts on deposit in the Trust Account (without accrued interest) by wire transfer payable in same-day funds if and when the Company
consummates an initial Business Combination. The Underwriters hereby agree that if no Business Combination is consummated within the
time period provided in the Company&rsquo;s amended and restated memorandum and articles of association (the &ldquo;<U>Charter</U>&rdquo;),
as such time period may be extended, and the funds held under the Trust Agreement are distributed to the holders of the Ordinary Shares
included in the Units sold pursuant to this Agreement (the &ldquo;<U>Public Shareholders</U>&rdquo;), (i)&nbsp;the Underwriters will
forfeit any rights or claims to the Deferred Discount and (ii)&nbsp;the Trustee is authorized to distribute the Deferred Discount to
the Public Shareholders on a pro rata basis. For the avoidance of doubt, the obligations of each Underwriter under this agreement shall
be fully satisfied upon the payment of the purchase price for the Offered Securities purchased by such Underwriter on the Closing Date
or the Additional Closing Date without any further conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company understands that the Underwriters intend to make a public offering of the Units (the &ldquo;<U>Offering</U>&rdquo;), and initially
to offer the Units on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters
may offer and sell Units to or through any affiliate of an Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Payment
for the Units shall be made by wire transfer in immediately available funds to the account specified by the Company to the Representatives
in the case of the Underwritten Units, at the offices of Shearman&nbsp;&amp; Sterling LLP, 599 Lexington Avenue, New York, New York 10022
at 10:00 A.M.&nbsp;New York City time on October&nbsp;17, 2022 or at such other time or place on the same or such other date, not later
than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing or, in the case of the Option
Units, on the date and at the time and place specified by the Representatives in the written notice of the Underwriters&rsquo; election
to purchase such Option Units. The Company shall not be obligated to sell or deliver any of the Underwritten Units, except upon tender
of payment by the Representatives for all Underwritten Units. The time and date of such payment for the Underwritten Units is referred
to herein as the &ldquo;Closing Date,&rdquo; and the time and date for such payment for the Option Units, if other than the Closing Date,
is herein referred to as the &ldquo;Additional Closing Date.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Payment for the
Units to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Representatives
for the respective accounts of the several Underwriters of the Units to be purchased on such date in definitive or book-entry form registered
in such names and in such denominations as the Representatives shall request in writing not later than two full business days prior to
the Closing Date or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection with the sale of such
Units duly paid by the Company. Delivery of the Units shall be made through the facilities of The Depository Trust Company unless the
Representatives shall otherwise instruct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company acknowledges and agrees that the Representatives and the other Underwriters are acting solely in the capacity of an arm&rsquo;s
length contractual counterparty to the Company with respect to the Offering contemplated hereby (including in connection with determining
the terms of the Offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally,
neither the Representatives nor any other Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting
or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible
for making its own independent investigation and appraisal of the transactions contemplated hereby, and neither the Representatives nor
the other Underwriters shall have any responsibility or liability to the Company with respect thereto. Any review by the Representatives
and the other Underwriters of the Company, the transactions contemplated hereby or other matters relating to such transactions will be
performed solely for the benefit of the Underwriters and shall not be on behalf of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties of the Company</U>. The Company represents and warrants to each Underwriter that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Preliminary
Prospectus.</I> No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary
Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the Securities
Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state
a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in
reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use in any Preliminary Prospectus, it being understood and agreed that the only such information
furnished by any Underwriter consists of the information described as such in Section&nbsp;7(b)&nbsp;hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Pricing
Disclosure Package</I>. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of the Additional
Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>
that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity
with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly
for use in such Pricing Disclosure Package, it being understood and agreed that the only such information furnished by any Underwriter
consists of the information described as such in Section&nbsp;7(b)&nbsp;hereof. No statement of material fact included in the Prospectus
has been omitted from the Pricing Disclosure Package and no statement of material fact included in the Pricing Disclosure Package that
is required to be included in the Prospectus has been omitted therefrom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Issuer
Free Writing Prospectus. </I>Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including
its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved
or referred to and will not prepare, make, use, authorize, approve or refer to any &ldquo;written communication&rdquo; (as defined in
Rule&nbsp;405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Units other than any
document not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a)&nbsp;of the Securities Act or Rule&nbsp;134 under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Form&nbsp;8-A</I>.
The Company has filed with the Commission a Form&nbsp;8-A (File No.&nbsp;001-41529), including an amendment thereto, providing for the
registration under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), of the Units, the Ordinary
Shares, the Rights and the Warrants, which registration is currently effective on the date hereof. The Units and the Ordinary Shares,
the Rights and the Warrants included as part of the Units have been authorized for listing, subject to official notice of issuance and
evidence of satisfactory distribution, on Nasdaq, and the Company knows of no reason or set of facts that is likely to adversely affect
such authorization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Emerging
Growth Company</I>. From the time of the initial confidential submission of the Registration Statement to the Commission (or, if earlier,
the first date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters
Communication) through the date hereof, the Company has been and is an &ldquo;emerging growth company,&rdquo; as defined in Section&nbsp;2(a)&nbsp;of
the Securities Act (an &ldquo;<U>Emerging Growth Company</U>&rdquo;). &ldquo;Testing-the-Waters Communication&rdquo; means any oral or
written communication with potential investors undertaken in reliance on Section&nbsp;5(d)&nbsp;of the Securities Act or Rule&nbsp;163B
under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Testing-the-Waters
Materials. </I>The Company (i)&nbsp;has not alone engaged in any Testing-the-Waters Communications other than Testing-the-Waters Communications
with the consent of the Representatives with entities that are qualified institutional buyers within the meaning of Rule&nbsp;144A under
the Securities Act or institutions that are accredited investors within the meaning of Rule&nbsp;501 under the Securities Act and (ii)&nbsp;has
not authorized anyone other than the Underwriters to engage in Testing-the-Waters Communications. The Company reconfirms that the Underwriters
have been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has not distributed or approved
for distribution any Written Testing-the-Waters Communications other than those listed on Annex B hereto. &ldquo;Written Testing-the-Waters
Communication&rdquo; means any Testing-the-Waters Communication that is a written communication within the meaning of Rule&nbsp;405 under
the Securities Act. Any individual Written Testing-the-Waters Communication does not conflict with the information contained in the Registration
Statement or the Pricing Disclosure Package, complied in all material respects with the Securities Act, and when taken together with
the Pricing Disclosure Package as of the Applicable Time, did not, and as of the Closing Date and as of the Additional Closing Date,
as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Registration
Statement and Prospectus.</I> The Registration Statement has been declared effective by the Commission. No order suspending the effectiveness
of the Registration Statement has been issued by the Commission, and no proceeding for that purpose or pursuant to Section&nbsp;8A of
the Securities Act against the Company or related to the Offering has been initiated or threatened by the Commission; as of the applicable
effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective
amendment complied and will comply in all material respects with the Securities Act, and did not and will not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein
not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the
Additional Closing Date, as the case may be, the Prospectus will comply in all material respects with the Securities Act and will not
contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or
warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement and
the Prospectus and any amendment or supplement thereto, it being understood and agreed that the only such information furnished by any
Underwriter consists of the information described as such in Section&nbsp;7(b)&nbsp;hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Financial
Statements.</I> The financial statements (including the related notes thereto) of the Company included in the Registration Statement,
the Pricing Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Securities
Act and present fairly the financial position of the Company as of the dates indicated and the results of their operations and the changes
in their cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting
principles (&ldquo;<U>GAAP</U>&rdquo;) in the United States applied on a consistent basis throughout the periods covered thereby, and
any supporting schedules included in the Registration Statement present fairly the information required to be stated therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Off-Balance
Sheet Arrangements</I>. The Company is not party to any off-balance sheet transactions, arrangements, obligations (including contingent
obligations), or other relationships with unconsolidated entities or other persons that may have a material current or future effect
on the Company&rsquo;s financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital
resources, or significant components of revenues or expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No Material Adverse Change.</I> Since the date of the most recent financial statements
of the Company included in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i)&nbsp;there has not
been any change in the capital stock, short-term debt or long-term debt of the Company, or any dividend or distribution of any kind
declared, set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any
development involving a prospective material adverse change, in or affecting the business, properties, management, financial
position, shareholders&rsquo; equity, results of operations or prospects of the Company; (ii)&nbsp;the Company has not entered into
any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company or incurred any
liability or obligation, direct or contingent, that is material to the Company; and (iii)&nbsp;the Company has not sustained any
loss or interference with its business that is material to the Company and that is either from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court
or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Organization
and Good Standing.</I> The Company has been duly organized and is validly existing and in good standing under the laws of its jurisdiction
of organization, is duly qualified to do business and is in good standing in each jurisdiction in which its ownership or lease of property
or the conduct of its business requires such qualification, and has all power and authority necessary to own or hold its properties and
to conduct the business in which it is engaged, except where the failure to be so qualified or in good standing or have such power or
authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial
position, shareholders&rsquo; equity, results of operations or prospects of the Company or on the performance by the Company of its obligations
under the Transaction Documents (a &ldquo;<U>Material Adverse Effect</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Capitalization.
</I>The Company has an authorized capitalization as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus
under the heading &ldquo;Capitalization&rdquo;; all the outstanding shares of capital stock of the Company have been duly and validly
authorized and issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar rights; except as described
in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no outstanding
rights (including, without limitation, pre-emptive rights), warrants or options to acquire, or instruments convertible into or exchangeable
for, any shares of capital stock or other equity interest in the Company or any contract, commitment, agreement, understanding or arrangement
of any kind relating to the issuance of any capital stock of the Company, any such convertible or exchangeable securities or any such
rights, warrants or options; the capital stock of the Company conforms in all material respects to the description thereof contained
in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The offers and sales of the outstanding securities
of the Company were at all relevant times either registered under the Securities Act, the applicable state securities and blue sky laws
or, based in part on the representations and warranties of the purchasers of such securities, exempt from such registration requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Prior
Securities Transactions.</I> No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit of,
any person or persons controlling, controlled by, or under common control with the Company from its inception through and including the
date hereof, except as disclosed in the Registration Statement, the Statutory Prospectus or the Prospectus. Neither the Company nor any
of its affiliates has, prior to the date hereof, made any offer or sale of any securities that are required to be &ldquo;integrated&rdquo;
pursuant to the Securities Act with the offer and sale of the Units pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Due
Authorization.</I> The Company has full right, power and authority to execute and deliver this Agreement and the other Transaction Documents
and to perform its obligations hereunder and thereunder; and all action required to be taken for the due and proper authorization, execution
and delivery by it of this Agreement and each of the other Transaction Documents and the consummation by it of the transactions contemplated
hereby and thereby has been duly and validly taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Underwriting
Agreement. </I>This Agreement has been duly authorized, executed and delivered by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Units. </I>The Units to be issued and sold by the Company hereunder have been duly authorized by the Company and, when issued and delivered
and paid for as provided herein, will be duly and validly issued, will constitute valid and legally binding obligations of the Company
enforceable against the Company in accordance with their terms, except as enforceability may be limited by applicable bankruptcy, insolvency
or similar laws affecting the enforcement of creditors&rsquo; rights generally or by equitable principles relating to enforceability
(&ldquo;<U>Enforceability Exceptions</U>&rdquo;), and will conform to the descriptions thereof in the Registration Statement, the Pricing
Disclosure Package and the Prospectus; and the issuance of the Units is not subject to any preemptive or similar rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Unit Shares. </I>The Ordinary Shares included in the Units have been duly authorized by the Company and, when issued and delivered against
payment for the Units by the Underwriters pursuant to this Agreement and the Charter of the Company, will be duly and validly issued
and delivered, will be fully paid and nonassessable, and will conform to the descriptions thereof in the Registration Statement, the
Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Founder Shares</I>. The Founder Shares have been duly authorized, validly issued and fully paid by the Company and are nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Units Warrants. </I>The Warrants included in the Units to be issued and sold by the Company hereunder have been duly authorized by the
Company and, when issued and delivered in the manner set forth in the Public Warrant Agreement against payment for the Units by the Underwriters
pursuant to this Agreement, will be duly and validly issued and delivered, will constitute valid and legally binding obligations of the
Company enforceable against the Company in accordance with their terms, subject to Enforceability Exceptions, and will conform to the
descriptions thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Warrant Shares. </I>The Ordinary Shares issuable upon exercise of the Warrants included in the Units and the Private Placement Warrants
(the &ldquo;<U>Warrant Shares</U>&rdquo;) have been duly authorized by the Company and, when issued and delivered against payment therefor
pursuant to the Warrants and the Private Placement Warrants, as applicable, the Warrant Agreements and the Charter of the Company, will
be duly and validly issued and delivered, will be fully paid and nonassessable; and such Warrant Shares have been duly authorized by
the Company and validly reserved for issuance. The holders of such Warrant Shares will not be subject to personal liability by reason
of being such holders; such Warrant Shares are not, and at the time such shares are issued, will not be subject to any preemptive or
other similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance
and sale of such Warrant Shares (other than such delivery at the time of issuance) has been duly and validly taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Private Placement Warrants. </I>The Private Placement Warrants to be issued and sold by the Company under the Private Placement Warrants
Purchase Agreement have been duly authorized by the Company and, when issued and delivered in the manner set forth in the Private Warrant
Agreement against payment therefor by the Sponsor pursuant to the Private Placement Warrants Purchase Agreement, will be duly and validly
issued and delivered, will constitute valid and legally binding obligations of the Company enforceable against the Company in accordance
with their terms, subject to Enforceability Exceptions, and will conform to the descriptions thereof in the Registration Statement, the
Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Units Rights. </I>The Rights included in the Units to be issued and sold by the Company hereunder have been duly authorized by the Company
and, when issued and delivered in the manner set forth in the Rights Agreement against payment for the Units by the Underwriters pursuant
to this Agreement, will be duly and validly issued and delivered, will constitute valid and legally binding obligations of the Company
enforceable against the Company in accordance with their terms, subject to Enforceability Exceptions, and will conform to the descriptions
thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 5pt">&#8239;</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Rights Shares. </I>The Ordinary Shares issuable upon exercise of the Rights included in the Units (the &ldquo;<U>Rights Shares</U>&rdquo;)
have been duly authorized by the Company and, when issued and delivered against payment therefor pursuant to the Rights, the Rights Agreement
and the Charter of the Company, will be duly and validly issued and delivered, will be fully paid and nonassessable; and such Rights
Shares have been duly authorized by the Company and validly reserved for issuance. The holders of such Rights Shares will not be subject
to personal liability by reason of being such holders; such Rights Shares are not, and at the time such shares are issued, will not be
subject to any preemptive or other similar contractual rights granted by the Company; and all corporate action required to be taken for
the authorization, issuance and sale of such Rights Shares (other than such delivery at the time of issuance) has been duly and validly
taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 7pt">&#8239;</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Trust Agreement. </I>The Trust Agreement has been duly authorized, executed and delivered by the Company and constitutes a valid and
legally binding obligation of the Company enforceable against the Company in accordance with its terms, subject to Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Warrant Agreements. </I>Each Warrant Agreement has been duly authorized, executed and delivered by the Company and constitutes a valid
and legally binding obligation of the Company enforceable against the Company in accordance with its terms, subject to Enforceability
Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Securities Subscription Agreement. </I>The Securities Subscription Agreement has been duly authorized, executed and delivered by the
Company and the Sponsor and constitutes a valid and legally binding obligation of the Company and the Sponsor enforceable against the
Company and the Sponsor in accordance with its terms, subject to Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 5pt">&#8239;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;<I>The
Private Placement Warrants Purchase Agreement. </I>The Private Placement Warrants Purchase Agreement has been duly authorized, executed
and delivered by the Company and the Sponsor and constitutes a valid and legally binding obligation of the Company and the Sponsor enforceable
against the Company and the Sponsor in accordance with its terms, subject to Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Registration and Shareholder Rights Agreement</I>. The Registration and Shareholder Rights Agreement has been duly authorized, executed
and delivered by the Company and constitutes a valid and legally binding obligation of the Company enforceable against the Company in
accordance with its terms, subject to Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 5pt">&#8239;</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;<I>The
Rights Agreement. </I>The Rights Agreement has been duly authorized, executed and delivered by the Company and constitutes a valid and
legally binding obligation of the Company enforceable against the Company in accordance with its terms, subject to Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Insider Letter. </I>The Insider Letter has been duly authorized, executed and delivered by the Company, the Sponsor and, to the Company&rsquo;s
knowledge, each officer, director and director nominee of the Company and constitutes a valid and legally binding obligation of the Company,
the Sponsor and, to the Company&rsquo;s knowledge, each officer, director and director nominee of the Company enforceable against the
Company, the Sponsor and, to the Company&rsquo;s knowledge, each officer, director and director nominee of the Company in accordance
with its terms, subject to Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Indemnity Agreement. </I>The Indemnity Agreement has been duly authorized, executed and delivered by the Company and, to the Company&rsquo;s
knowledge, each officer, director and director nominee of the Company and constitutes a valid and legally binding obligation of the Company
and, to the Company&rsquo;s knowledge, each officer, director and director nominee of the Company enforceable against the Company and,
to the Company&rsquo;s knowledge, each officer, director and director nominee of the Company in accordance with its terms, subject to
Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Administrative Services Agreement. </I>The Administrative Services Agreement has been duly authorized, executed and delivered by the
Company and constitutes a valid and legally binding obligation of the Company enforceable against the Company in accordance with its
terms, subject to Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Descriptions
of the Transaction Documents.</I> Each Transaction Document conforms in all material respects to the description thereof contained in
the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Violation or Default.</I> The Company is not (i)&nbsp;in violation of any provision in its charter or by-laws or similar organizational
documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default,
in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement
or other agreement or instrument to which the Company is a party or by which the Company is bound or to which any property or asset of
the Company is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order, rule&nbsp;or regulation of any court
or arbitrator or governmental or regulatory authority, except, in the case of clauses (ii)&nbsp;and (iii)&nbsp;above, for any such default
or violation that would not, individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Conflicts. </I>The execution, delivery and performance by the Company of each of the Transaction Documents, the issuance and sale of
the Units and the consummation of the transactions contemplated by the Transaction Documents or the Pricing Disclosure Package and the
Prospectus will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default
under, result in the termination, modification or acceleration of, or result in the creation or imposition of any lien, charge or encumbrance
upon any property, right or asset of the Company pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement
or instrument to which the Company is a party or by which the Company is bound or to which any property, right or asset of the Company
is subject, (ii)&nbsp;result in any violation of the provisions of the charter or by-laws or similar organizational documents of the
Company or (iii)&nbsp;result in the violation of any law or statute or any judgment, order, rule&nbsp;or regulation of any court or arbitrator
or governmental or regulatory authority, except, in the case of clauses (i)&nbsp;and (iii)&nbsp;above, for any such conflict, breach,
violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Consents Required.</I> No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or
governmental or regulatory authority is required for the execution, delivery and performance by the Company of each of the Transaction
Documents, the issuance and sale of the Units and the consummation of the transactions contemplated by the Transaction Documents, except
for the registration of the Units and the Ordinary Shares, the Rights and the Warrants included in the Units under the Securities Act
and such consents, approvals, authorizations, orders and registrations or qualifications as may be required by the Financial Industry
Regulatory Authority,&nbsp;Inc. (&ldquo;<U>FINRA</U>&rdquo;) and under applicable state securities laws in connection with the purchase
and distribution of the Units by the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Legal
Proceedings.</I> There are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries
or proceedings (&ldquo;<U>Actions</U>&rdquo;) pending to which the Company is or may be a party or to which any property of the Company
is or may be the subject that, individually or in the aggregate, if determined adversely to the Company, could reasonably be expected
to have a Material Adverse Effect; to the knowledge of the Company, no such Actions are threatened or contemplated by any governmental
or regulatory authority or threatened by others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Independent
Accountants</I>. WithumSmith+Brown, PC, who has certified certain financial statements of the Company, is an independent registered public
accounting firm with respect to the Company within the applicable rules&nbsp;and regulations adopted by the Commission and the Public
Company Accounting Oversight Board (United States) and as required by the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Disclosure.
</I>There is no franchise, contract or other document of a character required to be described in the Registration Statement or Prospectus,
or to be filed as an exhibit thereto, which is not described or filed as required (and the Pricing Disclosure Package contains in all
material respects the same description of the foregoing matters contained in the Prospectus); and the statements in the Pricing Disclosure
Package and the Prospectus under the headings &ldquo;Principal Shareholders,&rdquo; &ldquo;Certain Relationships and Related Party Transactions,&rdquo;
 &ldquo;Description of Securities,&rdquo; &ldquo;Underwriting&rdquo; and &ldquo;Taxation&rdquo; insofar as such statements summarize legal
matters, agreements, documents or proceedings discussed therein, are in all material respects accurate and fair summaries of such legal
matters, agreements, documents or proceedings. There are no business relationships or related party transactions involving the Company
or any other person required by the Securities Act to be described in the Registration Statement or Prospectus that have not been described
as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Investment
Company Act</I>. The Company is not and, after giving effect to the offering and sale of the Units and the Private Placement Warrants
and the application of the proceeds thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
will not be required to register as an &ldquo;investment company&rdquo; or an entity &ldquo;controlled&rdquo; by an &ldquo;investment
company&rdquo; within the meaning of the Investment Company Act of 1940, as amended, and the rules&nbsp;and regulations of the Commission
thereunder (collectively, the &ldquo;<U>Investment Company Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Taxes.
</I>The Company has paid all federal, state, local and foreign taxes and filed all tax returns required to be paid or filed through the
date hereof; and except as otherwise disclosed in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus,
there is no tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of its properties
or assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Licenses
and Permits</I>.&nbsp;The Company possesses all licenses, sub-licenses, certificates, permits and other authorizations issued by, and
has made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that
are necessary for the ownership or lease of its properties or the conduct of its business as described in each of the Registration Statement,
the Pricing Disclosure Package and the Prospectus, except where the failure to possess or make the same would not, individually or in
the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Disclosure
Controls</I>. The Company maintains an effective system of &ldquo;disclosure controls and procedures&rdquo; (as defined in Rule&nbsp;13a-15(e)&nbsp;of
the Exchange Act) that complies with the requirements of the Exchange Act to the extent required by Rule&nbsp;13a-15(e)&nbsp;of the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Cybersecurity;
Data Protection</I>. The Company&rsquo;s information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, &ldquo;<U>IT Systems</U>&rdquo;) are adequate for, and operate and perform in all
material respects as required in connection with the operation of the business of the Company as currently conducted. The Company has
implemented and maintained commercially reasonable controls, policies, procedures, and safeguards (including backup and disaster recovery
technology) to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security
of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (&ldquo;<U>Personal
Data</U>&rdquo;)) used in connection with its business, and there have been no breaches, violations, outages or unauthorized uses of
or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person,
nor any incidents under internal review or investigations relating to the same. The Company is presently in material compliance with
all applicable laws or statutes and all judgments, orders, rules&nbsp;and regulations of any court or arbitrator or governmental or regulatory
authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to
the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification, except where the
failure to be in compliance would not, individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Unlawful Payments.</I> Neither the Company, the Sponsor, nor any of their respective directors, director nominees, officers or employees,
nor, to the knowledge of the Company or the Sponsor, any agent, affiliate, representative or other person associated with or acting on
behalf of the Company or the Sponsor has (i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expense relating to political activity; (ii)&nbsp;made or taken an act in furtherance of an offer, promise or authorization
of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned
or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any
of the foregoing, or any political party or party official or candidate for political office; (iii)&nbsp;violated or is in violation
of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the
OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under
the Bribery Act 2010 of the United Kingdom, each as may be amended, or any other applicable anti-bribery or anti-corruption law of any
other relevant jurisdiction, or the rules&nbsp;or regulations thereunder (collectively, the &ldquo;<U>Anti-Corruption Laws</U>&rdquo;);
or (iv)&nbsp;made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including,
without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. No part of the
proceeds of the Offering will be used, directly or indirectly, in violation of the Anti-Corruption Laws. The Company has instituted,
maintains and enforces, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with
all applicable anti-bribery and anti-corruption laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Compliance
with Anti-Money Laundering Laws</I>. The operations of the Company and the Sponsor are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements, including those of the U.S. Bank Secrecy Act, as amended by Title
III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001
(USA PATRIOT Act) and the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes
of all jurisdictions where the Company conducts business, the rules&nbsp;and regulations thereunder and any related or similar rules,
regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &ldquo;<U>Anti-Money Laundering
Laws</U>&rdquo;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or the Sponsor with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company or
the Sponsor, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Conflicts with Sanctions Laws. </I>Neither the Company, the Sponsor, nor any of their respective directors, director nominees, officers
or employees, nor, to the knowledge of the Company or the Sponsor, any agent, affiliate, representative or other person associated with
or acting on behalf of the Company or the Sponsor is, or is controlled or 50% or more owned in the aggregate by or is acting on behalf
of, one or more individuals or entities that are (i)&nbsp;currently the subject or the target of any sanctions administered or enforced
by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury or
the U.S. Department of State or the Bureau of Industry and Security of the U.S. Department of Commerce and including, without limitation,
the designation as a &ldquo;<U>specially designated national</U>&rdquo; or &ldquo;<U>blocked person</U>&rdquo;), the United Nations Security
Council, the European Union, Her Majesty&rsquo;s Treasury or other relevant sanctions authority (collectively, &ldquo;<U>Sanctions</U>&rdquo;),
nor (ii)&nbsp;located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without
limitation, Crimea, Cuba,&nbsp;Iran, North Korea and Syria (each, a &ldquo;<U>Sanctioned Country</U>&rdquo;). The Company will not, directly
or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary,
joint venture partner or other person or entity (i)&nbsp;to fund or facilitate any activities of or business with any person that, at
the time of such funding or facilitation, is the subject or target of Sanctions, (ii)&nbsp;to fund or facilitate any activities of or
business in any Sanctioned Country or (iii)&nbsp;in any other manner that will result in a violation by any person (including any person
participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions. For the past five years, neither
the Company nor the Sponsor has knowingly engaged in and are now knowingly engaged in any dealings or transactions with any person that,
at the time of the dealing or transaction, is or was the subject or the target of Sanctions or with any Sanctioned Country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Registration Rights</I>. No person has the right to require the Company to register any securities for sale under the Securities Act
by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ww)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Compliance
with Nasdaq Rules</I>. There is and has been no failure on the part of the Company or, to the knowledge of the Company, any of the Company&rsquo;s
officers, directors or director nominees, in their capacities as such, to comply with (as and when applicable), and immediately following
the initial effective date of the Registration Statement the Company will be in compliance with, the applicable requirements of Nasdaq
Marketplace Rules. Further, there is and has been no failure on the part of the Company or, to the knowledge of the Company, any of the
Company&rsquo;s officers, directors or director nominees, in their capacities as such, to comply with (as and when applicable), and immediately
following the initial effective date of the Registration Statement the Company will be in compliance with, the phase-in requirements
and all other applicable provisions of Nasdaq corporate governance requirements set forth in the Nasdaq Marketplace Rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Taxes</I>.&nbsp;There
are no transfer, stamp, issue, registration, documentary or other similar taxes, duties, fees or charges under U.S. federal law or the
laws of any state, or any political subdivision thereof, or under the laws of any non-U.S. jurisdiction, required to be paid in connection
with the execution and delivery of this Agreement or the issuance or sale by the Company of the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(yy)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Questionnaires</I>.
All information contained in the questionnaires (the &ldquo;<U>Questionnaires</U>&rdquo;) completed by the Company and the Sponsor and,
to the knowledge of the Company, the Company&rsquo;s officers, directors and director nominees and provided to the Underwriters, is true
and correct and the Company has not become aware of any information that would cause the information disclosed in the Questionnaires
completed by the Company, the Sponsor or the Company&rsquo;s officers, directors and director nominees to become inaccurate and incorrect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(zz)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Acquisition
Target Not Selected</I>. Prior to the date hereof, the Company has not selected any potential Business Combination target and has not,
nor, to its knowledge, has anyone on its behalf, had any substantive discussions, directly or indirectly, with any potential Business
Combination target with respect to a Business Combination with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aaa)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Broker&rsquo;s Fees</I>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there
are no claims, payments, arrangements, contracts, agreements or understandings relating to the payment of a brokerage commission or finder&rsquo;s,
consulting, origination or similar fee by the Company, the Sponsor or any officer, director or director nominee of the Company with respect
to the sale of the Units hereunder or any other arrangements, agreements or understandings of the Company, the Sponsor or any such officer,
director or director nominee of the Company, or their respective affiliates, that may affect the Underwriters&rsquo; compensation, as
determined by the FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bbb)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Direct or Indirect Payments</I>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
the Company has not made any direct or indirect payments (in cash, securities or any other type of &ldquo;underwriting compensation&rdquo;
as defined in Rule&nbsp;5110(j)(22) of FINRA&rsquo;s Conduct Rules): (i)&nbsp;to any person, as a finder&rsquo;s fee, consulting fee
or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided
capital to the Company; (ii)&nbsp;to any person that, to the Company&rsquo;s knowledge, has been accepted by FINRA as a member of FINRA
(a &ldquo;<U>Member</U>&rdquo;); or (iii)&nbsp;to any person or entity that, to the Company&rsquo;s knowledge, has any direct or indirect
affiliation or association with any Member, within the twelve months prior to the initial effective date of the Registration Statement,
other than payments to the Underwriters pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ccc)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Underwriting Compensation</I>. No Member and/or any person associated or affiliated with a Member has received any underwriting compensation
in connection with a public offering that has not been completed according to the terms of an agreement entered into by the Company and
a participating Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ddd)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Investment Banking, Financial Advisory and/or Consulting.</I> During the period beginning 180 days prior to the initial filing of the
Registration Statement and ending on the initial effective date of the Registration Statement, no Member and/or any person associated
or affiliated with a Member has provided any investment banking, financial advisory and/or consulting services to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(eee)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Affiliation
with FINRA</I>. Except as disclosed in the Questionnaires provided to the Representatives, to the Company&rsquo;s knowledge, no officer,
director, director nominee or beneficial owner of 10% or more of any class of the Company&rsquo;s securities (whether debt or equity,
registered or unregistered, regardless of the time acquired or the source from which derived) (any such individual or entity, a &ldquo;<U>Company
Affiliate</U>&rdquo;) is a Member or a person associated or affiliated with a Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(fff)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Ownership
of FINRA Member Securities</I>. Except as disclosed in the Questionnaires provided to the Representatives, to the Company&rsquo;s knowledge,
no Company Affiliate is an owner of stock or other securities of any Member (other than securities purchased on the open market).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ggg)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Subordinated
Loans to FINRA Members</I>. To the Company&rsquo;s knowledge, no Company Affiliate has made a subordinated loan to any Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hhh)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Non</I>-<I>Compete</I>/<I>Non</I>-<I>Solicitation</I>.
Except as described in the Pricing Disclosure Package and the Prospectus, to the Company&rsquo;s knowledge, none of the Sponsor, officers,
directors or director nominees of the Company is subject to a non-competition agreement or non-solicitation agreement with any employer,
prior employer or other entity that could materially affect its, his or her ability to be and act in the capacity of shareholder, officer
or director of the Company, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Related
Party Transactions</I>. No relationship, direct or indirect, exists between or among any of the Company or any affiliate of the Company,
on the one hand, and any director, director nominee, officer, shareholder, special advisor, customer or supplier of the Company or any
affiliate of the Company, on the other hand, which is required by the Securities Act or the Exchange Act to be described in the Registration
Statement, Pricing Disclosure Package or the Prospectus that is not described as required. There are no outstanding loans, advances (except
normal advances for business expenses in the ordinary course of business) or guarantees of indebtedness by the Company to or for the
benefit of any of the officers, directors or director nominees of the Company or any of their respective family members. The Company
has not extended or maintained credit, arranged for the extension of credit, or renewed an extension of credit, in the form of a personal
loan to or for any officer, director or director nominee of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jjj)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Unlawful Influence</I>. The Company has not offered, or caused the Underwriters to offer, the Units to any person or entity with the
intention of unlawfully influencing: (a)&nbsp;a customer or supplier of the Company or any affiliate of the Company to alter the customer&rsquo;s
or supplier&rsquo;s level or type of business with the Company or such affiliate or (b)&nbsp;a journalist or publication to write or
publish favorable information about the Company or any such affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kkk)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Applicability
of Rule&nbsp;419</I>. Upon delivery and payment for the Units on the Closing Date and each Additional Closing Date, the Company will
not be subject to Rule&nbsp;419 under the Securities Act and none of the Company&rsquo;s outstanding securities will be deemed to be
a &ldquo;penny stock&rdquo; as defined in Rule&nbsp;3a51-1 under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(lll)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Absence
of Manipulation</I>. The Company has not taken, directly or indirectly, any action designed to or that would constitute or that might
reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mmm)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Margin
Rules</I>. Neither the issuance, sale and delivery of the Units nor the application of the proceeds thereof by the Company as described
in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board
of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nnn)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Statistical
and Market Data.</I> Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and
market-related data included in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, if any, is not
based on or derived from sources that are reliable and accurate in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ooo)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Sarbanes-Oxley
Act</I>. Solely to the extent that the Sarbanes-Oxley Act of 2002, as amended, and the rules&nbsp;and regulations promulgated by the
Commission thereunder (the &ldquo;<U>Sarbanes-Oxley Act</U>&rdquo;) have been applicable to the Company, there is and has been no failure
on the part of the Company or any of the Company&rsquo;s directors or officers, in their capacities as such, to comply with any provision
of the Sarbanes-Oxley Act, including Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ppp)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Status
under the Securities Act</I>. At the time of filing the Registration Statement and any post-effective amendment thereto the Company was
an &ldquo;ineligible issuer,&rdquo; as defined in Rule&nbsp;405 under the Securities Act solely because of subclause (B)&nbsp;of clause
(ii)&nbsp;of the definition thereof. The Company has paid the registration fee for the Offering pursuant to Rule&nbsp;456 under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qqq)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Ratings</I>. There are (and prior to the Closing Date, will be) no debt securities, convertible securities or preferred stock issued
or guaranteed by the Company that are rated by a &ldquo;nationally recognized statistical rating organization,&rdquo; as such term is
defined in Section&nbsp;3(a)(62) under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rrr)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Company
Ownership of Other Entities</I>. The Company does not own, and since its incorporation has not owned, an interest in any corporation,
partnership, limited liability company, joint venture, trust or other entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(sss)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Payments
in Foreign Currency</I>. Except as described in the Registration Statement, the Pricing Disclosure Package, under current laws and regulations
of the Cayman Islands, all dividends and other distributions declared and payable on the Units may be paid by the Company to the holder
thereof in United States dollars or Cayman Islands dollars that may be converted into foreign currency and freely transferred out of
the Cayman Islands and all such payments made to holders thereof or therein who are non-residents of the Cayman Islands will not be subject
to income, withholding or other taxes under laws and regulations of the Cayman Islands or any taxing authority thereof or therein and
will otherwise be free and clear of any other tax, duty, withholding or deduction in the Cayman Islands or any taxing authority thereof
or therein and without the necessity of obtaining any governmental authorization in the Cayman Islands or any political subdivision thereof
or therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ttt)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
Additional Services by Underwriters. The Company does not have any expectation, understanding or agreement with any Underwriter for such
Underwriter to provide any additional services to the Company after the consummation of the Offering relating to the initial Business
Combination, the financing thereof or other related transactions. Any Underwriter&rsquo;s provision of any such additional services in
connection with the initial Business Combination will require the Company&rsquo;s separate engagement of such Underwriter in connection
with the initial Business Combination and the entry into a related written engagement agreement between such Underwriter and the Company
setting forth the terms and conditions of the additional services to be provided by such Underwriter to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Further
Agreements of the Company</U>. The Company covenants and agrees with each Underwriter that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Required
Filings.</I> The Company will file the final Prospectus with the Commission within the time periods specified by Rule&nbsp;424(b)&nbsp;and
Rule&nbsp;430A under the Securities Act; and the Company will furnish copies of the Prospectus (to the extent not previously delivered)
to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement
in such quantities as the Representatives may reasonably request, unless the Underwriters otherwise consent to a later date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Delivery
of Copies.</I> The Company will deliver, upon request, without charge, (i)&nbsp;to the Representatives, signed copies of the Registration
Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith; and (ii)&nbsp;to
each Underwriter (A)&nbsp;a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits)
and (B)&nbsp;during the Prospectus Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and
supplements thereto) as the Representatives may reasonably request. As used herein, the term &ldquo;Prospectus Delivery Period&rdquo;
means such period of time after the first date of the public offering of the Units as in the opinion of counsel for the Underwriters
a prospectus relating to the Units is required by law to be delivered (or required to be delivered but for Rule&nbsp;172 under the Securities
Act) in connection with sales of the Units by any Underwriter or dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Amendments
or Supplements.</I> Before making, preparing, using, authorizing, approving, referring to or filing any amendment or supplement to the
Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company will furnish to the Representatives and counsel
for the Underwriters a copy of the proposed amendment or supplement for review and will not make, prepare, use, authorize, approve, refer
to or file any such proposed amendment or supplement to which the Representatives reasonably object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Notice
to the Representatives.</I> The Company will advise the Representatives promptly, and confirm such advice in writing, (i)&nbsp;when the
Registration Statement has become effective; (ii)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective;
(iii)&nbsp;when any supplement to the Pricing Disclosure Package, the Prospectus or any Written Testing-the-Waters Communication or any
amendment to the Prospectus has been filed or distributed; (iv)&nbsp;of any request by the Commission for any amendment to the Registration
Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration
Statement or any other request by the Commission for any additional information, including, but not limited to, any request for information
concerning any Testing-the-Waters Communication; (v)&nbsp;of the issuance by the Commission or any other governmental or regulatory authority
of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus,
any of the Pricing Disclosure Package, the Prospectus or any Written Testing-the-Waters Communication or the initiation or threatening
of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (vi)&nbsp;of the occurrence of any event or
development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure Package or any Written
Testing-the-Waters Communication as then amended or supplemented would include any untrue statement of a material fact or omit to state
a material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the
Pricing Disclosure Package or any Written Testing-the-Waters Communication is delivered to a purchaser, not misleading; and (vii)&nbsp;of
the receipt by the Company of any notice with respect to any suspension of the qualification of the Units for offer and sale in any jurisdiction
or the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent
the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary
Prospectus, any of the Pricing Disclosure Package or the Prospectus or any Written Testing-the-Waters Communication or suspending any
such qualification of the Units and, if any such order is issued, will obtain as soon as possible the withdrawal thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Ongoing
Compliance.</I> (1)&nbsp;If during the Prospectus Delivery Period (i)&nbsp;any event or development shall occur or condition shall exist
as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus
is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the
Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the
Commission and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments or supplements to
the Prospectus as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the
circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with law
and (2)&nbsp;if at any time prior to the Closing Date (i)&nbsp;any event or development shall occur or condition shall exist as a result
of which the Pricing Disclosure Package as then amended or supplemented would include any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Pricing
Disclosure Package is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Pricing Disclosure
Package to comply with law, the Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph
(c)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives
may designate such amendments or supplements to the Pricing Disclosure Package as may be necessary so that the statements in the Pricing
Disclosure Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package
is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Blue
Sky Compliance.</I> The Company will qualify the Units for offer and sale under the securities or Blue Sky laws of such jurisdictions
as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for distribution
of the Units; <U>provided</U> that the Company shall not be required to (i)&nbsp;qualify as a foreign corporation or other entity or
as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii)&nbsp;file any general
consent to service of process in any such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not
otherwise so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Earning
Statement. </I>The Company will make generally available to its security holders and the Representatives as soon as practicable an earning
statement that satisfies the provisions of Section&nbsp;11(a)&nbsp;of the Securities Act and Rule&nbsp;158 of the Commission promulgated
thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &ldquo;effective
date&rdquo; (as defined in Rule&nbsp;158) of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Clear
Market.</I> For a period of 180 days after the date of the Prospectus, the Company will not (i)&nbsp;offer, pledge, sell, contract to
sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement
under the Securities Act relating to, any Units, Ordinary Shares, Founder Shares, Rights, Warrants or any securities convertible into
or exercisable or exchangeable for any Units, Ordinary Shares, Founder Shares, Rights or Warrants, (ii)&nbsp;enter into any swap or other
arrangement that transfers, in whole or in part, any of the economic consequences of ownership of any Units, Ordinary Shares, Founder
Shares, Rights or Warrants or any such other securities, whether any such transaction described in clause (i)&nbsp;or (ii)&nbsp;above
is to be settled by delivery of Units or such other securities, in cash or otherwise or (iii)&nbsp;publicly disclose the intention to
undertake any of the foregoing, without the prior written consent of Citigroup Global Markets Inc., except, in each case, that the Company
may (a)&nbsp;issue and sell the Private Placement Warrants, (b)&nbsp;issue and sell the Option Units upon exercise of the option provided
for in Section&nbsp;2(b)&nbsp;hereof, (c)&nbsp;register with the Commission pursuant to the Registration and Shareholder Rights Agreement,
in accordance with the terms of the Registration and Shareholder Rights Agreement, the resale of the Founder Shares, the Private Placement
Warrants and warrants that may be issued upon conversion of working capital loans (and any Ordinary Shares issued or issuable upon the
exercise of any such Private Placement Warrants or warrants issued upon conversion of the working capital loans and upon conversion of
the Founder Shares), and (d)&nbsp;issue securities in connection with a Business Combination;&nbsp;<U>provided</U> that the foregoing
restrictions shall not apply to the forfeiture of any Founder Shares pursuant to their terms or any transfer of Founder Shares to any
current or future independent director of the Company (as long as such current or future independent director is subject to the terms
of the Insider Letter with respect to such Founder Shares at the time of such transfer; and as long as, to the extent any Section&nbsp;16
of the Exchange Act reporting obligation is triggered as a result of such transfer, any related Section&nbsp;16 of the Exchange Act filing
includes a practical explanation of the transfer).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agrees not to amend Section&nbsp;5 (Lock-up: Transfer Restrictions) of the Insider Letter without the written consent of </FONT><FONT STYLE="font-size: 10pt">Citigroup
Global Markets Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Use
of Proceeds.</I> The Company will apply the net proceeds from the sale of the Private Placement Warrants received by it in a manner materially
consistent with the applications described under the caption &ldquo;Use of Proceeds&rdquo; in the Pricing Disclosure Package and the
Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Use
of Free Writing Prospectus</I>. The Company agrees that it will not make any offer relating to the Units that would constitute an Issuer
Free Writing Prospectus or that would otherwise constitute a &ldquo;free writing prospectus&rdquo; (as defined in Rule&nbsp;405) required
to be filed by the Company with the Commission or retained by the Company under Rule&nbsp;433.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Stabilization.</I>&nbsp;Neither the Company nor its affiliates will take, directly or indirectly, any action designed to or that could
reasonably be expected to cause or result in any stabilization or manipulation of the price of the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Exchange
Listing.</I> The Company will use its reasonable best efforts to list, subject to notice of issuance, the Units, the Ordinary Shares,
the Rights and the Warrants on the Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Reports.
</I>For a period commencing on the initial effective date of the Registration Statement and ending five years from the date of the consummation
of the Business Combination or until such earlier time at which the Liquidation occurs, the Company shall, to the extent such information
or documents are not otherwise publicly available, upon written request from the Representatives, furnish to the Representatives copies
of such financial statements and other periodic and special reports as the Company from time to time furnishes generally to holders of
any class of securities, and, to the extent such information or documents are not otherwise publicly available, upon written request
from the Representatives, promptly furnish to the Representatives: (i)&nbsp;a copy of such registration statements, financial statements
and periodic and special reports as the Company shall be required to file with the Commission and from time to time furnishes generally
to holders of any such class of its securities in their capacities as such; and (ii)&nbsp;such additional documents and information with
respect to the Company and the affairs of any future subsidiaries of the Company as the Representatives may from time to time reasonably
request, all subject to the execution of a satisfactory confidentiality agreement. Any registration statements, financial statements,
periodic and special reports or other additional documents referred to in the preceding sentence filed or furnished on the Commission&rsquo;s
EDGAR website and publicly available will be considered furnished for the purposes of this Section&nbsp;4(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Filings.
</I>The Company will file with the Commission such reports as may be required by Rule&nbsp;463 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Emerging
Growth Company</I>. The Company will promptly notify the Representatives if the Company ceases to be an Emerging Growth Company at any
time prior to the later of (i)&nbsp;completion of the distribution of Units within the meaning of the Securities Act and (ii)&nbsp;completion
of the 180-day restricted period referred to in Section&nbsp;4(h)&nbsp;hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Exchange
Act Registration</I>. For a period commencing on the initial effective date of the Registration Statement and ending five years from
the date of the consummation of the Business Combination or until such earlier time at which the Liquidation occurs, the Company will
use commercially reasonable efforts to maintain the registration of the Ordinary Shares (or such other security into which such Ordinary
Share may be exchanged in connection with a Business Combination) under the provisions of the Exchange Act, except after giving effect
to a going private transaction after the completion of an initial Business Combination. For a period commencing on the initial effective
date of the Registration Statement and ending upon the consummation of the Business Combination or until such earlier time at which the
Liquidation occurs, the Company will use commercially reasonable efforts to maintain the registration of the Units, Rights and Warrants
under the provisions of the Exchange Act.&nbsp;During such applicable period, the Company will not deregister the Units, Ordinary Shares,
the Rights or Warrants under the Exchange Act (except in connection with an exchange pursuant to a Business Combination or a going private
transaction after the completion of an initial Business Combination) without the prior written consent of the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Current
Report on Form&nbsp;8-K</I>. The Company shall, on or before the date hereof, retain its independent registered public accounting firm
to audit the balance sheet of the Company as of the Closing Date (the &ldquo;<U>Audited Balance Sheet</U>&rdquo;) reflecting the receipt
by the Company of the proceeds of the Offering on the Closing Date. As soon as the Audited Balance Sheet becomes available, the Company
shall promptly, but not later than four business days after the Closing Date, file a Current Report on Form&nbsp;8-K with the Commission,
which Current Report shall contain the Company&rsquo;s Audited Balance Sheet. Additionally, upon the Company&rsquo;s receipt of the proceeds
from the exercise of all or any portion of the option provided for in Section&nbsp;2(b)&nbsp;hereof, the Company shall promptly, but
not later than four business days after the receipt of such proceeds, file a Current Report on Form&nbsp;8-K with the Commission, which
report shall disclose the Company&rsquo;s sale of the Option Units and its receipt of the proceeds therefrom, unless the receipt of such
proceeds are reflected in the Current Report on Form&nbsp;8-K referenced in the immediately prior sentence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Quarterly
Review</I>. For a period commencing on the initial effective date of the Registration Statement and ending five years from the date of
the consummation of the Business Combination or until such earlier time at which the Liquidation occurs or the Ordinary Shares, Rights
and Warrants cease to be publicly traded, the Company, at its expense, shall cause its regularly engaged independent registered public
accounting firm to review (but not audit) the Company&rsquo;s financial statements for each of the first three fiscal quarters prior
to the announcement of quarterly financial information, the filing of the Company&rsquo;s Form&nbsp;10-Q quarterly report and the mailing,
if any, of quarterly financial information to shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Rule&nbsp;462(b)&nbsp;Registration
Statement</I>. If the Company elects to rely upon Rule&nbsp;462(b)&nbsp;under the Securities Act, the Company shall file a Rule&nbsp;462(b)&nbsp;Registration
Statement with the Commission in compliance with Rule&nbsp;462(b)&nbsp;by 10:00 P.M., Washington, D.C. time, on the date of this Agreement,
and the Company shall at the time of filing either pay to the Commission the filing fee for the Rule&nbsp;462(b)&nbsp;Registration Statement
or give irrevocable instructions for the payment of such fee pursuant to Rule&nbsp;111&nbsp;under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Transfer
and Warrant Agent. </I>For a period commencing on the initial effective date of the Registration Statement and ending five years from
the date of the consummation of the Business Combination or until such earlier time at which the Liquidation occurs or the Ordinary Shares
and Warrants cease to be publicly traded, the Company shall retain a transfer and warrant agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Rights
Agent. </I>For a period commencing on the initial effective date of the Registration Statement and ending five years from the date of
the consummation of the Business Combination or until such earlier time at which the Liquidation occurs or the Ordinary Shares and Rights
cease to be publicly traded, the Company shall retain a rights agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Initial
Business Combination.</I> The Company will not consummate an initial Business Combination with any entity that is affiliated with the
Sponsor or any of the Company&rsquo;s officers or directors unless it or a committee of independent and disinterested members of its
board of directors obtains an opinion from an independent investment banking firm or from an independent accounting firm that commonly
renders valuation opinions that such initial Business Combination is fair to the Company from a financial point of view. The Company
shall not pay the Sponsor or its affiliates or any of the Company&rsquo;s officers, directors or any of their respective affiliates any
fees or compensation of any kind for services rendered to the Company prior to, or in connection with, the consummation of an initial
Business Combination;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that (x)&nbsp;such officers, directors and affiliates&nbsp;(i)&nbsp;may
receive reimbursement for out-of-pocket expenses incurred by them in connection with activities on the Company&rsquo;s behalf related
to identifying, investigating, negotiating and completing an initial Business Combination to the extent that such expenses do not exceed
the amount of available proceeds not deposited in the Trust Account, and (ii)&nbsp;may be repaid loans as described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus and (y)&nbsp;an affiliate of the Sponsor may receive up to $10,000 per month
pursuant to the Administrative Services Agreement for office space, utilities, administrative and support services provided to the Company,
none of which payments described in (x)&nbsp;or (y)&nbsp;will be made from the proceeds held in the Trust Account prior to completion
of the initial Business Combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>FINRA
Submissions.</I> For a period of 60 days following the effective date of the Registration Statement, in the event any person or entity
(regardless of any FINRA affiliation or association) is engaged to assist the Company in its search for a merger candidate or to provide
any other merger and acquisition services, or has provided or will provide any investment banking, financial, advisory and/or consulting
services to the Company, the Company agrees that it shall promptly provide to FINRA (via a FINRA submission), the Representatives and
their counsel a notification prior to entering into the agreement or transaction relating to a potential Business Combination: (i)&nbsp;the
identity of the person or entity providing any such services; (ii)&nbsp;complete details of all such services and copies of all agreements
governing such services prior to entering into the agreement or transaction; and (iii)&nbsp;justification as to why the value received
by any person or entity for such services is not underwriting compensation for the Offering. The Company also agrees that proper disclosure
of such arrangement or potential arrangement will be made in the tender offer materials or proxy statement, as applicable, which the
Company may file in connection with the Business Combination for purposes of offering redemption of shares held by its shareholders or
for soliciting shareholder approval, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Affiliates
or Associated Persons of Members. </I>The Company shall advise FINRA, the Representatives and their counsel if it is aware that any 10%
or greater shareholder of the Company becomes an affiliate or associated person of a Member participating in the distribution of the
Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Trust
Account Investments</I>. The Company shall cause the proceeds of the Offering and the sale from time to time of the Private Placement
Warrants to be held in the Trust Account to be invested only in United States government treasury bills with a maturity of 185 days or
less or in money market funds meeting certain conditions under Rule&nbsp;2a-7 under the Investment Company Act as set forth in the Trust
Agreement and disclosed in the Pricing Disclosure Package and the Prospectus. The Company will otherwise conduct its business in a manner
so that it will not become subject to the Investment Company Act. Furthermore, once the Company consummates an initial Business Combination,
it will not be required to register as an investment company under the Investment Company Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Use
of Funds in Trust Account</I>. During the period prior to the Company&rsquo;s initial Business Combination or Liquidation, the Company
may instruct the Trustee to release from the Trust Account, (i)&nbsp;solely from interest or other income earned on the funds held in
the Trust Account, the amounts necessary to pay income taxes, if any, and (ii)&nbsp;to pay Public Shareholders who properly redeem their
Public Shares (as defined below) in connection with a shareholder vote to approve an amendment to the Company&rsquo;s Charter (x)&nbsp;to
modify the substance or timing of the Company&rsquo;s obligation to provide its Public Shareholders the right to have their Public Shares
redeemed in connection with its initial Business Combination or to redeem 100% of the Company&rsquo;s outstanding Public Shares if the
Company has not consummated an initial Business Combination within the time period required by the Company&rsquo;s Charter or (y)&nbsp;with
respect to any other provision relating to the rights of its Public Shareholders. Otherwise, all funds held in the Trust Account (including
any interest income earned on the amounts held in the Trust Account (net of taxes payable thereon in accordance with the preceding sentence))
will remain in the Trust Account until the earlier of the consummation of the Company&rsquo;s initial Business Combination and the Liquidation;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that in the event of the Liquidation, up to $100,000 of interest income may be released to the Company if the proceeds of the Offering
held by the Company outside of the Trust Account are not sufficient to cover the costs and expenses associated with implementing the
Company&rsquo;s plan of dissolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Availability
of Authorized but Unissued Securities.</I> The Company will reserve and keep available that maximum number of its authorized but unissued
securities that are issuable upon the exercise of any of the Rights, Warrants and the Private Placement Warrants outstanding from time
to time and upon the conversion of the Founder Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Additional Issuances prior to the Business Combination</I>.&nbsp;Except as described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, prior to the earlier of the consummation of an initial Business Combination and the Liquidation, the Company
shall not issue (other than in replacement for lost, stolen or mutilated certificates) any Ordinary Shares, Rights, Warrants or any options
or other securities convertible into or exercisable or exchangeable for Ordinary Shares, or any preferred stock, in each case,&nbsp;that
(1)&nbsp;receive funds from the Trust Account or (2)&nbsp;vote as a class with the Public Shares (a)&nbsp;on any initial Business Combination
or (b)&nbsp;to approve an amendment to the Company&rsquo;s Charter to (i)&nbsp;extend the time the Company has to consummate a Business
Combination beyond the time period required by the Company&rsquo;s Charter or (ii)&nbsp;amend the foregoing provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Affiliate
Transactions</I>. Except as disclosed in the Registration Statement, the Company shall not pay the Sponsor, any of the Company&rsquo;s
directors or executive officers, any special advisor, or any of the Company&rsquo;s or their respective affiliates any fees or compensation
of any kind (including finder&rsquo;s and consulting fees reimbursement, monies in respect of any payment of a loan or other compensation
paid by the Company to the Sponsor, the Company&rsquo;s executive officers, directors or any of their respective affiliates, except as
otherwise disclosed in the Registration Statement) for services rendered to the Company prior to, or in connection with, the consummation
of the Initial Business Combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Audit
Committee Review</I>. Prior to the earlier of the consummation of an initial Business Combination and the Liquidation, the Company&rsquo;s
audit committee will review on a quarterly basis all payments made by the Company to the Sponsor, to the Company&rsquo;s officers or
directors, or to the Company&rsquo;s or any of such other persons&rsquo; respective affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Penny
Stock</I>. The Company agrees that it will use commercially reasonable efforts to prevent the Company from becoming subject to Rule&nbsp;419
under the Securities Act prior to the consummation of any Business Combination, including, but not limited to, using its best efforts
to prevent any of the Company&rsquo;s outstanding securities from being deemed to be a &ldquo;penny stock&rdquo; as defined in Rule&nbsp;3a51-1
under the Exchange Act during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Internal
Controls</I>. To the extent required by Rule&nbsp;13a-15(e)&nbsp;under the Exchange Act, the Company will maintain &ldquo;disclosure
controls and procedures&rdquo; (as defined under Rule&nbsp;13a-15(e)&nbsp;under the Exchange Act) and a system of internal accounting
controls sufficient to provide reasonable assurances that (i)&nbsp;transactions are executed in accordance with management&rsquo;s general
or specific authorization, (ii)&nbsp;transactions are recorded as necessary in order to permit preparation of financial statements in
accordance with GAAP and to maintain accountability for assets, (iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv)&nbsp;the recorded accountability for assets is compared with existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Maintenance
of Listing.</I> The Company will use commercially reasonable efforts to effect and maintain the listing of (x)&nbsp;the Units, Rights
and Warrants on the Nasdaq (or another national securities exchange) until the consummation of the Business Combination or until such
earlier time at which the Liquidation occurs, and (y)&nbsp;the Ordinary Shares on the Nasdaq (or another national securities exchange)
until five years from the date of the consummation of the Business Combination or until such earlier time at which Liquidation occurs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Sarbanes
Oxley.</I> As soon as legally required to do so, the Company and its directors and officers, in their capacities as such, shall take
all actions necessary to comply with any applicable provisions of the Sarbanes-Oxley Act, including Section&nbsp;402 related to loans
and Sections&nbsp;302 and 906 related to certifications, and to comply with the rules&nbsp;of the Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Charter.
</I>The Company shall not take any action or omit to take any action that would cause the Company to be in breach or violation of its
Charter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Consummate
the Initial Business Combination. </I>The Company, subject to any applicable provision of the Company&rsquo;s Charter, may consummate
the initial Business Combination and conduct redemptions of Public Shares for cash upon consummation of such Business Combination without
a shareholder vote pursuant to Rule&nbsp;13e-4 and Regulation&nbsp;14E under the Exchange Act, including the filing of tender offer documents
with the Commission. Such tender offer documents will contain substantially the same financial and other information about the initial
Business Combination and the redemption rights as is required under the Commission&rsquo;s proxy rules&nbsp;and will provide each shareholder
of the Company with the opportunity prior to the consummation of the initial Business Combination to redeem the Ordinary Shares held
by such shareholder for an amount of cash equal to (A)&nbsp;the aggregate amount then on deposit in the Trust Account, calculated as
of two business days prior to the consummation of the initial Business Combination, representing (x)&nbsp;the proceeds held in the Trust
Account from the Offering and the sale from time to time of the Private Placement Warrants and (y)&nbsp;any interest income earned on
the funds held in the Trust Account (which interest shall be net of taxes payable), divided by (B)&nbsp;the total number of Ordinary
Shares sold as part of the Units in the Offering (the &ldquo;<U>Public Shares</U>&rdquo;) then outstanding. If, however, a shareholder
vote is required by applicable law or stock exchange listing requirement in connection with the initial Business Combination, or the
Company decides to hold a shareholder vote for business or other reasons, the Company will submit such Business Combination to the Company&rsquo;s
shareholders for their approval (&ldquo;<U>Business Combination Vote</U>&rdquo;). With respect to the initial Business Combination Vote,
if any, each of the Sponsor and the Company&rsquo;s directors and officers has agreed to vote all of the Founder Shares and Public Shares
it then holds, if any, in favor of the Company&rsquo;s initial Business Combination. If the Company seeks shareholder approval of the
initial Business Combination, the Company will offer to each Public Shareholder the right to have its shares redeemed in conjunction
with a proxy solicitation pursuant to the proxy rules&nbsp;of the Commission at a per share redemption price (the &ldquo;<U>Redemption
Price</U>&rdquo;) equal to (I)&nbsp;the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior
to the consummation of the initial Business Combination, representing (1)&nbsp;the proceeds held in the Trust Account from the Offering
and the sale from time to time of the Private Placement Warrants and (2)&nbsp;interest income earned on the funds held in the Trust Account
(which interest shall be net of any taxes payable), divided by (II)&nbsp;the total number of Public Shares then outstanding. If the Company
seeks shareholder approval of the initial Business Combination, the Company may proceed with such Business Combination only if a majority
of the outstanding shares voted by the shareholders at a duly held shareholders meeting are voted to approve such Business Combination.
If, after seeking and receiving such shareholder approval, the Company elects to so proceed, it will redeem shares, at the Redemption
Price, from those Public Shareholders who validly and affirmatively requested such redemption. Only Public Shareholders who properly
exercise their redemption rights, in accordance with the applicable tender offer or proxy materials related to such Business Combination
and the Charter, shall be entitled to receive distributions from the Trust Account in connection with an initial Business Combination,
and the Company shall pay no distributions with respect to any other holders of shares of capital stock of the Company in connection
therewith. In the event that the Company does not effect a Business Combination by the time period required by the Company&rsquo;s Charter
(or such later date as has been approved pursuant to a valid amendment to the Company&rsquo;s Charter), the Company will (i)&nbsp;cease
all operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but not more than ten business days
thereafter, redeem 100% of the Company&rsquo;s outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and less up to $100,000
of such net interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely
extinguish Public Shareholders&rsquo; rights as shareholders (including the right to receive further liquidation distributions, if any),
and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the Company&rsquo;s remaining
shareholders and the Company&rsquo;s board of directors, dissolve and liquidate, subject in each case to the Company&rsquo;s obligations
under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. Only Public Shareholders holding
Ordinary Shares included in the Units shall be entitled to receive such redemption amounts and the Company shall pay no such redemption
amounts or any distributions in liquidation with respect to any other shares of capital stock of the Company. The Sponsor and the Company&rsquo;s
officers and directors have agreed that they will not propose any amendment to the Company&rsquo;s Charter (A)&nbsp;that would modify
the substance or timing of the Company&rsquo;s obligation to provide its Public Shareholders the right to have their Public Shares redeemed
in connection with its initial Business Combination or to redeem 100% of the Company&rsquo;s outstanding Public Shares if the Company
has not consummated an initial Business Combination within the time period required by the Company&rsquo;s Charter or (B)&nbsp;with respect
to any other provision relating to the rights of its Public Shareholders, unless the Company offers to the Public Shareholders the right
to redeem their Public Shares in connection with such amendment, as described in the Pricing Disclosure Package and Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Business
Combination Announcement</I>. In the event that the Company desires or is required by an applicable law or regulation to cause an announcement
(a &ldquo;<U>Business Combination Announcement</U>&rdquo;) to be placed in The Wall Street Journal, The New York Times or any other news
or media publication or outlet or to be made via a public filing or submission with the Commission announcing the consummation of an
initial Business Combination that indicates that the Underwriters were the underwriters in the Offering, the Company shall supply the
Representatives with a draft of the Business Combination Announcement and provide the Representatives with a reasonable advance opportunity
to comment thereon, subject to the agreement of the Underwriters to keep confidential such draft announcement in accordance with the
Representatives&rsquo; standard policies regarding confidential information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Deferred
Discount Payment</I>. Upon the consummation of the initial Business Combination, the Company will direct the Trustee to pay the Representatives,
on behalf of the Underwriters, the Deferred Discount out of the proceeds of the Offering held in the Trust Account. The Underwriters
shall have no claim to payment of any interest earned on the portion of the proceeds held in the Trust Account representing the Deferred
Discount. If the Company fails to consummate its initial Business Combination within the time period required by its Charter, the Deferred
Discount will not be paid to the Representatives and will, instead, be included in the Liquidation distribution of the proceeds held
in the Trust Account made to the Public Shareholders. In connection with any such Liquidation, the Underwriters forfeit any rights or
claims to the Deferred Discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Forfeiture.
</I>Upon the earlier to occur of the expiration and termination of the Underwriters&rsquo; over-allotment option, the Company shall cancel
or otherwise effect the forfeiture of Founder Shares from the Sponsor, in an aggregate amount equal to the number of Founder Shares determined
by multiplying (a)&nbsp;1,000,000 by (b)&nbsp;a fraction, (i)&nbsp;the numerator of which is 3,000,000 minus the number of Option Units
purchased by the Underwriters upon the exercise of their over-allotment option, and (ii)&nbsp;the denominator of which is 3,000,000.
For the avoidance of doubt, if the Underwriters exercise their over-allotment option in full, the Company shall not cancel or otherwise
effect the forfeiture of the Founder Shares pursuant to this Section&nbsp;4(mm).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Written
Testing-the-Waters Communication</I>. If at any time following the distribution of any Written Testing-the-Waters Communication, there
occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include
any untrue statement of a material fact or omitted or would omit to state any material fact necessary to make the statements therein
in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly (i)&nbsp;notify the Representatives
so that use of the Written Testing-the-Waters Communication may cease until it is amended or supplemented; (ii)&nbsp;amend or supplement,
at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission; and (iii)&nbsp;supply
any amendment or supplement to the Representatives in such quantities as may be reasonably requested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Delivery
of Agreements</I>. The Company will deliver to the Representative executed copies of the Trust Agreement, the Warrant Agreements, the
Securities Subscription Agreement, the Private Placement Warrants Purchase Agreement, the Registration and Shareholder Rights Agreement,
the Insider Letter, the Administrative Services Agreement and the Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Trust
Account Waiver.</I> The Company will seek to have all vendors, service providers (other than its independent registered public accounting
firm), prospective target businesses and other entities with which it does business enter into an agreement waiving any right, title,
interest or claim of any kind in or to any monies held in the Trust Account for the benefit of the Public Shareholders. The Company may
forego obtaining such waivers only if the Company&rsquo;s management shall have determined that such third party&rsquo;s engagement would
be significantly more beneficial to the Company than any alternative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Certification
of Beneficial Ownership</I>. The Company will deliver to each Underwriter (or its agent), on the date of execution of this Agreement,
a properly completed and executed Certification Regarding Beneficial Owners and Key Controllers of Legal Entity Customers, together with
copies of identifying documentation, and the Company undertakes to provide such additional supporting documentation as each Underwriter
may reasonably request in connection with the verification of the foregoing Certification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Agreements of the Underwriters</U>.&#8239;Each Underwriter hereby represents and agrees, severally and not
jointly, that it is not subject to any pending proceeding under Section&nbsp;8A of the Securities Act with respect to the Offering (and
will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Conditions
of Underwriters&rsquo; Obligations</U>. The obligation of each Underwriter to purchase the Underwritten Units on the Closing Date or
the Option Units on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company
of its covenants and other obligations hereunder and to the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Registration
Compliance; No Stop Order.</I> No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding
for such purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission; the
Prospectus shall have been timely filed with the Commission under the Securities Act and in accordance with Section&nbsp;4(a)&nbsp;hereof;
and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Representations
and Warranties.</I> The representations and warranties of the Company contained herein shall be true and correct on the date hereof and
on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its officers
made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional
Closing Date, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Material Adverse Change.</I> No event or condition of a type described in Section&nbsp;3(j)&nbsp;hereof shall have occurred or shall
exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and
the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Representatives makes it
impracticable or inadvisable to proceed with the offering, sale or delivery of the Units on the Closing Date or the Additional Closing
Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Officers&rsquo;
Certificate.</I> The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may
be, a certificate of the chief financial officer or chief accounting officer of the Company and one additional senior executive officer
of the Company who is satisfactory to the Representatives (i)&nbsp;confirming that such officers have carefully reviewed the Registration
Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations set forth in
Sections 3(b)&nbsp;and 3(c)&nbsp;hereof are true and correct, (ii)&nbsp;confirming that the other representations and warranties of the
Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on
its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be, and
(iii)&nbsp;to the effect set forth in paragraphs (a)&nbsp;and (c)&nbsp;above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Secretary&rsquo;s
Certificate</I>. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may
be, a certificate of the Secretary or Assistant Secretary of the Company, certifying (i)&nbsp;that the Charter is true and complete,
has not been modified and is in full force and effect, (ii)&nbsp;that the resolutions relating to the Offering contemplated by this Agreement
are in full force and effect and have not been modified, (iii)&nbsp;copies of all correspondence between the Company or its counsel and
the Commission, and (iv)&nbsp;as to the incumbency of the executive officers of the Company. The documents referred to in such certificate
shall be attached to such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Comfort
Letters.</I> On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, WithumSmith+Brown,
PC shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof
and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements and information
of the type customarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect to the financial statements
and certain financial information contained in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus;
<U>provided</U>, that the letter delivered on the Closing Date or the Additional Closing Date, as the case may be, shall use a &ldquo;cut-off&rdquo;
date no more than two business days prior to such Closing Date or such Additional Closing Date, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Opinions
and 10b-5 Letter of Counsel for the Company.</I> (i)&nbsp;Kirkland&nbsp;&amp; Ellis LLP, counsel for the Company, shall have furnished
to the Representatives, at the request of the Company, their written opinion and 10b-5 letter, dated the Closing Date or the Additional
Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives,
and (ii)&nbsp;Maples and Calder, Cayman Islands counsel for the Company, shall have furnished to the Representatives, at the request
of the Company, their written opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the
Underwriters, in form and substance reasonably satisfactory to the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Opinion
and 10b-5 Letter of Counsel for the Underwriters.</I> The Representatives shall have received on and as of the Closing Date or the Additional
Closing Date, as the case may be, an opinion and 10b-5 letter, addressed to the Underwriters, of Shearman&nbsp;&amp; Sterling LLP, counsel
for the Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received
such documents and information as they may reasonably request to enable them to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Legal Impediment to Issuance and Sale.</I> No action shall have been taken and no statute, rule, regulation or order shall have been
enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or
the Additional Closing Date, as the case may be, prevent the issuance or sale of the Units; and no injunction or order of any federal,
state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be,
prevent the issuance or sale of the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Good
Standing</I>. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be,
satisfactory evidence of the good standing of the Company in its jurisdiction of organization and its good standing in such other jurisdictions
as the Representatives may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate
governmental authorities of such jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Exchange
Listing.</I> The Units to be delivered on the Closing Date or the Additional Closing Date, as the case may be, shall have been approved
for listing on the Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Delivery
of Transaction Documents</I>. On or prior to the Closing Date, the Company shall have delivered to the Representatives executed copies
of the Trust Agreement, the Warrant Agreements, the Securities Subscription Agreement, the Private Placement Warrants Purchase Agreement,
the Registration and Shareholder Rights Agreement, the Insider Letter, the Administrative Services Agreement and the Rights Agreement,
and each of the Transaction Documents shall be in full force and effect on the Closing Date or the Additional Closing Date, as the case
may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Funding
of Private Placement Warrants.</I> At least one business day prior to the Closing Date or the Additional Closing Date, as applicable,
the Company shall have caused proceeds from the sale of the Private Placement Warrants to be deposited into the Trust Account such that
the cumulative amount deposited into the Trust Account as of such Closing Date or Additional Closing Date, as applicable, shall equal
the product of the number of Units sold in the public offering as of such Closing Date or Additional Closing Date, as applicable, and
the public offering price per Unit as set forth on the cover of the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>FINRA</I>.
FINRA shall not have raised any objection with respect to the fairness or reasonableness of the underwriting or other arrangements of
the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Additional
Documents.</I> On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to
the Representatives such further certificates and documents as the Representatives may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">All opinions, letters,
certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof
only if they are in form and substance reasonably satisfactory to counsel for the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification
and Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Indemnification
of the Underwriters.</I> The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors, managers, members,
employees, agents, representatives and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15
of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including,
without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as
such fees and expenses are incurred), joint or several, that arise out of, or are based upon, (i)&nbsp;any untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein
a material fact required to be stated therein or necessary in order to make the statements therein, not misleading, (ii)&nbsp;any untrue
statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary
Prospectus, any Written Testing-the-Waters Communication, any road show as defined in Rule&nbsp;433(h)&nbsp;under the Securities Act
(a &ldquo;road show&rdquo;) or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended),
or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading, or (iii)&nbsp;any untrue statement or alleged untrue statement
of a material fact contained in a proxy statement, a prospectus (or any amendment or supplement thereto), any preliminary prospectus,
any Written Testing-the-Waters Communication, or any road show, in each case used in connection with the initial Business Combination,
or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or
liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance
upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through
the Representatives expressly for use therein, it being understood and agreed that the only such information furnished by any Underwriter
consists of the information described as such in paragraph (b)&nbsp;below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Indemnification
of the Company.</I> Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its
officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15
of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a)&nbsp;above,
but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission
or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished
to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement, the Prospectus
(or any amendment or supplement thereto), any Preliminary Prospectus, any Written Testing-the-Waters Communication, any road show or
any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), it being understood and
agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus furnished
on behalf of each Underwriter: (y)&nbsp;the concession figure appearing in the fourth paragraph under the caption &ldquo;Underwriting&rdquo;
and (z)&nbsp;the fifteenth and sixteenth paragraphs related to stabilization, over-allotment, syndicate covering transactions and penalty
bids under the caption &ldquo;Underwriting.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Notice
and Procedures.</I> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be
brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this
Section&nbsp;7, such person (the &ldquo;<U>Indemnified Person</U>&rdquo;) shall promptly notify the person against whom such indemnification
may be sought (the &ldquo;<U>Indemnifying Person</U>&rdquo;) in writing; <U>provided</U> that the failure to notify the Indemnifying
Person shall not relieve it from any liability that it may have under the preceding paragraphs of this Section&nbsp;7 except to the extent
that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>,
<U>further</U>, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified
Person otherwise than under the preceding paragraphs of this Section&nbsp;7. If any such proceeding shall be brought or asserted against
an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying
Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section&nbsp;that the Indemnifying
Person may designate in such proceeding and shall pay the fees and expenses in such proceeding and shall pay the fees and expenses of
such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its
own counsel (including local counsel), but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless
(i)&nbsp;the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person
has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person
shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available
to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the
Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual
or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with
any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in
addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are
incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter
shall be designated in writing by the Representatives and any such separate firm for the Company, its directors, its officers who signed
the Registration Statement and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person
shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent, the
Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement.
Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse
the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for
any settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 30 days after
receipt by the Indemnifying Person of such request and (ii)&nbsp;the Indemnifying Person shall not have reimbursed the Indemnified Person
in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the
Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could
have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes
an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all
liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any admission
of fault, culpability or a failure to act by or on behalf of any Indemnified Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Contribution.
</I>If the indemnification provided for in paragraphs (a)&nbsp;or (b)&nbsp;above is unavailable to an Indemnified Person or insufficient
in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in
lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as
a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits
received by the Company, on the one hand, and the Underwriters on the other, from the Offering or (ii)&nbsp;if the allocation provided
by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits
referred to in clause (i)&nbsp;but also the relative fault of the Company, on the one hand, and the Underwriters on the other, in connection
with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable
considerations. The relative benefits received by the Company, on the one hand, and the Underwriters on the other, shall be deemed to
be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Units
and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth
in the table on the cover of the Prospectus, bear to the aggregate offering price of the Units. The relative fault of the Company, on
the one hand, and the Underwriters on the other, shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the
Company or by the Underwriters and the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Limitation
on Liability.</I> The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to paragraph
(d)&nbsp;above were determined by <U>pro rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or
by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d)&nbsp;above.
The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph
(d)&nbsp;above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified
Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (d)&nbsp;and (e), in no event shall
an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions
received by such Underwriter with respect to the Offering exceeds the amount of any damages that such Underwriter has otherwise been
required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation. For purposes of this Section&nbsp;7, each person who controls an Underwriter
within the meaning of either the Securities Act or the Exchange Act and each director, officer, employee, affiliate and agent of an Underwriter
shall have the same rights to contribution as such Underwriter, and each person who controls the Company within the meaning of either
the Securities Act or the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director
of the Company shall have the same rights to contribution as the Company, subject in each case to the applicable terms and conditions
of this paragraph (e).The Underwriters&rsquo; obligations to contribute pursuant to paragraphs (d)&nbsp;and (e)&nbsp;are several in proportion
to their respective purchase obligations hereunder and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Non-Exclusive
Remedies.</I> The remedies provided for in this Section&nbsp;7 are not exclusive and shall not limit any rights or remedies which may
otherwise be available to any Indemnified Person at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Effectiveness
of Agreement</U>. This Agreement shall become effective as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement may be terminated in the absolute discretion of the Representatives, by notice to the Company, if after the execution
and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Units, prior to the Additional Closing
Date (i)&nbsp;trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange or the Nasdaq;
(ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any over-the-counter
market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities;
or (iv)&nbsp;there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or
crisis, either within or outside the United States, that, in the sole judgment of the Representatives, is material and adverse and makes
it impracticable or inadvisable to proceed with the offering, sale or delivery of the Units on the Closing Date or the Additional Closing
Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Defaulting
Underwriter</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If,
on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the Units
that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the purchase
of such Units by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such
default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Units, then the Company shall be
entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase
such Units on such terms. If other persons become obligated or agree to purchase the Units of a defaulting Underwriter, either the non-defaulting
Underwriters or the Company may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five full business
days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in
the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any
amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the
term &ldquo;Underwriter&rdquo; includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed
in Schedule 1 hereto that, pursuant to this Section&nbsp;10, purchases Units that a defaulting Underwriter agreed but failed to purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If,
after giving effect to any arrangements for the purchase of the Units of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate number of Units that remain unpurchased on the Closing
Date or the Additional Closing Date, as the case may be, does not exceed 10% of the aggregate number of Units to be purchased on such
date, then the Company shall have the right to require each non-defaulting Underwriter to purchase the number of Units that such Underwriter
agreed to purchase hereunder on such date plus such Underwriter&rsquo;s pro rata share (based on the number of Units that such Underwriter
agreed to purchase on such date) of the Units of such defaulting Underwriter or Underwriters for which such arrangements have not been
made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If,
after giving effect to any arrangements for the purchase of the Units of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate number of Units that remain unpurchased on the Closing
Date or the Additional Closing Date, as the case may be, exceeds 10% of the aggregate amount of Units to be purchased on such date, or
if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this Agreement or, with respect to any Additional
Closing Date, the obligation of the Underwriters to purchase Units on the Additional Closing Date, as the case may be, shall terminate
without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant to this Section&nbsp;10
shall be without liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses
as set forth in Section&nbsp;11 hereof and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain in
effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Nothing
contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter
for damages caused by its default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Expenses</U><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Whether
or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause
to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i)&nbsp;the
costs incident to the authorization, issuance, sale, preparation and delivery of the Units and any taxes payable in that connection;
(ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary
Prospectus, any Pricing Disclosure Package and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution
thereof; (iii)&nbsp;the costs of reproducing and distributing each of the Transaction Documents; (iv)&nbsp;the fees and expenses of the
Company&rsquo;s counsel and independent accountants; (v)&nbsp;the fees and expenses incurred in connection with the registration or qualification
and determination of eligibility for investment of the Units under the laws of such jurisdictions as the Representatives may designate
and the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for the Underwriters);&nbsp;(vi)&nbsp;the
cost of preparing stock certificates; (vii)&nbsp;the costs and charges of any transfer agent, trustee, warrant agent and registrar; (viii)&nbsp;all
expenses and application fees incurred in connection with any filing with, and clearance of the offering by, FINRA (including the reasonable
and documented fees and expenses of counsel for the Underwriters relating to such filings up to $25,000); (ix)&nbsp;transportation and
other expenses incurred by the Company and its executive officers (and not the Underwriters) in connection with any &ldquo;road show&rdquo;
presentation to potential investors; and (x)&nbsp;all expenses and application fees related to the listing of the Units on the Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
(i)&nbsp;this Agreement is terminated pursuant to Section&nbsp;9, (ii)&nbsp;the Company for any reason fails to tender the Units for
delivery to the Underwriters or (iii)&nbsp;the Underwriters decline to purchase the Units for any reason permitted under this Agreement,
the Company agrees to reimburse the Underwriters severally for all reasonable and documented out-of-pocket costs and expenses (including
the reasonable and documented fees and expenses of their counsel) incurred by the Underwriters in connection with this Agreement and
the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Persons
Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter referred
to in Section&nbsp;7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable
right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Units from any Underwriter
shall be deemed to be a successor merely by reason of such purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Survival</U>.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriters contained
in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered
pursuant hereto shall survive the delivery of and payment for the Units and shall remain in full force and effect, regardless of any
termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors, officers,
controlling persons or affiliates referred to in Section&nbsp;7 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Defined Terms</U>. For purposes of this Agreement, (a)&nbsp;except where otherwise expressly provided, the term &ldquo;affiliate&rdquo;
has the meaning set forth in Rule&nbsp;405 under the Securities Act; and (b)&nbsp;the term &ldquo;business day&rdquo; means any day other
than a day on which banks are permitted or required to be closed in New York City; and (c)&nbsp;the term &ldquo;Liquidation&rdquo; means
the distributions of the Trust Account to the Public Shareholders in connection with the redemption of the Ordinary Shares held by the
Public Shareholders pursuant to the terms of the Company&rsquo;s Charter, as amended, if the Company fails to consummate a Business Combination
with the time period provided therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance
with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October&nbsp;26,
2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the
Company, which information may include the name and address of their respective clients, as well as other information that will allow
the Underwriters to properly identify their respective clients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Notices.
</I>All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
and confirmed by any standard form of telecommunication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Notices to the Underwriters
shall be given to the Representatives:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Citigroup
Global Markets Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">388 Greenwich
Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">New York, New York 10013</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">Attention: General Counsel,
facsimile: (646) 291- 1469</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">Guggenheim Securities, LLC<BR>
330 Madison Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">New York, New York 10017<BR>
Attention: James Schaefer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">Copy to: General Counsel</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">with a copy to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">Shearman&nbsp;&amp; Sterling
LLP<BR>
599 Lexington Avenue<BR>
New York, New York 10022<BR>
Attention: Ilir Mujalovic and William B. Nelson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Notices to the Company
shall be given to it at</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">Spring Valley Acquisition Corp.
II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">2100 McKinney Ave, Suite&nbsp;1675</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">Dallas, Texas 75201</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">Attention: Christopher Sorrells</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">with a copy to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">Kirkland&nbsp;&amp; Ellis LLP<BR>
609 Main Street<BR>
Houston, Texas 77002<BR>
Attention: Matthew R. Pacey, P.C. and Christian O. Nagler</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Governing
Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed
in accordance with the laws of the State of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Submission
to Jurisdiction.</I> The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough
of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in
such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive
and binding upon the Company and may be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Waiver
of Jury Trial.</I> <B>EACH OF THE PARTIES HERETO HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY IN ANY SUIT OR PROCEEDING ARISING OUT OF OR
RELATING TO THIS AGREEMENT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Recognition
of the U.S. Special Resolution Regimes</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&nbsp;In
the event that any Underwriter that is a Covered Entity (as defined below) becomes subject to a proceeding under a U.S. Special Resolution
Regime (as defined below), the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement,
will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and
any such interest and obligation, were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)&nbsp;In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate (as defined below) of such Underwriter becomes subject
to a proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be exercised
against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As used
in this Section&nbsp;16(e):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;BHC
Act Affiliate&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12
U.S.C. &sect; 1841(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;Covered
Entity&rdquo; means any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">(i)&nbsp;a
 &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">(ii)&nbsp;a
 &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">(iii)&nbsp;a
 &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;Default
Right&rdquo; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2
or 382.1, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;U.S.
Special Resolution Regime&rdquo; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Counterparts.
</I>This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication),
each of which shall be an original and all of which together shall constitute one and the same instrument. Counterparts may be delivered
via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic
Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method
and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Amendments
or Waivers.</I> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Headings.
</I>The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or
interpretation of, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Integration.
</I>This Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company and the Underwriters,
or any of them, with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">[<I>Signature Pages&nbsp;Follow</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">If the foregoing
is in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 3in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 3in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 3in"></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">SPRING VALLEY ACQUISITION CORP. II</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 3in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 3in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; width: 44%"><FONT STYLE="font-size: 10pt">/s/ Christopher Sorrells</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Christopher Sorrells</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: 3in"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">Chief Executive
    Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">[<I>Signature
Page&nbsp;to Underwriting Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Accepted: As of the date first written
above</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">CITIGROUP GLOBAL MARKETS INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">GUGGENHEIM SECURITIES, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">For itself and on behalf of the<BR>
several Underwriters listed<BR>
in Schedule 1 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">CITIGROUP GLOBAL MARKETS INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Scott Wexler</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Wexler</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director, Head of NAM Energy</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">GUGGENHEIM SECURITIES, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Jim Schaefer</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jim Schaefer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Managing Director</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">Schedule 1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 77%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Units</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Citigroup Global Markets Inc.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guggenheim Securities, LLC</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000,000</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">Annex A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Pricing Information Provided by Underwriters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The initial public
offering price per Unit for the Units is $10.00.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The number of Units
purchased by the Underwriters is 20,000,000. The Underwriters have an option to purchase an additional 3,000,000 Units to cover over-allotments,
if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">Annex B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Written Testing-the-Waters
Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Reference is made to the materials used
in the testing the waters presentation made to potential investors by the Company, to the extent such materials are deemed to be a &ldquo;written
communication&rdquo; within the meaning of Rule&nbsp;405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>tm216731d39_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 3.1</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE COMPANIES ACT (<FONT STYLE="text-transform: uppercase">As
Revised</FONT>)</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>MEMORANDUM AND ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-transform: uppercase"><B>(adopted by special
resolution dated 12 October&nbsp;2022 and effective on 12 october 2022)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
COMPANIES ACT (As Revised)</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>MEMORANDUM OF ASSOCIATION</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>OF</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-transform: uppercase"><B>(adopted by special
resolution dated 12 October&nbsp;2022 and effective on 12 October&nbsp;2022)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1</TD><TD STYLE="text-align: justify">The name of the Company is <B>Spring Valley Acquisition Corp. II</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2</TD><TD STYLE="text-align: justify">The Registered Office of the Company shall be at the offices of Maples Corporate Services Limited, PO
Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, or at such other place within the Cayman Islands as the Directors may decide.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3</TD><TD STYLE="text-align: justify">The objects for which the Company is established are unrestricted and the Company shall have full power
and authority to carry out any object not prohibited by the laws of the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4</TD><TD STYLE="text-align: justify">The liability of each Member is limited to the amount unpaid on such Member's shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5</TD><TD STYLE="text-align: justify">The share capital of the Company is US$33,100 divided into 300,000,000 Class&nbsp;A ordinary shares of
a par value of US$0.0001 each, 30,000,000 Class&nbsp;B ordinary shares of a par value of US$0.0001 each and 1,000,000 preference shares
of a par value of US$0.0001 each.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6</TD><TD STYLE="text-align: justify">The Company has power to register by way of continuation as a body corporate limited by shares under the
laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7</TD><TD STYLE="text-align: justify">Capitalised terms that are not defined in this Amended and Restated Memorandum of Association bear the
respective meanings given to them in the Amended and Restated Articles of Association of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
COMPANIES ACT (As Revised)</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ARTICLES OF ASSOCIATION</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>OF</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="text-transform: uppercase"><B>(adopted by special
resolution dated 12 october 2022 and effective on 12 october 2022)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1</B></TD><TD STYLE="text-align: justify"><B>Interpretation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">In the Articles Table A in the First Schedule to the Statute does not apply and, unless there is something
in the subject or context inconsistent therewith:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="padding-right: 10pt; width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Affiliate&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in respect of a person, means any other person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such person, and (a)&nbsp;in the case of a natural person, shall include, without limitation, such person&rsquo;s spouse, parents, children, siblings, mother-in-law and father-in-law and brothers and sisters-in-law, whether by blood, marriage or adoption or anyone residing in such person&rsquo;s home, a trust for the benefit of any of the foregoing, a company, partnership or any natural person or entity wholly or jointly owned by any of the foregoing and (b)&nbsp;in the case of an entity, shall include a partnership, a corporation or any natural person or entity which directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such entity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Applicable Law&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments, decisions, decrees or orders of any governmental authority applicable to such person.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Articles&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means these amended and restated articles of association of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Audit Committee&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the audit committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Auditor&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the person for the time being performing the duties of auditor of the Company (if any).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Business Combination&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination involving the Company, with one or more businesses or entities (the &quot;<B>target business</B>&quot;), which Business Combination: (a)&nbsp;as long as the securities of the Company are listed on the Nasdaq Capital Market, must occur with one or more target businesses that together have an aggregate fair market value of at least 80 per cent of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the signing of the definitive agreement to enter into such Business Combination; and (b)&nbsp;must not be solely effectuated with another blank cheque company or a similar company with nominal operations.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;business day&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorised or obligated by law to close in New York City.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Clearing House&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Class&nbsp;A Share&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a Class&nbsp;A ordinary share of a par value of US$0.0001 in the share capital of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Class&nbsp;B Share&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a Class&nbsp;B ordinary share of a par value of US$0.0001 in the share capital of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Company&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the above named company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Company&rsquo;s Website&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the website of the Company and/or its web-address or domain name (if any).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Compensation Committee&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the compensation committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Designated Stock Exchange&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means any United States national securities exchange on which the securities of the Company are listed for trading, including the Nasdaq Capital Market.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Directors&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the directors for the time being of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Dividend&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means any dividend (whether interim or final) resolved to be paid on Shares pursuant to the Articles.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Electronic Communication&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a communication sent by electronic means, including electronic posting to the Company&rsquo;s Website, transmission to any number, address or internet website (including the website of the Securities and Exchange Commission) or other electronic delivery methods as otherwise decided and approved by the Directors.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Electronic Record&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has the same meaning as in the Electronic Transactions Act.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Electronic Transactions Act&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the Electronic Transactions Act (As Revised) of the Cayman Islands.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Equity-linked Securities&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means any debt or equity securities that are convertible, exercisable or exchangeable for Class&nbsp;A Shares issued in a financing transaction in connection with a Business Combination, including but not limited to a private placement of equity or debt.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Exchange Act&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the United States Securities Exchange Act of 1934, as amended, or any similar U.S. federal statute and the rules&nbsp;and regulations of the Securities and Exchange Commission thereunder, all as the same shall be in effect at the time.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Founders&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means all Members immediately prior to the consummation of the IPO.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Independent Director&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has the same meaning as in the rules&nbsp;and regulations of the Designated Stock Exchange or in Rule&nbsp;10A-3 under the Exchange Act, as the case may be.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;IPO&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the Company's initial public offering of securities.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Member&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has the same meaning as in the Statute.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Memorandum&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the amended and restated memorandum of association of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Nominating Committee&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the Nominating Committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Officer&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a person appointed to hold an office in the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Ordinary Resolution&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a resolution passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting, and includes a unanimous written resolution. In computing the majority when a poll is demanded regard shall be had to the number of votes to which each Member is entitled by the Articles.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Over-Allotment Option&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the option of the Underwriters to purchase up to an additional 15 per cent of the firm units (as described in the Articles) issued in the IPO at a price equal to US$10 per unit, less underwriting discounts and commissions.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Preference Share&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a preference share of a par value of US$0.0001 in the share capital of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Public Share&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a Class&nbsp;A Share issued as part of the units (as described in the Articles) issued in the IPO.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Redemption Notice&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a notice in a form approved by the Company by which a holder of Public Shares is entitled to require the Company to redeem its Public Shares, subject to any conditions contained therein. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Register of Members&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the register of Members maintained in accordance with the Statute and includes (except where otherwise stated) any branch or duplicate register of Members.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Registered Office&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the registered office for the time being of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Representative&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a representative of the Underwriters.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Seal&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the common seal of the Company and includes every duplicate seal.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Securities and Exchange Commission&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the United States Securities and Exchange Commission.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Share&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a Class&nbsp;A Share, a Class&nbsp;B Share or a Preference Share and includes a fraction of a share in the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Special Resolution&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has the same meaning as in the Statute, and includes a unanimous written resolution.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Sponsor&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means Spring Valley Acquisition Sponsor II, LLC, a Delaware limited liability company, and its successors or assigns.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Statute&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the Companies Act (As Revised) of the Cayman Islands.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Treasury Share&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means a Share held in the name of the Company as a treasury share in accordance with the Statute.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Trust Account&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means the trust account established by the Company upon the consummation of the IPO and into which a certain amount of the net proceeds of the IPO, together with a certain amount of the proceeds of a private placement of warrants simultaneously with the closing date of the IPO, will be deposited.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&quot;Underwriter&quot;</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means an underwriter of the IPO from time to time and any successor underwriter.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">In the Articles:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">words importing the singular number include the plural number and vice versa;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">words importing the masculine gender include the feminine gender;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">words importing persons include corporations as well as any other legal or natural person;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">&quot;written&quot; and &quot;in writing&quot; include all modes of representing or reproducing words
in visible form, including in the form of an Electronic Record;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">&quot;shall&quot; shall be construed as imperative and &quot;may&quot; shall be construed as permissive;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">references to provisions of any law or regulation shall be construed as references to those provisions
as amended, modified, re-enacted or replaced;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">any phrase introduced by the terms &quot;including&quot;, &quot;include&quot;, &quot;in particular&quot;
or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">the term &quot;and/or&quot; is used herein to mean both &quot;and&quot; as well as &quot;or.&quot; The
use of &quot;and/or&quot; in certain contexts in no respects qualifies or modifies the use of the terms &quot;and&quot; or &quot;or&quot;
in others. The term &quot;or&quot; shall not be interpreted to be exclusive and the term &quot;and&quot; shall not be interpreted to require
the conjunctive (in each case, unless the context otherwise requires);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">headings are inserted for reference only and shall be ignored in construing the Articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">any requirements as to delivery under the Articles include delivery in the form of an Electronic Record;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">any requirements as to execution or signature under the Articles including the execution of the Articles
themselves can be satisfied in the form of an electronic signature as defined in the Electronic Transactions Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">sections 8 and 19(3)&nbsp;of the Electronic Transactions Act shall not apply;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">the term &quot;clear days&quot; in relation to the period of a notice means that period excluding the
day when the notice is received or deemed to be received and the day for which it is given or on which it is to take effect; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify">the term &quot;holder&quot; in relation to a Share means a person whose name is entered in the Register
of Members as the holder of such Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2</B></TD><TD STYLE="text-align: justify"><B>Commencement of Business</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify">The business of the Company may be commenced as soon after incorporation of the Company as the Directors
shall see fit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify">The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in
or about the formation and establishment of the Company, including the expenses of registration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3</B></TD><TD STYLE="text-align: justify"><B>Issue of Shares and other Securities</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company
in general meeting) and, where applicable, the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities and Exchange
Commission and/or any other competent regulatory authority or otherwise under Applicable Law, and without prejudice to any rights attached
to any existing Shares, the Directors may allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share)
with or without preferred, deferred or other rights or restrictions, whether in regard to Dividends or other distributions, voting, return
of capital or otherwise and to such persons, at such times and on such other terms as they think proper, and may also (subject to the
Statute and the Articles) vary such rights, save that the Directors shall not allot, issue, grant options over or otherwise dispose of
Shares (including fractions of a Share) to the extent that it may affect the ability of the Company to carry out a Class&nbsp;B Ordinary
Share Conversion set out in the Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">The Company may issue rights, options, warrants or convertible securities or securities of similar nature
conferring the right upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the Company
on such terms as the Directors may from time to time determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify">The Company may issue units of securities in the Company, which may be comprised of whole or fractional
Shares, rights, options, warrants or convertible securities or securities of similar nature conferring the right upon the holders thereof
to subscribe for, purchase or receive any class of Shares or other securities in the Company, upon such terms as the Directors may from
time to time determine. The securities comprising any such units which are issued pursuant to the IPO can only be traded separately from
one another on the 52nd day following the date of the prospectus relating to the IPO unless the Representative(s)&nbsp;determines that
an earlier date is acceptable, subject to the Company having filed a current report on Form&nbsp;8-K which includes an audited balance
sheet reflecting the Company&rsquo;s receipt of the gross proceeds at the closing of the IPO and the sale of the private placement warrants
with the Securities and Exchange Commission and a press release announcing when such separate trading will begin. Prior to such date,
the units can be traded, but the securities comprising such units cannot be traded separately from one another.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.4</TD><TD STYLE="text-align: justify">The Company shall not issue Shares to bearer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4</B></TD><TD STYLE="text-align: justify"><B>Register of Members</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">The Company shall maintain or cause to be maintained the Register of Members in accordance with the Statute.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">The Directors may determine that the Company shall maintain one or more branch registers of Members in
accordance with the Statute. The Directors may also determine which register of Members shall constitute the principal register and which
shall constitute the branch register or registers, and to vary such determination from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5</B></TD><TD STYLE="text-align: justify"><B>Closing Register of Members or Fixing Record Date</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify">For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or
any adjournment thereof, or Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination
of Members for any other purpose, the Directors may, after notice has been given by advertisement in an appointed newspaper or any other
newspaper or by any other means in accordance with the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities and
Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, provide that the Register of Members
shall be closed for transfers for a stated period which shall not in any case exceed forty days.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify">In lieu of, or apart from, closing the Register of Members, the Directors may fix in advance or arrears
a date as the record date for any such determination of Members entitled to notice of, or to vote at any meeting of the Members or any
adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any Dividend or other distribution,
or in order to make a determination of Members for any other purpose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.3</TD><TD STYLE="text-align: justify">If the Register of Members is not so closed and no record date is fixed for the determination of Members
entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a Dividend or other distribution,
the date on which notice of the meeting is sent or the date on which the resolution of the Directors resolving to pay such Dividend or
other distribution is passed, as the case may be, shall be the record date for such determination of Members. When a determination of
Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment
thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6</B></TD><TD STYLE="text-align: justify"><B>Certificates for Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify">A Member shall only be entitled to a share certificate if the Directors resolve that share certificates
shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. Share certificates
shall be signed by one or more Directors or other person authorised by the Directors. The Directors may authorise certificates to be issued
with the authorised signature(s)&nbsp;affixed by mechanical process. All certificates for Shares shall be consecutively numbered or otherwise
identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer shall be cancelled
and, subject to the Articles, no new certificate shall be issued until the former certificate representing a like number of relevant Shares
shall have been surrendered and cancelled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.2</TD><TD STYLE="text-align: justify">The Company shall not be bound to issue more than one certificate for Shares held jointly by more than
one person and delivery of a certificate to one joint holder shall be a sufficient delivery to all of them.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.3</TD><TD STYLE="text-align: justify">If a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms (if any)
as to evidence and indemnity and on the payment of such expenses reasonably incurred by the Company in investigating evidence, as the
Directors may prescribe, and (in the case of defacement or wearing out) upon delivery of the old certificate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4</TD><TD STYLE="text-align: justify">Every share certificate sent in accordance with the Articles will be sent at the risk of the Member or
other person entitled to the certificate. The Company will not be responsible for any share certificate lost or delayed in the course
of delivery.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.5</TD><TD STYLE="text-align: justify">Share certificates shall be issued within the relevant time limit as prescribed by the Statute, if applicable,
or as the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent
regulatory authority or otherwise under Applicable Law may from time to time determine, whichever is shorter, after the allotment or,
except in the case of a Share transfer which the Company is for the time being entitled to refuse to register and does not register, after
lodgement of a Share transfer with the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7</B></TD><TD STYLE="text-align: justify"><B>Transfer of Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.1</TD><TD STYLE="text-align: justify">Subject to the terms of the Articles, any Member may transfer all or any of his Shares by an instrument
of transfer provided that such transfer complies with the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities
and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. If the Shares in question were
issued in conjunction with rights, options, warrants or units issued pursuant to the Articles on terms that one cannot be transferred
without the other, the Directors shall refuse to register the transfer of any such Share without evidence satisfactory to them of the
like transfer of such right, option, warrant or unit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.2</TD><TD STYLE="text-align: justify">The instrument of transfer of any Share shall be in writing in the usual or common form or in a form prescribed
by the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent
regulatory authority or otherwise under Applicable Law or in any other form approved by the Directors and shall be executed by or on behalf
of the transferor (and if the Directors so require, signed by or on behalf of the transferee) and may be under hand or, if the transferor
or transferee is a Clearing House or its nominee(s), by hand or by machine imprinted signature or by such other manner of execution as
the Directors may approve from time to time. The transferor shall be deemed to remain the holder of a Share until the name of the transferee
is entered in the Register of Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8</B></TD><TD STYLE="text-align: justify"><B>Redemption, Repurchase and Surrender of Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, and, where applicable, the rules&nbsp;and regulations of the
Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable
Law, the Company may issue Shares that are to be redeemed or are liable to be redeemed at the option of the Member or the Company. The
redemption of such Shares, except Public Shares, shall be effected in such manner and upon such other terms as the Company may, by Special
Resolution, determine before the issue of such Shares. With respect to redeeming or repurchasing the Shares:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Members who hold Public Shares are entitled to request the redemption of such Shares in the circumstances
described in the Business Combination Article&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Class&nbsp;B Ordinary Shares held by the Sponsor shall be surrendered by the Sponsor for no consideration
on a pro-rata basis to the extent that the Over-Allotment Option is not exercised in full so that the Founders will own approximately
20 per cent of the Company&rsquo;s issued Shares after the IPO (exclusive of any securities purchased in a private placement simultaneously
with the IPO); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Public Shares shall be repurchased by way of tender offer in the circumstances set out in the Business
Combination Article&nbsp;hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.2</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, and, where applicable, the rules&nbsp;and regulations of the
Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable
Law, the Company may purchase its own Shares (including any redeemable Shares) in such manner and on such other terms as the Directors
may agree with the relevant Member. For the avoidance of doubt, redemptions, repurchases and surrenders of Shares in the circumstances
described in the Article&nbsp;above shall not require further approval of the Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.3</TD><TD STYLE="text-align: justify">The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner
permitted by the Statute, including out of capital.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.4</TD><TD STYLE="text-align: justify">The Directors may accept the surrender for no consideration of any fully paid Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9</B></TD><TD STYLE="text-align: justify"><B>Treasury Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.1</TD><TD STYLE="text-align: justify">The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share
shall be held as a Treasury Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.2</TD><TD STYLE="text-align: justify">The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they
think proper (including, without limitation, for nil consideration).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10</B></TD><TD STYLE="text-align: justify"><B>Variation of Rights of Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.1</TD><TD STYLE="text-align: justify">Subject to Article&nbsp;3.1, if at any time the share capital of the Company is divided into different
classes of Shares, all or any of the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that
class) may, whether or not the Company is being wound up, be varied without the consent of the holders of the issued Shares of that class
where such variation is considered by the Directors not to have a material adverse effect upon such rights; otherwise, any such variation
shall be made only with the consent in writing of the holders of not less than two thirds of the issued Shares of that class (other than
with respect to a waiver of the provisions of the Class&nbsp;B Ordinary Share Conversion Article&nbsp;hereof, which as stated therein
shall only require the consent in writing of the holders of a majority of the issued Shares of that class), or with the approval of a
resolution passed by a majority of not less than two thirds of the votes cast at a separate meeting of the holders of the Shares of that
class. For the avoidance of doubt, the Directors reserve the right, notwithstanding that any such variation may not have a material adverse
effect, to obtain consent from the holders of Shares of the relevant class. To any such meeting all the provisions of the Articles relating
to general meetings shall apply <I>mutatis mutandis</I>, except that the necessary quorum shall be one person holding or representing
by proxy at least one third of the issued Shares of the class and that any holder of Shares of the class present in person or by proxy
may demand a poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.2</TD><TD STYLE="text-align: justify">For the purposes of a separate class meeting, the Directors may treat two or more or all the classes of
Shares as forming one class of Shares if the Directors consider that such class of Shares would be affected in the same way by the proposals
under consideration, but in any other case shall treat them as separate classes of Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.3</TD><TD STYLE="text-align: justify">The rights conferred upon the holders of the Shares of any class issued with preferred or other rights
shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by the creation
or issue of further Shares ranking pari passu therewith or Shares issued with preferred or other rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11</B></TD><TD STYLE="text-align: justify"><B>Commission on Sale of Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company may, in so far as the Statute
permits, pay a commission to any person in consideration of his subscribing or agreeing to subscribe (whether absolutely or conditionally)
or procuring or agreeing to procure subscriptions (whether absolutely or conditionally) for any Shares. Such commissions may be satisfied
by the payment of cash and/or the issue of fully or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage
as may be lawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12</B></TD><TD STYLE="text-align: justify"><B>Non Recognition of Trusts</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall not be bound by or
compelled to recognise in any way (even when notified) any equitable, contingent, future or partial interest in any Share, or (except
only as is otherwise provided by the Articles or the Statute) any other rights in respect of any Share other than an absolute right to
the entirety thereof in the holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13</B></TD><TD STYLE="text-align: justify"><B>Lien on Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.1</TD><TD STYLE="text-align: justify">The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered
in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether
presently payable or not) by such Member or his estate, either alone or jointly with any other person, whether a Member or not, but the
Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of a
transfer of any such Share shall operate as a waiver of the Company's lien thereon. The Company's lien on a Share shall also extend to
any amount payable in respect of that Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.2</TD><TD STYLE="text-align: justify">The Company may sell, in such manner as the Directors think fit, any Shares on which the Company has a
lien, if a sum in respect of which the lien exists is presently payable, and is not paid within fourteen clear days after notice has been
received or deemed to have been received by the holder of the Shares, or to the person entitled to it in consequence of the death or bankruptcy
of the holder, demanding payment and stating that if the notice is not complied with the Shares may be sold.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.3</TD><TD STYLE="text-align: justify">To give effect to any such sale the Directors may authorise any person to execute an instrument of transfer
of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or his nominee shall be registered as the
holder of the Shares comprised in any such transfer, and he shall not be bound to see to the application of the purchase money, nor shall
his title to the Shares be affected by any irregularity or invalidity in the sale or the exercise of the Company's power of sale under
the Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.4</TD><TD STYLE="text-align: justify">The net proceeds of such sale after payment of costs, shall be applied in payment of such part of the
amount in respect of which the lien exists as is presently payable and any balance shall (subject to a like lien for sums not presently
payable as existed upon the Shares before the sale) be paid to the person entitled to the Shares at the date of the sale.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14</B></TD><TD STYLE="text-align: justify"><B>Call on Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.1</TD><TD STYLE="text-align: justify">Subject to the terms of the allotment and issue of any Shares, the Directors may make calls upon the Members
in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each Member shall (subject to receiving
at least fourteen clear days' notice specifying the time or times of payment) pay to the Company at the time or times so specified the
amount called on the Shares. A call may be revoked or postponed, in whole or in part, as the Directors may determine. A call may be required
to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon him notwithstanding the subsequent
transfer of the Shares in respect of which the call was made.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.2</TD><TD STYLE="text-align: justify">A call shall be deemed to have been made at the time when the resolution of the Directors authorising
such call was passed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.3</TD><TD STYLE="text-align: justify">The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.4</TD><TD STYLE="text-align: justify">If a call remains unpaid after it has become due and payable, the person from whom it is due shall pay
interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the Directors may determine (and
in addition all expenses that have been incurred by the Company by reason of such non-payment), but the Directors may waive payment of
the interest or expenses wholly or in part.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.5</TD><TD STYLE="text-align: justify">An amount payable in respect of a Share on issue or allotment or at any fixed date, whether on account
of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all the provisions of the Articles
shall apply as if that amount had become due and payable by virtue of a call.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.6</TD><TD STYLE="text-align: justify">The Directors may issue Shares with different terms as to the amount and times of payment of calls, or
the interest to be paid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.7</TD><TD STYLE="text-align: justify">The Directors may, if they think fit, receive an amount from any Member willing to advance all or any
part of the monies uncalled and unpaid upon any Shares held by him, and may (until the amount would otherwise become payable) pay interest
at such rate as may be agreed upon between the Directors and the Member paying such amount in advance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.8</TD><TD STYLE="text-align: justify">No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of
a Dividend or other distribution payable in respect of any period prior to the date upon which such amount would, but for such payment,
become payable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>15</B></TD><TD STYLE="text-align: justify"><B>Forfeiture of Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.1</TD><TD STYLE="text-align: justify">If a call or instalment of a call remains unpaid after it has become due and payable the Directors may
give to the person from whom it is due not less than fourteen clear days' notice requiring payment of the amount unpaid together with
any interest which may have accrued and any expenses incurred by the Company by reason of such non-payment. The notice shall specify where
payment is to be made and shall state that if the notice is not complied with the Shares in respect of which the call was made will be
liable to be forfeited.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.2</TD><TD STYLE="text-align: justify">If the notice is not complied with, any Share in respect of which it was given may, before the payment
required by the notice has been made, be forfeited by a resolution of the Directors. Such forfeiture shall include all Dividends, other
distributions or other monies payable in respect of the forfeited Share and not paid before the forfeiture.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.3</TD><TD STYLE="text-align: justify">A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as
the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the
Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred to any person the Directors may authorise
some person to execute an instrument of transfer of the Share in favour of that person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.4</TD><TD STYLE="text-align: justify">A person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall
surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to pay to the Company all monies
which at the date of forfeiture were payable by him to the Company in respect of those Shares together with interest at such rate as the
Directors may determine, but his liability shall cease if and when the Company shall have received payment in full of all monies due and
payable by him in respect of those Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.5</TD><TD STYLE="text-align: justify">A certificate in writing under the hand of one Director or Officer that a Share has been forfeited on
a specified date shall be conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the Share. The
certificate shall (subject to the execution of an instrument of transfer) constitute a good title to the Share and the person to whom
the Share is sold or otherwise disposed of shall not be bound to see to the application of the purchase money, if any, nor shall his title
to the Share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the
Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.6</TD><TD STYLE="text-align: justify">The provisions of the Articles as to forfeiture shall apply in the case of non payment of any sum which,
by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the Share or by way of premium
as if it had been payable by virtue of a call duly made and notified.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>16</B></TD><TD STYLE="text-align: justify"><B>Transmission of Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.1</TD><TD STYLE="text-align: justify">If a Member dies, the survivor or survivors (where he was a joint holder), or his legal personal representatives
(where he was a sole holder), shall be the only persons recognised by the Company as having any title to his Shares. The estate of a deceased
Member is not thereby released from any liability in respect of any Share, for which he was a joint or sole holder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.2</TD><TD STYLE="text-align: justify">Any person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation or dissolution
of a Member (or in any other way than by transfer) may, upon such evidence being produced as may be required by the Directors, elect,
by a notice in writing sent by him to the Company, either to become the holder of such Share or to have some person nominated by him registered
as the holder of such Share. If he elects to have another person registered as the holder of such Share he shall sign an instrument of
transfer of that Share to that person. The Directors shall, in either case, have the same right to decline or suspend registration as
they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or dissolution,
as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.3</TD><TD STYLE="text-align: justify">A person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution
of a Member (or in any other case than by transfer) shall be entitled to the same Dividends, other distributions and other advantages
to which he would be entitled if he were the holder of such Share. However, he shall not, before becoming a Member in respect of a Share,
be entitled in respect of it to exercise any right conferred by membership in relation to general meetings of the Company and the Directors
may at any time give notice requiring any such person to elect either to be registered himself or to have some person nominated by him
be registered as the holder of the Share (but the Directors shall, in either case, have the same right to decline or suspend registration
as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or
dissolution or any other case than by transfer, as the case may be). If the notice is not complied with within ninety days of being received
or deemed to be received (as determined pursuant to the Articles), the Directors may thereafter withhold payment of all Dividends, other
distributions, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>17</B></TD><TD STYLE="text-align: justify"><B>Class&nbsp;B Ordinary Share Conversion</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.1</TD><TD STYLE="text-align: justify">The rights attaching to the Class&nbsp;A Shares and Class&nbsp;B Shares shall rank <I>pari passu</I> in
all respects, and the Class&nbsp;A Shares and Class&nbsp;B Shares shall vote together as a single class on all matters (subject to the
Variation of Rights of Shares Article&nbsp;and the Appointment and Removal of Directors Article&nbsp;hereof) with the exception that the
holder of a Class&nbsp;B Share shall have the conversion rights referred to in this Article.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.2</TD><TD STYLE="text-align: justify">Class&nbsp;B Shares shall automatically convert into Class&nbsp;A Shares on a one-for-one basis (the &quot;<B>Initial
Conversion Ratio</B>&quot;): (a)&nbsp;at any time and from time to time at the option of the holders thereof; or (b)&nbsp;automatically
on the day of the consummation of a Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.3</TD><TD STYLE="text-align: justify">Notwithstanding the Initial Conversion Ratio, in the case that additional Class&nbsp;A Shares or any other
Equity-linked Securities, are issued, or deemed issued, by the Company in excess of the amounts offered in the IPO and related to the
consummation of a Business Combination, all Class&nbsp;B Shares in issue shall automatically convert into Class&nbsp;A Shares at the time
of the consummation of a Business Combination at a ratio for which the Class&nbsp;B Shares shall convert into Class&nbsp;A Shares will
be adjusted (unless the holders of a majority of the Class&nbsp;B Shares in issue agree to waive such anti-dilution adjustment with respect
to any such issuance or deemed issuance) so that the number of Class&nbsp;A Shares issuable upon conversion of all Class&nbsp;B Shares
will equal, on an as-converted basis, in the aggregate, 20 per cent of the sum of all Class&nbsp;A Shares and Class&nbsp;B Shares in issue
upon completion of the IPO plus all Class&nbsp;A Shares and Equity-linked Securities issued or deemed issued or issuable upon conversion
or exercise of any Equity linked Securities or rights issued or deemed issued by the Company in connection with or in relation to a Business
Combination excluding any Class&nbsp;A Shares or Equity-linked Securities issued, deemed issued, or to be issued, to any seller in a Business
Combination and any private placement warrants issued to the Sponsor or its Affiliates upon conversion of working capital loans made to
the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.4</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary contained herein, the foregoing adjustment to the Initial Conversion
Ratio may be waived as to any particular issuance or deemed issuance of additional Class&nbsp;A Shares or Equity-linked Securities by
the written consent or agreement of holders of a majority of the Class&nbsp;B Shares then in issue consenting or agreeing separately as
a separate class in the manner provided in the Variation of Rights of Shares Article&nbsp;hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.5</TD><TD STYLE="text-align: justify">The foregoing conversion ratio shall also be adjusted to account for any subdivision (by share subdivision,
exchange, capitalisation, rights issue, reclassification, recapitalisation or otherwise) or combination (by share consolidation, exchange,
reclassification, recapitalisation or otherwise) or similar reclassification or recapitalisation of the Class&nbsp;A Shares in issue into
a greater or lesser number of shares occurring after the original filing of the Articles without a proportionate and corresponding subdivision,
combination or similar reclassification or recapitalisation of the Class&nbsp;B Shares in issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.6</TD><TD STYLE="text-align: justify">Each Class&nbsp;B Share shall convert into its pro rata number of Class&nbsp;A Shares pursuant to this
Article. The pro rata share for each holder of Class&nbsp;B Shares will be determined as follows: each Class&nbsp;B Share shall convert
into such number of Class&nbsp;A Shares as is equal to the product of 1 multiplied by a fraction, the numerator of which shall be the
total number of Class&nbsp;A Shares into which all of the Class&nbsp;B Shares in issue shall be converted pursuant to this Article&nbsp;and
the denominator of which shall be the total number of Class&nbsp;B Shares in issue at the time of conversion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.7</TD><TD STYLE="text-align: justify">References in this Article&nbsp;to &quot;<B>converted</B>&quot;, &quot;<B>conversion</B>&quot; or &quot;<B>exchange</B>&quot;
shall mean the compulsory redemption without notice of Class&nbsp;B Shares of any Member and, on behalf of such Members, automatic application
of such redemption proceeds in paying for such new Class&nbsp;A Shares into which the Class&nbsp;B Shares have been converted or exchanged
at a price per Class&nbsp;B Share necessary to give effect to a conversion or exchange calculated on the basis that the Class&nbsp;A Shares
to be issued as part of the conversion or exchange will be issued at par. The Class&nbsp;A Shares to be issued on an exchange or conversion
shall be registered in the name of such Member or in such name as the Member may direct.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.8</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary in this Article, in no event may any Class&nbsp;B Share convert
into Class&nbsp;A Shares at a ratio that is less than one-for-one.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>18</B></TD><TD STYLE="text-align: justify"><B>Amendments of Memorandum and Articles of Association and Alteration of Capital</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.1</TD><TD STYLE="text-align: justify">The Company may by Ordinary Resolution:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">increase its share capital by such sum as the Ordinary Resolution shall prescribe and with such rights,
priorities and privileges annexed thereto, as the Company in general meeting may determine;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">consolidate and divide all or any of its share capital into Shares of larger amount than its existing
Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">convert all or any of its paid-up Shares into stock, and reconvert that stock into paid-up Shares of any
denomination;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">by subdivision of its existing Shares or any of them divide the whole or any part of its share capital
into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">cancel any Shares that at the date of the passing of the Ordinary Resolution have not been taken or agreed
to be taken by any person and diminish the amount of its share capital by the amount of the Shares so cancelled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.2</TD><TD STYLE="text-align: justify">All new Shares created in accordance with the provisions of the preceding Article&nbsp;shall be subject
to the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise
as the Shares in the original share capital.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.3</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute and the provisions of the Articles as regards the matters to
be dealt with by Ordinary Resolution, the Company may by Special Resolution:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">change its name;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">alter or add to the Articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">alter or add to the Memorandum with respect to any objects, powers or other matters specified therein;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">reduce its share capital or any capital redemption reserve fund.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>19</B></TD><TD STYLE="text-align: justify"><B>Offices and Places of Business</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the provisions of the Statute,
the Company may by resolution of the Directors change the location of its Registered Office. The Company may, in addition to its Registered
Office, maintain such other offices or places of business as the Directors determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>20</B></TD><TD STYLE="text-align: justify"><B>General Meetings</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.1</TD><TD STYLE="text-align: justify">All general meetings other than annual general meetings shall be called extraordinary general meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.2</TD><TD STYLE="text-align: justify">The Company may, but shall not (unless required by the Statute) be obliged to, in each year hold a general
meeting as its annual general meeting, and shall specify the meeting as such in the notices calling it. Any annual general meeting shall
be held at such time and place as the Directors shall appoint. At these meetings the report of the Directors (if any) shall be presented.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.3</TD><TD STYLE="text-align: justify">The Directors, the chief executive officer or the chairman of the board of Directors may call general
meetings, and, for the avoidance of doubt, Members shall not have the ability to call general meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.4</TD><TD STYLE="text-align: justify">Members seeking to bring business before the annual general meeting or to nominate candidates for appointment
as Directors at the annual general meeting must deliver notice to the principal executive offices of the Company not less than 120 calendar
days before the date of the Company&rsquo;s proxy statement released to Members in connection with the previous year&rsquo;s annual general
meeting or, if the Company did not hold an annual general meeting the previous year, or if the date of the current year's annual general
meeting has been changed by more than 30 days from the date of the previous year&rsquo;s annual general meeting, then the deadline shall
be set by the board of Directors with such deadline being a reasonable time before the Company begins to print and send its related proxy
materials.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>21</B></TD><TD STYLE="text-align: justify"><B>Notice of General Meetings</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.1</TD><TD STYLE="text-align: justify">At least five clear days' notice shall be given of any general meeting. Every notice shall specify the
place, the day and the hour of the meeting and the general nature of the business to be conducted at the general meeting and shall be
given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general
meeting of the Company shall, whether or not the notice specified in this Article&nbsp;has been given and whether or not the provisions
of the Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in the case of an annual general meeting, by all of the Members entitled to attend and vote thereat; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in the case of an extraordinary general meeting, by a majority in number of the Members having a right
to attend and vote at the meeting, together holding not less than ninety-five per cent in par value of the Shares giving that right.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.2</TD><TD STYLE="text-align: justify">The accidental omission to give notice of a general meeting to, or the non receipt of notice of a general
meeting by, any person entitled to receive such notice shall not invalidate the proceedings of that general meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>22</B></TD><TD STYLE="text-align: justify"><B>Proceedings at General Meetings</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.1</TD><TD STYLE="text-align: justify">No business shall be transacted at any general meeting unless a quorum is present. The holders of a majority
of the Shares being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorised representative
or proxy shall be a quorum.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.2</TD><TD STYLE="text-align: justify">A person may participate at a general meeting by conference telephone or other communications equipment
by means of which all the persons participating in the meeting can communicate with each other. Participation by a person in a general
meeting in this manner is treated as presence in person at that meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.3</TD><TD STYLE="text-align: justify">A resolution (including a Special Resolution) in writing (in one or more counterparts) signed by or on
behalf of all of the Members for the time being entitled to receive notice of and to attend and vote at general meetings (or, being corporations
or other non-natural persons, signed by their duly authorised representatives) shall be as valid and effective as if the resolution had
been passed at a general meeting of the Company duly convened and held.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.4</TD><TD STYLE="text-align: justify">If a quorum is not present within half an hour from the time appointed for the meeting to commence, the
meeting shall stand adjourned to the same day in the next week at the same time and/or place or to such other day, time and/or place as
the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the
meeting to commence, the Members present shall be a quorum.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.5</TD><TD STYLE="text-align: justify">The Directors may, at any time prior to the time appointed for the meeting to commence, appoint any person
to act as chairman of a general meeting of the Company or, if the Directors do not make any such appointment, the chairman, if any, of
the board of Directors shall preside as chairman at such general meeting. If there is no such chairman, or if he shall not be present
within fifteen minutes after the time appointed for the meeting to commence, or is unwilling to act, the Directors present shall elect
one of their number to be chairman of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.6</TD><TD STYLE="text-align: justify">If no Director is willing to act as chairman or if no Director is present within fifteen minutes after
the time appointed for the meeting to commence, the Members present shall choose one of their number to be chairman of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.7</TD><TD STYLE="text-align: justify">The chairman may, with the consent of a meeting at which a quorum is present (and shall if so directed
by the meeting) adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting
other than the business left unfinished at the meeting from which the adjournment took place.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.8</TD><TD STYLE="text-align: justify">When a general meeting is adjourned for thirty days or more, notice of the adjourned meeting shall be
given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of an adjourned meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.9</TD><TD STYLE="text-align: justify">If, prior to a Business Combination, a notice is issued in respect of a general meeting and the Directors,
in their absolute discretion, consider that it is impractical or undesirable for any reason to hold that general meeting at the place,
the day and the hour specified in the notice calling such general meeting, the Directors may postpone the general meeting to another place,
day and/or hour provided that notice of the place, the day and the hour of the rearranged general meeting is promptly given to all Members.
No business shall be transacted at any postponed meeting other than the business specified in the notice of the original meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.10</TD><TD STYLE="text-align: justify">When a general meeting is postponed for thirty days or more, notice of the postponed meeting shall be
given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of a postponed meeting.&nbsp;All
proxy forms submitted for the original general meeting shall remain valid for the postponed meeting.&nbsp;The Directors may postpone a
general meeting which has already been postponed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.11</TD><TD STYLE="text-align: justify">A resolution put to the vote of the meeting shall be decided on a poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.12</TD><TD STYLE="text-align: justify">A poll shall be taken as the chairman directs, and the result of the poll shall be deemed to be the resolution
of the general meeting at which the poll was demanded.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.13</TD><TD STYLE="text-align: justify">A poll demanded on the election of a chairman or on a question of adjournment shall be taken forthwith.
A poll demanded on any other question shall be taken at such date, time and place as the chairman of the general meeting directs, and
any business other than that upon which a poll has been demanded or is contingent thereon may proceed pending the taking of the poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.14</TD><TD STYLE="text-align: justify">In the case of an equality of votes the chairman shall be entitled to a second or casting vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>23</B></TD><TD STYLE="text-align: justify"><B>Votes of Members</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.1</TD><TD STYLE="text-align: justify">Subject to any rights or restrictions attached to any Shares, every Member present in any such manner
shall have one vote for every Share of which he is the holder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.2</TD><TD STYLE="text-align: justify">In the case of joint holders the vote of the senior holder who tenders a vote, whether in person or by
proxy (or, in the case of a corporation or other non-natural person, by its duly authorised representative or proxy), shall be accepted
to the exclusion of the votes of the other joint holders, and seniority shall be determined by the order in which the names of the holders
stand in the Register of Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.3</TD><TD STYLE="text-align: justify">A Member of unsound mind, or in respect of whom an order has been made by any court, having jurisdiction
in lunacy, may vote by his committee, receiver, curator bonis, or other person on such Member's behalf appointed by that court, and any
such committee, receiver, curator bonis or other person may vote by proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.4</TD><TD STYLE="text-align: justify">No person shall be entitled to vote at any general meeting unless he is registered as a Member on the
record date for such meeting nor unless all calls or other monies then payable by him in respect of Shares have been paid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.5</TD><TD STYLE="text-align: justify">No objection shall be raised as to the qualification of any voter except at the general meeting or adjourned
general meeting at which the vote objected to is given or tendered and every vote not disallowed at the meeting shall be valid. Any objection
made in due time in accordance with this Article&nbsp;shall be referred to the chairman whose decision shall be final and conclusive.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.6</TD><TD STYLE="text-align: justify">Votes may be cast either personally or by proxy (or in the case of a corporation or other non-natural
person by its duly authorised representative or proxy). A Member may appoint more than one proxy or the same proxy under one or more instruments
to attend and vote at a meeting. Where a Member appoints more than one proxy the instrument of proxy shall specify the number of Shares
in respect of which each proxy is entitled to exercise the related votes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.7</TD><TD STYLE="text-align: justify">A Member holding more than one Share need not cast the votes in respect of his Shares in the same way
on any resolution and therefore may vote a Share or some or all such Shares either for or against a resolution and/or abstain from voting
a Share or some or all of the Shares and, subject to the terms of the instrument appointing him, a proxy appointed under one or more instruments
may vote a Share or some or all of the Shares in respect of which he is appointed either for or against a resolution and/or abstain from
voting a Share or some or all of the Shares in respect of which he is appointed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>24</B></TD><TD STYLE="text-align: justify"><B>Proxies</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.1</TD><TD STYLE="text-align: justify">The instrument appointing a proxy shall be in writing and shall be executed under the hand of the appointor
or of his attorney duly authorised in writing, or, if the appointor is a corporation or other non natural person, under the hand of its
duly authorised representative. A proxy need not be a Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.2</TD><TD STYLE="text-align: justify">The Directors may, in the notice convening any meeting or adjourned meeting, or in an instrument of proxy
sent out by the Company, specify the manner by which the instrument appointing a proxy shall be deposited and the place and the time (being
not later than the time appointed for the commencement of the meeting or adjourned meeting to which the proxy relates) at which the instrument
appointing a proxy shall be deposited. In the absence of any such direction from the Directors in the notice convening any meeting or
adjourned meeting or in an instrument of proxy sent out by the Company, the instrument appointing a proxy shall be deposited physically
at the Registered Office not less than 48 hours before the time appointed for the meeting or adjourned meeting to commence at which the
person named in the instrument proposes to vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.3</TD><TD STYLE="text-align: justify">The chairman may in any event at his discretion declare that an instrument of proxy shall be deemed to
have been duly deposited. An instrument of proxy that is not deposited in the manner permitted, or which has not been declared to have
been duly deposited by the chairman, shall be invalid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.4</TD><TD STYLE="text-align: justify">The instrument appointing a proxy may be in any usual or common form (or such other form as the Directors
may approve) and may be expressed to be for a particular meeting or any adjournment thereof or generally until revoked. An instrument
appointing a proxy shall be deemed to include the power to demand or join or concur in demanding a poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.5</TD><TD STYLE="text-align: justify">Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the
previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy was executed, or the
transfer of the Share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer
was received by the Company at the Registered Office before the commencement of the general meeting, or adjourned meeting at which it
is sought to use the proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>25</B></TD><TD STYLE="text-align: justify"><B>Corporate Members</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.1</TD><TD STYLE="text-align: justify">Any corporation or other non-natural person which is a Member may in accordance with its constitutional
documents, or in the absence of such provision by resolution of its directors or other governing body, authorise such person as it thinks
fit to act as its representative at any meeting of the Company or of any class of Members, and the person so authorised shall be entitled
to exercise the same powers on behalf of the corporation which he represents as the corporation could exercise if it were an individual
Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.2</TD><TD STYLE="text-align: justify">If a Clearing House (or its nominee(s)), being a corporation, is a Member, it may authorise such persons
as it sees fit to act as its representative at any meeting of the Company or at any meeting of any class of Members provided that the
authorisation shall specify the number and class of Shares in respect of which each such representative is so authorised. Each person
so authorised under the provisions of this Article&nbsp;shall be deemed to have been duly authorised without further evidence of the facts
and be entitled to exercise the same rights and powers on behalf of the Clearing House (or its nominee(s)) as if such person was the registered
holder of such Shares held by the Clearing House (or its nominee(s)).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>26</B></TD><TD STYLE="text-align: justify"><B>Shares that May&nbsp;Not be Voted</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Shares in the Company that are beneficially
owned by the Company shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number
of outstanding Shares at any given time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>27</B></TD><TD STYLE="text-align: justify"><B>Directors</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.1</TD><TD STYLE="text-align: justify">There shall be a board of Directors consisting of not less than one person provided however that the Company
may by Ordinary Resolution increase or reduce the limits in the number of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.2</TD><TD STYLE="text-align: justify">The Directors shall be divided into three classes: Class&nbsp;I, Class&nbsp;II and Class&nbsp;III. The
number of Directors in each class shall be as nearly equal as possible. Upon the adoption of the Articles, the existing Directors shall
by resolution classify themselves as Class&nbsp;I, Class&nbsp;II or Class&nbsp;III Directors. The Class&nbsp;I Directors shall stand appointed
for a term expiring at the Company&rsquo;s first annual general meeting, the Class&nbsp;II Directors shall stand appointed for a term
expiring at the Company&rsquo;s second annual general meeting and the Class&nbsp;III Directors shall stand appointed for a term expiring
at the Company&rsquo;s third annual general meeting. Commencing at the Company&rsquo;s first annual general meeting, and at each annual
general meeting thereafter, Directors appointed to succeed those Directors whose terms expire shall be appointed for a term of office
to expire at the third succeeding annual general meeting after their appointment. Except as the Statute or other Applicable Law may otherwise
require, in the interim between annual general meetings or extraordinary general meetings called for the appointment of Directors and/or
the removal of one or more Directors and the filling of any vacancy in that connection, additional Directors and any vacancies in the
board of Directors, including unfilled vacancies resulting from the removal of Directors for cause, may be filled by the vote of a majority
of the remaining Directors then in office, although less than a quorum (as defined in the Articles), or by the sole remaining Director.
All Directors shall hold office until the expiration of their respective terms of office and until their successors shall have been appointed
and qualified. A Director appointed to fill a vacancy resulting from the death, resignation or removal of a Director shall serve for the
remainder of the full term of the Director whose death, resignation or removal shall have created such vacancy and until his successor
shall have been appointed and qualified.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>28</B></TD><TD STYLE="text-align: justify"><B>Powers of Directors</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, the Memorandum and the Articles and to any directions given
by Special Resolution, the business of the Company shall be managed by the Directors who may exercise all the powers of the Company. No
alteration of the Memorandum or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid
if that alteration had not been made or that direction had not been given. A duly convened meeting of Directors at which a quorum is present
may exercise all powers exercisable by the Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.2</TD><TD STYLE="text-align: justify">All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments
and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed as the case may be in
such manner as the Directors shall determine by resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.3</TD><TD STYLE="text-align: justify">The Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any
Director who has held any other salaried office or place of profit with the Company or to his widow or dependants and may make contributions
to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.4</TD><TD STYLE="text-align: justify">The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its
undertaking, property and assets (present and future) and uncalled capital or any part thereof and to issue debentures, debenture stock,
mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the Company or of
any third party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>29</B></TD><TD STYLE="text-align: justify"><B>Appointment and Removal of Directors</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.1</TD><TD STYLE="text-align: justify">Prior to the consummation of a Business Combination, the Company may by Ordinary Resolution of the holders
of the Class&nbsp;B Shares appoint any person to be a Director or may by Ordinary Resolution of the holders of the Class&nbsp;B Shares
remove any Director. For the avoidance of doubt, prior to the consummation of a Business Combination, holders of Class&nbsp;A Shares shall
have no right to vote on the appointment or removal of any Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.2</TD><TD STYLE="text-align: justify">The Directors may appoint any person to be a Director, either to fill a vacancy or as an additional Director
provided that the appointment does not cause the number of Directors to exceed any number fixed by or in accordance with the Articles
as the maximum number of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.3</TD><TD STYLE="text-align: justify">After the consummation of a Business Combination, the Company may by Ordinary Resolution appoint any person
to be a Director or may by Ordinary Resolution remove any Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.4</TD><TD STYLE="text-align: justify">Prior to the consummation of a Business Combination, Article&nbsp;29.1 may only be amended by a Special
Resolution passed by at least two-thirds of such Members (which shall include a simple majority of the holders of Class&nbsp;B Shares)
as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of which notice specifying the
intention to propose the resolution as a special resolution has been given, or by way of unanimous written resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>30</B></TD><TD STYLE="text-align: justify"><B>Vacation of Office of Director</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The office of a Director shall be vacated
if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Director gives notice in writing to the Company that he resigns the office of Director; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Director absents himself (for the avoidance of doubt, without being represented by proxy) from three
consecutive meetings of the board of Directors without special leave of absence from the Directors, and the Directors pass a resolution
that he has by reason of such absence vacated office; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Director dies, becomes bankrupt or makes any arrangement or composition with his creditors generally;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the Director is found to be or becomes of unsound mind; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">all of the other Directors (being not less than two in number) determine that he should be removed as
a Director, either by a resolution passed by all of the other Directors at a meeting of the Directors duly convened and held in accordance
with the Articles or by a resolution in writing signed by all of the other Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>31</B></TD><TD STYLE="text-align: justify"><B>Proceedings of Directors</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.1</TD><TD STYLE="text-align: justify">The quorum for the transaction of the business of the Directors may be fixed by the Directors, and unless
so fixed shall be a majority of the Directors then in office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.2</TD><TD STYLE="text-align: justify">Subject to the provisions of the Articles, the Directors may regulate their proceedings as they think
fit. Questions arising at any meeting shall be decided by a majority of votes. In the case of an equality of votes, the chairman shall
have a second or casting vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.3</TD><TD STYLE="text-align: justify">A person may participate in a meeting of the Directors or any committee of Directors by conference telephone
or other communications equipment by means of which all the persons participating in the meeting can communicate with each other at the
same time. Participation by a person in a meeting in this manner is treated as presence in person at that meeting. Unless otherwise determined
by the Directors, the meeting shall be deemed to be held at the place where the chairman is located at the start of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.4</TD><TD STYLE="text-align: justify">A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of
a committee of the Directors or, in the case of a resolution in writing relating to the removal of any Director or the vacation of office
by any Director, all of the Directors other than the Director who is the subject of such resolution shall be as valid and effectual as
if it had been passed at a meeting of the Directors, or committee of Directors as the case may be, duly convened and held.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.5</TD><TD STYLE="text-align: justify">A Director may, or other Officer on the direction of a Director shall, call a meeting of the Directors
by at least two days' notice in writing to every Director which notice shall set forth the general nature of the business to be considered
unless notice is waived by all the Directors either at, before or after the meeting is held. To any such notice of a meeting of the Directors
all the provisions of the Articles relating to the giving of notices by the Company to the Members shall apply <I>mutatis mutandis.</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.6</TD><TD STYLE="text-align: justify">The continuing Directors (or a sole continuing Director, as the case may be) may act notwithstanding any
vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant to the Articles as the necessary
quorum of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to be equal to
such fixed number, or of summoning a general meeting of the Company, but for no other purpose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.7</TD><TD STYLE="text-align: justify">The Directors may elect a chairman of their board and determine the period for which he is to hold office;
but if no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time appointed for
the meeting to commence, the Directors present may choose one of their number to be chairman of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.8</TD><TD STYLE="text-align: justify">All acts done by any meeting of the Directors or of a committee of the Directors shall, notwithstanding
that it is afterwards discovered that there was some defect in the appointment of any Director, and/or that they or any of them were disqualified,
and/or had vacated their office and/or were not entitled to vote, be as valid as if every such person had been duly appointed and/or not
disqualified to be a Director and/or had not vacated their office and/or had been entitled to vote, as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.9</TD><TD STYLE="text-align: justify">A Director may be represented at any meetings of the board of Directors by a proxy appointed in writing
by him. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be deemed to be that of the appointing
Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>32</B></TD><TD STYLE="text-align: justify"><B>Presumption of Assent</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A Director who is present at a meeting
of the board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless
his dissent shall be entered in the minutes of the meeting or unless he shall file his written dissent from such action with the person
acting as the chairman or secretary of the meeting before the adjournment thereof or shall forward such dissent by registered post to
such person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director who voted in favour
of such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>33</B></TD><TD STYLE="text-align: justify"><B>Directors' Interests</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.1</TD><TD STYLE="text-align: justify">A Director may hold any other office or place of profit under the Company (other than the office of Auditor)
in conjunction with his office of Director for such period and on such terms as to remuneration and otherwise as the Directors may determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.2</TD><TD STYLE="text-align: justify">A Director may act by himself or by, through or on behalf of his firm in a professional capacity for the
Company and he or his firm shall be entitled to remuneration for professional services as if he were not a Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.3</TD><TD STYLE="text-align: justify">A Director may be or become a director or other officer of or otherwise interested in any company promoted
by the Company or in which the Company may be interested as a shareholder, a contracting party or otherwise, and no such Director shall
be accountable to the Company for any remuneration or other benefits received by him as a director or officer of, or from his interest
in, such other company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.4</TD><TD STYLE="text-align: justify">No person shall be disqualified from the office of Director or prevented by such office from contracting
with the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or transaction entered into by
or on behalf of the Company in which any Director shall be in any way interested be or be liable to be avoided, nor shall any Director
so contracting or being so interested be liable to account to the Company for any profit realised by or arising in connection with any
such contract or transaction by reason of such Director holding office or of the fiduciary relationship thereby established. A Director
shall be at liberty to vote in respect of any contract or transaction in which he is interested provided that the nature of the interest
of any Director in any such contract or transaction shall be disclosed by him at or prior to its consideration and any vote thereon.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.5</TD><TD STYLE="text-align: justify">A general notice that a Director is a shareholder, director, officer or employee of any specified firm
or company and is to be regarded as interested in any transaction with such firm or company shall be sufficient disclosure for the purposes
of voting on a resolution in respect of a contract or transaction in which he has an interest, and after such general notice it shall
not be necessary to give special notice relating to any particular transaction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>34</B></TD><TD STYLE="text-align: justify"><B>Minutes</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Directors shall cause minutes to
be made in books kept for the purpose of recording all appointments of Officers made by the Directors, all proceedings at meetings of
the Company or the holders of any class of Shares and of the Directors, and of committees of the Directors, including the names of the
Directors present at each meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>35</B></TD><TD STYLE="text-align: justify"><B>Delegation of Directors' Powers</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.1</TD><TD STYLE="text-align: justify">The Directors may delegate any of their powers, authorities and discretions, including the power to sub-delegate,
to any committee consisting of one or more Directors (including, without limitation, the Audit Committee, the Compensation Committee and
the Nominating Committee). Any such delegation may be made subject to any conditions the Directors may impose and either collaterally
with or to the exclusion of their own powers and any such delegation may be revoked or altered by the Directors. Subject to any such conditions,
the proceedings of a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they
are capable of applying.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.2</TD><TD STYLE="text-align: justify">The Directors may establish any committees, local boards or agencies or appoint any person to be a manager
or agent for managing the affairs of the Company and may appoint any person to be a member of such committees, local boards or agencies.
Any such appointment may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion
of their own powers and any such appointment may be revoked or altered by the Directors. Subject to any such conditions, the proceedings
of any such committee, local board or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they
are capable of applying.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.3</TD><TD STYLE="text-align: justify">The Directors may adopt formal written charters for committees and, if so adopted, shall review and assess
the adequacy of such formal written charters on an annual basis. Each of these committees shall be empowered to do all things necessary
to exercise the rights of such committee set forth in the Articles and shall have such powers as the Directors may delegate pursuant to
the Articles and as required by the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
and/or any other competent regulatory authority or otherwise under Applicable Law. Each of the Audit Committee, the Compensation Committee
and the Nominating Committee, if established, shall consist of such number of Directors as the Directors shall from time to time determine
(or such minimum number as may be required from time to time by the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities
and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law). For so long as any class of
Shares is listed on the Designated Stock Exchange, the Audit Committee, the Compensation Committee and the Nominating Committee shall
be made up of such number of Independent Directors as is required from time to time by the rules&nbsp;and regulations of the Designated
Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.4</TD><TD STYLE="text-align: justify">The Directors may by power of attorney or otherwise appoint any person to be the agent of the Company
on such conditions as the Directors may determine, provided that the delegation is not to the exclusion of their own powers and may be
revoked by the Directors at any time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.5</TD><TD STYLE="text-align: justify">The Directors may by power of attorney or otherwise appoint any company, firm, person or body of persons,
whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory of the Company for such purpose
and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Directors under the Articles) and
for such period and subject to such conditions as they may think fit, and any such powers of attorney or other appointment may contain
such provisions for the protection and convenience of persons dealing with any such attorneys or authorised signatories as the Directors
may think fit and may also authorise any such attorney or authorised signatory to delegate all or any of the powers, authorities and discretions
vested in him.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.6</TD><TD STYLE="text-align: justify">The Directors may appoint such Officers as they consider necessary on such terms, at such remuneration
and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors may think fit. Unless otherwise
specified in the terms of his appointment an Officer may be removed by resolution of the Directors or Members. An Officer may vacate his
office at any time if he gives notice in writing to the Company that he resigns his office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>36</B></TD><TD STYLE="text-align: justify"><B>No Minimum Shareholding</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company in general meeting may fix
a minimum shareholding required to be held by a Director, but unless and until such a shareholding qualification is fixed a Director is
not required to hold Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>37</B></TD><TD STYLE="text-align: justify"><B>Remuneration of Directors</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.1</TD><TD STYLE="text-align: justify">The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall
determine, provided that no cash remuneration shall be paid to any Director by the Company prior to the consummation of a Business Combination.
The Directors shall also, whether prior to or after the consummation of a Business Combination, be entitled to be paid all travelling,
hotel and other expenses properly incurred by them in connection with their attendance at meetings of Directors or committees of Directors,
or general meetings of the Company, or separate meetings of the holders of any class of Shares or debentures of the Company, or otherwise
in connection with the business of the Company or the discharge of their duties as a Director, or to receive a fixed allowance in respect
thereof as may be determined by the Directors, or a combination partly of one such method and partly the other.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.2</TD><TD STYLE="text-align: justify">The Directors may by resolution approve additional remuneration to any Director for any services which
in the opinion of the Directors go beyond his ordinary routine work as a Director. Any fees paid to a Director who is also counsel, attorney
or solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to his remuneration as a Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>38</B></TD><TD STYLE="text-align: justify"><B>Seal</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.1</TD><TD STYLE="text-align: justify">The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority
of the Directors or of a committee of the Directors authorised by the Directors. Every instrument to which the Seal has been affixed shall
be signed by at least one person who shall be either a Director or some Officer or other person appointed by the Directors for the purpose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.2</TD><TD STYLE="text-align: justify">The Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals
each of which shall be a facsimile of the common Seal of the Company and, if the Directors so determine, with the addition on its face
of the name of every place where it is to be used.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.3</TD><TD STYLE="text-align: justify">A Director or Officer, representative or attorney of the Company may without further authority of the
Directors affix the Seal over his signature alone to any document of the Company required to be authenticated by him under seal or to
be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>39</B></TD><TD STYLE="text-align: justify"><B>Dividends, Distributions and Reserve</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.1</TD><TD STYLE="text-align: justify">Subject to the Statute and this Article&nbsp;and except as otherwise provided by the rights attached to
any Shares, the Directors may resolve to pay Dividends and other distributions on Shares in issue and authorise payment of the Dividends
or other distributions out of the funds of the Company lawfully available therefor. A Dividend shall be deemed to be an interim Dividend
unless the terms of the resolution pursuant to which the Directors resolve to pay such Dividend specifically state that such Dividend
shall be a final Dividend. No Dividend or other distribution shall be paid except out of the realised or unrealised profits of the Company,
out of the share premium account or as otherwise permitted by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.2</TD><TD STYLE="text-align: justify">Except as otherwise provided by the rights attached to any Shares, all Dividends and other distributions
shall be paid according to the par value of the Shares that a Member holds. If any Share is issued on terms providing that it shall rank
for Dividend as from a particular date, that Share shall rank for Dividend accordingly.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.3</TD><TD STYLE="text-align: justify">The Directors may deduct from any Dividend or other distribution payable to any Member all sums of money
(if any) then payable by him to the Company on account of calls or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.4</TD><TD STYLE="text-align: justify">The Directors may resolve that any Dividend or other distribution be paid wholly or partly by the distribution
of specific assets and in particular (but without limitation) by the distribution of shares, debentures, or securities of any other company
or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as
they think expedient and in particular may issue fractional Shares and may fix the value for distribution of such specific assets or any
part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust
the rights of all Members and may vest any such specific assets in trustees in such manner as may seem expedient to the Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.5</TD><TD STYLE="text-align: justify">Except as otherwise provided by the rights attached to any Shares, Dividends and other distributions may
be paid in any currency. The Directors may determine the basis of conversion for any currency conversions that may be required and how
any costs involved are to be met.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.6</TD><TD STYLE="text-align: justify">The Directors may, before resolving to pay any Dividend or other distribution, set aside such sums as
they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable for any purpose of the Company
and pending such application may, at the discretion of the Directors, be employed in the business of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.7</TD><TD STYLE="text-align: justify">Any Dividend, other distribution, interest or other monies payable in cash in respect of Shares may be
paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered address of the holder or,
in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such person
and to such address as such holder or joint holders may in writing direct. Every such cheque or warrant shall be made payable to the order
of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, other distributions,
bonuses, or other monies payable in respect of the Share held by them as joint holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.8</TD><TD STYLE="text-align: justify">No Dividend or other distribution shall bear interest against the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.9</TD><TD STYLE="text-align: justify">Any Dividend or other distribution which cannot be paid to a Member and/or which remains unclaimed after
six months from the date on which such Dividend or other distribution becomes payable may, in the discretion of the Directors, be paid
into a separate account in the Company's name, provided that the Company shall not be constituted as a trustee in respect of that account
and the Dividend or other distribution shall remain as a debt due to the Member. Any Dividend or other distribution which remains unclaimed
after a period of six years from the date on which such Dividend or other distribution becomes payable shall be forfeited and shall revert
to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>40</B></TD><TD STYLE="text-align: justify"><B>Capitalisation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Directors may at any time capitalise
any sum standing to the credit of any of the Company's reserve accounts or funds (including the share premium account and capital redemption
reserve fund) or any sum standing to the credit of the profit and loss account or otherwise available for distribution; appropriate such
sum to Members in the proportions in which such sum would have been divisible amongst such Members had the same been a distribution of
profits by way of Dividend or other distribution; and apply such sum on their behalf in paying up in full unissued Shares for allotment
and distribution credited as fully paid-up to and amongst them in the proportion aforesaid. In such event the Directors shall do all acts
and things required to give effect to such capitalisation, with full power given to the Directors to make such provisions as they think
fit in the case of Shares becoming distributable in fractions (including provisions whereby the benefit of fractional entitlements accrue
to the Company rather than to the Members concerned). The Directors may authorise any person to enter on behalf of all of the Members
interested into an agreement with the Company providing for such capitalisation and matters incidental or relating thereto and any agreement
made under such authority shall be effective and binding on all such Members and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>41</B></TD><TD STYLE="text-align: justify"><B>Books of Account</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.1</TD><TD STYLE="text-align: justify">The Directors shall cause proper books of account (including, where applicable, material&nbsp;underlying
documentation including contracts and invoices) to be kept with respect to all sums of money received and expended by the Company and
the matters in respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets
and liabilities of the Company. Such books of account must be retained for a minimum period of five years from the date on which they
are prepared. Proper books shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true
and fair view of the state of the Company's affairs and to explain its transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.2</TD><TD STYLE="text-align: justify">The Directors shall determine whether and to what extent and at what times and places and under what conditions
or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors and
no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred
by Statute or authorised by the Directors or by the Company in general meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.3</TD><TD STYLE="text-align: justify">The Directors may cause to be prepared and to be laid before the Company in general meeting profit and
loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>42</B></TD><TD STYLE="text-align: justify"><B>Audit</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.1</TD><TD STYLE="text-align: justify">The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors
determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.2</TD><TD STYLE="text-align: justify">Without prejudice to the freedom of the Directors to establish any other committee, if the Shares (or
depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, and if required by the rules&nbsp;and regulations
of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise
under Applicable Law, the Directors shall establish and maintain an Audit Committee as a committee of the Directors and shall adopt a
formal written Audit Committee charter and review and assess the adequacy of the formal written charter on an annual basis. The composition
and responsibilities of the Audit Committee shall comply with the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities
and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. The Audit Committee shall meet
at least once every financial quarter, or more frequently as circumstances dictate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.3</TD><TD STYLE="text-align: justify">If the Shares (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange,
the Company shall conduct an appropriate review of all related party transactions on an ongoing basis and shall utilise the Audit Committee
for the review and approval of potential conflicts of interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.4</TD><TD STYLE="text-align: justify">The remuneration of the Auditor shall be fixed by the Audit Committee (if one exists).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.5</TD><TD STYLE="text-align: justify">If the office of Auditor becomes vacant by resignation or death of the Auditor, or by his becoming incapable
of acting by reason of illness or other disability at a time when his services are required, the Directors shall fill the vacancy and
determine the remuneration of such Auditor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.6</TD><TD STYLE="text-align: justify">Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers
of the Company and shall be entitled to require from the Directors and Officers such information and explanation as may be necessary for
the performance of the duties of the Auditor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.7</TD><TD STYLE="text-align: justify">Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their
tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the
Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of
a company which is registered with the Registrar of Companies as an exempted company, and at any other time during their term of office,
upon request of the Directors or any general meeting of the Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.8</TD><TD STYLE="text-align: justify">Any payment made to members of the Audit Committee (if one exists) shall require the review and approval
of the Directors, with any Director interested in such payment abstaining from such review and approval.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.9</TD><TD STYLE="text-align: justify">The Audit Committee shall monitor compliance with the terms of the IPO and, if any non-compliance is identified,
the Audit Committee shall be charged with the responsibility to take all action necessary to rectify such non-compliance or otherwise
cause compliance with the terms of the IPO.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.10</TD><TD STYLE="text-align: justify">At least one member of the Audit Committee shall be an &quot;audit committee financial expert&quot; as
determined by the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other
competent regulatory authority or otherwise under Applicable Law. The &quot;audit committee financial expert&quot; shall have such past
employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience
or background which results in the individual&rsquo;s financial sophistication.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>43</B></TD><TD STYLE="text-align: justify"><B>Notices</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.1</TD><TD STYLE="text-align: justify">Notices shall be in writing and may be given by the Company to any Member either personally or by sending
it by courier, post, cable, telex, fax or e-mail to him or to his address as shown in the Register of Members (or where the notice is
given by e-mail by sending it to the e-mail address provided by such Member). Notice may also be served by Electronic Communication in
accordance with the rules&nbsp;and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other
competent regulatory authority or by placing it on the Company&rsquo;s Website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.2</TD><TD STYLE="text-align: justify">Where a notice is sent by:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">courier; service of the notice shall be deemed to be effected by delivery of the notice to a courier company,
and shall be deemed to have been received on the third day (not including Saturdays or Sundays or public holidays) following the day on
which the notice was delivered to the courier;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">post; service of the notice shall be deemed to be effected by properly addressing, pre paying and posting
a letter containing the notice, and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or public
holidays in the Cayman Islands) following the day on which the notice was posted;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">cable, telex or fax; service of the notice shall be deemed to be effected by properly addressing and sending
such notice and shall be deemed to have been received on the same day that it was transmitted;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">e-mail or other Electronic Communication; service of the notice shall be deemed to be effected by transmitting
the e-mail to the e-mail address provided by the intended recipient and shall be deemed to have been received on the same day that it
was sent, and it shall not be necessary for the receipt of the e-mail to be acknowledged by the recipient; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">placing it on the Company&rsquo;s Website; service of the notice shall be deemed to have been effected
one hour after the notice or document was placed on the Company&rsquo;s Website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.3</TD><TD STYLE="text-align: justify">A notice may be given by the Company to the person or persons which the Company has been advised are entitled
to a Share or Shares in consequence of the death or bankruptcy of a Member in the same manner as other notices which are required to be
given under the Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the
bankrupt, or by any like description at the address supplied for that purpose by the persons claiming to be so entitled, or at the option
of the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.4</TD><TD STYLE="text-align: justify">Notice of every general meeting shall be given in any manner authorised by the Articles to every holder
of Shares carrying an entitlement to receive such notice on the record date for such meeting except that in the case of joint holders
the notice shall be sufficient if given to the joint holder first named in the Register of Members and every person upon whom the ownership
of a Share devolves by reason of his being a legal personal representative or a trustee in bankruptcy of a Member where the Member but
for his death or bankruptcy would be entitled to receive notice of the meeting, and no other person shall be entitled to receive notices
of general meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>44</B></TD><TD STYLE="text-align: justify"><B>Winding Up</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">44.1</TD><TD STYLE="text-align: justify">If the Company shall be wound up, the liquidator shall apply the assets of the Company in satisfaction
of creditors' claims in such manner and order as such liquidator thinks fit. Subject to the rights attaching to any Shares, in a winding
up:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">if the assets available for distribution amongst the Members shall be insufficient to repay the whole
of the Company's issued share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the
Members in proportion to the par value of the Shares held by them; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if the assets available for distribution amongst the Members shall be more than sufficient to repay the
whole of the Company's issued share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members
in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares
in respect of which there are monies due, of all monies payable to the Company for unpaid calls or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">44.2</TD><TD STYLE="text-align: justify">If the Company shall be wound up the liquidator may, subject to the rights attaching to any Shares and
with the approval of a Special Resolution of the Company and any other approval required by the Statute, divide amongst the Members in
kind the whole or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may
for that purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members.
The liquidator may, with the like approval, vest the whole or any part of such assets in trustees upon such trusts for the benefit of
the Members as the liquidator, with the like approval, shall think fit, but so that no Member shall be compelled to accept any asset upon
which there is a liability.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>45</B></TD><TD STYLE="text-align: justify"><B>Indemnity and Insurance</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.1</TD><TD STYLE="text-align: justify">Every Director and Officer (which for the avoidance of doubt, shall not include auditors of the Company),
together with every former Director and former Officer (each an &quot;<B>Indemnified Person</B>&quot;) shall be indemnified out of the
assets of the Company against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses,
whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions other than such
liability (if any) that they may incur by reason of their own actual fraud, wilful neglect or wilful default. No Indemnified Person shall
be liable to the Company for any loss or damage incurred by the Company as a result (whether direct or indirect) of the carrying out of
their functions unless that liability arises through the actual fraud, wilful neglect or wilful default of such Indemnified Person. No
person shall be found to have committed actual fraud, wilful neglect or wilful default under this Article&nbsp;unless or until a court
of competent jurisdiction shall have made a finding to that effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.2</TD><TD STYLE="text-align: justify">The Company shall advance to each Indemnified Person reasonable attorneys' fees and other costs and expenses
incurred in connection with the defence of any action, suit, proceeding or investigation involving such Indemnified Person for which indemnity
will or could be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking
to repay the advanced amount to the Company if it shall be determined by final judgment or other final adjudication that such Indemnified
Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final adjudication
that such Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then such party shall
not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the Company (without interest)
by the Indemnified Person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.3</TD><TD STYLE="text-align: justify">The Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director
or Officer against any liability which, by virtue of any rule&nbsp;of law, would otherwise attach to such person in respect of any negligence,
default, breach of duty or breach of trust of which such person may be guilty in relation to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>46</B></TD><TD STYLE="text-align: justify"><B>Financial Year</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Unless the Directors otherwise prescribe,
the financial year of the Company shall end on 31st December&nbsp;in each year and, following the year of incorporation, shall begin on
1st January&nbsp;in each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>47</B></TD><TD STYLE="text-align: justify"><B>Transfer by Way of Continuation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the Company is exempted as defined
in the Statute, it shall, subject to the provisions of the Statute and with the approval of a Special Resolution, have the power to register
by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the
Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>48</B></TD><TD STYLE="text-align: justify"><B>Mergers and Consolidations</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall have the power to
merge or consolidate with one or more other constituent companies (as defined in the Statute) upon such terms as the Directors may determine
and (to the extent required by the Statute) with the approval of a Special Resolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>49</B></TD><TD STYLE="text-align: justify"><B>Business Combination</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.1</TD><TD STYLE="text-align: justify">Notwithstanding any other provision of the Articles, this Article&nbsp;shall apply during the period commencing
upon the adoption of the Articles and terminating upon the first to occur of the consummation of a Business Combination and the full distribution
of the Trust Account pursuant to this Article. In the event of a conflict between this Article&nbsp;and any other Articles, the provisions
of this Article&nbsp;shall prevail.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.2</TD><TD STYLE="text-align: justify">Prior to the consummation of a Business Combination, the Company shall either:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">submit such Business Combination to its Members for approval; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">provide Members with the opportunity to have their Shares repurchased by means of a tender offer for a
per-Share repurchase price payable in cash, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business
days prior to the consummation of such Business Combination, including interest earned on the Trust Account (net of taxes paid or payable,
if any), divided by the number of then issued Public Shares, provided that the Company shall not repurchase Public Shares in an amount
that would cause the Company's net tangible assets to be less than US$5,000,001 following such repurchases. Such obligation to repurchase
Shares is subject to the completion of the proposed Business Combination to which it relates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.3</TD><TD STYLE="text-align: justify">If the Company initiates any tender offer in accordance with Rule&nbsp;13e-4 and Regulation 14E of the
Exchange Act in connection with a proposed Business Combination, it shall file tender offer documents with the Securities and Exchange
Commission prior to completing such Business Combination which contain substantially the same financial and other information about such
Business Combination and the redemption rights as is required under Regulation 14A of the Exchange Act. If, alternatively, the Company
holds a general meeting to approve a proposed Business Combination, the Company will conduct any redemptions in conjunction with a proxy
solicitation pursuant to Regulation 14A of the Exchange Act, and not pursuant to the tender offer rules, and file proxy materials with
the Securities and Exchange Commission.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.4</TD><TD STYLE="text-align: justify">At a general meeting called for the purposes of approving a Business Combination pursuant to this Article,
in the event that such Business Combination is approved by Ordinary Resolution, the Company shall be authorised to consummate such Business
Combination, provided that the Company shall not consummate such Business Combination unless the Company has net tangible assets of at
least US$5,000,001 immediately prior to, or upon such consummation of, or any greater net tangible asset or cash requirement that may
be contained in the agreement relating to, such Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.5</TD><TD STYLE="text-align: justify">Any Member holding Public Shares who is not the Sponsor, a Founder, Officer or Director may, at least
two business days&rsquo; prior to any vote on a Business Combination, elect to have their Public Shares redeemed for cash, in accordance
with any applicable requirements provided for in the related proxy materials (the &quot;<B>IPO Redemption</B>&quot;), provided that no
such Member acting together with any Affiliate of his or any other person with whom he is acting in concert or as a partnership, limited
partnership, syndicate, or other group for the purposes of acquiring, holding, or disposing of Shares may exercise this redemption right
with respect to more than 15 per cent of the Public Shares in the aggregate without the prior consent of the Company and provided further
that any beneficial holder of Public Shares on whose behalf a redemption right is being exercised must identify itself to the Company
in connection with any redemption election in order to validly redeem such Public Shares. If so demanded, the Company shall pay any such
redeeming Member, regardless of whether he is voting for or against such proposed Business Combination, a per-Share redemption price payable
in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation
of the Business Combination, including interest earned on the Trust Account (such interest shall be net of taxes payable) and not previously
released to the Company to pay its taxes, divided by the number of then issued Public Shares (such redemption price being referred to
herein as the &quot;<B>Redemption Price</B>&quot;), but only in the event that the applicable proposed Business Combination is approved
and consummated. The Company shall not redeem Public Shares that would cause the Company&rsquo;s net tangible assets to be less than US$5,000,001
following such redemptions (the &quot;<B>Redemption Limitation</B>&quot;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.6</TD><TD STYLE="text-align: justify">A Member may not withdraw a Redemption Notice once submitted to the Company unless the Directors determine
(in their sole discretion) to permit the withdrawal of such redemption request (which they may do in whole or in part).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.7</TD><TD STYLE="text-align: justify">In the event that the Company does not consummate a Business Combination within 15 months from the closing
of the IPO, or such later time as the Members may approve in accordance with the Articles, the Company shall:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">cease all operations except for the purpose of winding up;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares,
at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on
the funds held in the Trust Account and not previously released to the Company (less taxes payable and up to US$100,000 of interest to
pay dissolution expenses), divided by the number of then Public Shares in issue, which redemption will completely extinguish public Members'
rights as Members (including the right to receive further liquidation distributions, if any); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">as promptly as reasonably possible following such redemption, subject to the approval of the Company's
remaining Members and the Directors, liquidate and dissolve,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">subject in each case to its obligations
under Cayman Islands law to provide for claims of creditors and other requirements of Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.8</TD><TD STYLE="text-align: justify">Notwithstanding Article&nbsp;49.7 or any other provision of the Articles, without approval of the Members,
the Directors may, if requested by the Sponsor, its affiliates or designees and upon no less than five days&rsquo; advance notice to the
Company prior to the initial deadline referred to in Article&nbsp;49.7, extend the initial period of time to consummate a Business Combination
a maximum of two times, by an additional three months per extension, subject to the Sponsor, its affiliates or designees purchasing for
each such extension an additional 2,000,000 private placement warrants (or up to 2,300,000 private placement warrants if the Over-Allotment
Option is exercised in full) at $1.00 per warrant and depositing the US$2,000,000 (or up to US$2,300,000 if the Over-Allotment Option
is exercised in full) in proceeds into the Trust Account on or prior to the date of the expiration of the initial 15-month deadline, or
subsequent 18-month deadline, as applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.9</TD><TD STYLE="text-align: justify">In the event that any amendment is made to the Articles:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">to modify the substance or timing of the Company&rsquo;s obligation to allow redemption in connection
with a Business Combination or redeem 100 per cent of the Public Shares if the Company does not consummate a Business Combination within
15 months from the closing of the IPO or within any extension period as described in Article&nbsp;49.8, or such later time as the Members
may approve in accordance with the Articles; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">with respect to any other provision relating to Members&rsquo; rights or pre-Business Combination activity,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">each holder of Public Shares who is
not the Sponsor, a Founder, Officer or Director shall be provided with the opportunity to redeem their Public Shares upon the approval
or effectiveness of any such amendment at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust
Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes,
divided by the number of then outstanding Public Shares. The Company&rsquo;s ability to provide such redemption in this Article&nbsp;is
subject to the Redemption Limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.10</TD><TD STYLE="text-align: justify">A holder of Public Shares shall be entitled to receive distributions from the Trust Account only in the
event of an IPO Redemption, a repurchase of Shares by means of a tender offer pursuant to this Article, or a distribution of the Trust
Account pursuant to this Article. In no other circumstance shall a holder of Public Shares have any right or interest of any kind in the
Trust Account.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.11</TD><TD STYLE="text-align: justify">After the issue of Public Shares, and prior to the consummation of a Business Combination, the Company
shall not issue additional Shares or any other securities that would entitle the holders thereof to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">receive funds from the Trust Account; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">vote as a class with Public Shares on a Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.12</TD><TD STYLE="text-align: justify">The uninterested Independent Directors shall approve any transaction or transactions between the Company
and any of the following parties:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">any Member owning an interest in the voting power of the Company that gives such Member a significant
influence over the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any Director or Officer and any Affiliate of such Director or Officer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.13</TD><TD STYLE="text-align: justify">A Director may vote in respect of a Business Combination in which such Director has a conflict of interest
with respect to the evaluation of such Business Combination. Such Director must disclose such interest or conflict to the other Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.14</TD><TD STYLE="text-align: justify">As long as the securities of the Company are listed on the Nasdaq Capital Market, the Company must complete
one or more Business Combinations having an aggregate fair market value of at least 80 per cent of the assets held in the Trust Account
(excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the Company's
signing a definitive agreement in connection with a Business Combination. A Business Combination must not be effectuated with another
blank cheque company or a similar company with nominal operations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.15</TD><TD STYLE="text-align: justify">The Company may enter into a Business Combination with a target business that is Affiliated with the Sponsor,
a Founder, a Director or an Officer. In the event the Company seeks to consummate a Business Combination with a target that is Affiliated
with the Sponsor, a Founder, a Director or an Officer, the Company, or a committee of Independent Directors, will obtain an opinion from
an independent investment banking firm or another valuation or appraisal firm that regularly renders fairness opinions on the type of
target business the Company is seeking to acquire that is a member of the United States Financial Industry Regulatory Authority or an
independent accounting firm that such a Business Combination is fair to the Company from a financial point of view.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>50</B></TD><TD STYLE="text-align: justify"><B>Business Opportunities</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">50.1</TD><TD STYLE="text-align: justify">To the fullest extent permitted by Applicable Law, no individual serving as a Director or an Officer (&quot;<B>Management</B>&quot;)
shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same
or similar business activities or lines of business as the Company. To the fullest extent permitted by Applicable Law, the Company renounces
any interest or expectancy of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter
which may be a corporate opportunity for Management, on the one hand, and the Company, on the other. Except to the extent expressly assumed
by contract, to the fullest extent permitted by Applicable Law, Management shall have no duty to communicate or offer any such corporate
opportunity to the Company and shall not be liable to the Company or its Members for breach of any fiduciary duty as a Member, Director
and/or Officer solely by reason of the fact that such party pursues or acquires such corporate opportunity for itself, himself or herself,
directs such corporate opportunity to another person, or does not communicate information regarding such corporate opportunity to the
Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">50.2</TD><TD STYLE="text-align: justify">Except as provided elsewhere in this Article, the Company hereby renounces any interest or expectancy
of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate
opportunity for both the Company and Management, about which a Director and/or Officer who is also a member of Management acquires knowledge.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">50.3</TD><TD STYLE="text-align: justify">To the extent a court might hold that the conduct of any activity related to a corporate opportunity that
is renounced in this Article&nbsp;to be a breach of duty to the Company or its Members, the Company hereby waives, to the fullest extent
permitted by Applicable Law, any and all claims and causes of action that the Company may have for such activities. To the fullest extent
permitted by Applicable Law, the provisions of this Article&nbsp;apply equally to activities conducted in the future and that have been
conducted in the past.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>tm216731d39_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B><I>Execution
Version</I></B></P>

<P STYLE="margin: 0; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PUBLIC WARRANT AGREEMENT<BR>
between<BR>
SPRING VALLEY ACQUISITION CORP. II<BR>
and<BR>
CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of October&nbsp;12, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS WARRANT AGREEMENT (this
 &ldquo;<U>Agreement</U>&rdquo;), dated as of October&nbsp;12, 2022, is by and between Spring Valley Acquisition Corp. II, a Cayman Islands
exempted company (the &ldquo;<U>Company</U>&rdquo;), and Continental Stock Transfer&nbsp;&amp; Trust Company, a New York limited purpose
trust company, as warrant agent (the &ldquo;<U>Warrant Agent,</U>&rdquo; also referred to herein as the &ldquo;<U>Transfer Agent</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company is engaged
in an initial public offering (the &ldquo;<U>Offering</U>&rdquo;) of units of the Company&rsquo;s equity securities, each such unit comprised
of one Class&nbsp;A ordinary share, par value $0.0001 per share (&ldquo;<U>Ordinary Shares</U>&rdquo;), and one-half of one redeemable
Warrant (as defined below) (the &ldquo;<U>Units</U>&rdquo;) and, in connection therewith, has determined to issue and deliver up to 11,500,000
warrants (including up to 1,500,000 warrants subject to the Over-allotment Option) to public investors in the Offering (the &ldquo;<U>Warrants</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, each whole Warrant
entitles the holder thereof to purchase one whole Ordinary Share for $11.50 per share, subject to adjustment as described herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company has filed
with the U.S. Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) a registration statement on Form&nbsp;S-1, File
No.&nbsp;333-253156 (the &ldquo;<U>Registration Statement</U>&rdquo;) and prospectus (the &ldquo;<U>Prospectus</U>&rdquo;), for the registration,
under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the issuance of the Units, the Warrants and
the Ordinary Shares included in the Units;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration,
transfer, exchange, redemption and exercise of the Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights,
limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, all acts and things
have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or
on behalf of the Warrant Agent (if a physical certificate is issued), as provided herein, the valid, binding and legal obligations of
the Company, and to authorize the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual agreements herein contained, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>1</B></FONT></TD><TD STYLE="text-align: justify"><B><U>Appointment of Warrant Agent</U>.</B> The Company hereby appoints the Warrant Agent to act as agent
for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with
the express terms and conditions set forth in this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>2</B></FONT></TD><TD STYLE="text-align: justify"><B>Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Form&nbsp;of
Warrant</U>. Each Warrant shall initially be issued in registered form only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Effect
of Countersignature</U>. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement,
a certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Warrant
Register</U>. The Warrant Agent shall maintain books (the &ldquo;<U>Warrant Register</U>&rdquo;) for the registration of the initial issuance
of the Warrants and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants in book-entry form, the Warrant
Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance
with instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Warrants shall be shown on,
and the transfer of such ownership shall be effected through, records maintained by institutions that have accounts with The Depository
Trust Company (the &ldquo;<U>Depository</U>&rdquo;) (such institution, with respect to a Warrant in its account, a &ldquo;<U>Participant</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If the Depository subsequently
ceases to make its book-entry settlement system available for the Warrants, the Company may instruct the Warrant Agent regarding making
other arrangements for book-entry settlement. In the event that the Warrants are not eligible for, or it is no longer necessary to have
the Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depository to deliver to the Warrant
Agent for cancellation each book-entry Warrant, and the Company shall instruct the Warrant Agent to deliver to the Depository definitive
certificates in physical form evidencing such Warrants which shall be in the form annexed hereto as <U>Exhibit&nbsp;A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Physical certificates, if issued,
shall be signed by, or bear the facsimile signature of, the Chairman of the board of directors of the Company (the &ldquo;<U>Board</U>&rdquo;),
Chief Executive Officer, Chief Financial Officer, the President or the Secretary or other principal officer of the Company. In the event
the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person
signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the
date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registered
Holder</U>. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat
the person in whose name such Warrant is registered in the Warrant Register (the &ldquo;<U>Registered Holder</U>&rdquo;) as the absolute
owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on any physical
certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes,
and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Detachability
of Warrants</U>. The Ordinary Shares and Warrants comprising the Units shall begin separate trading on the fifty-second (52<SUP>nd</SUP>)
day following the date of the Prospectus or, if such fifty-second (52<SUP>nd</SUP>) day is not on a day other than a Saturday, Sunday
or federal holiday on which banks in New York City are generally open for normal business (a &ldquo;<U>Business Day</U>&rdquo;), then
on the immediately succeeding Business Day following such date, or earlier (the &ldquo;<U>Detachment Date</U>&rdquo;) with the consent
of Citigroup Global Markets Inc., as representative of the several underwriters, but in no event shall the Ordinary Shares and the Warrants
comprising the Units be separately traded until (A)&nbsp;the Company has filed a current report on Form&nbsp;8-K with the Commission containing
an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including the proceeds received
by the Company from the exercise by the underwriters of their right to purchase additional Units in the Offering (the &ldquo;<U>Over-allotment
Option</U>&rdquo;), if the Over-allotment Option is exercised or waived prior to the filing of such current report on Form&nbsp;8-K, and
(B)&nbsp;the Company issues a press release and files with the Commission a current report on Form&nbsp;8-K announcing when such separate
trading shall begin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Fractional Warrants Other Than as Part&nbsp;of Units</U>. The Company shall not issue fractional Warrants other than as part of the Units,
each of which is comprised of one Ordinary Share and one-third of one Warrant. If, upon the detachment of Warrants from Units or otherwise,
a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number the number
of Warrants to be issued to such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>3</B></FONT></TD><TD STYLE="text-align: justify"><B>Terms and Exercise of Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Warrant
Price</U>. Each whole Warrant, when countersigned by the Warrant Agent, shall entitle the Registered Holder thereof, subject to the provisions
of such Warrant and of this Agreement, to purchase from the Company the number of Ordinary Shares stated therein, at the price of $11.50
per share, subject to the adjustments provided in <U>Section&nbsp;4</U> hereof and in the last sentence of this <U>Section&nbsp;3.1</U>.
The term &ldquo;<U>Warrant Price</U>&rdquo; as used in this Agreement shall mean the price per share at which each Ordinary Share may
be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the
Expiration Date (as defined below) for a period of not less than twenty (20) Business Days, <U>provided</U>, that the Company shall provide
at least twenty (20) days prior written notice of such reduction to Registered Holders of the Warrants and, <U>provided</U>, <U>further</U>,
that any such reduction shall be identical among all of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Duration
of Warrants</U>. A Warrant may be exercised only during the period (the &ldquo;<U>Exercise Period</U>&rdquo;) commencing on the later
of: (i)&nbsp;the date that is thirty (30) days after the first date on which the Company completes a merger, consolidation, share exchange,
asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more businesses or
entities (a &ldquo;<U>Business Combination</U>&rdquo;), or (ii)&nbsp;the date that is twelve (12) months from the date of the closing
of the Offering and terminating at the earlier to occur of; (x)&nbsp;5:00 p.m., New York City time on the date that is five (5)&nbsp;years
after the date on which the Company completes its initial Business Combination, (y)&nbsp;the liquidation of the Company, or (z)&nbsp;5:00
p.m., New York City time on the Redemption Date (as defined below) as provided in <U>Section&nbsp;6.2</U> hereof (the &ldquo;<U>Expiration
Date</U>&rdquo;); <U>provided</U>, <U>however</U>, that the exercise of any Warrant shall be subject to the satisfaction of any applicable
conditions, as set forth in <U>subsection 3.3.2</U> hereof, with respect to an effective registration statement. Except with respect to
the right to receive the Redemption Price (as defined below), in the event of a redemption (as set forth in <U>Section&nbsp;6</U> hereof),
each Warrant not exercised on or before the Expiration Date shall become null and void, and all rights thereunder and all rights in respect
thereof under this Agreement shall cease at 5:00 p.m., New York City time on the Expiration Date. The Company in its sole discretion may
extend the duration of the Warrants by delaying the Expiration Date; <U>provided</U>, that the Company shall provide at least twenty (20)
days prior written notice of any such extension to Registered Holders of the Warrants and, <U>provided</U>, <U>further</U>, that any such
extension shall be identical in duration among all the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercise
of Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Payment</U>.
Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the Warrant Agent, may be exercised by the
Registered Holder thereof by surrendering it at the office of the Warrant Agent, or at the office of its successor as Warrant Agent, in
the Borough of Manhattan, City and State of New York, with the subscription form, as set forth in the Warrant, duly executed, and by paying
in full the Warrant Price for each full Ordinary Share as to which the Warrant is exercised and any and all applicable taxes due in connection
with the exercise of the Warrant, the exchange of the Warrant for the Ordinary Shares and the issuance of such Ordinary Share, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD STYLE="text-align: justify">in lawful money of the United States, in good certified check or good bank draft payable to the Warrant
Agent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD STYLE="text-align: justify">in the event of a redemption pursuant to <U>Section&nbsp;6.1</U> hereof in which the Board has elected
to require all holders of the Warrants to exercise such Warrants on a &ldquo;cashless basis,&rdquo; by surrendering the Warrants for that
number of Ordinary Shares equal to the quotient obtained by dividing (x)&nbsp;the product of the number of Ordinary Shares underlying
the Warrants, multiplied by the difference between the Warrant Price and the &ldquo;<U>Fair Market Value</U>&rdquo;, as defined in this
<U>subsection 3.3.1(b)</U>&nbsp;by (y)&nbsp;the Fair Market Value. Solely for purposes of this <U>subsection 3.3.1(b)</U>&nbsp;and <U>Section&nbsp;6.1</U>,
the &ldquo;<U>Fair Market Value</U>&rdquo; shall mean the 10-Day Average Closing Price (as defined below) as of the date on which the
notice of redemption is sent to the holders of the Warrants, pursuant to <U>Section&nbsp;6.2</U> hereof; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD STYLE="text-align: justify">as provided in <U>Section&nbsp;7.4</U> hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Issuance
of Ordinary Shares on Exercise</U>. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment
of the Warrant Price (if payment is pursuant to <U>subsection 3.3.1(a)</U>&nbsp;hereof), the Company shall issue to the Registered Holder
of such Warrant a book-entry position or certificate, as applicable, for the number of full Ordinary Shares to which he, she or it is
entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in
full, a new book-entry position or countersigned Warrant, as applicable, for the number of Ordinary Shares as to which such Warrant shall
not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any Ordinary Shares pursuant to
the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities
Act with respect to the Ordinary Shares underlying the Warrants is then effective and a prospectus relating thereto is current or a valid
exemption from registration is available. No Warrant shall be exercisable and the Company shall not be obligated to issue Ordinary Shares
upon exercise of a Warrant unless the Ordinary Shares issuable upon such Warrant exercise has been registered, qualified or deemed to
be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants.
In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of
such Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless, in which case the
purchaser of a Unit containing such Warrants shall have paid the full purchase price for the Unit solely for the Ordinary Shares underlying
such Unit. In no event will the Company be required to net cash settle the Warrant exercise. The Company may require holders of Warrants
to settle the Warrant on a &ldquo;cashless basis&rdquo; pursuant to <U>Section&nbsp;7.4.2</U> hereof. If, by reason of any exercise of
Warrants on a &ldquo;cashless basis&rdquo;, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive
a fractional interest in an Ordinary Share, the Company shall round down to the nearest whole number the number of Ordinary Shares to
be issued to such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Valid
Issuance</U>. All Ordinary Shares issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued,
fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.3.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Date
of Issuance</U>. Each person in whose name any book-entry position or certificate, as applicable, for Ordinary Shares is issued shall
for all purposes be deemed to have become the holder of record of such Ordinary Shares on the date on which the Warrant, or book-entry
position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of
such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share
transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder
of such Ordinary Shares at the close of business on the next succeeding date on which the share transfer books or book-entry system of
the Warrant Agent are open.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.3.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Maximum
Percentage</U>. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained
in this <U>subsection 3.3.5</U>; however, no holder of a Warrant shall be subject to this <U>subsection 3.3.5</U> unless he, she or it
makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder&rsquo;s Warrant,
and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person
(together with such person&rsquo;s affiliates), to the Warrant Agent&rsquo;s actual knowledge, would beneficially own in excess of 9.8%,
or such other amount as a holder may specify (the &ldquo;<U>Maximum Percentage</U>&rdquo;) of the Ordinary Shares outstanding immediately
after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of Ordinary Shares beneficially owned
by such person and its affiliates shall include the number of Ordinary Shares issuable upon exercise of the Warrant with respect to which
the determination of such sentence is being made, but shall exclude Ordinary Shares that would be issuable upon (x)&nbsp;exercise of the
remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y)&nbsp;exercise or conversion
of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates
(including, without limitation, any convertible notes or convertible preferred share or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Securities Exchange Act of 1934, as amended
(the &ldquo;<U>Exchange Act</U>&rdquo;). For purposes of the Warrant, in determining the number of issued and outstanding Ordinary Shares,
the holder may rely on the number of issued and outstanding Ordinary Shares as reflected in (1)&nbsp;the Company&rsquo;s most recent annual
report on Form&nbsp;10-K, quarterly report on Form&nbsp;10-Q, current report on Form&nbsp;8-K or other public filing with the Commission
as the case may be, (2)&nbsp;a more recent public announcement by the Company or (3)&nbsp;any other notice by the Company or the Transfer
Agent setting forth the number of Ordinary Shares issued and outstanding. For any reason at any time, upon the written request of the
holder of the Warrant, the Company shall, within two (2)&nbsp;Business Days, confirm orally and in writing to such holder the number of
Ordinary Shares then outstanding. In any case, the number of issued and outstanding Ordinary Shares shall be determined after giving effect
to the conversion or exercise of equity securities of the Company by the holder and its affiliates since the date as of which such number
of issued and outstanding Ordinary Shares was reported. By written notice to the Company, the holder of a Warrant may from time to time
increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such notice; <U>provided</U>,
<U>however</U>, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>4</B></FONT></TD><TD STYLE="text-align: justify"><B>Adjustments.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Share
Dividends</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Share
Dividends and Split-Ups</U>. If after the date hereof, and subject to the provisions of <U>Section&nbsp;4.6</U> hereof, the number of
issued and outstanding Ordinary Shares is increased by a share dividend payable in Ordinary Shares, or by a split-up of Ordinary Shares,
or other similar event, then, on the effective date of such share dividend, split-up or similar event, the number of Ordinary Shares issuable
on exercise of each Warrant shall be increased in proportion to such increase in the issued and outstanding Ordinary Shares. A rights
offering to holders of Ordinary Shares entitling holders to purchase Ordinary Shares at a price less than the &ldquo;<U>Fair Market Value</U>&rdquo;
(as defined below) shall be deemed a share dividend of a number of Ordinary Shares equal to the product of (i)&nbsp;the number of Ordinary
Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible
into or exercisable for the Ordinary Shares) multiplied by (ii)&nbsp;one (1)&nbsp;minus the quotient of (x)&nbsp;the price per Ordinary
Share paid in such rights offering divided by (y)&nbsp;the Fair Market Value. For purposes of this <U>subsection 4.1.1</U>, if the rights
offering is for securities convertible into or exercisable for Ordinary Shares, in determining the price payable for the Ordinary Shares,
there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or
conversion. &ldquo;<U>10-Day Average Closing Price</U>&rdquo; means, as of any date, the average last reported sale price of the Ordinary
Shares as reported during the ten (10)&nbsp;trading day period ending on the trading day prior to such date. &ldquo;<U>Fair Market Value</U>&rdquo;
means the 10-Day Average Closing Price as of the first (1<SUP>st</SUP>) date on which the Ordinary Shares trade on the applicable exchange
or in the applicable market, regular way, without the right to receive such rights. Notwithstanding anything to the contrary herein, no
Ordinary Shares shall be issued at less than their par value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.1.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Extraordinary
Dividends</U>. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution
in cash, securities or other assets to the holders of the Ordinary Shares on account of such Ordinary Shares (or other shares of the Company&rsquo;s
share capital into which the Warrants are convertible), other than (a)&nbsp;as described in <U>subsection 4.1.1</U> above, (b)&nbsp;Ordinary
Cash Dividends (as defined below), (c)&nbsp;to satisfy the redemption rights of the holders of the Ordinary Shares in connection with
a proposed initial Business Combination, (d)&nbsp;to satisfy the redemption rights of the holders of Ordinary Shares in connection with
a shareholder vote to approve an amendment to the Company&rsquo;s amended and restated memorandum and articles of association to modify
the substance or timing of the Company&rsquo;s obligation to redeem 100% of the Ordinary Shares if the Company does not complete its initial
Business Combination within the period set forth in the Company&rsquo;s amended and restated memorandum and articles of association, or
(e)&nbsp;in connection with the redemption of the Ordinary Shares included in the Units sold in the Offering upon the Company&rsquo;s
failure to complete the Company&rsquo;s initial Business Combination (any such non-excluded event being referred to herein as an &ldquo;<U>Extraordinary
Dividend</U>&rdquo;), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary
Dividend, by the amount of cash and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets
paid on each Ordinary Share in respect of such Extraordinary Dividend. For purposes of this <U>subsection 4.1.2</U>, &ldquo;<U>Ordinary
Cash Dividends</U>&rdquo; means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts
of all other cash dividends and cash distributions paid on the Ordinary Shares during the 365-day period ending on the date of declaration
of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this <U>Section&nbsp;4</U>
and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of Ordinary Shares
issuable on exercise of each Warrant) does not exceed $0.50.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Aggregation
of Shares</U>. If after the date hereof, and subject to the provisions of <U>Section&nbsp;4.6</U> hereof, the number of issued and outstanding
Ordinary Shares is decreased by a consolidation, combination, reverse share split or reclassification of Ordinary Shares or other similar
event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number
of Ordinary Shares issuable on exercise of each Warrant shall be decreased in proportion to such decrease in issued and outstanding Ordinary
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Adjustments
in Warrant Price</U>. Whenever the number of Ordinary Shares purchasable upon the exercise of the Warrants is adjusted, as provided in
<U>Section&nbsp;4.1</U> or <U>4.2</U> hereof, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price
immediately prior to such adjustment by a fraction (x)&nbsp;the numerator of which shall be the number of Ordinary Shares purchasable
upon the exercise of the Warrants immediately prior to such adjustment, and (y)&nbsp;the denominator of which shall be the number of Ordinary
Shares so purchasable immediately thereafter. If, (a)&nbsp;in connection with the closing of the initial Business Combination, the Company
issues additional Ordinary Shares or securities of the Company which are convertible into, or exchangeable or exercisable for, equity
securities of the Company, including any securities issued by the Company which are pledged to secure any obligation of any holder to
purchase equity securities of the Company, at an issue price or effective issue price of less than $9.20 per Ordinary Share, with such
issue price or effective issue price to be determined in good faith by the Board (and in the case of any such issuance to the Sponsor
or its affiliates, without taking into account any Ordinary Shares of the Company issued prior to the Offering and held by the Sponsor
or such affiliates, as applicable, prior to such issuance) (the &ldquo;<U>Newly Issued Price</U>&rdquo;), (b)&nbsp;the aggregate gross
proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of
the initial Business Combination (net of redemptions), and (c)&nbsp;the volume weighted average trading price of the Ordinary Shares during
the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination
(such price, the &ldquo;<U>market value</U>&rdquo;) is below $9.20 per share, (i)&nbsp;the Warrant Price shall be adjusted (to the nearest
cent) to be equal to 115% of the higher of the market value and the Newly Issued Price, and (ii)&nbsp;the $18.00 per share redemption
trigger price described in <U>Section&nbsp;6.1</U> hereof shall be adjusted (to the nearest cent) to be equal to 180% of the higher of
the market value and the Newly Issued Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Replacement
of Securities upon Reorganization,&nbsp;etc.</U> In case of any reclassification or reorganization of the issued and outstanding Ordinary
Shares (other than a change covered by <U>Section&nbsp;4.1</U> or <U>4.2</U> hereof or that solely affects the par value of such Ordinary
Shares), or in the case of any merger or consolidation of the Company with or into another entity in which any &ldquo;person&rdquo; or
 &ldquo;group&rdquo; (as such terms are used in Section&nbsp;13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act) acquires more than 50% of the
voting power of the Company&rsquo;s securities, or in the case of any sale or conveyance to another corporation or entity of the assets
or other property of the Company as an entirety or substantially as an entirety, the holders of the Warrants shall thereafter have the
right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the Ordinary
Shares of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind
and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s)&nbsp;immediately
prior to such event (the &ldquo;<U>Alternative Issuance</U>&rdquo;); <U>provided</U>, <U>however</U>, that if the holders of the Ordinary
Shares were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such
consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which
each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders
of the Ordinary Shares in such consolidation or merger that affirmatively make such election; <U>provided</U>, <U>further</U>, that if
less than seventy percent (70%) of the consideration receivable by the holders of the Ordinary Shares in the applicable event is payable
in the form of ordinary shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an
established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered
Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event
by the Company pursuant to a current report on Form&nbsp;8-K filed with the Commission, the Warrant Price shall be reduced by an amount
(in dollars) equal to the difference of (i)&nbsp;the Warrant Price in effect prior to such reduction minus (ii)&nbsp;(A)&nbsp;the Per
Share Consideration (as defined below) (but in no event less than zero) minus (B)&nbsp;the Black-Scholes Warrant Value (as defined below).
The &ldquo;<U>Black-Scholes Warrant Value</U>&rdquo; means the value of a Warrant immediately prior to the consummation of the applicable
event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (&ldquo;<U>Bloomberg</U>&rdquo;),
as calculated by an accounting, appraisal, investment banking firm or consultant of nationally recognized standing that is, in the good
faith judgment of the Board, qualified to make such calculation. For purposes of calculating such amount, (1)&nbsp;<U>Section&nbsp;6.1
</U>shall be taken into account, (2)&nbsp;the price of each Ordinary Share shall be the 10-Day Average Closing Price as of the effective
date of the applicable event, (3)&nbsp;the assumed volatility shall be the ninety (90) day volatility obtained from the HVT function on
Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4)&nbsp;the
assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. &ldquo;<U>Per
Share Consideration</U>&rdquo; means (i)&nbsp;if the consideration paid to holders of the Ordinary Shares consists exclusively of cash,
the amount of such cash per Ordinary Share, and (ii)&nbsp;in all other cases, the average last reported sale price of the Ordinary Shares
as reported during the ten (10)&nbsp;trading day period ending on the trading day prior to the effective date of the applicable event.
If any reclassification or reorganization also results in a change in Ordinary Shares covered by <U>subsection 4.1.1</U> hereof, then
such adjustment shall be made pursuant to <U>subsection 4.1.1</U> or <U>Sections 4.2</U>, or <U>4.3</U> hereof and this <U>Section&nbsp;4.4</U>.
The provisions of this <U>Section&nbsp;4.4</U> shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations,
sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of
the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notices
of Changes in Warrant</U>. Upon every adjustment of the Warrant Price or the number of Ordinary Shares issuable upon exercise of a Warrant,
the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment
and the increase or decrease, if any, in the number of Ordinary Shares purchasable at such price upon the exercise of a Warrant, setting
forth in reasonable detail the method of calculation and the facts upon which such calculation is based; <U>provided</U>, <U>however</U>,
that no adjustment to the number of Ordinary Shares issuable upon exercise of a Warrant shall be required until cumulative adjustments
amount to one percent (1%) or more of the number of Ordinary Shares issuable upon exercise of a Warrant as last adjusted; <U>provided</U>,
<U>further</U>, that any such adjustments that are not made are carried forward and taken into account in any subsequent adjustment. Notwithstanding
the foregoing, all such carried forward adjustments shall be made (i)&nbsp;in connection with any subsequent adjustment that (taken together
with such carried forward adjustments) would result in a change of at least one percent (1%) in the number of Ordinary Shares issuable
upon exercise of a Warrant and (ii)&nbsp;on the exercise date of any Warrant. Upon the occurrence of any event specified in <U>Sections
4.1</U>, <U>4.2</U>, <U>4.3</U> or <U>4.4</U> hereof, the Company shall give written notice of the occurrence of such event to each holder
of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event.
Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Fractional Shares</U>. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue a fractional
Ordinary Share upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this <U>Section&nbsp;4</U>, the holder
of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon
such exercise, round down to the nearest whole number the number of Ordinary Shares to be issued to such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Form&nbsp;of
Warrant</U>. The form of Warrant need not be changed because of any adjustment pursuant to this <U>Section&nbsp;4</U>, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of Ordinary Shares as is stated in the Warrants initially issued
pursuant to this Agreement; <U>provided</U>, <U>however</U>, that the Company may at any time in its sole discretion make any change in
the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued
or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>5</B></FONT></TD><TD STYLE="text-align: justify"><B>Transfer and Exchange of Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registration
of Transfer</U>. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register,
upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions
for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant
shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant
Agent to the Company from time to time upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Procedure
for Surrender of Warrants</U>. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer,
and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the
Warrants so surrendered, representing an equal aggregate number of Warrants; <U>provided</U>, <U>however</U>, that in the event that a
Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in
exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and
indicating whether the new Warrants must also bear a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Transfers
of Fractions of Warrants</U>. The Warrant Agent shall not be required to effect any registration of transfer or exchange of Warrants which
would require the issuance of a Warrant certificate or book-entry position for a fraction of a Warrant, except as part of the Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Service
Charges</U>. No service charge shall be made for any exchange or registration of transfer of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Warrant
Execution and Countersignature</U>. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms
of this Agreement, the Warrants required to be issued pursuant to the provisions of this <U>Section&nbsp;5</U>, and the Company, whenever
required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Transfer
of Warrants</U>. Prior to the Detachment Date, the Warrants may be transferred or exchanged only together with the Unit in which such
Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore,
each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding
the foregoing, the provisions of this <U>Section&nbsp;5.6</U> shall have no effect on any transfer of Warrants on and after the Detachment
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>6</B></FONT></TD><TD STYLE="text-align: justify"><B>Redemption of Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Redemption
of Warrants for Cash</U>. All, but not less than all, of the outstanding Warrants may be redeemed for cash, at the option of the Company,
at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as
described in <U>Section&nbsp;6.2</U> hereof, at a Redemption Price of $0.01 per Warrant, <U>provided</U> that the last reported sale price
of the Ordinary Shares has been at least $18.00 per share (subject to adjustment in compliance with <U>Section&nbsp;4</U> hereof), on
each of twenty (20) trading days within the thirty (30) trading day period ending on the third (3<SUP>rd</SUP>) trading day prior to the
date on which notice of the redemption is given and <U>provided</U>, that there is an effective registration statement covering the Ordinary
Shares issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period
(as defined in <U>Section&nbsp;6.2</U> hereof) or the Company has elected to require the exercise of the Warrants on a &ldquo;cashless
basis&rdquo; pursuant to <U>subsection 3.3.1(b)</U>&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Date
Fixed for, and Notice of Redemption; Redemption Price</U>. In the event that the Company elects to redeem the Warrants pursuant to <U>Section&nbsp;6.1
</U>hereof, the Company shall fix a date for the redemption (the &ldquo;<U>Redemption Date</U>&rdquo;). Notice of redemption shall be
mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the &ldquo;<U>30-day
Redemption Period</U>&rdquo;) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on
the registration books. As used in this Agreement, &ldquo;<U>Redemption Price</U>&rdquo; shall mean the price per Warrant at which any
Warrants are redeemed pursuant to <U>Section&nbsp;6.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercise
After Notice of Redemption</U>. The Warrants may be exercised, for cash (or on a &ldquo;cashless basis&rdquo; pursuant to <U>subsection
3.3.1(b)</U>&nbsp;hereof, if applicable) at any time after notice of redemption shall have been given by the Company pursuant to <U>Section&nbsp;6.2
</U>hereof and prior to the Redemption Date. In the event that the Company determines to require all holders of Warrants to exercise their
Warrants on a &ldquo;cashless basis&rdquo; pursuant to <U>subsection 3.3.1(b)</U>&nbsp;hereof, the notice of redemption shall contain
instructions on how to calculate the number of Ordinary Shares to be received upon exercise of the Warrants. On and after the Redemption
Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption
Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>7</B></FONT></TD><TD STYLE="text-align: justify"><B>Other Provisions Relating to Rights of Holders of Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Rights as Shareholder</U>. A Warrant does not entitle the Registered Holder thereof to any of the rights of a shareholder of the Company,
including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent
or to receive notice as shareholder in respect of the meetings of shareholders or the election of directors of the Company or any other
matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Lost,
Stolen, Mutilated, or Destroyed Warrants</U>. If any Warrant is lost, stolen, mutilated or destroyed, the Company and the Warrant Agent
may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant,
include the surrender thereof), issue a new Warrant of like denomination, tenor and date as the Warrant so lost, stolen, mutilated or
destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost,
stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Reservation
of Ordinary Shares</U>. The Company shall at all times reserve and keep available a number of its authorized but unissued Ordinary Shares
that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registration
of Ordinary Shares; Cashless Exercise at Company&rsquo;s Option</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registration
of Ordinary Shares</U>. The Company agrees that as soon as practicable, but in no event later than twenty (20) Business Days after the
closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a registration
statement for the registration, under the Securities Act, of the Ordinary Shares issuable upon exercise of the Warrants. The Company shall
use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement,
and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of this
Agreement. If any such registration statement has not been declared effective by the sixtieth (60<SUP>th</SUP>) Business Day following
the closing of the Company&rsquo;s initial Business Combination, holders of the Warrants shall have the right, during the period beginning
on the sixty-first (61<SUP>st</SUP>) Business Day after the closing of the Company&rsquo;s initial Business Combination and ending upon
such registration statement being declared effective by the Commission, and during any other period when the Company shall fail to have
maintained an effective registration statement covering the Ordinary Shares issuable upon exercise of the Warrants, to exercise such Warrants
on a &ldquo;cashless basis,&rdquo; by exchanging the Warrants (in accordance with Section&nbsp;3(a)(9)&nbsp;of the Securities Act (or
any successor statute) or another exemption) for that number of Ordinary Shares per Warrant equal to (A)&nbsp;the quotient obtained by
dividing (x)&nbsp;the excess of the 10-Day Average Closing Price as of the date of exchange over the Warrant Price by (y)&nbsp;10-Day
Average Closing Price as of the date of exchange. The date that notice of cashless exercise is received by the Warrant Agent shall be
conclusively determined by the Warrant Agent. In connection with the &ldquo;cashless exercise&rdquo; of a Warrant, the Company shall,
upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities
law experience) stating that (i)&nbsp;the exercise of the Warrants on a cashless basis in accordance with this <U>subsection 7.4.1</U>
is not required to be registered under the Securities Act and (ii)&nbsp;the Ordinary Shares issued upon such exercise shall be freely
tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule&nbsp;144 under
the Securities Act (or any successor rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except
as provided in <U>subsection 7.4.2</U> hereof, for the avoidance of any doubt, unless and until all of the Warrants have been exercised,
the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this <U>subsection
7.4.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Cashless
Exercise at Company&rsquo;s Option</U>. If the Ordinary Shares are at the time of any exercise of a Warrant not listed on a national securities
exchange such that they satisfy the definition of a &ldquo;covered security&rdquo; under Section&nbsp;18(b)(1)&nbsp;of the Securities
Act (or any successor statute), the Company may, at its option, (i)&nbsp;require holders of Warrants who exercise Warrants to exercise
such Warrants on a &ldquo;cashless basis&rdquo; in accordance with Section&nbsp;3(a)(9)&nbsp;of the Securities Act (or any successor statute)
as described in <U>subsection 7.4.1</U> hereof and (ii)&nbsp;in the event the Company so elects, the Company shall (x)&nbsp;not be required
to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Ordinary Shares issuable
upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary and (y)&nbsp;use its commercially reasonable
efforts to register or qualify for sale the Ordinary Shares issuable upon exercise of the Warrants under the blue sky laws of the state
of residence of the exercising Warrant holder to the extent an exemption is not available. To exercise the Warrants on a cashless basis
pursuant to <U>Section&nbsp;7.4.2</U>, each Registered Holder would pay the Warrant Price by surrendering the Warrants in exchange for
a number of Ordinary Shares equal to the quotient obtained by dividing (i)&nbsp;the product of (A)&nbsp;the number of the Ordinary Shares
underlying the Warrants and (B)&nbsp;the excess of the &ldquo;<U>Fair Market Value</U>&rdquo; (as defined in this <U>subsection 7.4.2</U>)
over the Warrant Price of the Warrants by (ii)&nbsp;the Fair Market Value. Solely for purposes of this <U>subsection 7.4.2</U>, the &ldquo;<U>Fair
Market Value</U>&rdquo; shall mean 10-Day Average Trading Price as of the date on which the notice of exercise is received by the Warrant
Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>8</B></FONT></TD><TD STYLE="text-align: justify"><B>Concerning the Warrant Agent and Other Matters.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">8.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Payment
of Taxes</U>. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant
Agent in respect of the issuance or delivery of Ordinary Shares upon the exercise of the Warrants, but the Company and the Warrant Agent
shall not be obligated to pay any transfer taxes in respect of the Warrants or such Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">8.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Resignation,
Consolidation, or Merger of Warrant Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Appointment
of Successor Warrant Agent</U>. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days&rsquo; notice in writing to the Company. If the office
of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after
it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with
such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court
of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company&rsquo;s cost. Any
successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing
under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State
of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or
state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties,
and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further
act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the
expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor
Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any
and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority,
powers, rights, immunities, duties, and obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice
of Successor Warrant Agent</U>. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the
predecessor Warrant Agent and the Transfer Agent for the Ordinary Shares not later than the effective date of any such appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Merger
or Consolidation of Warrant Agent</U>. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any
entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under
this Agreement without any further act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">8.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Fees
and Expenses of Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Remuneration</U>.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant
to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably
incur in the execution of its duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Further
Assurances</U>. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and
delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying
out or performing of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">8.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Liability
of Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Reliance
on Company Statement</U>. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or
desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact
or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established
by a statement signed by the Chairman of the Board, Chief Executive Officer, Chief Financial Officer, the President or the Secretary or
other principal officer of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action
taken or suffered in good faith by it pursuant to the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Indemnity</U>.
The Warrant Agent shall be liable hereunder only for its own, or its representatives&rsquo;, gross negligence, willful misconduct, fraud,
bad faith or material breach of this Agreement. The Company agrees to indemnify the Warrant Agent and save it harmless against any and
all liabilities, including judgments, out-of-pocket costs and reasonable outside counsel fees, for anything done or omitted by the Warrant
Agent in the execution of this Agreement, except as a result of the Warrant Agent&rsquo;s or its representatives&rsquo; gross negligence,
willful misconduct, fraud, bad faith or material breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exclusions</U>.
The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any
covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments
required under the provisions of <U>Section&nbsp;4</U> hereof or responsible for the manner, method, or amount of any such adjustment
or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make
any representation or warranty as to the authorization or reservation of any Ordinary Shares to be issued pursuant to this Agreement or
any Warrant or as to whether any Ordinary Shares shall, when issued, be valid and fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">8.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Acceptance
of Agency</U>. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms
and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently
account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of Ordinary Shares through the exercise
of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">8.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Waiver</U>.
The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (&ldquo;<U>Claim</U>&rdquo;) in, or
to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof,
by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment
or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims
against the Trust Account and any and all rights to seek access to the Trust Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>9</B></FONT></TD><TD STYLE="text-align: justify"><B>Miscellaneous Provisions.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Successors</U>.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the
benefit of their respective successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notices</U>.
Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant
to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five (5)&nbsp;days after deposit of such notice, postage prepaid, addressed (until another address is filed in
writing by the Company with the Warrant Agent), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Spring Valley Acquisition Corp. II<BR>
2100 McKinney Ave., Suite&nbsp;1675<BR>
Dallas, Texas 75201<BR>
Attention: Robert Kaplan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">with a copy to (which shall
not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Kirkland&nbsp;&amp; Ellis LLP<BR>
609 Main Street<BR>
Houston, Texas 77002<BR>
Attention: Matthew R. Pacey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any notice, statement or demand
authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently
given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5)&nbsp;days
after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company),
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Continental Stock Transfer&nbsp;&amp; Trust Company<BR>
1 State Street, 30<SUP>th</SUP> Floor<BR>
New York, NY 10004<BR>
Attention: Compliance Department</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Applicable
Law; Exclusive Forum</U>. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all
respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application
of the substantive laws of another jurisdiction. Subject to applicable law, the Company hereby agrees that any action, proceeding or claim
against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York
or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to
suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of
the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in
the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this <U>Section&nbsp;9.3</U>. If any action,
the subject matter of which is within the scope of the forum provisions above, is filed in a court other than a court located within the
State of New York or the United States District Court for the Southern District of New York (a &ldquo;foreign action&rdquo;) in the name
of any Warrant holder, such Warrant holder shall be deemed to have consented to: (x)&nbsp;the personal jurisdiction of the state and federal
courts located within the State of New York or the United States District Court for the Southern District of New York in connection with
any action brought in any such court to enforce the forum provisions (an &ldquo;enforcement action&rdquo;), and (y)&nbsp;having service
of process made upon such Warrant holder in any such enforcement action by service upon such warrant holder&rsquo;s counsel in the foreign
action as agent for such warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Persons
Having Rights under this Agreement</U>. Nothing in this Agreement shall be construed to confer upon, or give to, any person, corporation
or other entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy or claim under or by reason
of this Agreement or of any covenant, condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises,
and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and
assigns and of the Registered Holders of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Examination
of the Warrant Agreement</U>. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in
the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require
any such holder to submit such holder&rsquo;s Warrant for inspection by the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Counterparts;
Electronic Signatures</U>. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.
A signature to this Agreement transmitted electronically shall have the same authority, effect and enforceability as an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Effect
of Headings</U>. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Amendments</U>.
This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of (i)&nbsp;curing any
ambiguity or to correct any mistake, including to conform the provisions hereof to the description of the terms of the Warrants and this
Agreement set forth in the Prospectus or (ii)&nbsp;adding or changing any provisions with respect to matters or questions arising under
this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the rights of the Registered
Holders. All other modifications or amendments, including any modification or amendment to increase the Warrant Price or shorten the Exercise
Period shall require the vote or written consent of the Registered Holders of fifty percent (50%) of the then outstanding Warrants. Notwithstanding
the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to <U>Sections 3.1</U> and
<U>3.2</U> hereof, respectively, without the consent of the Registered Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Severability</U>.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible and be valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>SPRING VALLEY ACQUISITION CORP. II</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 47%; font-size: 10pt">/s/ Christopher Sorrells</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Name: Christopher Sorrells</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Title: Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Public
Warrant Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, as Warrant Agent</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 47%; font-size: 10pt">/s/ Steven Vacante&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Name: Steven Vacante</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Title: Vice President</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page to Public
Warrant Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A<BR>
</B>[Form&nbsp;of Warrant Certificate]<BR>
<B>[FACE]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Number</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants<BR>
THIS WARRANT SHALL BE NULL AND VOID IF NOT EXERCISED PRIOR<BR>
TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR<BR>
IN THE WARRANT AGREEMENT DESCRIBED BELOW<BR>
SPRING VALLEY ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Incorporated Under the Laws of the State of
Delaware</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CUSIP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrant Certificate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>This Warrant Certificate
certifies that</I></B>, or registered assigns, is the registered holder of warrant(s)&nbsp;evidenced hereby (the &ldquo;<B><I>Warrants</I></B>&rdquo;
and each, a &ldquo;<B><I>Warrant</I></B>&rdquo;) to purchase Class&nbsp;A ordinary shares, $0.0001 par value per share (&ldquo;<B><I>Ordinary
Shares</I></B>&rdquo;), of Spring Valley Acquisition Corp. II, a Cayman Islands exempted corporation (the &ldquo;<B><I>Company</I></B>&rdquo;).
Each whole Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to receive
from the Company that number of fully paid and non-assessable Ordinary Shares as set forth below, at the exercise price (the &ldquo;<B><I>Warrant
Price</I></B>&rdquo;) as determined pursuant to the Warrant Agreement, payable in lawful money of the United States of America upon surrender
of this Warrant Certificate and payment of the Warrant Price (or through &ldquo;<B><I>cashless exercise</I></B>&rdquo; as provided for
in the Warrant Agreement) at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and
in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them
in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each whole Warrant is initially
exercisable for one fully paid and non-assessable Ordinary Share. No fractional shares will be issued upon exercise of any Warrant. If,
upon the exercise of Warrants, a holder would be entitled to receive a fractional interest in an Ordinary Share, the Company will, upon
exercise, round down to the nearest whole number of the number of Ordinary Shares to be issued to the holder of the Warrant. The number
of Ordinary Shares issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events as set forth
in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The initial Warrant Price
per Ordinary Share for any Warrant is equal to $11.50 per share. The Warrant Price is subject to adjustment upon the occurrence of certain
events as set forth in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the conditions
set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the
end of such Exercise Period, such Warrants shall become null and void. The Warrants may be redeemed, subject to certain conditions, as
set forth in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made to
the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes
have the same effect as though fully set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Warrant Certificate shall
not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Warrant Certificate shall
be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2"><B>SPRING VALLEY ACQUISITION CORP. II</B> <B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="width: 50%">&nbsp;</TD>
<TD STYLE="width: 3%; font-size: 10pt">By:</TD>
<TD STYLE="width: 47%; border-bottom: black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt">Name: </TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">Title: </TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2"><B>CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, as Warrant Agent</B> <B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD STYLE="font-size: 10pt">By:</TD>
<TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt">Name:</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD>&nbsp;</TD>
<TD COLSPAN="2" STYLE="font-size: 10pt">Title:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Form&nbsp;of Warrant Certificate]<BR>
[Reverse]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Warrants evidenced by
this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive Ordinary Shares and
are issued or to be issued pursuant to a Warrant Agreement dated as of [__], 202[_] (the &ldquo;<B><I>Warrant Agreement</I></B>&rdquo;),
duly executed and delivered by the Company to Continental Stock Transfer&nbsp;&amp; Trust Company, a New York corporation, as warrant
agent (or successor warrant agent) (collectively, the &ldquo;<B><I>Warrant Agent</I></B>&rdquo;), which Warrant Agreement is hereby incorporated
by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations,
duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words &ldquo;<B><I>holders</I></B>&rdquo; or &ldquo;<B><I>holder</I></B>&rdquo;
meaning the Registered Holders or Registered Holder, respectively) of the Warrants. A copy of the Warrant Agreement may be obtained by
the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have
the meanings given to them in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Warrants may be exercised
at any time during the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate
may exercise them by surrendering this Warrant Certificate, with the form of election to purchase set forth hereon properly completed
and executed, together with payment of the Warrant Price as specified in the Warrant Agreement (or through &ldquo;<B><I>cashless exercise</I></B>&rdquo;
as provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise
of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there
shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything else
in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i)&nbsp;a registration
statement covering the Ordinary Shares to be issued upon exercise is effective under the Securities Act and (ii)&nbsp;a prospectus thereunder
relating to the Ordinary Shares is current, except through &ldquo;<B><I>cashless exercise</I></B>&rdquo; as provided for in the Warrant
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Warrant Agreement provides
that upon the occurrence of certain events the number of Ordinary Shares issuable upon exercise of the Warrants and the Warrant Price
set forth on the face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would
be entitled to receive a fractional interest in an Ordinary Share, the Company shall, upon exercise, round down to the nearest whole number
of Ordinary Shares to be issued to the holder of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Warrant Certificates, when
surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative
or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement,
but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate
a like number of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon due presentation for
registration of transfer of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates
of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s)&nbsp;in exchange for this
Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental
charge imposed in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and the Warrant
Agent may deem and treat the Registered Holder(s)&nbsp;hereof as the absolute owner(s)&nbsp;of this Warrant Certificate (notwithstanding
any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the
holder(s)&nbsp;hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the
contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a shareholder of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Election to Purchase<BR>
(To Be Executed Upon Exercise of Warrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby irrevocably
elects to exercise the right, represented by this Warrant Certificate, to receive Ordinary Shares and herewith tenders payment for such
Ordinary Shares to the order of Spring Valley Acquisition Corp. II (the &ldquo;<B><I>Company</I></B>&rdquo;) in the amount of $ in accordance
with the terms hereof. The undersigned requests that a certificate for such Ordinary Shares be registered in the name of, whose address
is and that such Ordinary Shares be delivered to whose address is. If said number of Ordinary Shares is less than all of the Ordinary
Shares purchasable hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary
Shares be registered in the name of, whose address is and that such Warrant Certificate be delivered to, whose address is.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Warrant
is to be exercised on a &ldquo;<B><I>cashless</I></B>&rdquo; basis pursuant to <U>subsection 3.3.1(b)</U>&nbsp;of the Warrant Agreement,
the number of Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with <U>subsection 3.3.1(b)</U>&nbsp;of
the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Warrant
is to be exercised on a &ldquo;<B><I>cashless</I></B>&rdquo; basis pursuant to <U>Section&nbsp;7.4</U> of the Warrant Agreement, the number
of Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with <U>Section&nbsp;7.4</U> of the Warrant
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Warrant
may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i)&nbsp;the number of Ordinary Shares that
this Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for
such cashless exercise and (ii)&nbsp;the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise
the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive Ordinary
Shares. If said number of Ordinary Shares is less than all of the Ordinary Shares purchasable hereunder (after giving effect to the cashless
exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered
in the name of, whose address is and that such Warrant Certificate be delivered to, whose address is.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date:&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
20[_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">(Signature)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">(Address)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">(Tax Identification Number)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SIGNATURE(S)&nbsp;SHOULD BE GUARANTEED BY
AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO SECURITIES AND EXCHANGE COMMISSION RULE 17Ad-15 (OR ANY SUCCESSOR RULE) UNDER THE SECURITIES
EXCHANGE ACT OF 1934, AS AMENDED).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>5
<FILENAME>tm216731d39_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 4.2</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><I>Execution Version</I></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PRIVATE WARRANT AGREEMENT<BR>
between<BR>
SPRING VALLEY ACQUISITION CORP. II<BR>
and<BR>
CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of October&nbsp;12, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS WARRANT AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;),
dated as of October&nbsp;12, 2022, is by and between Spring Valley Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<U>Company</U>&rdquo;),
and Continental Stock Transfer&nbsp;&amp; Trust Company, a New York limited purpose trust company, as warrant agent (the &ldquo;<U>Warrant
Agent,</U>&rdquo; also referred to herein as the &ldquo;<U>Transfer Agent</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, on October&nbsp;12, 2022, the Company
entered into that certain Private Placement Warrants Purchase Agreement with Spring Valley Acquisition Sponsor II, LLC, a Delaware limited
liability company (the &ldquo;<U>Sponsor</U>&rdquo;), pursuant to which the Sponsor will purchase an aggregate of 12,000,000 warrants
(or up to 13,350,000 warrants if the over-allotment option is exercised in full) simultaneously with the closing of the Offering (as defined
below) (and the closing of the over-allotment option, if applicable) bearing the legend set forth in <U>Exhibit&nbsp;A</U> hereto (the
 &ldquo;<U>Private Placement Warrants</U>&rdquo;) at a purchase price of $1.00 per Private Placement Warrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, in order to finance the Company&rsquo;s
transaction costs in connection with an intended initial Business Combination (as defined below), the Sponsor or affiliates of the Sponsor
or certain of the Company&rsquo;s officers and directors may, but are not obligated to, loan the Company funds as the Company may require,
of which up to $1,500,000 of such loans may be convertible into up to an additional 1,500,000 Private Placement Warrants (the &ldquo;<U>Working
Capital Warrants</U>&rdquo; and, together with the Private Placement Warrants, the &ldquo;<U>Warrants</U>&rdquo;) at a price of $1.00
per warrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, in order to extend the time available
for the Company to consummate an initial business combination for an additional three months, the Sponsor or its affiliates or designees
must deposit into the trust account $2,000,000 (or up to $2,300,000 if the underwriters&rsquo; over-allotment option is exercised in full
($0.10 per Class&nbsp;A ordinary share in either case), adjusted proportionately in the case of a partial exercise). Any such payments
would be made in the form of a loan that will be non-interest bearing and payable upon the consummation of the initial business combination.
Such loan may be converted into additional private placement warrants upon the consummation of the initial business combination, at a
price of $1.00 per warrant, at the option of the Sponsor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company is engaged in an initial public
offering (the &ldquo;<U>Offering</U>&rdquo;) of units of the Company&rsquo;s equity securities, each such unit comprised of one Class&nbsp;A
ordinary share of the Company, par value $0.0001 per share (&ldquo;<U>Ordinary Shares</U>&rdquo;), one right to receive one-tenth of one
Class&nbsp;A ordinary share upon the consummation of the initial business combination and one-half of one public warrant (the &ldquo;<U>Units</U>&rdquo;)
and, in connection therewith, has determined to issue and deliver up to 11,500,000 warrants (including up to 1,500,000 warrants subject
to the Over-allotment Option) to public investors in the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company has filed with the U.S. Securities
and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) a registration statement on Form&nbsp;S-1, File No.&nbsp;333-253156 (the
 &ldquo;<U>Registration Statement</U>&rdquo;) and prospectus (the &ldquo;<U>Prospectus</U>&rdquo;), for the registration, under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the issuance of the Units, the Warrants and the Ordinary Shares
included in the Units;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company desires the Warrant Agent
to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer,
exchange and exercise of the Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company desires to provide for the
form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of
rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, all acts and things have been done and
performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant
Agent (if a physical certificate is issued), as provided herein, the valid, binding and legal obligations of the Company, and to authorize
the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the mutual
agreements herein contained, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>1</B></FONT></TD><TD><B><U>Appointment of Warrant Agent</U>. </B>The Company hereby appoints the Warrant Agent to act as agent for the Company for the
Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the express terms and
conditions set forth in this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>2</B></FONT></TD><TD><B>Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="color: #010000">2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT> <U>Form&nbsp;of Warrant</U>. Each Warrant shall initially be issued in registered form only.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Effect
of Countersignature</U>. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement,
a certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="color: #010000">2.3</FONT> &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">2.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Warrant
Register</U>. The Warrant Agent shall maintain books (the &ldquo;<U>Warrant Register</U>&rdquo;) for the registration of the initial issuance
of the Warrants and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants in book-entry form, the Warrant
Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance
with instructions delivered to the Warrant Agent by the Company. If requested, the Registered Holder of a Warrant shall be issued a definitive
certificate in physical form evidencing such Warrants which shall be in the form attached hereto as <U>Exhibit&nbsp;B</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Physical certificates, if issued, shall be signed
by, or bear the facsimile signature of, the Chairman of the board of directors of the Company (the &ldquo;<U>Board</U>&rdquo;), Chief
Executive Officer, Chief Financial Officer, the President or the Secretary or other principal officer of the Company. In the event the
person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed
the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date
of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">2.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registered
Holder</U>. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat
the person in whose name such Warrant is registered in the Warrant Register (the &ldquo;<U>Registered Holder</U>&rdquo;) as the absolute
owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on any physical
certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes,
and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>3</B></FONT></TD><TD><B>Terms and Exercise of Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Warrant
Price</U>. Each whole Warrant, when countersigned by the Warrant Agent, shall entitle the Registered Holder thereof, subject to the provisions
of such Warrant and of this Agreement, to purchase from the Company the number of Ordinary Shares stated therein, at the price of $11.50
per share, subject to the adjustments provided in <U>Section&nbsp;4</U> hereof and in the penultimate sentence of this <U>Section&nbsp;3.1</U>.
The term &ldquo;<U>Warrant Price</U>&rdquo; as used in this Agreement shall mean the price per share at which each Ordinary Share may
be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the
Expiration Date (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company shall provide at
least twenty (20) days prior written notice of such reduction to Registered Holders of the Warrants and, provided, further, that any such
reduction shall be identical among all of the Warrants. The term &ldquo;<U>Business Day</U>&rdquo; means a day other than a Saturday,
Sunday or federal holiday, on which banks in New York City are generally open for normal business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Duration
of Warrants</U>. A Warrant may be exercised only during the period (the &ldquo;<U>Exercise Period</U>&rdquo;) commencing on the later
of: (i)&nbsp;the date that is thirty (30) days after the first date on which the Company completes a merger, consolidation, share exchange,
asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more businesses or
entities (a &ldquo;<U>Business Combination</U>&rdquo;), or (ii)&nbsp;the date that is twelve (12) months from the date of the closing
of the Offering and terminating at the earlier to occur of; (x)&nbsp;5:00 p.m., New York City time on the date that is five (5)&nbsp;years
after the date on which the Company completes its initial Business Combination and (y)&nbsp;the liquidation of the Company (the &ldquo;<U>Expiration
Date</U>&rdquo;); provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions,
as set forth in <U>subsection 3.3.2</U> hereof, with respect to an effective registration statement. Each Warrant not exercised on or
before the Expiration Date shall become null and void, and all rights thereunder and all rights in respect thereof under this Agreement
shall cease at 5:00 p.m., New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the
Warrants by delaying the Expiration Date; provided, that the Company shall provide at least twenty (20) days prior written notice of any
such extension to Registered Holders of the Warrants and, provided, further, that any such extension shall be identical in duration among
all the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercise
of Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">3.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Payment</U>.
Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the Warrant Agent, may be exercised by the
Registered Holder thereof by surrendering it (if evidenced by definitive certificate) at the office of the Warrant Agent, or at the office
of its successor as Warrant Agent, in the Borough of Manhattan, City and State of New York, with the subscription form, as set forth in
the Warrant, duly executed, and by paying in full the Warrant Price for each full Ordinary Share as to which the Warrant is exercised
and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the Ordinary Shares
and the issuance of such Ordinary Share, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>in lawful money of the United States, in good certified check or good bank draft payable to the Warrant Agent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>by surrendering the Warrants for that number of Ordinary Shares equal to the quotient obtained by dividing (x)&nbsp;the product of
the number of Ordinary Shares underlying the Warrants, multiplied by the excess of the 10-Day Average Closing Price, as of the date prior
to the date on which notice of exercise is sent or given to the Warrant Agent, less the Warrant Price by (y)&nbsp;the 10-Day Average Closing
Price. &ldquo;<U>10-Day Average Closing Price</U>&rdquo; means, as of any date, the average last reported sale price of the Ordinary Shares
as reported during the ten (10)&nbsp;trading day period ending on the trading day prior to such date. &ldquo;<U>Last Reported Sale Price</U>&rdquo;
shall mean the last reported sale price of the Ordinary Shares on the date prior to the date on which notice of exercise of the Warrant
is sent to the Warrant Agent; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>as provided in <U>Section&nbsp;6.4</U> hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">3.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Issuance
of Ordinary Shares on Exercise</U>. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment
of the Warrant Price (if payment is pursuant to <U>subsection 3.3.1(a)</U>&nbsp;hereof), the Company shall issue to the Registered Holder
of such Warrant a book-entry position or certificate, as applicable, for the number of full Ordinary Shares to which he, she or it is
entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in
full, a new book-entry position or countersigned Warrant, as applicable, for the number of Ordinary Shares as to which such Warrant shall
not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any Ordinary Shares pursuant to
the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities
Act with respect to the Ordinary Shares underlying the Warrants is then effective and a prospectus relating thereto is current or a valid
exemption from registration is available. No Warrant shall be exercisable and the Company shall not be obligated to issue Ordinary Shares
upon exercise of a Warrant unless the Ordinary Shares issuable upon such Warrant exercise has been registered, qualified or deemed to
be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants.
In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of
such Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless, in which case the
purchaser of a Unit containing such Warrants shall have paid the full purchase price for the Unit solely for the Ordinary Shares underlying
such Unit. In no event will the Company be required to net cash settle the Warrant exercise. If, by reason of any exercise of Warrants
on a &ldquo;cashless basis&rdquo;, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional
interest in an Ordinary Share, the Company shall round down to the nearest whole number the number of Ordinary Shares to be issued to
such holder. Notwithstanding anything in this Agreement, for so long as any Warrant is held by the Sponsor, such Warrant will not be exercisable
more than five (5)&nbsp;years from the effective date of the Registration Statement, in accordance with Financial Industry Regulatory
Authority,&nbsp;Inc. (&ldquo;<U>FINRA</U>&rdquo;) Rules. In addition, no such Warrant will contain terms which allow the Sponsor to receive
or accrue cash dividends prior to the exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">3.3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Valid
Issuance</U>. All Ordinary Shares issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued,
fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">3.3.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Date
of Issuance</U>. Each person in whose name any book-entry position or certificate, as applicable, for Ordinary Shares is issued shall
for all purposes be deemed to have become the holder of record of such Ordinary Shares on the date on which the Warrant, or book-entry
position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of
such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share
transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder
of such Ordinary Shares at the close of business on the next succeeding date on which the share transfer books or book-entry system of
the Warrant Agent are open.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">3.3.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Maximum
Percentage</U>. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained
in this <U>subsection 3.3.5</U>; however, no holder of a Warrant shall be subject to this <U>subsection 3.3.5</U> unless he, she or it
makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder&rsquo;s Warrant,
and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person
(together with such person&rsquo;s affiliates), to the Warrant Agent&rsquo;s actual knowledge, would beneficially own in excess of 9.8%,
or such other amount as a holder may specify (the &ldquo;<U>Maximum Percentage</U>&rdquo;) of the Ordinary Shares outstanding immediately
after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of Ordinary Shares beneficially owned
by such person and its affiliates shall include the number of Ordinary Shares issuable upon exercise of the Warrant with respect to which
the determination of such sentence is being made, but shall exclude Ordinary Shares that would be issuable upon (x)&nbsp;exercise of the
remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y)&nbsp;exercise or conversion
of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates
(including, without limitation, any convertible notes or convertible preferred shares or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Securities Exchange Act of 1934, as amended
(the &ldquo;<U>Exchange Act</U>&rdquo;). For purposes of the Warrant, in determining the number of issued and outstanding Ordinary Shares,
the holder may rely on the number of issued and outstanding Ordinary Shares as reflected in (1)&nbsp;the Company&rsquo;s most recent annual
report on Form&nbsp;10-K, quarterly report on Form&nbsp;10-Q, current report on Form&nbsp;8-K or other public filing with the Commission
as the case may be, (2)&nbsp;a more recent public announcement by the Company or (3)&nbsp;any other notice by the Company or the Transfer
Agent setting forth the number of Ordinary Shares issued and outstanding. For any reason at any time, upon the written request of the
holder of the Warrant, the Company shall, within two (2)&nbsp;Business Days, confirm orally and in writing to such holder the number of
Ordinary Shares then outstanding. In any case, the number of issued and outstanding Ordinary Shares shall be determined after giving effect
to the conversion or exercise of equity securities of the Company by the holder and its affiliates since the date as of which such number
of issued and outstanding Ordinary Shares was reported. By written notice to the Company, the holder of a Warrant may from time to time
increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such notice; <U>provided</U>,
<U>however</U>, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">3.3.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Lock-up
of Private Placement Warrants</U>. The Warrants held by the Sponsor and the Ordinary Shares that are issuable upon exercise of such Warrants
have been deemed compensation by the FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule&nbsp;5110(e)(1), commencing
on the effective date of the Registration Statement. Pursuant to FINRA Rule&nbsp;5110(e)(1), these securities will not be sold during
the Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put
or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately
following the effective date of the Registration Statement or commencement of sales of the Offering, except to any underwriter and selected
dealer participating in the Offering and their bona fide officers or partners (provided that all securities so transferred remain subject
to the lockup restriction above for the remainder of the time period) or pursuant to another exception to the applicability of FINRA Rule&nbsp;5110(e)(1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>4</B></FONT></TD><TD><B>Adjustments.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">4.1</FONT></TD><TD><U>Share Dividends</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">4.1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Share
Dividends and Split-Ups</U>. If after the date hereof, and subject to the provisions of <U>Section&nbsp;4.6</U> hereof, the number of
issued and outstanding Ordinary Shares is increased by a share dividend payable in Ordinary Shares, or by a split-up of Ordinary Shares,
or other similar event, then, on the effective date of such share dividend, split-up or similar event, the number of Ordinary Shares issuable
on exercise of each Warrant shall be increased in proportion to such increase in the issued and outstanding Ordinary Shares. A rights
offering to holders of Ordinary Shares entitling holders to purchase Ordinary Shares at a price less than the &ldquo;<U>Fair Market Value</U>&rdquo;
(as defined below) shall be deemed a share dividend of a number of Ordinary Shares equal to the product of (i)&nbsp;the number of Ordinary
Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible
into or exercisable for the Ordinary Shares) multiplied by (ii)&nbsp;one (1)&nbsp;minus the quotient of (x)&nbsp;the price per Ordinary
Share paid in such rights offering divided by (y)&nbsp;the Fair Market Value. For purposes of this <U>subsection 4.1.1</U>, if the rights
offering is for securities convertible into or exercisable for Ordinary Shares, in determining the price payable for the Ordinary Shares,
there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or
conversion. &ldquo;<U>Fair Market Value</U>&rdquo; means the 10-Day Average Closing Price as of the first (1<SUP>st</SUP>) date on which
the Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.
Notwithstanding anything to the contrary herein, no Ordinary Shares shall be issued at less than their par value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">4.1.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Extraordinary
Dividends</U>. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution
in cash, securities or other assets to the holders of the Ordinary Shares on account of such Ordinary Shares (or other shares of the Company&rsquo;s
share capital into which the Warrants are convertible), other than (a)&nbsp;as described in <U>subsection 4.1.1</U> above, (b)&nbsp;Ordinary
Cash Dividends (as defined below), (c)&nbsp;to satisfy the redemption rights of the holders of the Ordinary Shares in connection with
a proposed initial Business Combination, (d)&nbsp;to satisfy the redemption rights of the holders of Ordinary Shares in connection with
a shareholder vote to approve an amendment to the Company&rsquo;s amended and restated memorandum and articles of association to modify
the substance or timing of the Company&rsquo;s obligation to redeem 100% of the Ordinary Shares if the Company does not complete its initial
Business Combination within the period set forth in the Company&rsquo;s amended and restated memorandum and articles of association, or
(e)&nbsp;in connection with the redemption of the Ordinary Shares included in the Units sold in the Offering upon the Company&rsquo;s
failure to complete the Company&rsquo;s initial Business Combination (any such non-excluded event being referred to herein as an &ldquo;<U>Extraordinary
Dividend</U>&rdquo;), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary
Dividend, by the amount of cash and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets
paid on each Ordinary Share in respect of such Extraordinary Dividend. For purposes of this <U>subsection 4.1.2</U>, &ldquo;<U>Ordinary
Cash Dividends</U>&rdquo; means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts
of all other cash dividends and cash distributions paid on the Ordinary Shares during the 365-day period ending on the date of declaration
of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this <U>Section&nbsp;4</U>
and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of Ordinary Shares
issuable on exercise of each Warrant) does not exceed $0.50.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Aggregation
of Shares</U>. If after the date hereof, and subject to the provisions of <U>Section&nbsp;4.6</U> hereof, the number of issued and outstanding
Ordinary Shares is decreased by a consolidation, combination, reverse share split or reclassification of Ordinary Shares or other similar
event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number
of Ordinary Shares issuable on exercise of each Warrant shall be decreased in proportion to such decrease in issued and outstanding Ordinary
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Adjustments
in Warrant Price</U>. Whenever the number of Ordinary Shares purchasable upon the exercise of the Warrants is adjusted, as provided in
<U>Section&nbsp;4.1</U> or <U>4.2</U> hereof, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price
immediately prior to such adjustment by a fraction (x)&nbsp;the numerator of which shall be the number of Ordinary Shares purchasable
upon the exercise of the Warrants immediately prior to such adjustment, and (y)&nbsp;the denominator of which shall be the number of Ordinary
Shares so purchasable immediately thereafter. If, (a)&nbsp;in connection with the closing of the initial Business Combination, the Company
issues additional Ordinary Shares or securities of the Company which are convertible into, or exchangeable or exercisable for, equity
securities of the Company, including any securities issued by the Company which are pledged to secure any obligation of any holder to
purchase equity securities of the Company, at an issue price or effective issue price of less than $9.20 per Ordinary Share, with such
issue price or effective issue price to be determined in good faith by the Board (and in the case of any such issuance to the Sponsor
or its affiliates, without taking into account any Ordinary Shares of the Company issued prior to the Offering and held by the Sponsor
or such affiliates, as applicable, prior to such issuance) (the &ldquo;<U>Newly Issued Price</U>&rdquo;), (b)&nbsp;the aggregate gross
proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of
the initial Business Combination (net of redemptions), and (c)&nbsp;the volume weighted average trading price of the Ordinary Shares during
the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination
(such price, the &ldquo;<U>market value</U>&rdquo;) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent)
to be equal to 115% of the higher of the market value and the Newly Issued Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">4.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Replacement
of Securities upon Reorganization,&nbsp;etc.</U> In case of any reclassification or reorganization of the issued and outstanding Ordinary
Shares (other than a change covered by <U>Section&nbsp;4.1</U> or <U>4.2</U> hereof or that solely affects the par value of such Ordinary
Shares), or in the case of any merger or consolidation of the Company with or into another entity in which any &ldquo;person&rdquo; or
 &ldquo;group&rdquo; (as such terms are used in Section&nbsp;13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act) acquires more than 50% of the
voting power of the Company&rsquo;s securities, or in the case of any sale or conveyance to another corporation or entity of the assets
or other property of the Company as an entirety or substantially as an entirety, the holders of the Warrants shall thereafter have the
right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the Ordinary
Shares of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind
and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s)&nbsp;immediately
prior to such event (the &ldquo;<U>Alternative Issuance</U>&rdquo;); provided, however, that if the holders of the Ordinary Shares were
entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation
or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall
become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Ordinary
Shares in such consolidation or merger that affirmatively make such election; provided, further, that if less than seventy percent (70%)
of the consideration receivable by the holders of the Ordinary Shares in the applicable event is payable in the form of shares in the
successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market,
or is to be so listed for trading or quoted immediately following such event, and if the Registered Holder properly exercises the Warrant
within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a current
report on Form&nbsp;8-K filed with the Commission, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference
of (i)&nbsp;the Warrant Price in effect prior to such reduction minus (ii)&nbsp;(A)&nbsp;the Per Share Consideration (as defined below)
(but in no event less than zero) minus (B)&nbsp;the Black-Scholes Warrant Value (as defined below). The &ldquo;<U>Black-Scholes Warrant
Value</U>&rdquo; means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes
Warrant Model for an uncapped American Call on Bloomberg Financial Markets (&ldquo;<U>Bloomberg</U>&rdquo;), as calculated by an accounting,
appraisal, investment banking firm or consultant of nationally recognized standing that is, in the good faith judgment of the Board, qualified
to make such calculation. For purposes of calculating such amount, (1)&nbsp;the price of each Ordinary Share shall be the average last
reported sale price of the Ordinary Shares as reported during the ten (10)&nbsp;trading day period ending on the trading day prior to
the applicable event, (2)&nbsp;the assumed volatility shall be the ninety (90) day volatility obtained from the HVT function on Bloomberg
determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (3)&nbsp;the assumed risk-free
interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. &ldquo;<U>Per Share
Consideration</U>&rdquo; means (i)&nbsp;if the consideration paid to holders of the Ordinary Shares consists exclusively of cash, the
amount of such cash per Ordinary Share, and (ii)&nbsp;in all other cases, the average last reported sale price of the Ordinary Shares
as reported during the ten (10)&nbsp;trading day period ending on the trading day prior to the effective date of the applicable event.
If any reclassification or reorganization also results in a change in Ordinary Shares covered by <U>subsection 4.1.1</U> hereof, then
such adjustment shall be made pursuant to <U>subsection 4.1.1</U> or <U>Sections 4.2</U>, or <U>4.3</U> hereof and this <U>Section&nbsp;4.4</U>.
The provisions of this <U>Section&nbsp;4.4</U> shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations,
sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of
the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">4.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notices
of Changes in Warrant</U>. Upon every adjustment of the Warrant Price or the number of Ordinary Shares issuable upon exercise of a Warrant,
the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment
and the increase or decrease, if any, in the number of Ordinary Shares purchasable at such price upon the exercise of a Warrant, setting
forth in reasonable detail the method of calculation and the facts upon which such calculation is based; provided, however, that no adjustment
to the number of Ordinary Shares issuable upon exercise of a Warrant shall be required until cumulative adjustments amount to one percent
(1%) or more of the number of Ordinary Shares issuable upon exercise of a Warrant as last adjusted; provided, further, that any such adjustments
that are not made are carried forward and taken into account in any subsequent adjustment. Notwithstanding the foregoing, all such carried
forward adjustments shall be made (i)&nbsp;in connection with any subsequent adjustment that (taken together with such carried forward
adjustments) would result in a change of at least one percent (1%) in the number of Ordinary Shares issuable upon exercise of a Warrant
and (ii)&nbsp;on the exercise date of any Warrant. Upon the occurrence of any event specified in <U>Sections 4.1</U>, <U>4.2</U>, <U>4.3</U>
or <U>4.4</U> hereof, the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address
set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice,
or any defect therein, shall not affect the legality or validity of such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">4.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Fractional Shares</U>. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue a fractional
Ordinary Share upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this <U>Section&nbsp;4</U>, the holder
of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon
such exercise, round down to the nearest whole number the number of Ordinary Shares to be issued to such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">4.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Form&nbsp;of
Warrant</U>. The form of Warrant need not be changed because of any adjustment pursuant to this <U>Section&nbsp;4</U>, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of Ordinary Shares as is stated in the Warrants initially issued
pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of
Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned,
whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>5</B></FONT></TD><TD><B>Transfer and Exchange of Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">5.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Transferability</U>.
Subject to compliance with applicable law, the Warrants may be transferred, assigned or sold to any person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">5.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registration
of Transfer</U>. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register,
upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions
for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant
shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant
Agent to the Company from time to time upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">5.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Procedure
for Surrender of Warrants</U>. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer,
and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the
Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that in the event that a Warrant surrendered
for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until
the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the
new Warrants must also bear a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">5.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Transfers
of Fractions of Warrants</U>. The Warrant Agent shall not be required to effect any registration of transfer or exchange of Warrants which
would require the issuance of a Warrant certificate or book-entry position for a fraction of a Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">5.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Service
Charges</U>. No service charge shall be made for any exchange or registration of transfer of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">5.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Warrant
Execution and Countersignature</U>. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms
of this Agreement, the Warrants required to be issued pursuant to the provisions of this <U>Section&nbsp;5</U>, and the Company, whenever
required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>6</B></FONT></TD><TD><B>Other Provisions Relating to Rights of Holders of Warrants.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">6.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Rights as Shareholder</U>. A Warrant does not entitle the Registered Holder thereof to any of the rights of a shareholder of the Company,
including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent
or to receive notice as shareholder in respect of the meetings of shareholders or the election of directors of the Company or any other
matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">6.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Lost,
Stolen, Mutilated, or Destroyed Warrants</U>. If any Warrant is lost, stolen, mutilated or destroyed, the Company and the Warrant Agent
may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant,
include the surrender thereof), issue a new Warrant of like denomination, tenor and date as the Warrant so lost, stolen, mutilated or
destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost,
stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">6.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Reservation
of Ordinary Shares</U>. The Company shall at all times reserve and keep available a number of its authorized but unissued Ordinary Shares
that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">6.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Registration
of the Ordinary Shares</U>. The Company agrees that as soon as practicable, but in no event later than twenty (20) Business Days after
the closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a registration
statement for the registration, under the Securities Act, of the Ordinary Shares issuable upon exercise of the Warrants. The Company shall
use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement,
and a current prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>7</B></FONT></TD><TD><B>Concerning the Warrant Agent and Other Matters.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">7.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Payment
of Taxes</U>. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant
Agent in respect of the issuance or delivery of Ordinary Shares upon the exercise of the Warrants, but the Company and the Warrant Agent
shall not be obligated to pay any transfer taxes in respect of the Warrants or such Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">7.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Resignation,
Consolidation, or Merger of Warrant Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">7.2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Appointment
of Successor Warrant Agent</U>. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days&rsquo; notice in writing to the Company. If the office
of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after
it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with
such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court
of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company&rsquo;s cost. Any
successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing
under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State
of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or
state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties,
and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further
act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the
expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor
Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any
and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority,
powers, rights, immunities, duties, and obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">7.2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice
of Successor Warrant Agent</U>. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the
predecessor Warrant Agent and the Transfer Agent for the Ordinary Shares not later than the effective date of any such appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">7.2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Merger
or Consolidation of Warrant Agent</U>. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any
entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under
this Agreement without any further act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">7.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Fees
and Expenses of Warrant Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">7.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Remuneration</U>.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant
to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably
incur in the execution of its duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">7.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Further
Assurances</U>. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and
delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying
out or performing of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">7.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Liability
of Warrant Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">7.4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Reliance
on Company Statement</U>. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or
desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact
or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established
by a statement signed by the Chairman of the Board, Chief Executive Officer, Chief Financial Officer, the President or the Secretary or
other principal officer of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action
taken or suffered in good faith by it pursuant to the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">7.4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Indemnity</U>.
The Warrant Agent shall be liable hereunder only for its own, or its representatives&rsquo;, gross negligence, willful misconduct, fraud,
bad faith or material breach of this Agreement. The Company agrees to indemnify the Warrant Agent and save it harmless against any and
all liabilities, including judgments, out-of-pocket costs and reasonable outside counsel fees, for anything done or omitted by the Warrant
Agent in the execution of this Agreement, except as a result of the Warrant Agent&rsquo;s or its representatives&rsquo; gross negligence,
willful misconduct, fraud, bad faith or material breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="color: #010000">7.4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exclusions</U>.
The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any
covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments
required under the provisions of <U>Section&nbsp;4</U> hereof or responsible for the manner, method, or amount of any such adjustment
or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make
any representation or warranty as to the authorization or reservation of any Ordinary Shares to be issued pursuant to this Agreement or
any Warrant or as to whether any Ordinary Shares shall, when issued, be valid and fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">7.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Acceptance
of Agency</U>. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms
and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently
account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of Ordinary Shares through the exercise
of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">7.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Waiver</U>.
The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (&ldquo;Claim&rdquo;) in, or to any
distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by
and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment or
satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims against
the Trust Account and any and all rights to seek access to the Trust Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000"><B>8</B></FONT></TD><TD><B>Miscellaneous Provisions.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Successors</U>.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the
benefit of their respective successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notices</U>.
Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant
to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five (5)&nbsp;days after deposit of such notice, postage prepaid, addressed (until another address is filed in
writing by the Company with the Warrant Agent), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Spring Valley Acquisition Corp. II<BR>
2100 McKinney Ave., Suite&nbsp;1675<BR>
Dallas, Texas 75201<BR>
Attention: Robert Kaplan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Kirkland&nbsp;&amp; Ellis LLP<BR>
609 Main Street<BR>
Houston, Texas 77002<BR>
Attention: Matthew R. Pacey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Any notice, statement or demand authorized by this
Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when
so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5)&nbsp;days after
deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company),
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Continental Stock Transfer&nbsp;&amp; Trust Company<BR>
1 State Street, 30<SUP>th</SUP> Floor<BR>
New York, NY 10004<BR>
Attention: Compliance Department</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Applicable
Law; Exclusive Forum</U>. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all
respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application
of the substantive laws of another jurisdiction. Subject to applicable law, the Company hereby agrees that any action, proceeding or
claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of
New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which
jurisdiction shall be exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive
jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will
not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district
courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest
in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this <U>Section&nbsp;9.3</U>. If any
action, the subject matter of which is within the scope of the forum provisions above, is filed in a court other than a court located
within the State of New York or the United States District Court for the Southern District of New York (a &ldquo;foreign action&rdquo;)
in the name of any Warrant holder, such Warrant holder shall be deemed to have consented to: (x)&nbsp;the personal jurisdiction of the
state and federal courts located within the State of New York or the United States District Court for the Southern District of New York
in connection with any action brought in any such court to enforce the forum provisions (an &ldquo;enforcement action&rdquo;), and (y)&nbsp;having
service of process made upon such Warrant holder in any such enforcement action by service upon such warrant holder&rsquo;s counsel in
the foreign action as agent for such warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Persons
Having Rights under this Agreement</U>. Nothing in this Agreement shall be construed to confer upon, or give to, any person, corporation
or other entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy or claim under or by reason
of this Agreement or of any covenant, condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises,
and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and
assigns and of the Registered Holders of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Examination
of the Warrant Agreement</U>. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in
the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require
any such holder to submit such holder&rsquo;s Warrant for inspection by the Warrant Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Counterparts;
Electronic Signatures</U>. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.
A signature to this Agreement transmitted electronically shall have the same authority, effect and enforceability as an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Effect
of Headings</U>. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Amendments</U>.
This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of (i)&nbsp;curing any
ambiguity or to correct any mistake, including to conform the provisions hereof to the description of the terms of the Warrants and this
Agreement set forth in the Prospectus or (ii)&nbsp;adding or changing any provisions with respect to matters or questions arising under
this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the rights of the Registered
Holders. All other modifications or amendments, including any modification or amendment to increase the Warrant Price or shorten the Exercise
Period shall require the vote or written consent of the Registered Holders of fifty percent (50%) of the then outstanding Warrants. Notwithstanding
the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to <U>Sections 3.1</U> and
<U>3.2</U> hereof, respectively, without the consent of the Registered Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: #010000">8.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Severability</U>.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible and be valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit&nbsp;A &ndash; Legend<BR>
Exhibit&nbsp;B &ndash; Form&nbsp;of Warrant Certificate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be duly executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; font-size: 10pt">/s/ Christopher Sorrells</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt">Name: Christopher Sorrells</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title: Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Private Warrant Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, as Warrant
    Agent</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; font-size: 10pt"><B>/</B>s/ Steven Vacante</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt">Name: Steven Vacante</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;Vice President</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Private Warrant Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A<BR>
LEGEND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY&nbsp;NOT BE OFFERED, SOLD, TRANSFERRED
OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN
EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT
BY AND AMONG SPRING VALLEY ACQUISITION CORP. II (THE &ldquo;COMPANY&rdquo;), SPRING VALLEY ACQUISITION SPONSOR II, LLC AND THE OTHER PARTIES
THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY&nbsp;NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS
AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN <U>SECTION&nbsp;3</U> OF THE WARRANT AGREEMENT
REFERRED TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN <U>SECTION&nbsp;2</U> OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING
WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SECURITIES EVIDENCED BY THIS CERTIFICATE AND ORDINARY SHARES OF THE
COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED
BY THE COMPANY.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>EXHIBIT&nbsp;B<BR>
</B>[Form&nbsp;of Warrant Certificate]<BR>
<B>[FACE]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants<BR>
THIS WARRANT SHALL BE NULL AND VOID IF NOT EXERCISED PRIOR<BR>
TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR<BR>
IN THE WARRANT AGREEMENT DESCRIBED BELOW<BR>
SPRING VALLEY ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Incorporated Under the Laws of the State of
Delaware</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CUSIP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrant Certificate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>This Warrant Certificate certifies that</I></B>,
or registered assigns, is the registered holder of warrant(s)&nbsp;evidenced hereby (the &ldquo;<B><I>Warrants</I></B>&rdquo; and each,
a &ldquo;<B><I>Warrant</I></B>&rdquo;) to purchase Class&nbsp;A ordinary shares, $0.0001 par value per share (&ldquo;<B><I>Ordinary Shares</I></B>&rdquo;),
of Spring Valley Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;). Each whole Warrant
entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to receive from the Company
that number of fully paid and non-assessable Ordinary Shares as set forth below, at the exercise price (the &ldquo;<B><I>Warrant Price</I></B>&rdquo;)
as determined pursuant to the Warrant Agreement, payable in lawful money of the United States of America upon surrender of this Warrant
Certificate and payment of the Warrant Price (or through &ldquo;<B><I>cashless exercise</I></B>&rdquo; as provided for in the Warrant
Agreement) at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant
Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each whole Warrant is initially exercisable for
one fully paid and non-assessable Ordinary Share. No fractional shares will be issued upon exercise of any Warrant. If, upon the exercise
of Warrants, a holder would be entitled to receive a fractional interest in an Ordinary Share, the Company will, upon exercise, round
down to the nearest whole number of the number of Ordinary Shares to be issued to the holder of the Warrant. The number of Ordinary Shares
issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events as set forth in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The initial Warrant Price per Ordinary Share for
any Warrant is equal to $11.50 per share. The Warrant Price is subject to adjustment upon the occurrence of certain events as set forth
in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the conditions set forth in the Warrant
Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period,
such Warrants shall become null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Reference is hereby made to the further provisions
of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as
though fully set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Warrant Certificate shall not be valid unless
countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Warrant Certificate shall be governed by and
construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt">Name: </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title: </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, as Warrant
    Agent</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt">Name:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Form&nbsp;of Warrant Certificate]<BR>
[Reverse]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Warrants evidenced by this Warrant Certificate
are part of a duly authorized issue of Warrants entitling the holder on exercise to receive Ordinary Shares and are issued or to be issued
pursuant to a Warrant Agreement dated as of [__], 202[_] (the &ldquo;<B><I>Warrant Agreement</I></B>&rdquo;), duly executed and delivered
by the Company to Continental Stock Transfer&nbsp;&amp; Trust Company, a New York limited purpose trust company, as warrant agent (or
successor warrant agent) (collectively, the &ldquo;<B><I>Warrant Agent</I></B>&rdquo;), which Warrant Agreement is hereby incorporated
by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations,
duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words &ldquo;<B><I>holders</I></B>&rdquo; or &ldquo;<B><I>holder</I></B>&rdquo;
meaning the Registered Holders or Registered Holder, respectively) of the Warrants. A copy of the Warrant Agreement may be obtained by
the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have
the meanings given to them in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Warrants may be exercised at any time during the
Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by
surrendering this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together
with payment of the Warrant Price as specified in the Warrant Agreement (or through &ldquo;<B><I>cashless exercise</I></B>&rdquo; as provided
for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise of Warrants
evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued
to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding anything else in this Warrant Certificate
or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i)&nbsp;a registration statement covering the Ordinary
Shares to be issued upon exercise is effective under the Securities Act and (ii)&nbsp;a prospectus thereunder relating to the Ordinary
Shares is current, except through &ldquo;<B><I>cashless exercise</I></B>&rdquo; as provided for in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Warrant Agreement provides that upon the occurrence
of certain events the number of Ordinary Shares issuable upon exercise of the Warrants and the Warrant Price set forth on the face hereof
may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional
interest in Ordinary Shares, the Company shall, upon exercise, round down to the nearest whole number of Ordinary Shares to be issued
to the holder of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Warrant Certificates, when surrendered at the principal
corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney duly authorized
in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any
service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon due presentation for registration of transfer
of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing
in the aggregate a like number of Warrants shall be issued to the transferee(s)&nbsp;in exchange for this Warrant Certificate, subject
to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection
therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company and the Warrant Agent may deem and
treat the Registered Holder(s)&nbsp;hereof as the absolute owner(s)&nbsp;of this Warrant Certificate (notwithstanding any notation of
ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s)&nbsp;hereof,
and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the
Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a shareholder of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Election to Purchase<BR>
(To Be Executed Upon Exercise of Warrant)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned hereby irrevocably elects to exercise
the right, represented by this Warrant Certificate, to receive Ordinary Shares and herewith tenders payment for such Ordinary Shares to
the order of Spring Valley Acquisition Corp. II (the &ldquo;<B><I>Company</I></B>&rdquo;) in the amount of $ in accordance with the terms
hereof. The undersigned requests that a certificate for such Ordinary Shares be registered in the name of, whose address is and that such
Ordinary Shares be delivered to whose address is. If said number of Ordinary Shares is less than all of the Ordinary Shares purchasable
hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered
in the name of, whose address is and that such Warrant Certificate be delivered to, whose address is.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event that the Warrant is to be exercised
on a &ldquo;<B><I>cashless</I></B>&rdquo; basis pursuant to <U>Section&nbsp;3.3.1(b)</U>&nbsp;of the Warrant Agreement, the number of
Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with <U>3.3.1(b)</U>&nbsp;of the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event that the Warrant is to be exercised
on a &ldquo;<B><I>cashless</I></B>&rdquo; basis pursuant to <U>Section&nbsp;7.4</U> of the Warrant Agreement, the number of Ordinary Shares
that this Warrant is exercisable for shall be determined in accordance with <U>Section&nbsp;7.4</U> of the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event that the Warrant may be exercised,
to the extent allowed by the Warrant Agreement, through cashless exercise (i)&nbsp;the number of Ordinary Shares that this Warrant is
exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise
and (ii)&nbsp;the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right, represented
by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive Ordinary Shares. If said number
of Ordinary Shares is less than all of the Ordinary Shares purchasable hereunder (after giving effect to the cashless exercise), the undersigned
requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered in the name of, whose
address is and that such Warrant Certificate be delivered to, whose address is.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: , 20[_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-top: black 1pt solid; font-size: 10pt">(Signature)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; font-size: 10pt">(Address)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; font-size: 10pt">(Tax Identification Number)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">THE SIGNATURE(S)&nbsp;SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR
INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION
PROGRAM, PURSUANT TO SECURITIES AND EXCHANGE COMMISSION RULE 17Ad-15 (OR ANY SUCCESSOR RULE) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS AMENDED).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>6
<FILENAME>tm216731d39_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT><B><I>Execution
Version</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Rights Agreement (this
 &ldquo;<B><I>Agreement</I></B>&rdquo;) is made as of&#8239;October&nbsp;12, 2022, by and between Spring Valley Acquisition Corp. II, a
Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;), and Continental Stock Transfer&nbsp;&amp; Trust Company, a
New York limited purpose trust, as rights agent (in such capacity, the &ldquo;<B><I>Rights Agent</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company is engaged
in a public offering (the &ldquo;<B><I>Public Offering</I></B>&rdquo;) of 20,000,000 units (the &ldquo;<B><I>Units</I></B>&rdquo;) of
the Company (and up to&#8239;3,000,000 additional Units if the underwriters&rsquo; over-allotment option is exercised in full), each Unit
consisting of one Class&#8239;A ordinary share of the Company, par value $0.0001&#8239;per share (the &ldquo;<B><I>Ordinary Shares</I></B>&rdquo;),
one right to receive one-tenth of one Ordinary Share upon the happening of the triggering event described herein (the &ldquo;<B><I>Right</I></B>&rdquo;),
and one half of one redeemable public warrant to purchase one Ordinary Share (the &ldquo;<B><I>Warrant</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, simultaneously with
the consummation of the Public Offering, the Company will issue and deliver up to an aggregate of 23,000,000 rights upon consummation
of the offering, 3,000,000 of which are attributable to the over-allotment option;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company has filed
with the Securities and Exchange Commission (the &ldquo;<B><I>SEC</I></B>&rdquo;) a Registration Statement on Form&#8239;S-1, File No.&nbsp;333-253156
(the &ldquo;<B><I>Registration Statement</I></B>&rdquo;), and related Prospectus (the &ldquo;<B><I>Prospectus</I></B>&rdquo;), for the
registration, under the Securities Act of&#8239;1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;), of, among other securities,
the Rights and the Ordinary Shares issuable to the holders of the Rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
the Rights Agent to act on behalf of the Company, and the Rights Agent is willing to so act, in connection with the issuance, registration,
transfer and exchange of the Rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
to provide for the form and provisions of the Rights, the terms upon which they shall be issued, and the respective rights, limitation
of rights, and immunities of the Company, the Rights Agent, and the holders of the Rights; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, all acts and things
have been done and performed which are necessary to make the Rights, when executed on behalf of the Company and countersigned by or on
behalf of the Rights Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution
and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual agreements herein contained, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Appointment
of Rights Agent</U>. The Company hereby appoints the Rights Agent to act as agent for the Company for the Rights, and the Rights Agent
hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Form&nbsp;of
Right</U>. Each Right shall be issued in registered form only, shall be in substantially the form of <U>Exhibit&#8239;A</U> hereto, the
provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, a Chairperson of the Board, the
Chief Executive Officer, the Chief Financial Officer, or any person designated as an authorized person by the appropriate corporate authorization
(&ldquo;<B><I>Authorized Person</I></B>&rdquo;). In the event the person whose facsimile signature has been placed upon any Right shall
have ceased to serve in the capacity in which such person signed the Right before such Right is issued, it may be issued with the same
effect as if he or she had not ceased to be such at the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Effect
of Countersignature</U>. Unless and until countersigned by the Rights Agent pursuant to this Agreement, a Right shall be invalid and of
no effect and may not be exchanged for Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Right
Register</U>. The Rights Agent shall maintain books (the &ldquo;<B><I>Right Register</I></B>&rdquo;) for the registration of original
issuance and the registration of transfer of the Rights. Upon the initial issuance of the Rights, the Rights Agent shall issue and register
the Rights in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered
to the Rights Agent by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registered
Holder</U>. Prior to due presentment for registration of transfer of any Right, the Company and the Rights Agent may deem and treat the
person in whose name such Right shall be registered upon the Right Register (the &ldquo;<B><I>Registered Holder</I></B>&rdquo;) as the
absolute owner of such Right and of each Right represented thereby (notwithstanding any notation of ownership or other writing on the
Right Certificate made by anyone other than the Company or the Rights Agent), for the purpose of the exchange thereof, and for all other
purposes, and neither the Company nor the Rights Agent shall be affected by any notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Detachability
of Rights</U>. Each of the securities comprising the Units will begin to trade separately on (i)&nbsp;the fifty second (52nd) day following
the date of the Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New
York City are generally open for normal business (a &ldquo;<B><I>Business Day</I></B>&rdquo;), then on the immediately succeeding Business
Day following, or (ii)&nbsp;such earlier date as Citigroup Global Markets Inc. and Guggenheim Securities, LLC shall determine is acceptable
(such date, the &ldquo;<B><I>Detachment Date</I></B>&rdquo;). In no event will separate trading of the securities comprising the Units
commence until, if the Detachment Date is earlier than the 52nd day following the date of the Prospectus, the Company issues a press release
announcing when such separate trading shall begin. Upon the Detachment Date, holders of Units will have the option to continue to hold
Units or separate their Units into the component pieces.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Terms
and Exchange of Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rights</U>.
Each Right shall entitle the holder thereof to receive one-tenth of one Ordinary Share upon the happening of an Exchange Event (defined
below). No additional consideration shall be paid by a holder of Rights in order to receive his, her or its Ordinary Shares upon an Exchange
Event as the purchase price for such Ordinary Shares has been included in the purchase price for the Units. In no event will the Company
be required to net cash settle the Rights or issue fractional Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exchange
Event</U>. An &ldquo;<B><I>Exchange Event</I></B>&rdquo; shall occur upon the Company&rsquo;s consummation of an initial Business Combination
(as defined in the Company&rsquo;s Amended and Restated Memorandum and Articles of Association).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exchange
of Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Issuance
of Ordinary Shares</U>. As soon as practicable upon the occurrence of an Exchange Event, the Company shall direct holders of the Rights
to return their Rights Certificates to the Rights Agent. If the Company is not the surviving entity in a Business Combination, the holder
of Rights must affirmatively elect to such conversion. Upon receipt of a valid Rights Certificate, the Company shall issue to the Registered
Holder of such Right(s)&nbsp;the number of full Ordinary Shares to which he, she or it is entitled, registered in such name or names as
may be directed by him, her or it and issue to such Registered Holder(s)&nbsp;a certificate or book-entry position for such shares. Notwithstanding
the foregoing, or any provision contained in this Agreement to the contrary, in no event will the Company be required to net cash settle
the Rights. The Company shall not issue fractional shares upon exchange of Rights. In the event that any holder would otherwise be entitled
to any fractional share upon exchange of Rights, at the time of an Exchange Event, the Company will instruct the Rights Agent how any
such entitlement will be addressed. To the fullest extent permitted by the Company&rsquo;s Amended and Restated Memorandum and Articles
of Association the Company reserves the right to deal with any such fractional entitlement at the relevant time in accordance with Cayman
Islands law, which would include the rounding down of any entitlement to receive Ordinary Shares to the nearest whole share (and in effect
extinguishing any fractional entitlement), or the holder being entitled to hold any remaining fractional entitlement (without any share
being issued) and to aggregate the same with any future fractional entitlement to receive shares in the Company until the holder is entitled
to receive a whole number. Any rounding down and extinguishment may be done with or without any in lieu cash payment or other compensation
being made to the holder of the relevant Rights, such that value received on exchange of the Rights may be considered less than the value
that the holder would otherwise expect to receive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Valid
Issuance</U>. All Ordinary Shares issued upon an Exchange Event in conformity with this Agreement shall be validly issued, fully paid
and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Date
of Issuance</U>. Each person in whose name any such certificate or book-entry position for Ordinary Shares is issued shall for all purposes
be deemed to have become the holder of record of such shares on the date of the Exchange Event, irrespective of the date of delivery of
such certificate or entry of position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.3.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Company
Not Surviving Following Exchange Event</U>. Upon an Exchange Event in which the Company does not continue as the publicly held reporting
entity, the definitive agreement will provide for the holders of Rights to receive the same per share consideration the holders of the
Ordinary Shares will receive in such transaction, for the number of shares such holder is entitled to pursuant to <U>Section&#8239;3.3.1
</U>above. If the Company does not continue as the publicly held reporting entity upon an Exchange Event, each holder of a Right will
be required to affirmatively convert his/her or its rights in order to receive the one-tenth of one share underlying each right (without
paying any additional consideration) upon consummation of the Exchange Event. In such a case, each holder of a Right will be required
to indicate his, her or its election to convert the Rights into underlying Ordinary Shares as well as to return the original certificates
evidencing the Rights to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Duration
of Rights</U>. If an Exchange Event does not occur within the time period set forth in the Company&rsquo;s Amended and Restated Memorandum
and Articles of Association, as the same may be amended from time to time, the Rights shall expire and shall be worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
and Exchange of Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
of Transfer</U>. The Rights Agent shall register the transfer, from time to time, of any outstanding Right upon the Right Register, upon
surrender of such Right for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions
for transfer. Upon any such transfer, a new Right representing an equal aggregate number of Rights shall be issued and the old Right shall
be cancelled by the Rights Agent. The Rights so cancelled shall be delivered by the Rights Agent to the Company from time to time upon
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Procedure
for Surrender of Rights</U>. Rights may be surrendered to the Rights Agent, together with a written request for exchange or transfer,
and thereupon the Rights Agent shall issue in exchange therefor one or more new Rights as requested by the Registered Holder of the Rights
so surrendered, representing an equal aggregate number of Rights; provided, however, that in the event that a Right surrendered for transfer
bears a restrictive legend and the new Rights to be issued will not bear a restrictive legend, the Rights Agent shall not cancel such
Right and issue new Rights in exchange therefor until the Rights Agent has received an opinion of counsel for the Company stating that
such transfer may be made and indicating no restrictive legend is required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fractional
Rights</U>. The Rights Agent shall not be required to effect any registration of transfer or exchange which will result in the issuance
of a Right Certificate for a fraction of a Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Service
Charges</U>. No service charge shall be made for any exchange or registration of transfer of Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Adjustments
to Conversion Ratios</U>. The number of Ordinary Shares that the holders of Rights are entitled to receive as a result of the occurrence
of an Exchange Event shall be equitably adjusted to reflect appropriately the effect of any share split, reverse share split, share dividend,
reorganization, recapitalization, reclassification, combination, exchange of shares or other like change with respect to the Ordinary
Shares occurring on or after the date hereof and prior to the Exchange Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Right
Execution and Countersignature</U>. The Rights Agent is hereby authorized to countersign and to deliver, in accordance with the terms
of this Agreement, the Rights required to be issued pursuant to the provisions of this <U>Section&#8239;4</U>, and the Company, whenever
required by the Rights Agent, will supply the Rights Agent with Rights duly executed on behalf of the Company for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Other
Provisions Relating to Rights of Holders of Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights as Shareholder</U>. Until the exchange of a Right for Ordinary Shares as provided for herein, a Right does not entitle the Registered
Holder thereof to any of the rights of a shareholder of the Company, including, without limitation, the right to receive dividends, or
other distributions, exercise any preemptive rights to vote or to consent or to receive notice as shareholders in respect of the meetings
of shareholders or the election of directors of the Company or any other matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Lost,
Stolen, Mutilated, or Destroyed Rights</U>. If any Right is lost, stolen, mutilated, or destroyed, the Company and the Rights Agent may
on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Right, include
the surrender thereof), issue a new Right of like denomination, tenor, and date as the Right so lost, stolen, mutilated, or destroyed.
Any such new Right shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated,
or destroyed Right shall be at any time enforceable by anyone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reservation
of Ordinary Shares</U>. The Company shall at all times reserve and keep available a number of its authorized but unissued Ordinary Shares
that will be sufficient to permit the exchange of all outstanding Rights issued pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Concerning
the Rights Agent and Other Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Taxes</U>. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Rights
Agent in respect of the issuance or delivery of Ordinary Shares upon the exchange of Rights, but the Company shall not be obligated to
pay any transfer taxes in respect of the Rights or such Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Resignation,
Consolidation, or Merger of Rights Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Appointment
of Successor Rights Agent</U>. The Rights Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from
all further duties and liabilities hereunder after giving sixty (60)&#8239;days&rsquo; notice in writing to the Company. If the office
of the Rights Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
Rights Agent in place of the Rights Agent. If the Company shall fail to make such appointment within a period of&#8239;30&#8239;days after
it has been notified in writing of such resignation or incapacity by the Rights Agent or by the holder of the Right (who shall, with such
notice, submit his, her or its Right for inspection by the Company), then the holder of any Right may apply to the Supreme Court of the
State of New York for the County of New York for the appointment of a successor Rights Agent at the Company&rsquo;s cost. Any successor
Rights Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing under the
laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York,
and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority.
After appointment, any successor Rights Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations
of its predecessor Rights Agent with like effect as if originally named as Rights Agent hereunder, without any further act or deed; but
if for any reason it becomes necessary or appropriate, the predecessor Rights Agent shall execute and deliver, at the expense of the Company,
an instrument transferring to such successor Rights Agent all the authority, powers, and rights of such predecessor Rights Agent hereunder;
and upon request of any successor Rights Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing
for more fully and effectually vesting in and confirming to such successor Rights Agent all such authority, powers, rights, immunities,
duties, and obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
of Successor Rights Agent</U>. In the event a successor Rights Agent shall be appointed, the Company shall give notice thereof to the
predecessor Rights Agent and the transfer agent for the Ordinary Shares not later than the effective date of any such appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Merger
or Consolidation of Rights Agent</U>. Any entity into which the Rights Agent may be merged or with which it may be consolidated or any
entity resulting from any merger or consolidation to which the Rights Agent shall be a party shall be the successor Rights Agent under
this Agreement without any further act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fees
and Expenses of Rights Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remuneration</U>.
The Company agrees to pay the Rights Agent reasonable remuneration for its services as such Rights Agent hereunder and shall, pursuant
to its obligations under this Agreement, reimburse the Rights Agent upon demand for all expenditures that the Rights Agent may reasonably
incur in the execution of its duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Further
Assurances</U>. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and
delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Rights Agent for the carrying
out or performing of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Liability
of Rights Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reliance
on Company Statement</U>. Whenever in the performance of its duties under this Agreement, the Rights Agent shall deem it necessary or
desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact
or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established
by a statement signed by the Chief Executive Officer, Chief Financial Officer or another Authorized Person and delivered to the Rights
Agent. The Rights Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnity</U>.
The Rights Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. Subject to <U>Section&#8239;6.6
</U>below, the Company agrees to indemnify the Rights Agent and save it harmless against any and all liabilities, including judgments,
out-of-pocket costs and reasonable outside counsel fees, for anything done or omitted by the Rights Agent in the execution of this Agreement
except as a result of the Rights Agent&rsquo;s gross negligence, willful misconduct, fraud or bad faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exclusions</U>.
The Rights Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
of any Right (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition
contained in this Agreement or in any Right; nor shall it by any act hereunder be deemed to make any representation or warranty as to
the authorization or reservation of any Ordinary Shares to be issued pursuant to this Agreement or any Right or as to whether any Ordinary
Shares will, when issued, be valid and fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acceptance
of Agency</U>. The Rights Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms
and conditions herein set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Waiver</U>.
The Rights Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (&ldquo;<B><I>Claim</I></B>&rdquo;)
in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date
hereof, by and between the Company and Continental Stock Transfer&nbsp;&amp; Trust Company as trustee thereunder) and hereby agrees not
to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous
Provisions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors</U>.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent shall bind and inure to the
benefit of their respective successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any notice, statement or demand authorized by this Agreement to be given or made by the Rights Agent or by the holder of any Right to
or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by
the Company with the Rights Agent), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Spring Valley Acquisition Corp. II<BR>
2100 McKinney Ave, Suite&nbsp;1675</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Dallas, TX 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: Robert Kaplan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">Kirkland&nbsp;&amp; Ellis LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">609 Main Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Houston, Texas 77002<BR>
Attn: Matthew Pacey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any notice, statement or demand
authorized by this Agreement to be given or made by the holder of any Right or by the Company to or on the Rights Agent shall be sufficiently
given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after
deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Rights Agent with the Company), as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Continental Stock Transfer&nbsp;&amp; Trust Company<BR>
One State Street, 30th Floor<BR>
New York, New York 10004<BR>
Attn: Compliance Department</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Applicable
Law and Exclusive Forum</U>. The validity, interpretation, and performance of this Agreement and of the Rights shall be governed in all
respects by the laws of the State of New York, without giving effect to conflict of laws. Subject to applicable law, the Company and the
Rights Agent hereby agree that any action, proceeding or claim against either of them arising out of or relating in any way to this Agreement,
including under the Securities Act, shall be brought and enforced in the courts of the State of New York located in the County of New
York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be the exclusive forum for any such action, proceeding or claim. The Company and the Rights Agent hereby waive any objection to
such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this
paragraph will not apply to suits brought to enforce (i)&#8239;any liability or duty created by the Securities Exchange Act of&#8239;1934,
as amended (the &ldquo;Exchange Act&rdquo;), or the rules&nbsp;and regulations thereunder for which Section&#8239;27 of the Exchange Act
creates exclusive federal jurisdiction or (ii)&#8239;any other claim for which the federal district courts of the United States of America
are the sole and exclusive forum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any person or entity purchasing
or otherwise acquiring any interest in the Rights shall be deemed to have notice of and to have consented to the forum provisions in this
<U>Section&#8239;7.3</U>. If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court
other than a court located within the State and County of New York or the United States District Court for the Southern District of New
York (a &ldquo;<B><I>foreign action</I></B>&rdquo;) in the name of any Rights holder, such Rights holder shall be deemed to have consented
to: (x)&#8239;the personal jurisdiction of the state and federal courts located within the State and County of New York or the United
States District Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum
provisions (an &ldquo;<B><I>enforcement action</I></B>&rdquo;), and (y)&#8239;having service of process made upon such Rights holder in
any such enforcement action by service upon such Rights holder&rsquo;s counsel in the foreign action as agent for such Rights holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Persons
Having Rights under this Agreement</U>. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions
hereof is intended, or shall be construed, to confer upon, or give to, any person, corporation or other entity other than the parties
hereto and the Registered Holders of the Rights and any right, remedy, or claim under or by reason of this Agreement or of any covenant,
condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this
Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders
of the Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Examination
of the Right Agreement</U>. A copy of this Agreement shall be available at all reasonable times at the office of the Rights Agent in the
Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Right. The Rights Agent may require any
such holder to submit his, her or its Right for inspection by it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Counterparts</U>.
This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Effect
of Headings</U>. The Section&nbsp;headings herein are for convenience only and are not part of this Agreement and shall not affect the
interpretation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendments</U>.
This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of (i)&nbsp;curing any
ambiguity, or correcting any mistake, including conforming the provision hereof to the description of the rights and this Agreement, set
forth in the Prospectus, or defective provision contained herein, (ii)&nbsp;or adding or changing any provisions with respect to matters
or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely
affect the rights of the Registered Holders under this Agreement in any material respect, or (iii)&nbsp;making any amendments that are
necessary in the good faith determination of the Board (taking into account then existing market precedents for initial public offerings
of special purpose acquisition companies underwritten by bulge bracket investment banks) to allow for the rights to be or continue to
be, as applicable, classified as equity in the Company&rsquo;s financial statements; provided that no such amendment pursuant to clause
(iii)&nbsp;will, in the aggregate, materially affect the legal rights of Registered Holders of the then outstanding rights under this
Agreement. All other modifications or amendments shall require the written consent or vote of the Registered Holders of a majority of
the then outstanding Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible and be valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
this Agreement has been duly executed by the parties hereto as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2"><B>SPRING VALLEY ACQUISITION CORP. II</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; font-size: 10pt">/s/ Christopher Sorrells</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name: Christopher Sorrells</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title: Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>[Signature
Page&nbsp;to Rights Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, as Rights Agent</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By: </TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; font-size: 10pt">/s/ Steven Vacante</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name: Steven Vacante</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title: Vice President</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>[Signature
Page&nbsp;to Rights Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 240px; font-size: 10pt; text-align: justify"><B>NUMBER</B></TD>
    <TD STYLE="font-size: 10pt; text-align: right"><B>RIGHTS</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>A CAYMAN ISLANDS EXEMPTED COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RIGHTS CERTIFICATE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>SEE REVERSE FOR<BR>
CERTAIN DEFINITIONS<BR>
CUSIP ______</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>_</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>This Rights Certificate
certifies that</I></B>, for value received, ______________________, or registered assigns, is the registered holder of a right or rights
(each, a &ldquo;<B><I>Right</I></B>&rdquo;) to automatically receive one-tenth of one Class&#8239;A ordinary share, par value $0.0001&#8239;per
share (&ldquo;<B><I>Ordinary Share</I></B>&rdquo;), of SPRING VALLEY ACQUISITION CORP. II (the &ldquo;<B><I>Company</I></B>&rdquo;) for
each Right evidenced by this Rights Certificate on the Company&rsquo;s completion of an initial business combination (as defined in the
final prospectus relating to the Company&rsquo;s initial public offering (&ldquo;<B><I>Prospectus</I></B>&rdquo;) upon surrender of this
Rights Certificate pursuant to the Rights Agreement between the Company and Continental Stock Transfer&nbsp;&amp; Trust Company, as Rights
Agent (the &ldquo;<B><I>Rights Agent</I></B>&rdquo;). In no event will the Company be required to net cash settle any Right or issue a
fractional Ordinary Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon liquidation of the Company in the event an
initial business combination is not consummated during the required period as identified in the Company&rsquo;s Amended and Restated Memorandum
and Articles of Association, the Rights shall expire and be worthless. As more fully described in the Company&rsquo;s final prospectus
dated [&#9679;], 2022, the holder of a Right shall have no right or interest of any kind in the Company&rsquo;s trust account established
in connection with the Company&rsquo;s initial public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon due presentment for registration of transfer
of the Right Certificate at the office or agency of Continental Stock Transfer&nbsp;&amp; Trust Company, the Rights Agent, a new Right
Certificate or Right Certificates of like tenor and evidencing in the aggregate a like number of Rights shall be issued to the transferee
in exchange for this Right Certificate, without charge except for any applicable tax or other governmental charge. The Company shall not
issue fractional shares upon exchange of Rights. The Company reserves the right to deal with any fractional entitlement at the relevant
time in any manner (as provided in the Rights Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and the Rights Agent may deem and
treat the registered holder as the absolute owner of this Right Certificate (notwithstanding any notation of ownership or other writing
hereon made by anyone), for the purpose of any conversion hereof, of any distribution to the registered holder, and for all other purposes,
and neither the Company nor the Rights Agent shall be affected by any notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Right does not entitle the registered holder
to any of the rights of a shareholder of the Company. This Right shall be governed by and construed in accordance with the internal laws
of the State of New York, without regard to conflicts of laws principles thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dated:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>SPRING VALLEY ACQUISITION CORP. II</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="width: 5%; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 42%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Title: &nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY</B>, as Right Agent &nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Title: &nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following abbreviations,
when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to
applicable laws or regulations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 6pt; padding-left: 6pt; font-size: 10pt">TEN COM &ndash; as tenants in common</TD>
    <TD STYLE="width: 50%; padding-right: 6pt; padding-left: 6pt; font-size: 10pt">UNIF GIFT MIN Custodian ACT - under U.S.&#8239;Uniform&#8239;Gifts to Minor Act</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt">TEN ENT &ndash; as tenants by the entireties</TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt">(Cust)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(Minor)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt">JT TEN &ndash; as joint tenants with right of survivorship and not as tenants in common</TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Additional Abbreviations may also be used though
not in the above list.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will furnish without
charge to each security holder who so requests the powers, designations, preferences and relative, participating, optional or other special
rights of each class of equity securities or series thereof of the Company and the qualifications, limitations, or restrictions of such
preferences and/or rights. This certificate and the rights represented thereby are issued and shall be held subject to all the provisions
of the Rights Agreement, the Company&rsquo;s Amended and Restated Memorandum and Articles of Association and all amendments thereto and
resolutions of the Board of Directors providing for the issuance of securities (copies of which may be obtained from the secretary of
the Company), to all of which the holder of this certificate by acceptance hereof assents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>For value received, _________________________
hereby sell(s), assign(s)&nbsp;and transfer(s)&nbsp;unto</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING
NUMBER OF ASSIGNEE</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(PLEASE PRINT OR TYPEWRITE
NAME AND ADDRESS,&nbsp;INCLUDING ZIP CODE, OF ASSIGNEE(S)) <I>Rights represented by the within Certificate, and do hereby irrevocably
constitute and appoint ______________________________________________ Attorney to transfer the said rights on the books of the within
named Company will full power of substitution in the premises.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Dated</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTICE: </B>THE SIGNATURE TO THIS ASSIGNMENT
MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY
CHANGE WHATEVER.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signature(s)&nbsp;Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SIGNATURE(S)&nbsp;MUST BE GUARANTEED BY AN
ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE
GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE&#8239;17Ad-15 UNDER THE UNITED STATES SECURITIES EXCHANGE ACT OF&#8239;1934, AS AMENDED).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As more fully described in the Company&rsquo;s
final prospectus dated [&#9679;], 2022, the holder of this certificate shall have no right or interest of any kind in or to the funds
held in the Company&rsquo;s trust account established in connection with the Company&rsquo;s initial public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>tm216731d39_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT><B><I>Execution
Version</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INVESTMENT MANAGEMENT TRUST AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Investment Management Trust Agreement (this
 &ldquo;<B><I>Agreement</I></B>&rdquo;) is made effective as of October&nbsp;12, 2022 by and between Spring Valley Acquisition Corp. II,
a Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;), and Continental Stock Transfer&nbsp;&amp; Trust Company,
a New York limited purpose trust company (the &ldquo;<B><I>Trustee</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company&rsquo;s registration
statement on Form&nbsp;S-1, File No.&nbsp;333-253156 (the &ldquo;<B><I>Registration Statement</I></B>&rdquo;) and prospectus (the
 &ldquo;<B><I>Prospectus</I></B>&rdquo;) for the initial public offering of the Company&rsquo;s units (the
 &ldquo;<B><I>Units</I></B>&rdquo;), each of which consists of one of the Company&rsquo;s Class&nbsp;A ordinary shares, par value
$0.0001 per share (the &ldquo;<B><I>Ordinary Shares</I></B>&rdquo;), one right to receive one-tenth of one Ordinary Share, and
one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Ordinary Share (such initial
public offering hereinafter referred to as the &ldquo;<B><I>Public Offering</I></B>&rdquo;), has been declared effective as of the
date hereof by the U.S. Securities and Exchange Commission; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company has entered into an Underwriting
Agreement (the &ldquo;<B><I>Underwriting Agreement</I></B>&rdquo;) with Citigroup Global Markets Inc. and Guggenheim Securities, LLC,
as representatives (the &ldquo;<B><I>Representatives</I></B>&rdquo;) to the several underwriters (the &ldquo;<B><I>Underwriters</I></B>&rdquo;)
named therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, simultaneously with the Public Offering,
the Company&rsquo;s sponsor (the &ldquo;<B><I>Sponsor</I></B>&rdquo;) will be purchasing 12,000,000 warrants (&ldquo;<B><I>Private Placement
Warrants</I></B>&rdquo;) from the Company for an aggregate purchase price of $12,000,000 up to 13,350,000 Private Placement Warrants for
an aggregate purchase price of up to $13,350,000 if the underwriters&rsquo; over-allotment option is exercised in full);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, as described in the Prospectus, $205,000,000
of the gross proceeds of the Public Offering and sale of the Private Placement Warrants (as defined in the Underwriting Agreement) (or
$235,750,000 if the Underwriters&rsquo; option to purchase additional units is exercised in full) will be delivered to the Trustee to
be deposited and held in a segregated trust account located at all times in the United States (the &ldquo;<B><I>Trust Account</I></B>&rdquo;)
for the benefit of the Company and the holders of the Ordinary Shares included in the Units issued in the Public Offering as hereinafter
provided (the amount to be delivered to the Trustee (and any interest subsequently earned thereon) is referred to herein as the &ldquo;<B><I>Property</I></B>,&rdquo;
the shareholders for whose benefit the Trustee shall hold the Property will be referred to as the &ldquo;<B><I>Public Shareholders</I></B>,&rdquo;
and the Public Shareholders and the Company will be referred to together as the &ldquo;<B><I>Beneficiaries</I></B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, pursuant to the Underwriting Agreement,
a portion of the Property equal to $7,000,000, or $8,050,000 if the Underwriters&rsquo; option to purchase additional units is exercised
in full, is attributable to deferred underwriting discounts and commissions that will be payable by the Company to the Underwriters upon
the consummation of the Business Combination (as defined below) (the &ldquo;<B><I>Deferred Discount</I></B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company and the Trustee desire to
enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">NOW THEREFORE,&nbsp;IT IS AGREED:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Agreements
and Covenants of Trustee</U>. The Trustee hereby agrees and covenants to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Hold
the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in the Trust Account established by the Trustee
in the United States at Morgan Stanley&nbsp;&amp; Co. LLC, (or at another U.S. chartered commercial bank with consolidated assets of $100
billion or more) in the United States, maintained by Trustee and at a brokerage institution selected by the Trustee that is reasonably
satisfactory to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Manage,
supervise and administer the Trust Account subject to the terms and conditions set forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
a timely manner, upon the written instruction of the Company, invest and reinvest the Property in United States government
securities within the meaning of Section&nbsp;2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185
days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3)&nbsp;and (d)(4)&nbsp;of
Rule&nbsp;2a-7 promulgated under the Investment Company Act of 1940, as amended (or any successor rule), which invest only in direct
U.S. government treasury obligations, as determined by the Company; the Trustee may not invest in any other securities or assets, it
being understood that the Trust Account will earn no interest while account funds are uninvested awaiting the Company&rsquo;s
instructions hereunder the Trustee may earn bank credits or other consideration;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Collect
and receive, when due, all principal, interest or other income arising from the Property, which shall become part of the &ldquo;<B><I>Property</I></B>,&rdquo;
as such term is used herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Promptly
notify the Company and the Representatives of all communications received by the Trustee with respect to any Property requiring action
by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Supply
any necessary information or documents as may be requested by the Company (or its authorized agents) in connection with the Company&rsquo;s
preparation of the tax returns relating to assets held in the Trust Account;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Participate
in any plan or proceeding for protecting or enforcing any right or interest arising from the Property if, as and when instructed by the
Company to do so;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Render
to the Company monthly written statements of the activities of, and amounts in, the Trust Account reflecting all receipts and disbursements
of the Trust Account;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Commence
liquidation of the Trust Account only after and promptly after (x)&nbsp;receipt of, and only in accordance with, the terms of a letter
from the Company (&ldquo;<B><I>Termination Letter</I></B>&rdquo;) in a form substantially similar to that attached hereto as either <U>Exhibit&nbsp;A</U>
or <U>Exhibit&nbsp;B</U>, as applicable, signed on behalf of the Company by its Chief Executive Officer, Chief Financial Officer or other
authorized officer of the Company, and complete the liquidation of the Trust Account and distribute the Property in the Trust Account,
including interest and other income earned on the funds held in the Trust Account and not previously released to the Company to pay its
income taxes (less up to $100,000 of interest to pay dissolution expenses) only as directed in the Termination Letter and the other documents
referred to therein, or (y)&nbsp;upon the date which is the later of (1)&nbsp;15 months after the closing of the Public Offering (or up
to 18 months if we extend the period of time to consummate a business combination) and (2)&nbsp;such later date as may be approved by
the Company&rsquo;s shareholders in accordance with the Company&rsquo;s amended and restated memorandum and articles of association, if
a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account shall be liquidated in accordance
with the procedures set forth in the Termination Letter attached as <U>Exhibit&nbsp;B</U> and the Property in the Trust Account, including
interest and other income earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes
(less up to $100,000 of interest to pay dissolution expenses), shall be distributed to the Public Shareholders of record as of such date.
It is acknowledged and agreed that there should be no reduction in the principal amount per share initially deposited in the Trust Account;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as <U>Exhibit&nbsp;C</U>
(a &ldquo;<B><I>Tax Payment Withdrawal Instruction</I></B>&rdquo;), withdraw from the Trust Account and distribute to the Company the
amount of interest and other income earned on the Property requested by the Company to cover any tax obligation owed by the Company as
a result of assets of the Company or interest or other income earned on the Property, which amount shall be delivered directly to the
Company by electronic funds transfer or other method of prompt payment, and the Company shall forward such payment to the relevant taxing
authority, so long as there is no reduction in the principal amount per share initially deposited in the Trust Account; <U>provided</U>,
<U>however</U>, that to the extent there is not sufficient cash in the Trust Account to pay such tax obligation, the Trustee shall liquidate
such assets held in the Trust Account as shall be designated by the Company in writing to make such distribution (it being acknowledged
and agreed that any such amount in excess of interest income earned on the Property shall not be payable from the Trust Account). The
written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to said funds, and
the Trustee shall have no responsibility to look beyond said request;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as <U>Exhibit&nbsp;D </U>(a
 &ldquo;<B><I>Shareholder Redemption Withdrawal Instruction</I></B>&rdquo;), the Trustee shall distribute to the remitting brokers on
behalf of Public Shareholders redeeming Ordinary Shares the amount required to pay redeemed Ordinary Shares from Public Shareholders
pursuant to the Company&rsquo;s amended and restated memorandum and articles of association; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Not
make any withdrawals or distributions from the Trust Account other than pursuant to <U>Section&nbsp;1(i)</U>, (j)&nbsp;or <U>(k)</U>&nbsp;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Agreements
and Covenants of the Company</U>. The Company hereby agrees and covenants to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Give
all instructions to the Trustee hereunder in writing, signed by the Company&rsquo;s Chief Executive Officer, Chief Financial Officer or
other authorized officer of the Company. In addition, except with respect to its duties under <U>Sections 1(i)</U>, (j)&nbsp;or <U>(k)</U>&nbsp;hereof,
the Trustee shall be entitled to rely on, and shall be protected in relying on, any verbal or telephonic advice or instruction which it,
in good faith and with reasonable care, believes to be given by any one of the persons authorized above to give written instructions,
provided that the Company shall promptly confirm such instructions in writing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject
to <U>Section&nbsp;4</U> hereof, hold the Trustee harmless and indemnify the Trustee from and against any and all expenses, including
reasonable counsel fees and disbursements, or losses suffered by the Trustee in connection with any action taken by it hereunder and in
connection with any action, suit or other proceeding brought against the Trustee involving any claim, or in connection with any claim
or demand, which in any way arises out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or any
interest and other income earned on the Property, except for expenses and losses resulting from the Trustee&rsquo;s gross negligence,
fraud or willful misconduct. Promptly after the receipt by the Trustee of notice of demand or claim or the commencement of any action,
suit or proceeding, pursuant to which the Trustee intends to seek indemnification under this <U>Section&nbsp;2(b)</U>, it shall notify
the Company in writing of such claim (hereinafter referred to as the &ldquo;<B><I>Indemnified Claim</I></B>&rdquo;). The Trustee shall
have the right to conduct and manage the defense against such Indemnified Claim; <U>provided</U> that the Trustee shall obtain the consent
of the Company with respect to the selection of counsel, which consent shall not be unreasonably withheld. The Trustee may not agree to
settle any Indemnified Claim without the prior written consent of the Company, which such consent shall not be unreasonably withheld.
The Company may participate in such action with its own counsel;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Pay
the Trustee the fees set forth on <U>Schedule A</U> hereto, including an initial acceptance fee, annual administration fee, and transaction
processing fee which fees shall be subject to modification by the parties from time to time. It is expressly understood that the Property
shall not be used to pay such fees unless and until it is distributed to the Company pursuant to <U>Sections 1(i)</U>&nbsp;through <U>1(k)</U>&nbsp;hereof.
The Company shall pay the Trustee the initial acceptance fee and the first annual administration fee at the consummation of the Public
Offering. The Trustee shall refund to the Company the annual administration fee (on a pro rata basis) with respect to any period after
the liquidation of the Trust Account. The Company shall not be responsible for any other fees or charges of the Trustee except as set
forth in this <U>Section&nbsp;2(c)</U>&nbsp;and as may be provided in <U>Section&nbsp;2(b)</U>&nbsp;hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
connection with any vote of the Company&rsquo;s shareholders regarding a merger, share exchange, asset acquisition, share purchase, reorganization
or similar business combination involving the Company and one or more businesses (the &ldquo;<B><I>Business Combination</I></B>&rdquo;),
provide to the Trustee an affidavit or certificate of the inspector of elections for the shareholder meeting verifying the vote of such
shareholders regarding such Business Combination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Provide
the Representatives with a copy of any Termination Letter(s)&nbsp;and/or any other correspondence that is sent to the Trustee with respect
to any proposed withdrawal from the Trust Account promptly after it issues the same;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Unless
otherwise agreed between the Company and the Representatives, ensure that any Instruction Letter (as defined in <U>Exhibit&nbsp;A</U>)
delivered in connection with a Termination Letter in the form of <U>Exhibit</U>&nbsp;A expressly provides that the Deferred Discount is
paid directly to the account or accounts directed by the Representatives on behalf of the Underwriters prior to any transfer of the funds
held in the Trust Account to the Company or any other person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Instruct
the Trustee to make only those distributions that are permitted under this Agreement, and refrain from instructing the Trustee to make
any distributions that are not permitted under this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Company seeks to amend any provisions of its amended and restated memorandum and articles of association (A)&nbsp;to modify the substance
or timing of the Company&rsquo;s obligation to allow redemption in connection with its Business Combination or to redeem 100% of the Company&rsquo;s
Ordinary Shares if it has not completed a Business Combination within 15 months (or 18 months if we extend the period of time to consummate
a business combination). from the closing date of the Public Offering or (B)&nbsp;with respect to any other provision relating to the
rights of holders of the Ordinary Shares (in each case, an &ldquo;<B><I>Amendment</I></B>&rdquo;), the Company will provide the Trustee
with an amendment notification letter in the form of <U>Exhibit&nbsp;D</U> providing instructions for the distribution of funds to Public
Shareholders who exercise their redemption option in connection with such Amendment; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Within
five (5)&nbsp;business days after the Underwriters exercise their option to purchase additional units (or any unexercised portion thereof)
or such option to purchase additional units expires, provide the Trustee with a notice in writing of the total amount of the Deferred
Discount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitations
of Liability</U>. The Trustee shall have no responsibility or liability to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Imply
obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than this Agreement
and that which is expressly set forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Take
any action with respect to the Property, other than as directed in <U>Section&nbsp;1</U> hereof, and the Trustee shall have no liability
to any third party except for liability arising out of the Trustee&rsquo;s gross negligence, fraud or willful misconduct;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Institute
any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any proceeding of any kind
with respect to, any of the Property unless and until it shall have received written instructions from the Company given as provided herein
to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any expenses incident thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Change
the investment of any Property, other than in compliance with <U>Section&nbsp;1</U> hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Refund
any depreciation in principal of any Property;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Assume
that the authority of any person designated by the Company to give instructions hereunder shall not be continuing unless provided otherwise
in such designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or omitted, in
good faith and in the Trustee&rsquo;s best judgment, except for the Trustee&rsquo;s gross negligence, fraud or willful misconduct. The
Trustee may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel
(including counsel chosen by the Trustee, which counsel may be the Company&rsquo;s counsel), statement, instrument, report or other paper
or document (not only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and acceptability
of any information therein contained) which the Trustee believes, in good faith and with reasonable care, to be genuine and to be signed
or presented by the proper person or persons. The Trustee shall not be bound by any notice or demand, or any waiver, modification, termination
or rescission of this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee, signed
by the proper party or parties and, if the duties or rights of the Trustee are affected, unless it shall give its prior written consent
thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Verify
the accuracy of the information contained in the Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Provide
any assurance that any Business Combination entered into by the Company or any other action taken by the Company is as contemplated by
the Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;File
information returns with respect to the Trust Account with any local, state or federal taxing authority or provide periodic written statements
to the Company documenting the taxes payable by the Company, if any, relating to any interest income earned on the Property;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prepare,
execute and file tax reports, income or other tax returns and pay any taxes with respect to any income generated by, and activities relating
to, the Trust Account, regardless of whether such tax is payable by the Trust Account or the Company, including, but not limited to, income
tax obligations, except pursuant to <U>Section&nbsp;1(j)</U>&nbsp;hereof; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Verify
calculations, qualify or otherwise approve the Company&rsquo;s written requests for distributions pursuant to <U>Sections 1(i)</U>, <U>1(j)&nbsp;</U>or
<U>1(k)</U>&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Trust
Account Waiver</U>. The Trustee has no right of set-off or any right, title, interest or claim of any kind
(&ldquo;<B><I>Claim</I></B>&rdquo;) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to
any monies in, the Trust Account that it may have now or in the future. In the event the Trustee has any Claim against the Company
under this Agreement, including, without limitation, under <U>Section&nbsp;2(b)</U>&nbsp;or <U>Section&nbsp;2(c)</U>&nbsp;hereof,
the Trustee shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the Property
or any monies in the Trust Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement shall terminate as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its reasonable efforts
to locate a successor trustee, pending which the Trustee shall continue to act in accordance with this Agreement. At such time that the
Company notifies the Trustee that a successor trustee has been appointed by the Company and has agreed to become subject to the terms
of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited
to the transfer of copies of the reports and statements relating to the Trust Account, whereupon this Agreement shall terminate; <U>provided</U>,
<U>however</U>, that in the event that the Company does not locate a successor trustee within ninety (90) days of receipt of the resignation
notice from the Trustee, the Trustee may submit an application to have the Property deposited with any court in the State of New York
or with the United States District Court for the Southern District of New York and upon such deposit, the Trustee shall be immune from
any liability whatsoever; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;At
such time that the Trustee has completed the liquidation of the Trust Account and its obligations in accordance with the provisions of
<U>Section&nbsp;1(i)</U>&nbsp;hereof and distributed the Property in accordance with the provisions of the Termination Letter, this Agreement
shall terminate except with respect to <U>Section&nbsp;2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with respect to funds transferred
from the Trust Account. The Company and the Trustee will each restrict access to confidential information relating to such security procedures
to authorized persons. Each party must notify the other party immediately if it has reason to believe unauthorized persons may have obtained
access to such confidential information, or of any change in its authorized personnel. In executing funds transfers, the Trustee shall
rely upon all information supplied to it by the Company, including, account names, account numbers, and all other identifying information
relating to a Beneficiary, Beneficiary&rsquo;s bank or intermediary bank. Except for any liability arising out of the Trustee&rsquo;s
gross negligence, fraud or willful misconduct, the Trustee shall not be liable for any loss, liability or expense resulting from any error
in the information or transmission of the funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect
to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. This Agreement may
be executed in several original or facsimile counterparts, each one of which shall constitute an original, and together shall constitute
but one instrument. Signatures to this Agreement transmitted via facsimile or e-mail shall be valid and effective to bind the party so
signing (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, (e.g., <U>www.docusign.com</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement contains the entire agreement and understanding of the parties hereto with respect to the subject matter hereof. Except for
<U>Section&nbsp;1(i)</U>, <U>1(j)</U>&nbsp;and <U>1(k)</U>&nbsp;hereof (which sections may not be modified, amended or deleted without
the affirmative vote of at least fifty percent (50%) of the then outstanding Ordinary Shares and Class&nbsp;B ordinary shares, par value
$0.0001 per share, of the Company, voting together as a single class; <U>provided that</U> no such amendment will affect any Public Shareholder
who has properly elected to redeem his or her Ordinary Shares in connection with a shareholder vote to amend this Agreement (A)&nbsp;to
modify the substance or timing of the Company&rsquo;s obligation to provide for the redemption of the Ordinary Shares in connection with
an initial Business Combination or an Amendment or to redeem 100% of its Ordinary Shares if the Company does not complete its initial
Business Combination within the time frame specified in the Company&rsquo;s amended and restated memorandum and articles of association
or (B)&nbsp;with respect to any other provision relating to the rights of holders of the Ordinary Shares), this Agreement or any provision
hereof may only be changed, amended or modified (other than to correct a typographical error) by a writing signed by each of the parties
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, State of New York,
for purposes of resolving any disputes hereunder. AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT,
EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing and shall
be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or by electronic
mail:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">if to the Trustee, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Continental Stock Transfer&nbsp;&amp; Trust Company<BR>
1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0in">Attn: Francis Wolf&nbsp;&amp; Celeste
Gonzalez<BR>
<U>Email: fwolf@continentalstock.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&#8239;&#8239;&#8239;&#8239;&#8239;<U>cgonzalez@continentalstock.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">if to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Spring Valley Acquisition Corp. II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">2100 McKinney Ave, Suite&nbsp;1675</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Dallas, TX 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attn: Robert Kaplan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><U>Email: robert.kaplan@sv-ac.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">in each case, with copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Kirkland&nbsp;&amp; Ellis LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">609 Main Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Houston, Texas 77002</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attn: Matthew Pacey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in">&#8239;&#8239;Christian O. Nagler</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><U>E-mail: matt.pacey@kirkland.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>cnagler@kirkland.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Citigroup Global Markets Inc.<BR>
388 Greenwich Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, New York 10013</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attn: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Fax: (646) 291-1469</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Guggenheim Securities, LLC<BR>
330 Madison Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, New York 10017<BR>
Attention: James Schaefer<BR>
Copy to: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Shearman&nbsp;&amp; Sterling LLP<BR>
599 Lexington Avenue<BR>
New York, New York 10022<BR>
Attn.: Ilir Mujalovic</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in">&#8239;&#8239;&#8239;William B. Nelson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
of the Company and the Trustee hereby represents that it has the full right and power and has been duly authorized to enter into this
Agreement and to perform its respective obligations as contemplated hereunder. The Trustee acknowledges and agrees that it shall not make
any claims or proceed against the Trust Account, including by way of set-off, and shall not be entitled to any funds in the Trust Account
under any circumstance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement is the joint product of the Trustee and the Company and each provision hereof has been subject to the mutual consultation, negotiation
and agreement of such parties and shall not be construed for or against any party hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall
together constitute one and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission
shall constitute valid and sufficient delivery thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
of the Company and the Trustee hereby acknowledges and agrees that the Representatives on behalf of the Underwriters are third-party beneficiaries
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as specified herein, no party to this Agreement may assign its rights or delegate its obligations hereunder to any other person or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>IN WITNESS WHEREOF</B>, the parties have duly executed this Investment
Management Trust Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, </B>as Trustee</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Francis Wolf</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Francis Wolf</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT><I>[Investment Management Trust Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPRING VALLEY ACQUISITION CORP. II</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Christopher Sorrells</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Sorrells</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I></I> <I>[Investment Management Trust Agreement]</I> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Fee Item</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Time and method of payment</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Amount</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Initial acceptance fee</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 35%; font-size: 10pt; text-align: left; padding-left: 2.25pt">Initial closing of IPO by wire transfer</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">3,500.00</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">Annual fee</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-left: 2.25pt">First year, initial closing of IPO by wire transfer; thereafter on the anniversary
    of the effective date of the IPO by wire transfer or check</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">10,000.00</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt; text-align: left">Transaction processing fee for disbursements to Company under
    Sections 1(i),(j), and (k)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 2.25pt">Billed by Trustee to Company under Section&nbsp;1</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">250.00</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Managing the deposits of additional Property into the Trust
    Account following the initial extension 15 months after closing of the offering pursuant to Section&nbsp;1(i)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 2.25pt">Billed to Company monthly upon delivery of service pursuant to
    Section&nbsp;1(i)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">400.00</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">Paying Agent services as required pursuant to Section&nbsp;1(i)&nbsp;and 1(k)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 2.25pt">Billed to Company upon delivery of service pursuant to
    Section&nbsp;1</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">Prevailing rates</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT><I>[Schedule
A to Investment Management Trust Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Letterhead of Company]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Insert date]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer&nbsp;&amp; Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf&nbsp;&amp; Celeste Gonzalez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify"><U>Trust Account - Termination
                                            Letter</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear
Mr.&nbsp;Wolf and Ms.&nbsp;Gonzalez:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to <U>Section&nbsp;1(i)</U>&nbsp;of the
Investment Management Trust Agreement between Spring Valley Acquisition Corp. II (the &ldquo;<B><I>Company</I></B>&rdquo;) and Continental
Stock Transfer&nbsp;&amp; Trust Company (&ldquo;<B><I>Trustee</I></B>&rdquo;), dated as of [&#9679;], 2022 (the &ldquo;<B><I>Trust Agreement</I></B>&rdquo;),
this is to advise you that the Company has entered into an agreement with (the &ldquo;<B><I>Target Business</I></B>&rdquo;) to consummate
a business combination with Target Business (the &ldquo;<B><I>Business Combination</I></B>&rdquo;) on or about <B>[insert date]</B>. The
Company shall notify you at least seventy-two (72) hours in advance of the actual date (or such shorter time period as you may agree)
of the consummation of the Business Combination (the &ldquo;<B><I>Consummation Date</I></B>&rdquo;). Capitalized terms used but not defined
herein shall have the meanings set forth in the Trust Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with the terms of the Trust Agreement,
we hereby authorize you to commence to liquidate all of the assets of the Trust Account, and to transfer the proceeds into the trust operating
account at Morgan Stanley&nbsp;&amp; Co. LLC to the effect that, on the Consummation Date, all of the funds held in the Trust Account
will be immediately available for transfer to the account or accounts that the Representatives (with respect to the Deferred Discount)
and the Company shall direct on the Consummation Date. It is acknowledged and agreed that while the funds are on deposit in said trust
operating account at Morgan Stanley&nbsp;&amp; Co. LLC awaiting distribution, neither the Company nor the Representatives will earn any
interest or dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On the Consummation Date (i)&nbsp;counsel for the
Company shall deliver to you written notification that the Business Combination has been consummated, or will be consummated substantially
concurrently with your transfer of funds to the accounts as directed by the Company (the &ldquo;<B><I>Notification</I></B>&rdquo;), and
(ii)&nbsp;the Company shall deliver to you (a)&nbsp;a certificate by the Chief Executive Officer, Chief Financial Officer or other authorized
officer of the Company, which verifies that the Business Combination has been approved by a vote of the Company&rsquo;s shareholders,
if a vote is held and (b)&nbsp;joint written instruction signed by the Company and the Representatives with respect to the transfer of
the funds held in the Trust Account, including payment of the Deferred Discount from the Trust Account (the &ldquo;<B><I>Instruction Letter</I></B>&rdquo;).
You are hereby directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the Notification
and the Instruction Letter, in accordance with the terms of the Instruction Letter. In the event that certain deposits held in the Trust
Account may not be liquidated by the Consummation Date without penalty, you will notify the Company in writing of the same and the Company
shall direct you as to whether such funds should remain in the Trust Account and be distributed after the Consummation Date to the Company.
Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the
Trust Account, your obligations under the Trust Agreement shall be terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event that the Business Combination is not
consummated on the Consummation Date described in the notice thereof and we have not notified you on or before the original Consummation
Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the funds held in the Trust
Account shall be reinvested as provided in Section&nbsp;1(c)&nbsp;of the Trust Agreement on the business day immediately following the
Consummation Date as set forth in such notice as soon thereafter as possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spring Valley Acquisition Corp. II</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">cc: Citigroup Global Markets Inc. and Guggenheim Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT><I>[Schedule
A to Investment Management Trust Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Letterhead of Company]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Insert date]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer&nbsp;&amp; Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf&nbsp;&amp; Celeste Gonzalez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify"><U>Trust Account - Termination
                                            Letter</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear
Mr.&nbsp;Wolf and Ms.&nbsp;Gonzalez:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to <U>Section&nbsp;1(i)</U>&nbsp;of the
Investment Management Trust Agreement between Spring Valley Acquisition Corp. II (the &ldquo;<B><I>Company</I></B>&rdquo;) and Continental
Stock Transfer&nbsp;&amp; Trust Company (the &ldquo;<B><I>Trustee</I></B>&rdquo;), dated as of [&#9679;], 2022 (the &ldquo;<B><I>Trust
Agreement</I></B>&rdquo;), this is to advise you that the Company has been unable to effect a business combination with a target business
(the &ldquo;<B><I>Business Combination</I></B>&rdquo;) within the time frame specified in the Company&rsquo;s Amended and Restated Memorandum
and Articles of Association, as described in the Company&rsquo;s Prospectus relating to the Public Offering. Capitalized terms used but
not defined herein shall have the meanings set forth in the Trust Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with the terms of the Trust Agreement,
we hereby authorize you to liquidate all of the assets in the Trust Account and to transfer the total proceeds into the trust operating
account at Morgan Stanley&nbsp;&amp; Co. LLC to await distribution to the Public Shareholders. The Company has selected as the effective
date for the purpose of determining when the Public Shareholders will be entitled to receive their share of the liquidation proceeds.
It is acknowledged that no interest will be earned by the Company on the liquidation proceeds while on deposit in the trust operating
account. You agree to be the Paying Agent of record and, in your separate capacity as Paying Agent, agree to distribute said funds directly
to the Company&rsquo;s Public Shareholders in accordance with the terms of the Trust Agreement and the Amended and Restated Memorandum
and Articles of Association of the Company. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed
expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated, except to the extent
otherwise provided in <U>Section&nbsp;1(j)</U>&nbsp;of the Trust Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spring Valley Acquisition Corp. II</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">cc: Citigroup Global Markets Inc. and Guggenheim Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>[Schedule
A to Investment Management Trust Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Letterhead of Company]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Insert date]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer&nbsp;&amp; Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf&nbsp;&amp; Celeste Gonzalez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify"><U>Trust Account - Tax Payment Withdrawal Instruction</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Dear Mr.&nbsp;Wolf and Ms.&nbsp;Gonzalez:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to <U>Section&nbsp;1(j)</U>&nbsp;of the
Investment Management Trust Agreement between Spring Valley Acquisition Corp. II (the &ldquo;<B><I>Company</I></B>&rdquo;) and Continental
Stock Transfer&nbsp;&amp; Trust Company (the &ldquo;<B><I>Trustee</I></B>&rdquo;), dated as of [&#9679;], 2022 (the &ldquo;<B><I>Trust
Agreement</I></B>&rdquo;), the Company hereby requests that you deliver to the Company $ of the interest income earned on the Property
as of the date hereof. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company needs such funds to pay for the tax
obligations as set forth on the attached tax return or tax statement. In accordance with the terms of the Trust Agreement, you are hereby
directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company&rsquo;s operating
account at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[WIRE INSTRUCTION INFORMATION]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spring Valley Acquisition Corp. II</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">cc: Citigroup Global Markets Inc. and Guggenheim Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>[Schedule
A to Investment Management Trust Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Letterhead of Company]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Insert date]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer&nbsp;&amp; Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf&nbsp;&amp; Celeste Gonzalez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify"><U>Trust Account - Shareholder Redemption Withdrawal Instruction<BR>
</U>Dear Mr.&nbsp;Wolf and Ms.&nbsp;Gonzalez:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to <U>Section&nbsp;1(k)</U>&nbsp;of the
Investment Management Trust Agreement between Spring Valley Acquisition Corp. II (the &ldquo;<B><I>Company</I></B>&rdquo;) and Continental
Stock Transfer&nbsp;&amp; Trust Company (the &ldquo;<B><I>Trustee</I></B>&rdquo;), dated as of [&#9679;], 2022 (the &ldquo;<B><I>Trust
Agreement</I></B>&rdquo;), the Company hereby requests that you deliver to the Company&rsquo;s shareholders $ of the principal and interest
income earned on the Property as of the date hereof. Capitalized terms used but not defined herein shall have the meanings set forth in
the Trust Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to Section&nbsp;1(k)&nbsp;of the Trust
Agreement, this is to advise you that the Company has sought an Amendment. Accordingly, in accordance with the terms of the Trust Agreement,
we hereby authorize you to liquidate a sufficient portion of the Trust Account and to transfer $[&#9679;] of the proceeds of the Trust
Account to the trust operating account at [&#9679;] for distribution to the shareholders that have requested redemption of their shares
in connection with such Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spring Valley Acquisition Corp. II</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">cc: Citigroup Global Markets Inc. and Guggenheim Securities, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT><I>[Schedule
A to Investment Management Trust Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>tm216731d39_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution Version</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT
(this &ldquo;<B><I>Agreement</I></B>&rdquo;), dated as of October&nbsp;12, 2022, is made and entered into by and among Spring Valley
Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;), Spring Valley Acquisition Sponsor
II, LLC, a Delaware limited liability company (the &ldquo;<B><I>Sponsor</I></B>&rdquo;), and the undersigned parties listed under Holder
on the signature page&nbsp;hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party
to this Agreement pursuant to <U>Section&nbsp;6.2</U> of this Agreement, a &ldquo;<B><I>Holder</I></B>&rdquo; and collectively the &ldquo;<B><I>Holders</I></B>&rdquo;)<I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, the Company has 7,666,667 Class&nbsp;B
ordinary shares, par value $0.0001 per share (the &ldquo;<B><I>Class&nbsp;B Ordinary Shares</I></B>&rdquo;), issued and outstanding,
of which up to 1,000,000 may be surrendered to the Company for no consideration if the Underwriters&rsquo; (as defined below) option
to purchase additional units in connection with the Company&rsquo;s initial public offering is not exercised in full. Each unit consists
of one Class&nbsp;A ordinary share of the Company, par value $0.0001 per share (the &ldquo;<B><I>Ordinary Shares</I></B>&rdquo;), one
right to receive one-tenth of one Ordinary Share, and one-half of one redeemable warrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, the Class&nbsp;B Ordinary Shares
are convertible into Ordinary Shares at the time of the initial Business Combination (as defined below), or earlier at the option of
the holder, on a one-for-one basis, subject to adjustment, on the terms and conditions provided in the Company&rsquo;s amended and restated
memorandum and articles of association, as may be amended from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, on October&nbsp;12, 2022, the
Company and the Sponsor entered into that certain Private Placement Warrants Purchase Agreement, pursuant to which the Sponsor agreed
to purchase 12,000,000 warrants (or up to 13,350,000 warrants if the Underwriters&rsquo; option to purchase additional units in connection
with the Company&rsquo;s initial public offering is exercised in full) (the &ldquo;<B><I>Private Placement Warrants</I></B>&rdquo;) in
a private placement transaction occurring simultaneously with the closing of the Company&rsquo;s initial public offering. Each Private
Placement Warrant entitles the holder to purchase on Ordinary Share at an exercise price of $11.50 per Ordinary Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, in order to finance the Company&rsquo;s
transaction costs in connection with an intended Business Combination, the Sponsor or certain of the Company&rsquo;s officers or directors
may, but are not obligated to, loan the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible
into an additional 1,500,000 Private Placement Warrants (the &ldquo;<B><I>Working Capital Warrants</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, to extend the period of time the
Company will have to consummate an initial Business Combination, the Sponsor, its affiliates or designees may loan to the Company up
to an aggregate of $2,000,000 (or up to $2,300,000 if the underwriters&rsquo; over-allotment option is exercised in full), which loan
is convertible into additional Private Placement Warrants at a price of $1.00 per Private Placement Warrant at the option of the Sponsor;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, the Company and the Holders desire
to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect to certain
securities of the Company, as set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>NOW</B>, <B>THEREFORE</B>, in consideration
of the mutual representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;1<BR>
</B></FONT><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>Definitions</U></B>.
The terms defined in this <I>Article&nbsp;I</I> shall, for all purposes of this Agreement, have the respective meanings set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Adverse Disclosure</I></B>&rdquo;
shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the principal executive
officer or principal financial officer of the Company, after consultation with counsel to the Company, (i)&nbsp;would be required to
be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case
of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii)&nbsp;would
not be required to be made at such time if the Registration Statement were not being filed, and (iii)&nbsp;the Company has a bona fide
business purpose for not making such information public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Agreement</I></B>&rdquo; shall have
the meaning given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Board</I></B>&rdquo; shall mean the
Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Business Combination</I></B>&rdquo;
shall mean any merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one
or more businesses, involving the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Class&nbsp;B
Ordinary Shares</I></B>&rdquo; shall have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Commission</I></B>&rdquo;
shall mean the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Company</I></B>&rdquo;
shall have the meaning given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Demand Registration</I></B>&rdquo;
shall have the meaning given in <U>subsection 2.1.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Demanding Holder</I></B>&rdquo;
shall have the meaning given in <U>subsection 2.1.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Exchange Act</I></B>&rdquo; shall
mean the Securities Exchange Act of 1934, as it may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Form&nbsp;S-1</I></B>&rdquo;
shall have the meaning given in <U>subsection 2.1.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Form&nbsp;S-3</I></B>&rdquo;
shall have the meaning given in <U>subsection 2.3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Founder Shares</I></B>&rdquo; shall
mean the Class&nbsp;B Ordinary Shares and shall be deemed to include the Ordinary Shares issuable upon conversion thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Founder Shares Lock-up Period</I></B>&rdquo;
shall mean, with respect to the Founder Shares, the period ending on the earlier of (A)&nbsp;one year after the completion of the Company&rsquo;s
initial Business Combination and (B)&nbsp;subsequent to the Business Combination, (x)&nbsp;if the last reported sales price of the Ordinary
Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and
other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company&rsquo;s
initial Business Combination or (y)&nbsp;the date on which the Company completes a liquidation, merger, share exchange, reorganization
or other similar transaction that results in all of the Company&rsquo;s shareholders having the right to exchange their Ordinary Shares
for cash, securities or other property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Holders</I></B>&rdquo; shall have
the meaning given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Insider Letter</I></B>&rdquo; shall
mean that certain letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and each of the Company&rsquo;s
officers, directors and director nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Maximum Number
of Securities</I></B>&rdquo; shall have the meaning given in <U>subsection 2.1.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Misstatement</I></B>&rdquo; shall
mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light
of the circumstances under which they were made) not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Nominee</I></B>&rdquo;
is defined in <U>Section&nbsp;6.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Ordinary Shares</I></B>&rdquo;
shall have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Permitted Transferees</I></B>&rdquo;
shall mean a person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities prior to
the expiration of the Founder Shares Lock-up Period or Private Placement Lock-up Period, as the case may be, under the Insider Letter
and any other applicable agreement between such Holder and the Company, and to any transferee thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Piggyback Registration</I></B>&rdquo;
shall have the meaning given in <U>subsection 2.2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Private Placement Lock-up Period</I></B>&rdquo;
shall mean, with respect to Private Placement Warrants that are held by the initial purchasers of such Private Placement Warrants or
their Permitted Transferees, and any of the Ordinary Shares issued or issuable upon the exercise or conversion of the Private Placement
Warrants and that are held by the initial purchasers of the Private Placement Warrants or their Permitted Transferees, the period ending
30 days after the completion of the Company&rsquo;s initial Business Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Private Placement
Warrants</I></B>&rdquo; shall have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Prospectus</I></B>&rdquo; shall mean
the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and
all post-effective amendments and including all material incorporated by reference in such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Pro Rata</I></B>&rdquo;
shall have the meaning given in <U>subsection 2.1.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Registrable Security</I></B>&rdquo;
shall mean (a)&nbsp;the Founder Shares (including any Ordinary Shares or other equivalent equity security issued or issuable upon the
conversion of any such Founder Shares or exercisable for Ordinary Shares), (b)&nbsp;the Private Placement Warrants (including any Ordinary
Shares issued or issuable upon the exercise of any such Private Placement Warrants), (c)&nbsp;the Working Capital Warrants (including
any Ordinary Shares issued or issuable upon the conversion of working capital loans), (d)&nbsp;any outstanding Ordinary Shares or any
other equity security (including the Ordinary Shares issued or issuable upon the exercise of any other equity security) of the Company
held by a Holder as of the date of this Agreement, and (e)&nbsp;any other equity security of the Company issued or issuable with respect
to any such Ordinary Shares by way of a share capitalization or share split or in connection with a combination of shares, recapitalization,
merger, consolidation or reorganization; <U>provided</U>, <U>however</U>, that, as to any particular Registrable Security, such securities
shall cease to be Registrable Securities when: (i)&nbsp;a Registration Statement with respect to the sale of such securities shall have
become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance
with such Registration Statement; (ii)&nbsp;such securities shall have been otherwise transferred, new certificates for such securities
not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution of such
securities shall not require registration under the Securities Act; (iii)&nbsp;such securities shall have ceased to be outstanding; or
(iv)&nbsp;such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Registration</I></B>&rdquo; shall
mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules&nbsp;and regulations promulgated thereunder, and such registration statement becoming
effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Registration
Expenses</I></B>&rdquo; shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority,&nbsp;Inc.)
and any securities exchange on which the Ordinary Shares are then listed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;fees
and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters
in connection with blue sky qualifications of Registrable Securities);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(C)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;printing,
messenger, telephone and delivery expenses;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(D)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;reasonable
fees and disbursements of counsel for the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(E)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;reasonable
fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such
Registration; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(F)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;reasonable
fees and expenses of one (1)&nbsp;legal counsel selected by the majority-in-interest of the Demanding Holders initiating a Demand Registration
to be registered for offer and sale in the applicable Registration or the Takedown Requesting Holder initiating an Underwritten Shelf
Takedown.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Registration Statement</I></B>&rdquo;
shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including
the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration
statement, and all exhibits to and all material incorporated by reference in such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Requesting Holder</I></B>&rdquo;
shall have the meaning given in <U>subsection 2.1.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Securities Act</I></B>&rdquo;
shall mean the Securities Act of 1933, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Shelf</I></B>&rdquo;
shall have the meaning given in <U>subsection 2.3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Sponsor</I></B>&rdquo;
shall have the meaning given in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Sponsor Director</I></B>&rdquo;
means an individual elected to the Board that has been nominated by the Sponsor pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Subsequent Shelf
Registration</I></B>&rdquo; shall have the meaning given in <U>subsection 2.3.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Takedown Requesting
Holder</I></B>&rdquo; shall have the meaning given in <U>subsection 2.3.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Underwriter</I></B>&rdquo; shall
mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such dealer&rsquo;s
market-making activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Underwritten Registration</I></B>&rdquo;
or &ldquo;<B><I>Underwritten Offering</I></B>&rdquo; shall mean a Registration in which securities of the Company are sold to an Underwriter
in a firm commitment underwriting for distribution to the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Underwritten
Shelf Takedown</I></B>&rdquo; shall have the meaning given in <U>subsection 2.3.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Working Capital
Warrants</I></B>&rdquo; shall have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;2<BR>
</B></FONT><B>REGISTRATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Demand
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Request
for Registration</U>. Subject to the provisions of <U>subsection 2.1.4</U> and <U>Section&nbsp;2.4</U> hereof, at any time and from time
to time on or after the date the Company consummates the Business Combination, the Holders of at least a majority in interest of the
then-outstanding number of Registrable Securities (the &ldquo;<B><I>Demanding Holders</I></B>&rdquo;<I>) </I>may make a written demand
for Registration of all or part of their Registrable Securities, which written demand shall describe the amount and type of securities
to be included in such Registration and the intended method(s)&nbsp;of distribution thereof (such written demand a &ldquo;<B><I>Demand
Registration</I></B>&rdquo;<I>).</I> The Company shall, within five (5)&nbsp;days of the Company&rsquo;s receipt of the Demand Registration,
notify, in writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter
wishes to include all or a portion of such Holder&rsquo;s Registrable Securities in a Registration pursuant to a Demand Registration
(each such Holder that includes all or a portion of such Holder&rsquo;s Registrable Securities in such Registration, a &ldquo;<B><I>Requesting
Holder</I></B>&rdquo;<I>)</I> shall so notify the Company, in writing, within three (3)&nbsp;business days after the receipt by the Holder
of the notice from the Company. Upon receipt by the Company of any such written notification from a Requesting Holder(s)&nbsp;to the
Company, such Requesting Holder(s)&nbsp;shall be entitled to have their Registrable Securities included in a Registration pursuant to
a Demand Registration and the Company shall effect, as soon thereafter as practicable, but not more than forty five (45) days immediately
after the Company&rsquo;s receipt of the Demand Registration, the Registration of all Registrable Securities requested by the Demanding
Holders and Requesting Holders pursuant to such Demand Registration. Under no circumstances shall the Company be obligated to effect
more than an aggregate of three (3)&nbsp;Registrations pursuant to a Demand Registration under this <U>subsection 2.1.1</U> with respect
to any or all Registrable Securities; <U>provided</U>, <U>however</U>, that a Registration shall not be counted for such purposes unless
a Form&nbsp;S-1 or any similar long-form registration statement that may be available at such time (&ldquo;<B><I>Form&nbsp;S-1</I></B>&rdquo;<I>)
</I>has become effective and all of the Registrable Securities requested by the Requesting Holders to be registered on behalf of the
Requesting Holders in such Form&nbsp;S-1 Registration have been sold, in accordance with <U>Section&nbsp;3.1</U> of this Agreement; <U>provided</U>,
<U>further</U>, that an Underwritten Shelf Takedown shall not count as a Demand Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.1.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Effective
Registration</U>. Notwithstanding the provisions of <U>subsection 2.1.1</U> above or any other part of this Agreement, a Registration
pursuant to a Demand Registration shall not count as a Registration unless and until (i)&nbsp;the Registration Statement filed with the
Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and (ii)&nbsp;the
Company has complied with all of its obligations under this Agreement with respect thereto; <U>provided</U>, <U>further</U>, that if,
after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to a
Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any
other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared effective,
unless and until, (i)&nbsp;such stop order or injunction is removed, rescinded or otherwise terminated and (ii)&nbsp;a majority-in-interest
of the Demanding Holders initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly
notify the Company in writing, but in no event later than five (5)&nbsp;days, of such election; <U>provided</U>, <U>further</U>, that
the Company shall not be obligated or required to file another Registration Statement until the Registration Statement that has been
previously filed with respect to a Registration pursuant to a Demand Registration becomes effective or is subsequently terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.1.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Underwritten
Offering</U>. Subject to the provisions of <U>subsection 2.1.4</U> and <U>Section&nbsp;2.4</U> hereof, if a majority-in-interest of the
Demanding Holders so advise the Company as part of their Demand Registration that the offering of the Registrable Securities pursuant
to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder
(if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder&rsquo;s participation in such
Underwritten Offering and the inclusion of such Holder&rsquo;s Registrable Securities in such Underwritten Offering to the extent provided
herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this <U>subsection
2.1.3</U> shall enter into an underwriting agreement in customary form with the Underwriter(s)&nbsp;selected for such Underwritten Offering
by the majority-in-interest of the Demanding Holders initiating the Demand Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.1.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reduction
of Underwritten Offering</U>. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a Demand Registration,
in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar amount or number
of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other
Ordinary Shares or other equity securities that the Company desires to sell and the Ordinary Shares, if any, as to which a Registration
has been requested pursuant to separate written contractual piggy-back registration rights held by any other shareholders who desire
to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering without
adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering
(such maximum dollar amount or maximum number of such securities, as applicable, the &ldquo;<B><I>Maximum Number of Securities</I></B>&rdquo;<I>),
</I>then the Company shall include in such Underwritten Offering, as follows: (i)&nbsp;first, the Registrable Securities of the Demanding
Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder
and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities
that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred
to herein as &ldquo;<B><I>Pro Rata</I></B>&rdquo;)) that can be sold without exceeding the Maximum Number of Securities; (ii)&nbsp;second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Ordinary Shares or other
equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (iii)&nbsp;third,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i)&nbsp;and (ii), the Ordinary
Shares or other equity securities of other persons or entities that the Company is obligated to register in a Registration pursuant to
separate written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.1.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Demand
Registration Withdrawal</U>. A majority-in-interest of the Demanding Holders initiating a Demand Registration or a majority-in-interest
of the Requesting Holders (if any), pursuant to a Registration under <U>subsection 2.1.1</U> shall have the right to withdraw from a
Registration pursuant to such Demand Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter
or Underwriters (if any) of their intention to withdraw from such Registration prior to the effectiveness of the Registration Statement
filed with the Commission with respect to the Registration of their Registrable Securities pursuant to such Demand Registration. Notwithstanding
anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with
a Registration pursuant to a Demand Registration prior to its withdrawal under this <U>subsection 2.1.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Piggyback
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Piggyback
Rights</U>. If, at any time on or after the date the Company consummates a Business Combination, the Company proposes to file a Registration
Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or
exchangeable for, or convertible into equity securities, for its own account or for the account of shareholders of the Company (or by
the Company and by the shareholders of the Company including, without limitation, pursuant to <U>Section&nbsp;2.1</U> hereof), other
than a Registration Statement (i)&nbsp;filed in connection with any employee stock option or other benefit plan, (ii)&nbsp;for an exchange
offer or offering of securities solely to the Company&rsquo;s existing shareholders, (iii)&nbsp;for an offering of debt that is convertible
into equity securities of the Company or (iv)&nbsp;for a dividend reinvestment plan, then the Company shall give written notice of such
proposed filing to all of the Holders of Registrable Securities as soon as practicable but not less than seven (7)&nbsp;days before the
anticipated filing date of such Registration Statement, which notice shall (A)&nbsp;describe the amount and type of securities to be
included in such offering, the intended method(s)&nbsp;of distribution, and the name of the proposed managing Underwriter or Underwriters,
if any, in such offering, and (B)&nbsp;offer to all of the Holders of Registrable Securities the opportunity to register the sale of
such number of Registrable Securities as such Holders may request in writing within three (3)&nbsp;business days after receipt of such
written notice (such Registration a &ldquo;<B><I>Piggyback Registration</I></B>&rdquo;)<I>. </I>The Company shall, in good faith, cause
such Registrable Securities to be included in such Piggyback Registration and shall use its best efforts to cause the managing Underwriter
or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this <U>subsection
2.2.1</U> to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included
in such Registration and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s)&nbsp;of
distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this
<U>subsection 2.2.1</U> shall enter into an underwriting agreement in customary form with the Underwriter(s)&nbsp;selected for such Underwritten
Offering by the Company. The notice periods set forth in this <U>subsection 2.2.1</U> shall not apply to an Underwritten Shelf Takedown
conducted in accordance with <U>subsection 2.3.3.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reduction
of Piggyback Registration</U>. If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback
Registration (other than Underwritten Shelf Takedown), in good faith, advises the Company and the Holders of Registrable Securities participating
in the Piggyback Registration in writing that the dollar amount or number of the Ordinary Shares that the Company desires to sell, taken
together with (i)&nbsp;the Ordinary Shares, if any, as to which Registration has been demanded pursuant to separate written contractual
arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (ii)&nbsp;the Registrable Securities
as to which registration has been requested pursuant <U>Section&nbsp;2.2</U> hereof, and (iii)&nbsp;the Ordinary Shares, if any, as to
which Registration has been requested pursuant to separate written contractual piggy-back registration rights of other shareholders of
the Company, exceeds the Maximum Number of Securities, then:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Registration is undertaken for the Company&rsquo;s account, the Company shall include in any such Registration (A)&nbsp;first, the
Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of
Securities; and (B)&nbsp;second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause
(A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to <U>subsection
2.2.1</U> hereof, Pro Rata based on the respective number of Registrable Securities that each Holder has so requested exercising its
rights to register its Registrable Securities pursuant to <U>subsection 2.2.1</U> hereof, which can be sold without exceeding the Maximum
Number of Securities; and (C)&nbsp;third, to the extent that the Maximum Number of Securities has not been reached under the foregoing
clauses (A)&nbsp;and (B), the Ordinary Shares, if any, as to which Registration has been requested pursuant to written contractual piggy-back
registration rights of other shareholders of the Company, which can be sold without exceeding the Maximum Number of Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the Company shall
include in any such Registration (A)&nbsp;first, the Ordinary Shares or other equity securities, if any, of such requesting persons or
entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B)&nbsp;second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of
Holders exercising their rights to register their Registrable Securities pursuant to <U>subsection 2.2.1</U>, Pro Rata, which can be
sold without exceeding the Maximum Number of Securities; (C)&nbsp;third, to the extent that the Maximum Number of Securities has not
been reached under the foregoing clauses (A)&nbsp;and (B), the Ordinary Shares or other equity securities that the Company desires to
sell, which can be sold without exceeding the Maximum Number of Securities; and (D)&nbsp;fourth, to the extent that the Maximum Number
of Securities has not been reached under the foregoing clauses (A), (B)&nbsp;and (C), the Ordinary Shares or other equity securities
for the account of other persons or entities that the Company is obligated to register pursuant to separate written contractual arrangements
with such persons or entities, which can be sold without exceeding the Maximum Number of Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Piggyback
Registration Withdrawal</U>. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for
any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its
intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission
with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for
withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission
in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything
to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback
Registration prior to its withdrawal under this <U>subsection 2.2.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.2.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Unlimited
Piggyback Registration Rights</U>. For purposes of clarity, any Registration effected pursuant to <U>Section&nbsp;2.2</U> hereof shall
not be counted as a Registration pursuant to a Demand Registration effected under <U>Section&nbsp;2.1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Shelf
Registrations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Holders of Registrable Securities may at any time, and from time to time, request in writing that the Company, pursuant to Rule&nbsp;415
under the Securities Act (or any successor rule&nbsp;promulgated thereafter by the Commission), register the resale of any or all of
their Registrable Securities on Form&nbsp;S-3 or similar short form registration statement that may be available at such time (&ldquo;<B><I>Form&nbsp;S-3</I></B>&rdquo;)<I>,
</I>or if the Company is ineligible to use Form&nbsp;S-3, on Form&nbsp;S-1; a registration statement filed pursuant to this <U>subsection
2.3.1</U> (a &ldquo;<B><I>Shelf</I></B>&rdquo;) shall provide for the resale of the Registrable Securities included therein pursuant
to any method or combination of methods legally available to, and requested by, any Holder. Within three (3)&nbsp;days of the Company&rsquo;s
receipt of a written request from a Holder or Holders of Registrable Securities for a Registration on a Shelf, the Company shall promptly
give written notice of the proposed Registration to all other Holders of Registrable Securities, and each Holder of Registrable Securities
who thereafter wishes to include all or a portion of such Holder&rsquo;s Registrable Securities in such Registration shall so notify
the Company, in writing, within three (3)&nbsp;business days after the receipt by the Holder of the notice from the Company. As soon
as practicable thereafter, but not more than ten (10)&nbsp;days after the Company&rsquo;s initial receipt of such written request for
a Registration on a Shelf, the Company shall register all or such portion of such Holder&rsquo;s Registrable Securities as are specified
in such written request, together with all or such portion of Registrable Securities of any other Holder or Holders joining in such request
as are specified in the written notification given by such Holder or Holders; <U>provided</U>, <U>however</U>, that the Company shall
not be obligated to effect any such Registration pursuant to this <U>subsection 2.3.1</U> if the Holders of Registrable Securities, together
with the Holders of any other equity securities of the Company entitled to inclusion in such Registration, propose to sell the Registrable
Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000. The Company shall
maintain each Shelf in accordance with the terms hereof, and shall prepare and file with the SEC such amendments, including post-effective
amendments, and supplements as may be necessary to keep such Shelf continuously effective, available for use and in compliance with the
provisions of the Securities Act until such time as there are no longer any Registrable Securities included on such Shelf. In the event
the Company files a Shelf on Form&nbsp;S-1, the Company shall use its commercially reasonable efforts to convert the Form&nbsp;S-1 to
a Form&nbsp;S-3 as soon as practicable after the Company is eligible to use Form&nbsp;S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities included thereon are
still outstanding, the Company shall use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf
to again become effective under the Securities Act (including obtaining the prompt withdrawal of any order suspending the effectiveness
of such Shelf), and shall use its commercially reasonable efforts to as promptly as is reasonably practicable amend such Shelf in a manner
reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional registration
statement (a &ldquo;<B><I>Subsequent Shelf Registration</I></B>&rdquo;) registering the resale of all Registrable Securities including
on such Shelf, and pursuant to any method or combination of methods legally available to, and requested by, any Holder. If a Subsequent
Shelf Registration is filed, the Company shall use its commercially reasonable efforts to (i)&nbsp;cause such Subsequent Shelf Registration
to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof and (ii)&nbsp;keep such
Subsequent Shelf Registration continuously effective, available for use and in compliance with the provisions of the Securities Act until
such time as there are no longer any Registrable Securities included thereon. Any such Subsequent Shelf Registration shall be on Form&nbsp;S-3
to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate
form. In the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis,
the Company, upon request of a Holder shall promptly use its commercially reasonable efforts to cause the resale of such Registrable
Securities to be covered by either, at the Company&rsquo;s option, a Shelf (including by means of a post-effective amendment) or a Subsequent
Shelf Registration and cause the same to become effective as soon as practicable after such filing and such Shelf or Subsequent Shelf
Registration shall be subject to the terms hereof; <U>provided</U>, <U>however</U>, the Company shall only be required to cause such
Registrable Securities to be so covered once annually after inquiry of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;At
any time and from time to time after a Shelf has been declared effective by the Commission, the Sponsor may request to sell all or any
portion of its Registrable Securities in an underwritten offering that is registered pursuant to the Shelf (each, an &ldquo;<B><I>Underwritten
Shelf Takedown</I></B>&rdquo;); <U>provided</U> that the Company shall only be obligated to effect an Underwritten Shelf Takedown if
such offering shall include securities with a total offering price (including piggyback securities and before deduction of underwriting
discounts) reasonably expected to exceed, in the aggregate, $10,000,000. All requests for Underwritten Shelf Takedowns shall be made
by giving written notice to the Company at least 48 hours prior to the public announcement of such Underwritten Shelf Takedown, which
shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown and the expected
price range (net of underwriting discounts and commissions) of such Underwritten Shelf Takedown. The Company shall include in any Underwritten
Shelf Takedown the securities requested to be included by any holder (each a &ldquo;<B><I>Takedown Requesting Holder</I></B>&rdquo;)
at least 24 hours prior to the public announcement of such Underwritten Shelf Takedown pursuant to written contractual piggyback registration
rights of such holder (including to those set forth herein). The Sponsor shall have the right to select the underwriter(s)&nbsp;for such
offering (which shall consist of one or more reputable nationally recognized investment banks), subject to the Company&rsquo;s prior
approval which shall not be unreasonably withheld, conditioned or delayed. For purposes of clarity, any Registration effected pursuant
to this <U>subsection 2.3.3</U> shall not be counted as a Registration pursuant to a Demand Registration effected under <U>Section&nbsp;2.1
</U>hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.3.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the managing Underwriter or Underwriters in an Underwritten Shelf Takedown, in good faith, advises the Company, the Sponsor and the Takedown
Requesting Holders (if any) in writing that the dollar amount or number of Registrable Securities that the Sponsor and the Takedown Requesting
Holders (if any) desire to sell, taken together with all other Ordinary Shares or other equity securities that the Company desires to
sell, exceeds the Maximum Number of Securities, then the Company shall include in such Underwritten Shelf Takedown, as follows: (i)&nbsp;first,
the Registrable Securities of the Sponsor that can be sold without exceeding the Maximum Number of Securities; (ii)&nbsp;second, to the
extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Ordinary Shares or other equity
securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (iii)&nbsp;third,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i)&nbsp;and (ii), the Ordinary
Shares or other equity securities of the Takedown Requesting Holders, if any, that can be sold without exceeding the Maximum Number of
Securities, determined Pro Rata based on the respective number of Registrable Securities that each Takedown Requesting Holder has so
requested to be included in such Underwritten Shelf Takedown.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.3.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Sponsor shall have the right to withdraw from an Underwritten Shelf Takedown for any or no reason whatsoever upon written notification
to the Company and the Underwriter or Underwriters (if any) of its intention to withdraw from such Underwritten Shelf Takedown prior
to the public announcement of such Underwritten Shelf Takedown. Notwithstanding anything to the contrary in this Agreement, the Company
shall be responsible for the Registration Expenses incurred in connection with an Underwritten Shelf Takedown prior to a withdrawal under
this <U>subsection 2.3.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictions
on Registration Rights</U>. If (A)&nbsp;during the period starting with the date sixty (60) days prior to the Company&rsquo;s good faith
estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company
initiated Registration and provided that the Company has delivered written notice to the Holders prior to receipt of a Demand Registration
pursuant to <U>subsection 2.1.1</U> and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable
Registration Statement to become effective; (B)&nbsp;the Holders have requested an Underwritten Registration and the Company and the
Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C)&nbsp;in the good faith judgment of
the Board such Registration would be seriously detrimental to the Company and the Board concludes as a result that it is essential to
defer the filing of such Registration Statement at such time, then in each case the Company shall furnish to such Holders a certificate
signed by the Chairman of the Board stating that in the good faith judgment of the Board it would be seriously detrimental to the Company
for such Registration Statement to be filed in the near future and that it is therefore essential to defer the filing of such Registration
Statement. In such event, the Company shall have the right to defer such filing for a period of not more than thirty (30) days; <U>provided</U>,
<U>however</U>, that the Company shall not defer its obligation in this manner more than once in any 12-month period. Notwithstanding
anything to the contrary contained in this Agreement, no Registration shall be effected or permitted and no Registration Statement shall
become effective, with respect to any Registrable Securities held by any Holder, until after the expiration of the Founder Shares Lock-Up
Period or the Private Placement Lock-Up Period, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;3<BR>
</B></FONT><B>COMPANY PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General
Procedures</U>. If at any time on or after the date the Company consummates a Business Combination the Company is required to effect
the Registration of Registrable Securities, the Company shall use its best efforts to effect such Registration to permit the sale of
such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as
expeditiously as possible:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;prepare
and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and use its
reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities
covered by such Registration Statement have been sold;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;prepare
and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the
Prospectus, as may be requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules, regulations
or instructions applicable to the registration form used by the Company or by the Securities Act or rules&nbsp;and regulations thereunder
to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance
with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;prior
to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters,
if any, and the Holders of Registrable Securities included in such Registration, and such Holders&rsquo; legal counsel, copies of such
Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including
all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including
each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such
Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities
owned by such Holders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;prior
to any public offering of Registrable Securities, use its best efforts to (i)&nbsp;register or qualify the Registrable Securities covered
by the Registration Statement under such securities or &ldquo;blue sky&rdquo; laws of such jurisdictions in the United States as the
Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request
and (ii)&nbsp;take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered
with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and
do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such
Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; <U>provided</U>, <U>however</U>,
that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required
to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it
is not then otherwise so subject;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;cause
all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities issued
by the Company are then listed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;provide
a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date
of such Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;advise
each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any
stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding
for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal if
such stop order should be issued;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;at
least five (5)&nbsp;days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration
Statement or Prospectus (other than by way of a document incorporated by reference) furnish a copy thereof to each seller of such Registrable
Securities or its counsel;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;notify
the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act,
of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes
a Misstatement, and then to correct such Misstatement as set forth in <U>Section&nbsp;3.4</U> hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;permit
a representative of the Holders, the Underwriters, if any, and any attorney or accountant retained by such Holders or Underwriter to
participate, at each such person&rsquo;s own expense, in the preparation of the Registration Statement, and cause the Company&rsquo;s
officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, attorney or
accountant in connection with the Registration; <U>provided</U>, <U>however</U>, that such representatives or Underwriters enter into
a confidentiality agreement, in form and substance reasonably satisfactory to the Company, prior to the release or disclosure of any
such information;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;obtain
a &ldquo;cold comfort&rdquo; letter from the Company&rsquo;s independent registered public accountants in the event of an Underwritten
Registration, in customary form and covering such matters of the type customarily covered by &ldquo;cold comfort&rdquo; letters as the
managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;on
the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel
representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any,
and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being
given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions
and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the managing Underwriter of such offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;make
available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12)
months beginning with the first day of the Company&rsquo;s first full calendar quarter after the effective date of the Registration Statement
which satisfies the provisions of Section&nbsp;11(a)&nbsp;of the Securities Act and Rule&nbsp;158 thereunder (or any successor rule&nbsp;promulgated
thereafter by the Commission);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.15&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable
efforts to make available senior executives of the Company to participate in customary &ldquo;road show&rdquo; presentations that may
be reasonably requested by the Underwriter in any Underwritten Offering; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3.1.16&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;otherwise,
in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in connection
with such Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Expenses</U>. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the
Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters&rsquo; commissions
and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of &ldquo;Registration Expenses,&rdquo;
all reasonable fees and expenses of any legal counsel representing the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Requirements
for Participation in Underwritten Offerings</U>. No person may participate in any Underwritten Offering for equity securities of the
Company pursuant to a Registration initiated by the Company hereunder unless such person (i)&nbsp;agrees to sell such person&rsquo;s
securities on the basis provided in any underwriting arrangements approved by the Company and (ii)&nbsp;completes and executes all customary
questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be
reasonably required under the terms of such underwriting arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Suspension
of Sales; Adverse Disclosure</U>. Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains
a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of
a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and
file such supplement or amendment as soon as practicable after the time of such notice), or until it is advised in writing by the Company
that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect
of any Registration at any time would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration
Statement of financial statements that are unavailable to the Company for reasons beyond the Company&rsquo;s control, the Company may,
upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such
Registration Statement for the shortest period of time, but in no event more than thirty (30) days, determined in good faith by the Company
to be necessary for such purpose. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend,
immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection
with any sale or offer to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period
during which it exercised its rights under this <U>Section&nbsp;3.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reporting
Obligations</U>. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company
under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period)
all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a)&nbsp;or 15(d)&nbsp;of the Exchange Act
and to promptly furnish the Holders with true and complete copies of all such filings. The Company further covenants that it shall take
such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell
Ordinary Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by
Rule&nbsp;144 promulgated under the Securities Act (or any successor rule&nbsp;promulgated thereafter by the Commission, to the extent
that such rule&nbsp;or such successor rule&nbsp;is available to the Company), including providing any legal opinions. Upon the request
of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied
with such requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;4<BR>
</B></FONT><B>INDEMNIFICATION AND CONTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and each
person who controls such Holder (within the meaning of the Securities Act or the Exchange Act) against all losses, claims, damages, liabilities
and expenses (including attorneys&rsquo; fees) caused by any untrue or alleged untrue statement of material fact contained in any Registration
Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of
a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same
are caused by or contained in any information furnished in writing to the Company by such Holder expressly for use therein. The Company
shall indemnify the Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of
the Securities Act or the Exchange Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.1.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to
the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration
Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and officers and agents and each
person who controls the Company (within the meaning of the Securities Act or the Exchange Act) against any losses, claims, damages, liabilities
and expenses (including without limitation reasonable attorneys&rsquo; fees) resulting from any untrue statement of material fact contained
in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of
a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that
such untrue statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use
therein; <U>provided</U>, <U>however</U>, that the obligation to indemnify shall be several, not joint and several, among such Holders
of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the
net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of
Registrable Securities shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within
the meaning of the Securities Act or the Exchange Act) to the same extent as provided in the foregoing with respect to indemnification
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.1.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
person entitled to indemnification herein shall (i)&nbsp;give prompt written notice to the indemnifying party of any claim with respect
to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person&rsquo;s right to indemnification
hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii)&nbsp;unless in such indemnified party&rsquo;s
reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit
such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense
is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its
consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume
the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such
indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may
exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall,
without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled
in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement)
or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party
of a release from all liability in respect to such claim or litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.1.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on
behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer
of securities. The Company and each Holder of Registrable Securities participating in an offering also agrees to make such provisions
as are reasonably requested by any indemnified party for contribution to such party in the event the Company&rsquo;s or such Holder&rsquo;s
indemnification is unavailable for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.1.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="background-color: white">If
the indemnification provided under <U>Section&nbsp;4.1</U> hereof from the indemnifying party is unavailable or insufficient to hold
harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying
party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result
of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying
party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or
alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information
supplied by, such indemnifying party or indemnified party, and the indemnifying party&rsquo;s and indemnified party&rsquo;s relative
intent, knowledge, access to information and opportunity to correct or prevent such action; <U>provided</U>, <U>however</U>, that the
liability of any Holder under this <U>subsection 4.1.5</U> shall be limited to the amount of the net proceeds received by such Holder
in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities
referred to above shall be deemed to include, subject to the limitations set forth in <U>subsections 4.1.1</U>, <U>4.1.2</U> and <U>4.1.3
</U>above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding.
The parties hereto agree that it would not be just and equitable if contribution pursuant to this <U>subsection 4.1.5</U> were determined
by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to
in this <U>subsection 4.1.5</U>. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the
Securities Act) shall be entitled to contribution pursuant to this <U>subsection</U></FONT><U> 4.1.6</U> from any person who was not
guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;5<BR>
SHAREHOLDER RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject
to the terms and conditions of this Agreement, at any time and from time to time on or after the date that the Company consummates a
Business Combination and for so long as the Sponsor holds any Registrable Securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Sponsor shall have the right, but not the obligation, to designate three individuals to be appointed or nominated, as the case may be,
for election to the Board (including any successor, each, a &ldquo;<B><I>Nominee</I></B>&rdquo;) by giving written notice to the Company
on or before the time such information is reasonably requested by the Board or the Nominating Committee of the Board, as applicable,
for inclusion in a proxy statement for a meeting of shareholders provided to the Sponsor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company will, as promptly as practicable, use its best efforts to take all necessary and desirable actions (including, without limitation,
calling special meetings of the Board and the shareholders and recommending, supporting and soliciting proxies) so that there are three
Sponsor Directors serving on the Board at all times.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall, to the fullest extent permitted by applicable law, use its best efforts to take all actions necessary to ensure that:
(i)&nbsp;each Nominee is included in the Board&rsquo;s slate of nominees to the shareholders of the Company for each election of Directors;
and (ii)&nbsp;each Nominee is included in the proxy statement prepared by management of the Company in connection with soliciting proxies
for every meeting of the shareholders of the Company called with respect to the election of members of the Board, and at every adjournment
or postponement thereof, and on every action or approval by written consent of the shareholders of the Company or the Board with respect
to the election of members of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
a vacancy occurs because of the death, disability, disqualification, resignation, or removal of a Sponsor Director or for any other reason,
the Sponsor shall be entitled to designate such person&rsquo;s successor, and the Company will, as promptly as practicable following
such designation, use its best efforts to take all necessary and desirable actions, to the fullest extent permitted by law, within its
control such that such vacancy shall be filled with such successor Nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
a Nominee is not elected because of such Nominee&rsquo;s death, disability, disqualification, withdrawal as a nominee or for any other
reason, the Sponsor shall be entitled to designate promptly another Nominee and the Company will take all necessary and desirable actions
within its control such that the director position for which such Nominee was nominated shall not be filled pending such designation
or the size of the Board shall be increased by one and such vacancy shall be filled with such successor Nominee as promptly as practicable
following such designation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;As
promptly as reasonably practicable following the request of any Sponsor Director, the Company shall enter into an indemnification agreement
with such Sponsor Director, in the form entered into with the other members of the Board. The Company shall pay the reasonable, documented
out-of-pocket expenses incurred by the Sponsor Director in connection with his or her services provided to or on behalf of the Company,
including attending meetings or events attended explicitly on behalf of the Company at the Company&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall (i)&nbsp;purchase directors&rsquo; and officers&rsquo; liability insurance in an amount determined by the Board to be reasonable
and customary and (ii)&nbsp;for so long as a Sponsor Director serves as a Director of the Company, maintain such coverage with respect
to such Sponsor Director; <U>provided</U> that upon removal or resignation of such Sponsor Director for any reason, the Company shall
take all actions reasonably necessary to extend such directors&rsquo; and officers&rsquo; liability insurance coverage for a period of
not less than six years from any such event in respect of any act or omission occurring at or prior to such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
so long as a Sponsor Director serves as a Director of the Company, the Company shall not amend, alter or repeal any right to indemnification
or exculpation covering or benefiting any Director nominated pursuant to this Agreement as and to the extent consistent with applicable
law, whether such right is contained in the Company&rsquo;s amended and restated memorandum and articles of association, each as amended,
or another document (except to the extent such amendment or alteration permits the Company to provide broader indemnification or exculpation
rights on a retroactive basis than permitted prior thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
Nominee may, but does not need to qualify as &ldquo;independent&rdquo; pursuant to listing standards of the Nasdaq Capital Market (or
such other national securities exchange upon which the Company&rsquo;s securities are then listed), except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
Nominee will be subject to the Company&rsquo;s customary due diligence process, including its review of a completed questionnaire and
a background check. Based on the foregoing, the Company may object to any Nominee provided (a)&nbsp;it does so in good faith, and (b)&nbsp;such
objection is based upon any of the following: (i)&nbsp;such Nominee was convicted in a criminal proceeding or is a named subject of a
pending criminal proceeding (excluding traffic violations and other minor offenses), (ii)&nbsp;such Nominee was the subject of any order,
judgment, or decree not subsequently reversed, suspended or vacated of any court of competent jurisdiction, permanently or temporarily
enjoining such proposed director from, or otherwise limiting, the following activities: (A)&nbsp;engaging in any type of business practice,
or (B)&nbsp;engaging in any activity in connection with the purchase or sale of any security or in connection with any violation of federal
or state securities laws, (iii)&nbsp;such Nominee was the subject of any order, judgment or decree, not subsequently reversed, suspended
or vacated, of any federal or state authority barring, suspending or otherwise limiting for more than 60 days the right of such person
to engage in any activity described in clause (ii)(B), or to be associated with persons engaged in such activity, (iv)&nbsp;such proposed
director was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any federal or state
securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended or vacated,
or (v)&nbsp;such proposed director was the subject of, or a party to any federal or state judicial or administrative order, judgment,
decree, or finding, not subsequently reversed, suspended or vacated, relating to a violation of any federal or state securities laws
or regulations. In the event the Board reasonably finds the Nominee to be unsuitable based upon one or more of the foregoing clauses
(i)&nbsp;through (v)&nbsp;and reasonably objects to the identified director, Sponsor shall be entitled to propose a different nominee
to the Board within 30 calendar days of the Company&rsquo;s notice to Sponsor of its objection to the Nominee and such replacement Nominee
shall be subject to the review process outlined above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5.1.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall take all necessary action to cause a Nominee chosen by the Sponsor, at the request of such Nominee to be elected to the
board of directors (or similar governing body) of each material operating subsidiary of the Company. The Nominee, as applicable, shall
have the right to attend (in person or remotely) any meetings of the board of directors (or similar governing body or committee thereof)
of each subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any notice or communication under this Agreement must be in writing and given by (i)&nbsp;deposit in the United States mail, addressed
to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii)&nbsp;delivery in person
or by courier service providing evidence of delivery, or (iii)&nbsp;transmission by hand delivery, electronic mail, telecopy, telegram
or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently
given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed
and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time
as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused
by the addressee upon presentation. Any notice or communication under this Agreement must be addressed to the partis as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">If to the Company:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">2100 McKinney Ave, Suite&nbsp;1675</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Dallas, TX 75201</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.7in; font-size: 10pt">Attention:</TD>
    <TD STYLE="font-size: 10pt">Christopher Sorrells</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Email:</TD>
    <TD STYLE="font-size: 10pt">chris.sorrells@sv-ac.com</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">with copy to:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">Kirkland&nbsp;&amp; Ellis LLP</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">609 Main Street</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">New York, New York 70002</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Attention:</TD>
    <TD STYLE="font-size: 10pt">Christian O. Nagler</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Matthew R. Pacey</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Email:</TD>
    <TD STYLE="font-size: 10pt">cnagler@kirkland.com</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">matt.pacey@kirkland.com</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If to any Holder, at such Holder&rsquo;s address
or facsimile number as set forth in the Company&rsquo;s books and records. Any party may change its address for notice at any time and
from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) days after
delivery of such notice as provided in this <U>Section&nbsp;6.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Assignment;
No Third Party Beneficiaries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or
in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prior
to the expiration of the Founder Shares Lock-up Period or the Private Placement Lock-up Period, as the case may be, no Holder may assign
or delegate such Holder&rsquo;s rights, duties or obligations under this Agreement, in whole or in part, except in connection with a
transfer of Registrable Securities by such Holder to a Permitted Transferee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and
the permitted assigns of the Holders, which shall include Permitted Transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.2.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this
Agreement and <U>Section&nbsp;6.2</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">6.2.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
assignment by any party hereto of such party&rsquo;s rights, duties and obligations hereunder shall be binding upon or obligate the Company
unless and until the Company shall have received (i)&nbsp;written notice of such assignment as provided in <U>Section&nbsp;6.1</U> hereof
and (ii)&nbsp;the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions
of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment
made other than as provided in this <U>Section&nbsp;6.2</U> shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible that is valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Counterparts</U>.
This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original,
and all of which together shall constitute the same instrument, but only one of which need be produced. Signatures to this Agreement
transmitted via facsimile or e-mail shall be valid and effective to bind the party so signing (including any electronic signature covered
by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable
law, e.g., <U>www.docusign.com</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement</U>. This Agreement (including all agreements entered into pursuant hereto and all certificates and instruments delivered pursuant
hereto and thereto) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior
and contemporaneous agreements, representations, understandings, negotiations and discussions between the parties, whether oral or written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law; Venue</U>. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY&nbsp;BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY
AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW
YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>WAIVER
OF TRIAL BY JURY</U>. EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES THE RIGHT TO A TRIAL BY JURY IN ANY ACTION, SUIT, COUNTERCLAIM
OR OTHER PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF, CONNECTED WITH OR RELATING TO THIS AGREEMENT, THE
TRANSACTIONS CONTEMPLATED HEREBY, OR THE ACTIONS OF THE SPONSOR IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendments
and Modifications</U>. Upon the written consent of the Company and the Holders of at least a majority in interest of the Registrable
Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be
waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing,
any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of the Company,
in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected.
No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or
the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder
or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or
preclude the exercise of any other rights or remedies hereunder or thereunder by such party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Titles
and Headings</U>. Titles and headings of sections of this Agreement are for convenience only and shall not affect the construction of
any provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Waivers
and Extensions</U>. Any party to this Agreement may waive any right, breach or default which such party has the right to waive, provided
that such waiver will not be effective against the waiving party unless it is in writing, is signed by such party, and specifically refers
to this Agreement. Waivers may be made in advance or after the right waived has arisen or the breach or default waived has occurred.
Any waiver may be conditional. No waiver of any breach of any agreement or provision herein contained shall be deemed a waiver of any
preceding or succeeding breach thereof nor of any other agreement or provision herein contained. No waiver or extension of time for performance
of any obligations or acts shall be deemed a waiver or extension of the time for performance of any other obligations or acts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies
Cumulative</U>. In the event that the Company fails to observe or perform any covenant or agreement to be observed or performed under
this Agreement, the Holders may proceed to protect and enforce its rights by suit in equity or action at law, whether for specific performance
of any term contained in this Agreement or for an injunction against the breach of any such term or in aid of the exercise of any power
granted in this Agreement or to enforce any other legal or equitable right, or to take any one or more of such actions, without being
required to post a bond. None of the rights, powers or remedies conferred under this Agreement shall be mutually exclusive, and each
such right, power or remedy shall be cumulative and in addition to any other right, power or remedy, whether conferred by this Agreement
or now or hereafter available at law, in equity, by statute or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Other
Registration Rights</U>. The Company represents and warrants that no person, other than a Holder of Registrable Securities, has any right
to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration
filed by the Company for the sale of securities for its own account or for the account of any other person. Further, the Company represents
and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and
in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Term</U>.
This Agreement shall terminate upon the earlier of (i)&nbsp;the tenth anniversary of the date of this Agreement and (ii)&nbsp;the date
as of which no Registrable Securities remain outstanding. The provisions of <U>Section&nbsp;3.5</U> and <U>Article&nbsp;IV</U> shall
survive any termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[<I>SIGNATURE PAGES FOLLOW</I>]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution Version</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>IN WITNESS WHEREOF</B>, the undersigned have caused this Agreement
to be executed as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>COMPANY:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>SPRING VALLEY ACQUISITION CORP. II</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 45%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; font-size: 10pt">/s/ Christopher Sorrells</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Name:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Christopher Sorrells</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Registration and Shareholder
Rights Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>HOLDERS:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>SPRING VALLEY ACQUISITION SPONSOR II, LLC</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 45%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; font-size: 10pt">/s/ David Levinson</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Name:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">David Levinson</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Corporate Secretary</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Registration and Shareholder
Rights Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>9
<FILENAME>tm216731d39_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><I>Execution Version</I></B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT
(as it may from time to time be amended and including all exhibits referenced herein, this <B>&ldquo;<I>Agreement</I>&rdquo;</B>), dated
as of October&nbsp;12, 2022, is entered into by and between Spring Valley Acquisition Corp. II, a Cayman Islands exempted company (the
<B>&ldquo;<I>Company</I>&rdquo;</B>), and Spring Valley Acquisition Sponsor II, LLC, a Delaware limited liability company (the <B><I>&ldquo;Purchaser&rdquo;</I></B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company intends to consummate an initial
public offering of the Company&rsquo;s units (the <B>&ldquo;<I>Public Offering</I>&rdquo;</B>), each unit consisting of one Class&nbsp;A
ordinary share of the Company, par value $0.0001 per share (each, a <B>&ldquo;<I>Share</I>&rdquo;</B>), one right to receive one-tenth
of one Share and one-half of one redeemable warrant, each whole warrant entitling the holder to purchase one Share at an exercise price
of $11.50 per Share, as set forth in the Company&rsquo;s Registration Statement on Form&nbsp;S-l, filed with the U.S. Securities and Exchange
Commission (the <B>&ldquo;<I>SEC</I>&rdquo;</B>), File Number 333-253156, under the Securities Act of 1933, as amended (the <B>&ldquo;<I>Securities
Act</I>&rdquo;</B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Purchaser has agreed to purchase an
aggregate of 12,000,000 warrants (and up to 1,350,000 additional warrants if the underwriters in the Public Offering exercise their option
to purchase additional units in full) (the <B>&ldquo;<I>Private Placement Warrants</I>&rdquo;</B>), each Private Placement Warrant entitling
the holder to purchase one Share at an exercise price of $11.50 per Share, at a price of $1.00 per warrant, subject to adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, in order to finance the Company&rsquo;s
transaction costs in connection with an intended Business Combination, the Sponsor or certain of the Company&rsquo;s officers or directors
may, but are not obligated to, loan the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible
into an additional 1,500,000 Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, to extend the period of time the Company
will have to consummate an initial Business Combination, the Sponsor, its affiliates or designees may loan to the Company up to an aggregate
of $2,000,000 (or up to $2,300,000 if the underwriters&rsquo; over-allotment option is exercised in full), which loan is convertible into
additional Private Placement Warrants at a price of $1.00 per Private Placement Warrant at the option of the Sponsor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW THEREFORE, in consideration of the mutual promises
contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties to this Agreement hereby, intending legally to be bound, agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section&nbsp;1. Authorization, Purchase and Sale; Terms of the Private
Placement Warrants.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorization
of the Private Placement Warrants</U>. The Company has duly authorized the issuance and sale of the Private Placement Warrants to the
Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchase
and Sale of the Private Placement Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
the date of the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the
Company (the <B>&ldquo;<I>IPO Closing Date</I>&rdquo;</B>), the Company shall issue and sell to the Purchaser, and the Purchaser shall
purchase from the Company, 12,000,000 Private Placement Warrants at a price of $1.00 per warrant for an aggregate purchase price of $12,000,000
(the <B><I>&ldquo;Purchase Price&rdquo;</I></B>). The Purchaser shall pay the Purchase Price by wire transfer of immediately available
funds in the following amounts: (i)&nbsp;$2,000,000 to the Company at a financial institution to be chosen by the Company, and (ii)&nbsp;$10,000,000
to the trust account maintained by Continental Stock Transfer&nbsp;&amp; Trust Company, acting as trustee (the <B>&ldquo;<I>Trust Account</I>&rdquo;</B>),
in each case in accordance with the Company&rsquo;s wiring instructions, at least one (1)&nbsp;business day prior to the IPO Closing Date.
On the IPO Closing Date, subject to the receipt of funds pursuant to the immediately prior sentence, the Company, at its option, shall
deliver a certificate evidencing the Private Placement Warrants purchased on such date duly registered in the Purchaser&rsquo;s name to
the Purchaser or effect such delivery in book-entry form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
the date of the closing of the option to purchase additional units, if any, in connection with the Public Offering or on such earlier
time and date as may be mutually agreed by the Purchaser and the Company (the <B>&ldquo;<I>Over-Allotment Closing Date</I>&rdquo;</B>),
the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, up to 1,350,000 Private Placement
Warrants (or, to the extent the option to purchase additional units is not exercised in full, a lesser number of Private Placement Warrants
in proportion to the portion of the option that is exercised) at a price of $1.00 per warrant for an aggregate purchase price of up to
$1,350,000 (the <B>&ldquo;<I>Over-Allotment Purchase Price</I>&rdquo;</B>). The Purchaser shall pay the Over-Allotment Purchase Price
in accordance with the Company&rsquo;s wire instruction by wire transfer of immediately available funds to the Trust Account, at least
one (1)&nbsp;business day prior to the Over-Allotment Closing Date. On the Over-Allotment Closing Date, subject to the receipt of funds
pursuant to the immediately prior sentence, the Company shall, at its option, deliver a certificate evidencing the Private Placement Warrants
purchased on such date duly registered in the Purchaser&rsquo;s name to the Purchaser or effect such delivery in book-entry form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C. &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Terms of the Private Placement Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
Private Placement Warrant shall have the terms set forth in a Private Warrant Agreement to be entered into by the Company and a warrant
agent on the IPO Closing Date, in connection with the Public Offering (the <B>&ldquo;<I>Warrant Agreement</I>&rdquo;</B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the IPO Closing Date, the Company and the Purchaser shall enter into a registration and shareholder rights agreement (the
<B>&ldquo;<I>Registration and Shareholder Rights Agreement</I>&rdquo;</B>) pursuant to which the Company will grant certain registration
rights to the Purchaser relating to the Private Placement Warrants and the Shares underlying the Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Representations
and Warranties of the Company. </B>As a material inducement to the Purchaser to enter into this Agreement and purchase the Private Placement
Warrants, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive each Closing
Date) that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Incorporation
and Corporate Power</U>. The Company is an exempted company duly incorporated, validly existing and in good standing under the laws of
the Cayman Islands and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected
to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite
corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorization:
No Breach</U>. The execution, delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized
by the Company as of the Closing Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable in accordance
with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability
relating to or affecting creditors&rsquo; rights and to general equitable principles (whether considered in a proceeding in equity or
law). Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Private Placement
Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their terms as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
execution and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement
Warrants, the issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment of and compliance with the respective
terms hereof and thereof by the Company, do not and will not as of the Closing Date (a)&nbsp;conflict with or result in a breach of the
terms, conditions or provisions of, (b)&nbsp;constitute a default under, (c)&nbsp;result in the creation of any lien, security interest,
charge or encumbrance upon the Company&rsquo;s share capital or assets under, (d)&nbsp;result in a violation of, or (e)&nbsp;require any
authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative
or governmental body or agency pursuant to the memorandum and articles of association of the Company (in effect on the date hereof or
as may be amended prior to completion of the Public Offering) or any material law, statute, rule&nbsp;or regulation to which the Company
is subject, or any agreement, order, judgment or decree to which the Company is subject, except for any filings required after the date
hereof under federal or state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Title
to Securities</U>. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, and upon registration
in the Company&rsquo;s register of members, the Shares issuable upon exercise of the Private Placement Warrants will be duly and validly
issued, fully paid and nonassessable. On the date of issuance of the Private Placement Warrants, the Shares issuable upon exercise of
the Private Placement Warrants shall have been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the terms
hereof and the Warrant Agreement, and upon registration in the Company&rsquo;s register of members, the Purchaser will have good title
to the Private Placement Warrants purchased by it and the Shares issuable upon exercise of such Private Placement Warrants, free and clear
of all liens, claims and encumbrances of any kind, other than (i)&nbsp;transfer restrictions hereunder and under the other agreements
contemplated hereby, (ii)&nbsp;transfer restrictions under federal and state securities laws, and (iii)&nbsp;liens, claims or encumbrances
imposed due to the actions of the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governmental
Consents</U>. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required
in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any
other transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Regulation
D Qualification</U>. Neither the Company nor, to its actual knowledge, any of its affiliates, members, officers, directors or beneficial
shareholders of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule&nbsp;506(d)&nbsp;of
Regulation D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section&nbsp;3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Representations
and Warranties of the Purchaser.</B> As a material inducement to the Company to enter into this Agreement and issue and sell the Private
Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and warranties
shall survive each Closing Date) that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Organization
and Requisite Authority</U>. The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorization:
No Breach</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors&rsquo;
rights and to general equitable principles (whether considered in a proceeding in equity or law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser
does not and shall not as of each Closing Date (a)&nbsp;conflict with or result in a breach by the Purchaser of the terms, conditions
or provisions of, (b)&nbsp;constitute a default under, (c)&nbsp;result in the creation of any lien, security interest, charge or encumbrance
upon the Purchaser&rsquo;s equity or assets under, (d)&nbsp;result in a violation of, or (e)&nbsp;require authorization, consent, approval,
exemption or other action by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant
to the Purchaser&rsquo;s organizational documents in effect on the date hereof or as may be amended prior to completion of the contemplated
Public Offering, or any material law, statute, rule&nbsp;or regulation to which the Purchaser is subject, or any agreement, instrument,
order, judgment or decree to which the Purchaser is subject, except for any filings required after the date hereof under federal or state
securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Investment
Representations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such
exercise (collectively, the <B>&ldquo;<I>Securities</I>&rdquo;</B>) for its own account, for investment purposes only and not with a view
towards, or for resale in connection with, any public sale or distribution thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser is an <B>&ldquo;<I>accredited investor</I>&rdquo;</B> as such term is defined in Rule&nbsp;501(a)(3)&nbsp;of Regulation D under
the Securities Act, and the Purchaser has not experienced a disqualifying event as enumerated pursuant to Rule&nbsp;506(d)&nbsp;of Regulation
D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and
the Purchaser&rsquo;s compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser did not decide to enter into this Agreement as a result of any general solicitation or general advertising within the meaning
of Rule&nbsp;502(c)&nbsp;under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials relating
to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to
ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities
involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the acquisition of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made
any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser
nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser understands that: (a)&nbsp;the Securities have not been and are not being registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless (1)&nbsp;subsequently registered thereunder or (2)&nbsp;sold
in reliance on an exemption therefrom; and (b)&nbsp;except as specifically set forth in the Registration and Shareholder Rights Agreement,
neither the Company nor any other person is under any obligation to register the Securities under the Securities Act or any state securities
laws or to comply with the terms and conditions of any exemption thereunder. In this regard, the Purchaser understands that the SEC has
taken the position that promoters or affiliates of a blank check company and their transferees, both before and after an initial business
combination transaction, are deemed to be <B>&ldquo;<I>underwriters</I>&rdquo;</B> under the Securities Act when reselling the securities
of a blank check company. Based on that position, Rule&nbsp;144 adopted pursuant to the Securities Act would not be available for resale
transactions of the Securities despite technical compliance with the requirements of such Rule, and the Securities can be resold only
through a registered offering or in reliance upon another exemption from the registration requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser has such knowledge and experience in financial and business matters, knowledge of the high degree of risk associated with investments
in the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment
in the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an
indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and will have
no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities. The Purchaser can
afford a complete loss of its investments in the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchaser understands that the Private Placement Warrants shall bear the legend substantially in the form set forth in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Conditions of the
Purchaser&rsquo;s Obligations.</B> The obligations of the Purchaser to purchase and pay for the Private Placement Warrants are subject
to the fulfillment, on or before each Closing Date, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties</U>. The representations and warranties of the Company contained in Section&nbsp;2 shall be true and correct at and as
of the Closing Date as though then made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Performance</U>.
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Injunction</U>. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Agreement and Registration and Shareholder Rights Agreement</U>. The Company shall have entered into the Warrant Agreement, in the form
of Exhibit&nbsp;A hereto, and the Registration and Shareholder Rights Agreement, in the form of Exhibit&nbsp;B hereto, in each case on
terms satisfactory to the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Conditions of the
Company&rsquo;s Obligations. </B>The obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment,
on or before each Closing Date, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties</U>. The representations and warranties of the Purchaser contained in Section&nbsp;3 shall be true and correct at and as
of such Closing Date as though then made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Performance</U>.
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by the Purchaser on or before such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Corporate
Consents</U>. The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance
of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Injunction</U>. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Agreement</U>. The Company shall have entered into the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Miscellaneous.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf
of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed
or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other than assignments
by the Purchaser to affiliates thereof (including, without limitation one or more of its members).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Counterparts</U>.
This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than one
party, but all such counterparts taken together shall constitute one and the same agreement. Signatures to this Agreement transmitted
via facsimile or e-mail shall be valid and effective to bind the party so signing (including any electronic signature covered by the U.S.
federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g.,
<U>www.docusign.com)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Descriptive
Headings: Interpretation</U>. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive
part of this Agreement. The use of the word &ldquo;including&rdquo; in this Agreement shall be by way of example rather than by limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed
in accordance with the internal laws of the State of New York, without giving effect to conflicts of law principles that would result
in the application of the laws of another jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">F.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendments</U>.
This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by the parties
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the parties hereto have executed this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>COMPANY:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 45%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; font-size: 10pt">/s/ Robert Kaplan</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Name:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Robert Kaplan</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Chief Financial Officer and Vice President of Business Development</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;to Private Placement Warrants
Purchase Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PURCHASER:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>SPRING VALLEY ACQUISITION SPONSOR II, LLC</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"></TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 45%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:</P></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; font-size: 10pt">/s/ David Levinson</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Name:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">David Levinson</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Corporate Secretary</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;to Private Placement Warrants
Purchase Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrant Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Registration and Shareholder Rights Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>10
<FILENAME>tm216731d39_ex10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><I>Execution Version</I></B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>INDEMNITY AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>THIS INDEMNITY AGREEMENT</B> (this &ldquo;<B><I>Agreement</I></B>&rdquo;)
is made as of October&nbsp;12, 2022, by and between Spring Valley Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;),
and Sharon Youngblood (&ldquo;<B><I>Indemnitee</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS, </B>highly competent persons have become
more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with adequate
protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their
service to and activities on behalf of such corporations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS, </B>the Board of Directors of the Company
(the &ldquo;<B><I>Board</I></B>&rdquo;) has determined that, in order to attract and retain qualified individuals, the Company will attempt
to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries
from certain liabilities. The amended and restated memorandum and articles of association of the Company (the &ldquo;<B><I>Articles</I></B>&rdquo;)
provide for the indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant
to applicable Cayman Islands law. The Articles provide that the indemnification provisions set forth therein are not exclusive, and thereby
contemplate that contracts may be entered into between the Company and members of the Board, officers and other persons with respect to
indemnification, hold harmless, exoneration, advancement and reimbursement rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS, </B>the uncertainties relating to such
insurance and to indemnification have increased the difficulty of attracting and retaining such persons;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS, </B>the Board has determined that the
increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company&rsquo;s shareholders
and that the Company should act to assure such persons that there will be increased certainty of such protection in the future;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS, </B>it is reasonable, prudent and necessary
for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons
to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that
they will not be so protected against liabilities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS, </B>this Agreement is a supplement
to and in furtherance of the Articles of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a substitute
therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS,&nbsp;</B>Indemnitee may not be willing
to serve as an officer or director without adequate protection, and the Company desires Indemnitee to serve in such capacity. Indemnitee
is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he or she
be so indemnified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>NOW, THEREFORE, </B>in consideration of the
premises and the covenants contained herein and subject to the provisions of the letter agreement dated as of October&nbsp;12, 2022, the
Company and Indemnitee do hereby covenant and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B>SERVICES TO THE COMPANY</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In consideration of the Company&rsquo;s covenants
and obligations hereunder,&nbsp;Indemnitee will serve or continue to serve as an officer, director, advisor, key employee or in any other
capacity of the Company, as applicable, for so long as Indemnitee is duly elected or appointed or retained or until Indemnitee tenders
his or her resignation or until Indemnitee is removed. The foregoing notwithstanding, this Agreement shall continue in full force and
effect after Indemnitee has ceased to serve as a director, officer, advisor, key employee or in any other capacity of the Company, as
provided in Section&nbsp;17. This Agreement, however, shall not impose any obligation on Indemnitee or the Company to continue Indemnitee&rsquo;s
service to the Company beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD><B>DEFINITIONS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As used in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>References to &ldquo;<B><I>agent</I></B>&rdquo; shall mean any person who is or was a director, officer or employee of the Company
or a Subsidiary of the Company or other person authorized by the Company to act for the Company, to include such person serving in such
capacity as a director, officer, employee, advisor, fiduciary or other official of another corporation, partnership, limited liability
company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company
or a Subsidiary of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>The terms &ldquo;<B><I>Beneficial Owner</I></B>&rdquo; and &ldquo;<B><I>Beneficial Ownership</I></B>&rdquo; shall have the meanings
set forth in Rule&nbsp;13d-3 promulgated under the Exchange Act as in effect on the date hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>&ldquo;<B><I>Delaware Court</I></B>&rdquo; shall mean the Court of Chancery of the State of Delaware.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(d)</FONT></TD><TD>A &ldquo;<B><I>Change in Control</I></B>&rdquo; shall be deemed to occur upon the earliest to occur after the date of this Agreement
of any of the following events:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(i)</FONT></TD><TD><U>Acquisition of Shares by Third Party</U>. Any Person, other than an affiliate of Spring Valley Acquisition Sponsor II, LLC (the
 &ldquo;<B><I>Sponsor</I></B>&rdquo;), is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing
fifteen percent (15%) or more of the combined voting power of the Company&rsquo;s then outstanding securities entitled to vote generally
in the election of directors, unless (1)&nbsp;the change in the relative Beneficial Ownership of the Company&rsquo;s securities by any
Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election
of directors, or (2)&nbsp;such acquisition was approved in advance by the Continuing Directors and such acquisition would not constitute
a Change in Control under part (iii)&nbsp;of this definition;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(ii)</FONT></TD><TD><U>Change in Board of Directors</U>. Individuals who, as of the date hereof, constitute the Board, and any new director whose election
by the Board or nomination for election by the Company&rsquo;s shareholders was approved by a vote of at least two thirds of the directors
then still in office who were directors on the date hereof or whose election or nomination for election was previously so approved (collectively,
the &ldquo;<B><I>Continuing Directors</I></B>&rdquo;), cease for any reason to constitute at least a majority of the members of the Board;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(iii)</FONT></TD><TD><U>Corporate Transactions</U>. The effective date of a merger, share exchange, asset acquisition, share purchase, reorganization or
similar business combination, involving the Company and one or more businesses (a &ldquo;<B><I>Business Combination</I></B>&rdquo;), in
each case, unless, following such Business Combination: (1)&nbsp;all or substantially all of the individuals and entities who were the
Beneficial Owners of securities entitled to vote generally in the election of directors immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 51% of the combined voting power of the then outstanding securities of the Company
entitled to vote generally in the election of directors resulting from such Business Combination (including, without limitation, a corporation
which as a result of such transaction owns the Company or all or substantially all of the Company&rsquo;s assets either directly or through
one or more Subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination, of
the securities entitled to vote generally in the election of directors; (2)&nbsp;other than an affiliate of the Sponsor, no Person (excluding
any corporation resulting from such Business Combination) is the Beneficial Owner, directly or indirectly, of 15% or more of the combined
voting power of the then outstanding securities entitled to vote generally in the election of directors of the surviving corporation except
to the extent that such ownership existed prior to the Business Combination; and (3)&nbsp;at least a majority of the board of directors
of the corporation resulting from such Business Combination were Continuing Directors at the time of the execution of the initial agreement,
or of the action of the Board, providing for such Business Combination;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(iv)</FONT></TD><TD><U>Liquidation</U>. The approval by the shareholders of the Company of a complete liquidation of the Company or an agreement or series
of agreements for the sale or disposition by the Company of all or substantially all of the Company&rsquo;s assets, other than factoring
the Company&rsquo;s current receivables or escrows due (or, if such approval is not required, the decision by the Board to proceed with
such a liquidation, sale, or disposition in one transaction or a series of related transactions); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(v)</FONT></TD><TD><U>Other Events</U>. There occurs any other event of a nature that would be required to be reported in response to Item 6(e)&nbsp;of
Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act,
whether or not the Company is then subject to such reporting requirement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(e)</FONT></TD><TD>&ldquo;<B><I>Corporate Status</I></B>&rdquo; describes the status of a person who is or was a director, officer, trustee, general
partner, manager, managing member, fiduciary, employee or agent of the Company or of any other Enterprise which such person is or was
serving at the request of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(f)</FONT></TD><TD>&ldquo;<B><I>Disinterested Director</I></B>&rdquo; shall mean a director of the Company who is not and was not a party to the Proceeding
in respect of which indemnification is sought by Indemnitee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(g)</FONT></TD><TD>&ldquo;<B><I>Enterprise</I></B>&rdquo; shall mean the Company and any other corporation, constituent corporation (including any constituent
of a constituent) absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party, limited
liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving
at the request of the Company as a director, officer, trustee, general partner, managing member, fiduciary, employee or agent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(h)</FONT></TD><TD>&ldquo;<B><I>Exchange Act</I></B>&rdquo; shall mean the Securities Exchange Act of 1934, as amended.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(i)</FONT></TD><TD>&ldquo;<B><I>Expenses</I></B>&rdquo; shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever,
including, without limitation, all reasonable attorneys&rsquo; fees and costs, retainers, court costs, transcript costs, fees of experts,
witness fees, travel expenses, fees of private investigators and professional advisors, duplicating costs, printing and binding costs,
telephone charges, postage, delivery service fees, fax transmission charges, secretarial services and all other disbursements, obligations
or expenses in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness
in, settlement or appeal of, or otherwise participating in, a Proceeding, including reasonable compensation for time spent by the Indemnitee
for which he or she is not otherwise compensated by the Company or any third party. Expenses also shall include Expenses incurred in connection
with any appeal resulting from any Proceeding, including without limitation the principal, premium, security for, and other costs relating
to any cost bond, supersedeas bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement
by Indemnitee or the amount of judgments or fines against Indemnitee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(j)</FONT></TD><TD>References to &ldquo;<B><I>fines</I></B>&rdquo; shall include any excise tax assessed on Indemnitee with respect to any employee benefit
plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(k)</FONT></TD><TD>References to &ldquo;<B><I>serving at the request of the Company</I></B>&rdquo; shall include any service as a director, officer,
employee, agent or fiduciary of the Company which imposes duties on, or involves services by, such director, officer, employee, agent
or fiduciary with respect to an employee benefit plan, its participants or beneficiaries; and if Indemnitee acted in good faith and in
a manner Indemnitee reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan,&nbsp;Indemnitee
shall be deemed to have acted in a manner &ldquo;<B><I>not opposed to the best interests of the Company</I></B>&rdquo; as referred to
in this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(l)</FONT></TD><TD>&ldquo;<B><I>Independent Counsel</I></B>&rdquo; shall mean a law firm or a member of a law firm with significant experience in matters
of corporate law and that neither presently is, nor in the past five years has been, retained to represent: (i)&nbsp;the Company or Indemnitee
in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other
indemnitees under similar indemnification agreements); or (ii)&nbsp;any other party to the Proceeding giving rise to a claim for indemnification
hereunder. Notwithstanding the foregoing, the term &ldquo;<B><I>Independent Counsel</I></B>&rdquo; shall not include any person who, under
the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company
or Indemnitee in an action to determine Indemnitee&rsquo;s rights under this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(m)</FONT></TD><TD>The term &ldquo;<B><I>Person</I></B>&rdquo; shall have the meaning as set forth in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Exchange
Act as in effect on the date hereof; provided, however, that &ldquo;<B><I>Person</I></B>&rdquo; shall exclude: (i)&nbsp;the Company; (ii)&nbsp;any
Subsidiaries of the Company; (iii)&nbsp;any employment benefit plan of the Company or of a Subsidiary of the Company or of any corporation
owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of shares of
the Company; and (iv)&nbsp;any trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a Subsidiary
of the Company or of a corporation owned directly or indirectly by the shareholders of the Company in substantially the same proportions
as their ownership of shares of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(n)</FONT></TD><TD>The term &ldquo;<B><I>Proceeding</I></B>&rdquo; shall include any threatened, pending or completed action, suit, arbitration, mediation,
alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding,
whether brought in the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims),
criminal, administrative or investigative or related nature, in which Indemnitee was, is, will or might be involved as a party or otherwise
by reason of the fact that Indemnitee is or was a director or officer of the Company, by reason of any action (or failure to act) taken
by him or her or of any action (or failure to act) on his or her part while acting as a director or officer of the Company, or by reason
of the fact that he or she is or was serving at the request of the Company as a director, officer, trustee, general partner, managing
member, fiduciary, employee or agent of any other Enterprise, in each case whether or not serving in such capacity at the time any liability
or expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided under this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(o)</FONT></TD><TD>The term &ldquo;<B><I>Subsidiary,</I></B>&rdquo; with respect to any Person, shall mean any corporation, limited liability company,
partnership, joint venture, trust or other entity of which a majority of the voting power of the voting equity securities or equity interest
is owned, directly or indirectly, by that Person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(p)</FONT></TD><TD>The phrase &ldquo;<B><I>to the fullest extent permitted by applicable law</I></B>&rdquo; shall include, but not be limited to: (a)&nbsp;to
the fullest extent authorized or permitted by the provision of applicable Cayman Islands law that authorizes or contemplates additional
indemnification by agreement, or the corresponding provision of any amendment to or replacement of applicable Cayman Islands law, and
(b)&nbsp;to the fullest extent authorized or permitted by any amendments to or replacements of applicable Cayman Islands law adopted after
the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD><B>INDEMNITY IN THIRD-PARTY PROCEEDINGS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the fullest extent permitted by applicable law,
the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Section&nbsp;3 if Indemnitee
was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding, other than
a Proceeding by or in the right of the Company to procure a judgment in its favor, by reason of Indemnitee&rsquo;s Corporate Status. Pursuant
to this Section&nbsp;3,&nbsp;Indemnitee shall be indemnified, held harmless and exonerated against all Expenses, judgments, liabilities,
fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with
or in respect of such Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement) actually, and reasonably incurred
by Indemnitee or on his or her behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in
good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company and, in the case
of a criminal Proceeding, had no reasonable cause to believe that his or her conduct was unlawful; provided, in no event shall Indemnitee
be entitled to be indemnified, held harmless or advanced any amounts hereunder in respect of any Expenses, judgments, liabilities, fines,
penalties and amounts paid in settlement (if any) that Indemnitee may incur by reason of his or her own actual fraud or intentional misconduct.
Indemnitee shall not be found to have committed actual fraud or intentional misconduct for any purpose of this Agreement unless or until
a court of competent jurisdiction shall have made a finding to that effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD><B>INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the fullest extent permitted by applicable law,
the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Section&nbsp;4 if Indemnitee
was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding by or in the
right of the Company to procure a judgment in its favor by reason of Indemnitee&rsquo;s Corporate Status. Pursuant to this Section&nbsp;4,&nbsp;Indemnitee
shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or her or on his or her
behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he
or she reasonably believed to be in or not opposed to the best interests of the Company. No indemnification, hold harmless or exoneration
for Expenses shall be made under this Section&nbsp;4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally
adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that any court in which the Proceeding
was brought or the Delaware Court shall determine upon application that, despite the adjudication of liability but in view of all the
circumstances of the case,&nbsp;Indemnitee is fairly and reasonably entitled to indemnification, to be held harmless or to exoneration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD><B>INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding any other provisions of this Agreement,
but subject to Section&nbsp;27, to the extent that Indemnitee was or is, by reason of Indemnitee&rsquo;s Corporate Status, a party to
(or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein,
in whole or in part, the Company shall, to the fullest extent permitted by applicable law, indemnify, hold harmless and exonerate Indemnitee
against all Expenses actually and reasonably incurred by him or her in connection therewith. If Indemnitee is not wholly successful in
such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding,
the Company shall, to the fullest extent permitted by applicable law, indemnify, hold harmless and exonerate Indemnitee against all Expenses
actually and reasonably incurred by him or her or on his or her behalf in connection with each successfully resolved claim, issue or matter.
If Indemnitee is not wholly successful in such Proceeding, the Company also shall, to the fullest extent permitted by applicable law,
indemnify, hold harmless and exonerate Indemnitee against all Expenses reasonably incurred in connection with a claim, issue or matter
related to any claim, issue, or matter on which Indemnitee was successful. For purposes of this Section&nbsp;5 and without limitation,
the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful
result as to such claim, issue or matter.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD><B>INDEMNIFICATION FOR EXPENSES OF A WITNESS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding any other provision of this Agreement,
but subject to Section&nbsp;27, to the extent that Indemnitee is, by reason of his or her Corporate Status, a witness or deponent in any
Proceeding to which Indemnitee is not a party or threatened to be made a party, he or she shall, to the fullest extent permitted by applicable
law, be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or her or on his or her
behalf in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.</B></TD><TD><B>ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND EXONERATION RIGHTS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding any limitation in Sections 3, 4
or 5, but subject to Section&nbsp;27, the Company shall, to the fullest extent permitted by applicable law, indemnify, hold harmless and
exonerate Indemnitee if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the
right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines, penalties and amounts paid in settlement
(including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines,
penalties and amounts paid in settlement) actually and reasonably incurred by Indemnitee in connection with the Proceeding. No indemnification,
hold harmless or exoneration rights shall be available under this Section&nbsp;7 on account of Indemnitee&rsquo;s conduct which constitutes
a breach of Indemnitee&rsquo;s duty of loyalty to the Company or its shareholders or is an act or omission not in good faith or which
involves intentional misconduct or a knowing violation of the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8.</B></TD><TD><B>CONTRIBUTION IN THE EVENT OF JOINT LIABILITY</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>To the fullest extent permissible under applicable law, if the indemnification, hold harmless and/or exoneration rights provided for
in this Agreement are unavailable to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying, holding
harmless or exonerating Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for judgments,
liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding without
requiring Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution it may have
at any time against Indemnitee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would
be if joined in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>The Company hereby agrees to fully indemnify, hold harmless and exonerate Indemnitee from any claims for contribution which may be
brought by officers, directors or employees of the Company other than Indemnitee who may be jointly liable with Indemnitee. Indemnitee
shall seek payments or advances from the Company only to the extent that such payments or advances are unavailable from any insurance
policy of the Company covering Indemnitee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9.</B></TD><TD><B>EXCLUSIONS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding any provision in this Agreement,
but subject to Section&nbsp;27, the Company shall not be obligated under this Agreement to make any indemnification, advance Expenses,
hold harmless or exoneration payment in connection with any claim made against Indemnitee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>for which payment has actually been received by or on behalf of Indemnitee under any insurance policy or other indemnity or advancement
provision, except with respect to any excess beyond the amount actually received under any insurance policy, contract, agreement, other
indemnity or advancement provision or otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within
the meaning of Section&nbsp;16(b)&nbsp;of the Exchange Act (or any successor rule) or similar provisions of state statutory law or common
law; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>except as otherwise provided in Sections 14(f)&nbsp;and (g)&nbsp;hereof, prior to a Change in Control, in connection with any Proceeding
(or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee
against the Company or its directors, officers, employees or other indemnitees, unless (i)&nbsp;the Board authorized the Proceeding (or
any part of any Proceeding) prior to its initiation or (ii)&nbsp;the Company provides the indemnification, hold harmless or exoneration
payment, in its sole discretion, pursuant to the powers vested in the Company under applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.</B></TD><TD><B>ADVANCES OF EXPENSES; DEFENSE OF CLAIM</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>Notwithstanding any provision of this Agreement to the contrary, but subject to Section&nbsp;27, and to the fullest extent not prohibited
by applicable law, the Company shall pay the Expenses incurred by Indemnitee (or reasonably expected by Indemnitee to be incurred by Indemnitee
within three months) in connection with any Proceeding within ten (10)&nbsp;days after the receipt by the Company of a statement or statements
requesting such advances from time to time, prior to the final disposition of any Proceeding. Advances shall, to the fullest extent permitted
by law, be unsecured and interest free. Advances shall, to the fullest extent permitted by law, be made without regard to Indemnitee&rsquo;s
ability to repay the Expenses and without regard to Indemnitee&rsquo;s ultimate entitlement to be indemnified, held harmless or exonerated
under the other provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing a Proceeding to
enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances
claimed. To the fullest extent required by applicable law, such payments of Expenses in advance of the final disposition of the Proceeding
shall be made only upon the Company&rsquo;s receipt of an undertaking, by or on behalf of Indemnitee, to repay the advanced amounts to
the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company under the provisions of this
Agreement, the Articles, applicable law or otherwise. If it shall be determined by a final judgment or other final adjudication that Indemnitee
was not so entitled to indemnification, any advancement shall be returned to the Company (without interest) by the Indemnitee. This Section&nbsp;10(a)&nbsp;shall
not apply to any claim made by Indemnitee for which an indemnification, hold harmless or exoneration payment is excluded pursuant to Section&nbsp;9,
but shall apply to any Proceeding referenced in Section&nbsp;9(b)&nbsp;prior to a final determination that Indemnitee is liable therefor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>The Company will be entitled to participate in the Proceeding at its own expense.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine,
penalty or limitation on Indemnitee without Indemnitee&rsquo;s prior written consent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.</B></TD><TD><B>PROCEDURE FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>Indemnitee agrees to notify promptly the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment,
information or other document relating to any Proceeding, claim, issue or matter therein which may be subject to indemnification, hold
harmless or exoneration rights, or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall
not relieve the Company of any obligation which it may have to Indemnitee under this Agreement, or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>Indemnitee may deliver to the Company a written application to indemnify, hold harmless or exonerate Indemnitee in accordance with
this Agreement. Such application(s)&nbsp;may be delivered from time to time and at such time(s)&nbsp;as Indemnitee deems appropriate in
his or her sole discretion. Following such a written application for indemnification by Indemnitee,&nbsp;Indemnitee&rsquo;s entitlement
to indemnification shall be determined according to Section&nbsp;12(a)&nbsp;of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12.</B></TD><TD><B>PROCEDURE UPON APPLICATION FOR INDEMNIFICATION</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>A determination, if required by applicable law, with respect to Indemnitee&rsquo;s entitlement to indemnification shall be made in
the specific case by one of the following methods, which shall be at the election of Indemnitee: (i)&nbsp;by a majority vote of the Disinterested
Directors, even though less than a quorum of the Board, (ii)&nbsp;by a committee of such directors designated by majority vote of such
directors, (iii)&nbsp;if there are no Disinterested Directors or if such directors so direct, by Independent Counsel in a written opinion
to the Board, a copy of which shall be delivered to Indemnitee, or (iv)&nbsp;by vote of the shareholders by ordinary resolution. The Company
promptly will advise Indemnitee in writing with respect to any determination that Indemnitee is or is not entitled to indemnification,
including a description of any reason or basis for which indemnification has been denied. If it is so determined that Indemnitee is entitled
to indemnification, payment to Indemnitee shall be made within ten (10)&nbsp;days after such determination. Indemnitee shall reasonably
cooperate with the person, persons or entity making such determination with respect to Indemnitee&rsquo;s entitlement to indemnification,
including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination.
Any costs or Expenses (including reasonable attorneys&rsquo; fees and disbursements) incurred by Indemnitee in so cooperating with the
person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee&rsquo;s
entitlement to indemnification) and the Company hereby agrees to indemnify and to hold Indemnitee harmless therefrom.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section&nbsp;12(a)&nbsp;hereof,
the Independent Counsel shall be selected as provided in this Section&nbsp;12(b). The Independent Counsel shall be selected by Indemnitee
(unless Indemnitee shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising
it of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements
of &ldquo;<B><I>Independent Counsel</I></B>&rdquo; as defined in Section&nbsp;2 of this Agreement. If the Independent Counsel is selected
by the Board, the Company shall give written notice to Indemnitee advising him or her of the identity of the Independent Counsel so selected
and certifying that the Independent Counsel so selected meets the requirements of &ldquo;<B><I>Independent Counsel</I></B>&rdquo; as defined
in Section&nbsp;2 of this Agreement. In either event,&nbsp;Indemnitee or the Company, as the case may be, may, within ten (10)&nbsp;days
after such written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written
objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so
selected does not meet the requirements of &ldquo;<B><I>Independent Counsel</I></B>&rdquo; as defined in Section&nbsp;2 of this Agreement,
and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person
so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected
may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined
that such objection is without merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification
pursuant to Section&nbsp;11(b)&nbsp;hereof, no Independent Counsel shall have been selected and not objected to, either the Company or
Indemnitee may petition the Delaware Court for resolution of any objection which shall have been made by the Company or Indemnitee to
the other&rsquo;s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the Delaware
Court, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel
under Section&nbsp;12(a)&nbsp;hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section&nbsp;14(a)&nbsp;of
this Agreement,&nbsp;Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the
applicable standards of professional conduct then prevailing).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent
Counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant
hereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.</B></TD><TD><B>PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination
shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification
in accordance with Section&nbsp;11(b)&nbsp;of this Agreement, and the Company shall have the burden of proof to overcome that presumption
in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure
of the Company (including by the Disinterested Directors or Independent Counsel) to have made a determination prior to the commencement
of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable
standard of conduct, nor an actual determination by the Company (including by the Disinterested Directors or Independent Counsel) that
Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has
not met the applicable standard of conduct.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>If the person, persons or entity empowered or selected under Section&nbsp;12 of this Agreement to determine whether Indemnitee is
entitled to indemnification shall not have made a determination within thirty (30) days after receipt by the Company of the request therefor,
the requisite determination of entitlement to indemnification shall, to the fullest extent permitted by law, be deemed to have been made
and Indemnitee shall be entitled to such indemnification, absent (i)&nbsp;a misstatement by Indemnitee of a material fact, or an omission
of a material fact necessary to make Indemnitee&rsquo;s statement not materially misleading, in connection with the request for indemnification,
or (ii)&nbsp;a final judicial determination that any or all such indemnification is expressly prohibited under applicable law; provided,
however, that such 30-day period may be extended for a reasonable time, not to exceed an additional fifteen (15) days, if the person,
persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time
for the obtaining or evaluating of documentation and/or information relating thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: lightgrey"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: lightgrey"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon
a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely
affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which
he or she reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding,
that Indemnitee had reasonable cause to believe that his or her conduct was unlawful.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(d)</FONT></TD><TD>For purposes of any determination of good faith,&nbsp;Indemnitee shall be deemed to have acted in good faith if Indemnitee&rsquo;s
action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee
by the directors, manager, or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise,
its Board, any committee of the Board or any director, trustee, general partner, manager or managing member, or on information or records
given or reports made to the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or managing
member, by an independent certified public accountant or by an appraiser or other expert selected by the Enterprise, its Board, any committee
of the Board or any director, trustee, general partner, manager or managing member. The provisions of this Section&nbsp;13(d)&nbsp;shall
not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the
applicable standard of conduct set forth in this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(e)</FONT></TD><TD>The knowledge and/or actions, or failure to act, of any other director, officer, trustee, partner, manager, managing member, fiduciary,
agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under
this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.</B></TD><TD><B>REMEDIES OF INDEMNITEE</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>In the event that (i)&nbsp;a determination is made pursuant to Section&nbsp;12 of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii)&nbsp;advancement of Expenses, to the fullest extent permitted by applicable law, is not timely
made pursuant to Section&nbsp;10 of this Agreement, (iii)&nbsp;no determination of entitlement to indemnification shall have been made
pursuant to Section&nbsp;12(a)&nbsp;of this Agreement within thirty (30) days after receipt by the Company of the request for indemnification,
(iv)&nbsp;payment of indemnification is not made pursuant to Sections 5, 6, 7 or the last sentence of Section&nbsp;12(a)&nbsp;of this
Agreement within ten (10)&nbsp;days after receipt by the Company of a written request therefor, (v)&nbsp;a contribution payment is not
made in a timely manner pursuant to Section&nbsp;8 of this Agreement, (vi)&nbsp;payment of indemnification pursuant to Section&nbsp;3
or 4 of this Agreement is not made within ten (10)&nbsp;days after a determination has been made that Indemnitee is entitled to indemnification,
or (vii)&nbsp;payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is not made
in accordance with this Agreement within ten (10)&nbsp;days after receipt by the Company of a written request therefor,&nbsp;Indemnitee
shall be entitled to an adjudication by the Delaware Court to such indemnification, hold harmless, exoneration, contribution or advancement
rights. Alternatively,&nbsp;Indemnitee, at his or her option, may seek an award in arbitration to be conducted by a single arbitrator
pursuant to the Commercial Arbitration Rules&nbsp;and Mediation Procedures of the American Arbitration Association. Except as set forth
herein, the Commercial Arbitration Rules&nbsp;and Mediation Procedures of the American Arbitration Association shall apply to any such
arbitration. The Company shall not oppose Indemnitee&rsquo;s right to seek any such adjudication or award in arbitration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>In the event that a determination shall have been made pursuant to Section&nbsp;12(a)&nbsp;of this Agreement that Indemnitee is not
entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;14 shall be conducted in all
respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>In any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;14,&nbsp;Indemnitee shall be presumed to be entitled
to be indemnified, held harmless, exonerated to receive advancement of Expenses under this Agreement and the Company shall have the burden
of proving Indemnitee is not entitled to be indemnified, held harmless, exonerated and to receive advancement of Expenses, as the case
may be, and the Company may not refer to or introduce into evidence any determination pursuant to Section&nbsp;12(a)&nbsp;of this Agreement
adverse to Indemnitee for any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Section&nbsp;14,&nbsp;Indemnitee
shall not be required to reimburse the Company for any advances pursuant to Section&nbsp;10 until a final determination is made with respect
to Indemnitee&rsquo;s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(d)</FONT></TD><TD>If a determination shall have been made pursuant to Section&nbsp;12(a)&nbsp;of this Agreement that Indemnitee is entitled to indemnification,
the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;14,
absent (i)&nbsp;a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&rsquo;s
statement not materially misleading, in connection with the request for indemnification, or (ii)&nbsp;a prohibition of such indemnification
under applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(e)</FONT></TD><TD>The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;14
that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or
before any such arbitrator that the Company is bound by all the provisions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(f)</FONT></TD><TD>The Company shall indemnify and hold harmless Indemnitee to the fullest extent permitted by law against all Expenses and, if requested
by Indemnitee, shall (within ten (10)&nbsp;days after the Company&rsquo;s receipt of such written request) pay to Indemnitee, to the fullest
extent permitted by applicable law, such Expenses which are incurred by Indemnitee in connection with any judicial proceeding or arbitration
brought by Indemnitee: (i)&nbsp;to enforce his or her rights under, or to recover damages for breach of, this Agreement or any other indemnification,
hold harmless, exoneration, advancement or contribution agreement or provision of the Articles now or hereafter in effect; or (ii)&nbsp;for
recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee, regardless of the outcome and
whether Indemnitee ultimately is determined to be entitled to such indemnification, hold harmless or exoneration right, advancement, contribution
or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was not brought by Indemnitee in good faith).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(g)</FONT></TD><TD>Interest shall be paid by the Company to Indemnitee at the legal rate under New York law for amounts which the Company indemnifies,
holds harmless or exonerates, or advances, or is obliged to indemnify, hold harmless or exonerate or advance for the period commencing
with the date on which Indemnitee requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement
of any Expenses and ending with the date on which such payment is made to Indemnitee by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>15.</B></TD><TD><B>SECURITY</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding anything herein to the contrary,
but subject to Section&nbsp;27, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and from
time to time provide security to Indemnitee for the Company&rsquo;s obligations hereunder through an irrevocable bank line of credit,
funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written
consent of Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>16.</B></TD><TD><B>NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION; PRIORITY OF OBLIGATIONS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>The rights of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at
any time be entitled under applicable law, the Articles, any agreement, a vote of shareholders or a resolution of directors, or otherwise.
No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under
this Agreement in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) or claim,
issue or matter therein arising out of, or related to, any action taken or omitted by such Indemnitee in his or her Corporate Status prior
to such amendment, alteration or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, permits
greater indemnification, hold harmless or exoneration rights or advancement of Expenses than would be afforded currently under the Articles
or this Agreement, then this Agreement (without any further action by the parties hereto) shall automatically be deemed to be amended
to require that the Company indemnifies the Indemnitee to the fullest extent permitted by law. No right or remedy herein conferred is
intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other
right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right
or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>The Articles permit the Company to purchase and maintain insurance or furnish similar protection or make other arrangements including,
but not limited to, providing a trust fund, letter of credit, or surety bond (&ldquo;<B><I>Indemnification Arrangements</I></B>&rdquo;)
on behalf of Indemnitee against any liability asserted against him or her or incurred by or on behalf of him or in such capacity as a
director, officer, employee or agent of the Company, or arising out of his or her status as such, whether or not the Company would have
the power to indemnify him or her against such liability under the provisions of this Agreement and the Articles. The purchase, establishment,
and maintenance of any such Indemnification Arrangement shall not in any way limit or affect the rights and obligations of the Company
or of Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Company
and Indemnitee shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under
any such Indemnification Arrangement.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, trustees,
partners, managers, managing members, fiduciaries, employees, or agents of the Company or of any other Enterprise which such person serves
at the request of the Company,&nbsp;Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the
maximum extent of the coverage available for any such director, officer, trustee, partner, managers, managing member, fiduciary, employee
or agent under such policy or policies. If, at the time the Company receives notice from any source of a Proceeding as to which Indemnitee
is a party or a participant (as a witness, deponent or otherwise), the Company has director and officer liability insurance in effect,
the Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective
policies. The Company shall thereafter use commercially reasonable efforts to cause such insurers to pay, on behalf of Indemnitee, all
amounts payable as a result of such Proceeding in accordance with the terms of such policies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(d)</FONT></TD><TD>In the event of any payment under this Agreement, the Company, to the fullest extent permitted by law, shall be subrogated to the
extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary
to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.
No such payment by the Company shall be deemed to relieve any insurer of its obligations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(e)</FONT></TD><TD>The Company&rsquo;s obligation to indemnify, hold harmless, exonerate or advance Expenses hereunder to Indemnitee who is or was serving
at the request of the Company as a director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent of any
other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification, hold harmless or exoneration payments
or advancement of expenses from such Enterprise. Notwithstanding any other provision of this Agreement to the contrary, but subject to
Section&nbsp;27, (i)&nbsp;Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, hold
harmless, exoneration, advancement, contribution or insurance coverage among multiple parties possessing such duties to Indemnitee prior
to the Company&rsquo;s satisfaction and performance of all its obligations under this Agreement, and (ii)&nbsp;the Company shall perform
fully its obligations under this Agreement without regard to whether Indemnitee holds, may pursue or has pursued any indemnification,
advancement, hold harmless, exoneration, contribution or insurance coverage rights against any person or entity other than the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(f)</FONT></TD><TD>Notwithstanding anything contained herein, the Company is the primary indemnitor, and any indemnification or advancement obligation
of the Sponsor or its affiliates or members or any other Person is secondary.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>17.</B></TD><TD><B>DURATION OF AGREEMENT</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All agreements and obligations of the Company contained
herein shall continue during the period Indemnitee serves as a director or officer of the Company or as a director, officer, trustee,
partner, manager, managing member, fiduciary, employee or agent of any other corporation, partnership, joint venture, trust, employee
benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter so long as Indemnitee
shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by Indemnitee pursuant
to Section&nbsp;14 of this Agreement) by reason of his or her Corporate Status, whether or not he or she is acting in any such capacity
at the time any liability or expense is incurred for which indemnification or advancement can be provided under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>18.</B></TD><TD><B>SEVERABILITY</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If any provision or provisions of this Agreement
shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)&nbsp;the validity, legality and enforceability of
the remaining provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this
Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable)
shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (b)&nbsp;such
provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to
the intent of the parties hereto; and (c)&nbsp;to the fullest extent possible, the provisions of this Agreement (including, without limitation,
each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable,
that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>19.</B></TD><TD><B>ENFORCEMENT AND BINDING EFFECT</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby
in order to induce Indemnitee to serve as a director, officer or key employee of the Company, and the Company acknowledges that Indemnitee
is relying upon this Agreement in serving as a director, officer or key employee of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>Without limiting any of the rights of Indemnitee under the Articles of the Company as they may be amended from time to time, this
Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior
agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(c)</FONT></TD><TD>The indemnification, hold harmless, exoneration and advancement of expenses rights provided by or granted pursuant to this Agreement
shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect
successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company), shall
continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or a director, officer, trustee,
general partner, manager, managing member, fiduciary, employee or agent of any other Enterprise at the Company&rsquo;s request, and shall
inure to the benefit of Indemnitee and his or her spouse, assigns, heirs, devisees, executors and administrators and other legal representatives.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(d)</FONT></TD><TD>The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to
all, substantially all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance
satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the
Company would be required to perform if no such succession had taken place.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(e)</FONT></TD><TD>The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate,
impracticable and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties
hereto agree that Indemnitee may, to the fullest extent permitted by law, enforce this Agreement by seeking, among other things, injunctive
relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive
relief and/or specific performance,&nbsp;Indemnitee shall not be precluded from seeking or obtaining any other relief to which he or she
may be entitled. The Company and Indemnitee further agree that Indemnitee shall, to the fullest extent permitted by law, be entitled to
such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions,
without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a
waiver, a bond or undertaking may be required of Indemnitee by a court of competent jurisdiction, and the Company hereby waives any such
requirement of such a bond or undertaking to the fullest extent permitted by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>20.</B></TD><TD><B>MODIFICATION AND WAIVER</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No supplement, modification or amendment of this
Agreement shall be binding unless executed in writing by the parties hereto. No waiver of any of the provisions of this Agreement shall
be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>21.</B></TD><TD><B>NOTICES</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All notices, requests, demands and other communications
under this Agreement shall be in writing and shall be deemed to have been duly given (i)&nbsp;if delivered by hand and receipted for by
the party to whom said notice or other communication shall have been directed, or (ii)&nbsp;if mailed by certified or registered mail
with postage prepaid, on the third (3rd) business day after the date on which it is so mailed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD>If to Indemnitee, at the address indicated on the signature page&nbsp;of this Agreement, or such other address as Indemnitee shall
provide in writing to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD>If to the Company, to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Spring Valley Acquisition Corp. II<BR>
2100 McKinney Ave, Suite&nbsp;1675<BR>
Dallas, TX 75201<BR>
Attention: Robert Kaplan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy, which shall not constitute notice, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Kirkland&nbsp;&amp; Ellis LLP&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">609 Main Street&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Houston, Texas 77002<BR>
Attn: Matthew Pacey&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Christian O. Nagler</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to any other address as may have been furnished to Indemnitee in
writing by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>22.</B></TD><TD><B>APPLICABLE LAW AND CONSENT TO JURISDICTION</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Agreement and the legal relations among the
parties shall be governed by, and construed and enforced in accordance with, the laws of the State of New York, without regard to its
conflict of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section&nbsp;14(a)&nbsp;of this Agreement,
to the fullest extent permitted by law, the Company and Indemnitee hereby irrevocably and unconditionally: (a)&nbsp;agree that any action
or proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court and not in any other state
or federal court in the United States of America or any court in any other country; (b)&nbsp;consent to submit to the exclusive jurisdiction
of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement; (c)&nbsp;waive any
objection to the laying of venue of any such action or proceeding in the Delaware Court; and (d)&nbsp;waive, and agree not to plead or
to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum,
or is subject (in whole or in part) to a jury trial. To the fullest extent permitted by law, the parties hereby agree that the mailing
of process and other papers in connection with any such action or proceeding in the manner provided by Section&nbsp;21 or in such other
manner as may be permitted by law, shall be valid and sufficient service thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>23.</B></TD><TD><B>IDENTICAL COUNTERPARTS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Agreement may be executed in one or more counterparts,
each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement.
Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of
this Agreement. Signatures to this Agreement transmitted via facsimile or e-mail shall be valid and effective to bind the party so signing
(including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., <U>www.docusign.com</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>24.</B></TD><TD><B>MISCELLANEOUS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The headings of the paragraphs of this Agreement
are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>25.</B></TD><TD><B>PERIOD OF LIMITATIONS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No legal action shall be brought and no cause of
action shall be asserted by or in the right of the Company against Indemnitee,&nbsp;Indemnitee&rsquo;s spouse, heirs, executors or personal
or legal representatives after the expiration of two years from the date of accrual of such cause of action, and any claim or cause of
action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such two-year
period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause of action such shorter
period shall govern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>26.</B></TD><TD><B>ADDITIONAL ACTS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If for the validation of any of the provisions
in this Agreement any act, resolution, approval or other procedure is required to the fullest extent permitted by law, the Company undertakes
to cause such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfill
its obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>27.</B></TD><TD><B>WAIVER OF CLAIMS TO TRUST ACCOUNT</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding anything contained herein to the
contrary,&nbsp;Indemnitee hereby agrees that it does not have any right, title, interest or claim of any kind (each, a &ldquo;<B><I>Claim</I></B>&rdquo;)
in or to any monies in the trust account established in connection with the Company&rsquo;s initial public offering for the benefit of
the Company and holders of shares issued in such offering, and hereby waives any Claim it may have in the future as a result of, or arising
out of, any services provided to the Company and will not seek recourse against such trust account for any reason whatsoever. Accordingly,&nbsp;Indemnitee
acknowledges and agrees that any indemnification provided hereto will only be able to be satisfied by the Company if (i)&nbsp;the Company
has sufficient funds outside of the Trust Account to satisfy its obligations hereunder or (ii)&nbsp;the Company consummates a Business
Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">19</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>28.</B></TD><TD><B>MAINTENANCE OF INSURANCE</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company shall use commercially reasonable efforts
to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee under this Agreement,
one or more policies of insurance with reputable insurance companies to provide the officers/directors of the Company with coverage for
losses from wrongful acts and omissions and to ensure the Company&rsquo;s performance of its indemnification obligations under this Agreement.
The Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage
available for any such director or officer under such policy or policies. In all such insurance policies, the Indemnitee shall be named
as an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most favorably insured
of the Company&rsquo;s directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[SIGNATURE PAGE FOLLOWS]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">20</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Indemnity Agreement to be signed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPRING VALLEY ACQUISITION CORP. II</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Christopher Sorrells</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Sorrells</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page&nbsp;to
Indemnity Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEMNITEE</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Christopher Sorrells</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Christopher Sorrells</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Robert Kaplan</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Robert Kaplan</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    David Buzby</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    David Buzby</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Richard Thompson</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Richard Thompson</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Sharon Youngblood</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Sharon Youngblood</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    David Levinson</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    David Levinson</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Kevin Pohler</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Kevin Pohler</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page&nbsp;to
Indemnity Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>11
<FILENAME>tm216731d39_ex10-5.htm
<DESCRIPTION>EXHIBIT 10.5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.5</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><I>Execution
Version</I></B></P>

<P STYLE="margin: 0; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SPRING VALLEY ACQUISITION CORP. II</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2100 McKinney Ave, Suite&nbsp;1675&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dallas, TX 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">October&nbsp;12, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Spring Valley Acquisition Sponsor II, LLC&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2100 McKinney Ave, Suite&nbsp;1675&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dallas, TX 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter will confirm our
agreement that, commencing on the effective date (the &ldquo;<B><I>Effective Date</I></B>&rdquo;) of the registration statement (the &ldquo;<B><I>Registration
Statement</I></B>&rdquo;) for the initial public offering (the &ldquo;<B><I>IPO</I></B>&rdquo;) of the securities of Spring Valley Acquisition
Corp. II (the &ldquo;<B><I>Company</I></B>&rdquo;) and continuing until the earlier of (i)&nbsp;the consummation by the Company of an
initial business combination and (ii)&nbsp;the Company&rsquo;s liquidation (in each case as described in the Registration Statement) (such
earlier date hereinafter referred to as the &ldquo;<B><I>Termination Date</I></B>&rdquo;), Spring Valley Acquisition Sponsor II, LLC (the
 &ldquo;<B><I>Sponsor</I></B>&rdquo;) shall take steps directly or indirectly to make available to the Company certain office space, secretarial
and administrative services as may be required by the Company from time to time, situated at 2100 McKinney Ave, Suite&nbsp;1675, Dallas,
Texas 75201 (or any successor location). In exchange therefore, the Company shall pay Sponsor or one of its affiliates a sum of $10,000
per month on the Effective Date and continuing monthly thereafter until the Termination Date. Sponsor hereby agrees that it does not have
any right, title, interest or claim of any kind (a &ldquo;<B><I>Claim</I></B>&rdquo;) in or to any monies that may be set aside in a trust
account (the &ldquo;<B><I>Trust Account</I></B>&rdquo;) that may be established upon the consummation of the IPO and hereby irrevocably
waives any Claim it may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company
and will not seek recourse against the Trust Account for any reason whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter agreement constitutes
the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings,
agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter
hereof or the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter agreement may
not be amended, modified or waived as to any particular provision, except by a written instrument executed by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties may not assign
this letter agreement and any of their rights, interests, or obligations hereunder without the consent of the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter agreement shall
be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York, without giving effect to
its choice of laws principles that will apply the laws of another jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter agreement may
be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall
constitute one and the same agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be
produced to evidence the existence of this letter agreement. Signatures to this letter agreement transmitted via facsimile or e-mail shall
be valid and effective to bind the party so signing (including any electronic signature covered by the U.S. federal ESIGN Act of 2000,
Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., <U>www.docusign.com</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">Very truly yours,</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>SPRING VALLEY ACQUISITION CORP. II</B></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Robert Kaplan</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right; width: 3%"></TD>
    <TD STYLE="vertical-align: top; width: 5%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P></TD>
    <TD STYLE="vertical-align: top; width: 42%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Robert Kaplan</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.1pt; text-indent: -35.1pt"></P></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"></TD>
    <TD STYLE="vertical-align: top">Title:</TD>
    <TD STYLE="vertical-align: top">Chief Financial Officer and Vice President of Business Development</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Administrative Services
Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 10pt">AGREED TO AND ACCEPTED BY:</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 10pt"><B>SPRING VALLEY ACQUISITION SPONSOR II, LLC</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ David Levinson</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right; width: 3%"></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 42%"><FONT STYLE="font-size: 10pt">David Levinson<BR> </FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Corporate Secretary</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Administrative Services
Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>12
<FILENAME>tm216731d39_ex10-6.htm
<DESCRIPTION>EXHIBIT 10.6
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.6</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><I>Execution Version</I></B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">October&nbsp;12, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Spring Valley Acquisition Corp. II&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2100 McKinney Ave, Suite&nbsp;1675</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dallas, TX 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Re: <U>Initial Public Offering</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This letter (this &ldquo;<B><I>Letter Agreement</I></B>&rdquo;)
is being delivered to you in accordance with the Underwriting Agreement (the &ldquo;<B><I>Underwriting Agreement</I></B>&rdquo;) entered
into by and among Spring Valley Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;), Citigroup
Global Markets Inc. and Guggenheim Securities, LLC, as representatives (the &ldquo;<B><I>Representatives</I></B>&rdquo;) of the several
underwriters (the &ldquo;<B><I>Underwriters</I></B>&rdquo;), relating to an underwritten initial public offering (the &ldquo;<B><I>Public
Offering</I></B>&rdquo;) of 23,000,000 of the Company&rsquo;s units (including 3,000,000 units that may be purchased pursuant to the Underwriters&rsquo;
option to purchase additional units, the &ldquo;<B><I>Units</I></B>&rdquo;), each comprising of one of the Company&rsquo;s Class&nbsp;A
ordinary shares, par value $0.0001 per share (the &ldquo;<B><I>Ordinary Shares</I></B>&rdquo;), one right to receive one-tenth of one
Class&nbsp;A Ordinary Share (each, a &ldquo;<B><I>Right</I></B>&rdquo;), and one-half of one redeemable warrant (each whole warrant, a
 &ldquo;<B><I>Warrant</I></B>&rdquo;). Each Warrant entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per
share, subject to adjustment. The Units will be sold in the Public Offering pursuant to a registration statement on Form&nbsp;S-l and
a prospectus (the &ldquo;<B><I>Prospectus</I></B>&rdquo;) filed by the Company with the U.S. Securities and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;).
Certain capitalized terms used herein are defined in <U>paragraph 1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order to induce the Company and the Underwriters
to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, Spring Valley Acquisition Sponsor II, LLC (the &ldquo;<B><I>Sponsor</I></B>&rdquo;)
and each of the undersigned (each, an &ldquo;<B><I>Insider</I></B>&rdquo; and, collectively, the &ldquo;<B><I>Insiders</I></B>&rdquo;)
hereby agree with the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>1. <U>Definitions</U></B>. As used herein, (i)&nbsp;&ldquo;<B><I>Business
Combination</I></B>&rdquo; shall mean a merger, share exchange, asset acquisition, share purchase, reorganization or similar business
combination with one or more businesses or entities; (ii)&nbsp;&ldquo;<B><I>Founder Shares</I></B>&rdquo; shall mean the 7,666,667 Class&nbsp;B
ordinary shares of the Company, par value $0.0001 per share, outstanding prior to the consummation of the Public Offering; (iii)&nbsp;&ldquo;<B><I>Private
Placement Warrants</I></B>&rdquo; shall mean the warrants to purchase Ordinary Shares of the Company that will be acquired by the Sponsor
for an aggregate purchase price of $12,000,000 (or up to $13,350,000 if the Underwriters&rsquo; exercise their option to purchase additional
units), or $1.00 per Warrant, in a private placement that shall close simultaneously with the consummation of the Public Offering (including
Ordinary Shares issuable upon conversion thereof); (iv)&nbsp;&ldquo;<B><I>Public Shareholders</I></B>&rdquo; shall mean the holders of
Ordinary Shares included in the Units issued in the Public Offering; (v)&nbsp;&ldquo;<B><I>Public Shares</I></B>&rdquo; shall mean the
Ordinary Shares included in the Units issued in the Public Offering; (vi)&nbsp;&ldquo;<B><I>Trust Account</I></B>&rdquo; shall mean the
trust account into which a portion of the net proceeds of the Public Offering and the sale of the Private Placement Warrants shall be
deposited; (vii)&nbsp;&ldquo;<B><I>Transfer</I></B>&rdquo; shall mean the (a)&nbsp;sale of, offer to sell, contract or agreement to sell,
hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment
or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of
Section&nbsp;16 of the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations of the Commission promulgated thereunder
with respect to, any security, (b)&nbsp;entry into any swap or other arrangement that transfers to another, in whole or in part, any of
the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities,
in cash or otherwise, or (c)&nbsp;public announcement of any intention to effect any transaction specified in clause (a)&nbsp;or (b);
and (viii)&nbsp;&ldquo;<B><I>Charter</I></B>&rdquo; shall mean the Company&rsquo;s Amended and Restated Memorandum and Articles of Association,
as the same may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>2. <U>Representations and Warranties</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;The Sponsor and each Insider, with respect
to itself, herself or himself, represent and warrant to the Company that it, she or he has the full right and power, without violating
any agreement to which it, she or he is bound (including, without limitation, any non-competition or non-solicitation agreement with any
employer or former employer), to enter into this Letter Agreement, as applicable, and to serve as an officer of the Company and/or a director
on the Company&rsquo;s Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;), as applicable, and each Insider hereby consents to
being named in the Prospectus, road show and any other materials as an officer and/or director of the Company, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;Each Insider represents and warrants, with
respect to herself or himself, that such Insider&rsquo;s biographical information furnished to the Company (including any such information
included in the Prospectus) is true and accurate in all material respects and does not omit any material information with respect to such
Insider&rsquo;s background. The Insider&rsquo;s questionnaire furnished to the Company is true and accurate in all material respects.
Each Insider represents and warrants that such Insider is not subject to or a respondent in any legal action for, any injunction, cease-and-desist
order or order or stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction;
such Insider has never been convicted of, or pleaded guilty to, any crime (i)&nbsp;involving fraud, (ii)&nbsp;relating to any financial
transaction or handling of funds of another person, or (iii)&nbsp;pertaining to any dealings in any securities and such Insider is not
currently a defendant in any such criminal proceeding; and such Insider has never been suspended or expelled from membership in any securities
or commodities exchange or association or had a securities or commodities license or registration denied, suspended or revoked.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>3. <U>Business Combination Vote</U></B>. It
is acknowledged and agreed that the Company shall not enter into a definitive agreement regarding a proposed Business Combination without
the prior consent of the Sponsor. The Sponsor and each Insider, with respect to itself, herself or himself, agrees that if the Company
seeks shareholder approval of a proposed initial Business Combination, then in connection with such proposed initial Business Combination,
it, she or he, as applicable, shall vote all Founder Shares and any Public Shares held by it, her or him, as applicable, in favor of such
proposed initial Business Combination (including any proposals recommended by the Board in connection with such Business Combination)
and not redeem any Public Shares held by it, her or him, as applicable, in connection with such shareholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>4. <U>Failure to Consummate a Business Combination:
Trust Account Waiver</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;The Sponsor and each Insider hereby agree,
with respect to itself, herself or himself, that in the event that the Company fails to consummate its initial Business Combination within
the time period set forth in the Charter, the Sponsor and each Insider shall take all reasonable steps to cause the Company to (i)&nbsp;cease
all operations except for the purpose of winding up; (ii)&nbsp;as promptly as reasonably possible but not more than 10 business days thereafter,
redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
including interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes (less
up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will
completely extinguish Public Shareholders&rsquo; rights as shareholders (including the right to receive further liquidation distributions,
if any); and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the Company&rsquo;s remaining
shareholders and the Board, liquidate and dissolve, subject in the case of clauses (ii)&nbsp;and (iii)&nbsp;to the Company&rsquo;s obligations
under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. The
Sponsor and each Insider agree not to propose any amendment to the Charter (i)&nbsp;that would modify the substance or timing of the Company&rsquo;s
obligation to provide holders of the Public Shares the right to have their shares redeemed in connection with an initial Business Combination
or to redeem 100% of the Public Shares if the Company does not complete an initial Business Combination within the required time period
set forth in the Charter or (ii)&nbsp;with respect to any other provision relating to the rights of holders of Public Shares unless the
Company provides its Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held
in the Trust Account and not previously released to the Company to pay taxes, if any, divided by the number of then-outstanding Public
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;<FONT STYLE="background-color: white">The
Sponsor and each Insider, with respect to itself, herself or himself, acknowledges that it, she or he has no right, title, interest or
claim of any kind in or to any monies held in the Trust Account or any other asset of the Company as a result of any liquidation of the
Company with respect to the Founder Shares held by it, her or him, if any. The Sponsor and each of the Insiders hereby further waive,
with respect to any Founder Shares</FONT> and Public Shares held by it, her or him, as applicable, any redemption rights it, she or he
may have in connection with the consummation of a Business Combination, including, without limitation, any such rights available in the
context of a shareholder vote to approve such Business Combination or a shareholder vote to approve an amendment to the Charter (i)&nbsp;that
would modify the substance or timing of the Company&rsquo;s obligation to provide holders of the Public Shares the right to have their
shares redeemed in connection with an initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated
an initial Business Combination within the time period set forth in the Charter or (ii)&nbsp;with respect to any other provision relating
to the rights of holders of Public Shares (although the Sponsor and the Insiders shall be entitled to liquidation rights with respect
to any Public Shares they hold if the Company fails to consummate a Business Combination within the required time period set forth in
the Charter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>5. <U>Lock-up: Transfer Restrictions</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;The Sponsor and the Insiders agree that
they shall not Transfer any Founder Shares (the &ldquo;<B><I>Founder Shares Lock-up</I></B>&rdquo;) until the earliest of (A)&nbsp;one
year after the completion of an initial Business Combination and (B)&nbsp;following the completion of an initial Business Combination,
the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the
Company&rsquo;s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property (the &ldquo;<B><I>Founder
Shares Lock-up Period</I></B>&rdquo;). Notwithstanding the foregoing, if, subsequent to a Business Combination, the closing price of the
Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, share consolidations,
reorganizations, recapitalizations and other similar transactions) for any 20 trading days within a 30-trading day period commencing at
least 120 days after the Company&rsquo;s initial Business Combination, the Founder Shares shall be released from the Founder Shares Lock-up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;The Sponsor and Insiders agree that they
shall not effectuate any Transfer of Private Placement Warrants or Ordinary Shares underlying such warrants until 30 days after the completion
of an initial Business Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&nbsp;Notwithstanding the provisions set forth
in <U>paragraphs 5(a)</U>, <U>5(b)</U>&nbsp;and <U>12(b)</U>, Transfers of the Founder Shares, Private Placement Warrants and Ordinary
Shares underlying the Private Placement Warrants are permitted (a)&nbsp;to the Company&rsquo;s officers or directors, any affiliate or
family member of any of the Company&rsquo;s officers or directors, any members or partners of the Sponsor or their affiliates, any affiliates
of the Sponsor, or any employees of such affiliates; (b)&nbsp;in the case of an individual, by gift to a member of one of the individual&rsquo;s
immediate family or to a trust, the beneficiary of which is a member of the individual&rsquo;s immediate family, an affiliate of such
person or to a charitable organization; (c)&nbsp;in the case of an individual, by virtue of laws of descent and distribution upon death
of the individual; (d)&nbsp;in the case of an individual, pursuant to a qualified domestic relations order; (e)&nbsp;by private sales
or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a
Business Combination at prices no greater than the price at which the Founder Shares, Private Placement Warrants or Ordinary Shares, as
applicable, were originally purchased; (f)&nbsp;by virtue of the Sponsor&rsquo;s organizational documents upon liquidation or dissolution
of the Sponsor; (g)&nbsp;to the Company for no value for cancellation in connection with the consummation of an initial Business Combination,
(h)&nbsp;in the event of the Company&rsquo;s liquidation prior to the completion of a Business Combination; or (i)&nbsp;in the event of
completion of a liquidation, merger, share exchange or other similar transaction which results in all of the Company&rsquo;s Public Shareholders
having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the completion of an initial Business
Combination; <U>provided</U>, <U>however</U>, that in the case of clauses (a)&nbsp;through (f)&nbsp;these permitted transferees must enter
into a written agreement agreeing to be bound by these transfer restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&nbsp;During the period commencing on the effective
date of the Underwriting Agreement and ending 180 days after such date, the Sponsor and each Insider shall not, without the prior written
consent of Citigroup Global Markets Inc., Transfer any Units, Ordinary Shares, Warrants, Rights or any other securities convertible into,
or exercisable or exchangeable for, Ordinary Shares held by it, her or him, as applicable, subject to certain exceptions enumerated in
Section&nbsp;6(h)&nbsp;of the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>6. <U>Remedies</U></B>. The Sponsor and each
of the Insiders hereby agree and acknowledge that (i)&nbsp;each of the Underwriters and the Company would be irreparably injured in the
event of a breach by the Sponsor or such Insider of its, her or his obligations, as applicable under <U>paragraphs 3</U>, <U>4</U>, <U>5</U>,
<U>7</U>, <U>10</U>, <U>11</U> and <U>12</U>, (ii)&nbsp;monetary damages may not be an adequate remedy for such breach and (iii)&nbsp;the
non-breaching party shall be entitled to injunctive relief, in addition to any other remedy that such party may have in law or in equity,
in the event of such breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>7. <U>Payments by the Company</U></B>. Except
as disclosed in the Prospectus, neither the Sponsor nor any affiliate of the Sponsor nor any director or officer of the Company nor any
affiliate of the officers shall receive from the Company any finder&rsquo;s fee, reimbursement, consulting fee, monies in respect of any
payment of a loan or other compensation prior to, or in connection with any services rendered in order to effectuate the consummation
of the Company&rsquo;s initial Business Combination (regardless of the type of transaction that it is).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>8. <U>Director and Officer Liability Insurance</U></B>.
The Company will maintain an insurance policy or policies providing directors&rsquo; and officers&rsquo; liability insurance, and the
Insiders shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available
for any of the Company&rsquo;s directors or officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>9. <U>Termination</U></B>. This Letter Agreement
shall terminate on the earlier of (i)&nbsp;the expiration of the Founder Shares Lock-up Period and (ii)&nbsp;the liquidation of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>10. <U>Indemnification</U></B>. In the event
of the liquidation of the Trust Account upon the failure of the Company to consummate its initial Business Combination within the time
period set forth in the Charter, the Sponsor (the &ldquo;<B><I>Indemnitor</I></B>&rdquo;) agrees to indemnify and hold harmless the Company
against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses
reasonably incurred in investigating, preparing or defending against any litigation, whether pending or threatened) to which the Company
may become subject as a result of any claim by (i)&nbsp;any third party for services rendered or products sold to the Company (except
for the Company&rsquo;s independent auditors) or (ii)&nbsp;any prospective target business with which the Company has discussed entering
into a transaction agreement (a &ldquo;<B><I>Target</I></B>&rdquo;); <U>provided</U>, <U>however</U>, that such indemnification of the
Company by the Indemnitor (x)&nbsp;shall apply only to the extent necessary to ensure that such claims by a third party for services rendered
or products sold to the Company or a Target do not reduce the amount of funds in the Trust Account to below the lesser of (i)&nbsp;$10.00
per Public Share and (ii)&nbsp;the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust
Account if less than $10.00 per Public Share due to reductions in the value of the trust assets, in each case net of interest that may
be withdrawn to pay the Company&rsquo;s tax obligations, (y)&nbsp;shall not apply to any claims by a third party or Target who executed
a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) and (z)&nbsp;shall
not apply to any claims under the Company&rsquo;s indemnity of the Underwriters against certain liabilities, including liabilities under
the Securities Act of 1933, as amended. The Indemnitor shall have the right to defend against any such claim with counsel of its choice
reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the Indemnitor, the Indemnitor
notifies the Company in writing that it shall undertake such defense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>11. <U>Forfeiture of Founder Shares</U></B><U>.</U>
To the extent that the Underwriters do not exercise their option to purchase additional Units within 45 days from the date of the Prospectus
in full (as further described in the Prospectus), the Sponsor agrees to automatically surrender to the Company for no consideration, for
cancellation at no cost, an aggregate number of Founder Shares so that the number of Founder Shares will equal 25% of the sum of the total
number of Ordinary Shares and Founder Shares outstanding at such time. The Sponsor and Insiders further agree that to the extent that
the size of the Public Offering is increased or decreased, the Company will effect a share capitalization or a share repurchase, as applicable,
with respect to the Founder Shares immediately prior to the consummation of the Public Offering in such amount as to maintain the number
of Founder Shares at 25% of the sum of the total number of Ordinary Shares and Founder Shares outstanding at such time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>12. <U>Unvested Founder Shares</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;The Sponsor agrees that upon and subject
to the completion of the Business Combination (the &ldquo;Business Combination Closing&rdquo;), 25% of the Founder Shares then held by
the Sponsor shall be considered to be newly unvested shares, which will vest only if the Share Price Level is achieved on or after the
first anniversary of the Business Combination Closing but before the fifth anniversary of the Business Combination Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;The Sponsor agrees that it shall not Transfer
any unvested Founder Shares prior to the date such Founder Shares become vested, except to the extent permitted by paragraph 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;Founder Shares, if any, that remain unvested
at the fifth anniversary of the Business Combination Closing will be forfeited, and shall be transferred by the Sponsor to the Company
without any consideration for such transfer. For the avoidance of doubt, the Founder Shares owned by the individual Insiders other than
the Sponsor shall not be subject to vesting or forfeiture; provided, however, that the Sponsor shall hold a sufficient number of unvested
Founder Shares to comply with the forfeiture provisions of this Letter Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;For purposes of this paragraph 12, the
 &ldquo;Share Price Level&rdquo; will be considered achieved only if the closing price of the Ordinary Shares on the Nasdaq Global Market
(or other exchange or other market where the Ordinary Shares are then traded) equals or exceeds $12.50 for any 20 trading days within
a 30 trading day period on or after the first anniversary of the Business Combination Closing but before the fifth anniversary of the
Business Combination Closing. The Share Price Level will be equitably adjusted on account of any share split, reverse share split or similar
equity restructuring transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;Notwithstanding the foregoing, in the
event the Company enters into a binding agreement on or before the fifth anniversary of the Business Combination Closing with respect
to a Sale (as defined below), all unvested Founder Shares shall vest on the day prior to the closing of such Sale. &ldquo;Sale&rdquo;
shall mean the occurrence of any of the following events (which, for the avoidance of doubt, shall not include the Business Combination):
(a)&nbsp;any person or any group of persons acting together which would constitute a &ldquo;group&rdquo; for purposes of Section&nbsp;13(d)&nbsp;of
the Exchange Act or any successor provisions thereto is or becomes the beneficial owner, directly or indirectly, of securities of the
Company representing more than 50% of the combined voting power of the Company&rsquo;s then outstanding voting securities, (b)&nbsp;there
is consummated a merger or consolidation of the Company with any other corporation or other entity, and, immediately after the consummation
of such merger or consolidation, either (x)&nbsp;the board of directors of the Company immediately prior to the merger or consolidation
does not constitute at least a majority of the board of directors of the company surviving the merger or, if the surviving company is
a subsidiary, the ultimate parent thereof, or (y)&nbsp;the voting securities of the Company immediately prior to such merger or consolidation
do not continue to represent or are not converted into more than 50% of the combined voting power of the then outstanding voting securities
of the person resulting from such merger or consolidation or, if the surviving company is a subsidiary, the ultimate parent thereof, or
(c)&nbsp;the shareholders of the Company approve a plan of complete liquidation or dissolution of the Company or there is consummated
an agreement or series of related agreements for the sale, lease or other disposition, directly or indirectly, by the Company of all or
substantially all of the assets of the Company and its subsidiaries, taken as a whole, other than such sale or other disposition by the
Company of all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to an entity at least 50% of
the combined voting power of the voting securities of which are owned by shareholders of the Company in substantially the same proportions
as their ownership of the Company immediately prior to such sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>13. <U>Entire Agreement</U></B>. This Letter
Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes
all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in
any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified
or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by all
parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>14. <U>Assignment</U></B>. No party hereto may
assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the
other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer
or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Sponsor, each of the Insiders
and each of their respective successors, heirs, personal representatives and assigns and permitted transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>15. <U>Counterparts</U></B>. This Letter Agreement
may be executed in any number of original or facsimile counterparts, and each of such counterparts shall for all purposes be deemed to
be an original, and all such counterparts shall together constitute but one and the same instrument. Signatures to this Agreement transmitted
via facsimile or e-mail shall be valid and effective to bind the party so signing (including any electronic signature covered by the U.S.
federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g.,
<U>www.docusign.com</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>16. <U>Effect of Headings</U></B>. The paragraph
headings herein are for convenience only and are not part of this Letter Agreement and shall not affect the interpretation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>17. <U>Severability</U></B>. This Letter Agreement
shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability
of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision,
the parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid
or unenforceable provision as may be possible and be valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>18. <U>Governing Law</U></B>. This Letter Agreement
shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflicts
of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i)&nbsp;all
agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought
and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and venue, which jurisdiction
and venue shall be exclusive, and (ii)&nbsp;waive any objection to such exclusive jurisdiction and venue or that such courts represent
an inconvenient forum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>19. <U>Notices</U></B>. Any notice, consent
or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent
by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or facsimile or other
electronic transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>20. </B>Each party hereto shall not be liable
for any breaches or misrepresentations contained in this Letter Agreement by any other party to this Letter Agreement (including, for
the avoidance of doubt, any Insider with respect to any other Insider), and no party shall be liable or responsible for the obligations
of another party, including, without limitation, indemnification obligations and notice obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SPRING VALLEY ACQUISITION SPONSOR II, LLC</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 45%; font-size: 10pt">/s/ David Levinson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt">David Levinson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Corporate Secretary</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">/s/ Christopher Sorrells</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Christopher Sorrells</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">/s/ Robert Kaplan</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Robert Kaplan</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">/s/ David Levinson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">David Levinson</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">/s/ Kevin Pohler</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Kevin Pohler</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">/s/ David Buzby</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">David Buzby</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">/s/ Richard Thompson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Richard Thompson</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid">/s/ Sharon Youngblood</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Sharon Youngblood</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt">Acknowledged and Agreed:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SPRING VALLEY ACQUISITION CORP. II</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font-size: 10pt">/s/ Christopher Sorrells</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%">Name:</TD>
    <TD STYLE="font-size: 10pt; width: 42%">Christopher Sorrells</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Insider Letter Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>svii-20221012.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaaJabOdzZR+eYkxtmB6bYkabyIt1XT17iceIdQmUZ4F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:SVII="http://sv-ac.com/20221012" elementFormDefault="qualified" targetNamespace="http://sv-ac.com/20221012">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://sv-ac.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="svii-20221012_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="svii-20221012_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="svii-20221012_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" name="UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" name="Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" name="RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>svii-20221012_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sv-ac.com/role/Cover" xlink:href="svii-20221012.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sv-ac.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" xlink:label="loc_SVIIUnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SVIIUnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" xlink:label="loc_SVIIRightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SVIIRightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" xlink:label="loc_SVIIRedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SVIIRedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>svii-20221012_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" xlink:label="SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" xlink:to="SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_lbl" xml:lang="en-US">Units, each consisting of one Class A ordinary share, $0.0001 par value, one right and one-half of one redeemable public warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" xlink:label="SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" xlink:to="SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_lbl" xml:lang="en-US">Rights included as part of the units to acquire one-tenth (1/10) of one share of Class A ordinary share [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" xlink:label="SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" xlink:to="SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_lbl" xml:lang="en-US">Redeemable public warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" xlink:to="SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember_doc" xml:lang="en-US">Units, each consisting of one Class A ordinary share, $0.0001 par value, one right and one-half of one redeemable public warrant</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" xlink:to="SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember_doc" xml:lang="en-US">Rights included as part of the units to acquire one-tenth (1/10) of one share of Class A ordinary share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" xlink:to="SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member_doc" xml:lang="en-US">Redeemable public warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>svii-20221012_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sv-ac.com/role/Cover" xlink:href="svii-20221012.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sv-ac.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiDocumentInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" xlink:label="loc_SVIIUnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SVIIUnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" xlink:label="loc_SVIIRightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SVIIRightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="svii-20221012.xsd#SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" xlink:label="loc_SVIIRedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SVIIRedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140627403264016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 12, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 12,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SPRING VALLEY
ACQUISITION CORP. II<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001843477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1579063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2100 McKinney Ave.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">308-5230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember', window );">Units, each consisting of one Class A ordinary share, $0.0001 par value, one right and one-half of one redeemable public warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Units, each consisting of one Class A ordinary share,
    $0.0001 par value, one right and one-half of one redeemable public warrant<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SVIIU<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A ordinary shares, par value $0.0001 per
    share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SVII<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember', window );">Rights included as part of the units to acquire one-tenth (1/10) of one share of Class A ordinary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Rights included as part of the units to acquire one-tenth
    (1/10) of one share of Class A ordinary share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SVIIR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member', window );">Redeemable public warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable
    public warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SVIIW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tm216731d39_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:SVII="http://sv-ac.com/20221012"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="svii-20221012.xsd" xlink:type="simple"/>
    <context id="From2022-10-12to2022-10-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843477</identifier>
        </entity>
        <period>
            <startDate>2022-10-12</startDate>
            <endDate>2022-10-12</endDate>
        </period>
    </context>
    <context id="From2022-10-122022-10-12_custom_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SVII:UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-12</startDate>
            <endDate>2022-10-12</endDate>
        </period>
    </context>
    <context id="From2022-10-122022-10-12_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-12</startDate>
            <endDate>2022-10-12</endDate>
        </period>
    </context>
    <context id="From2022-10-122022-10-12_custom_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SVII:Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-12</startDate>
            <endDate>2022-10-12</endDate>
        </period>
    </context>
    <context id="From2022-10-122022-10-12_custom_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001843477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SVII:RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-12</startDate>
            <endDate>2022-10-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-10-12to2022-10-12">0001843477</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-10-12to2022-10-12">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-10-12to2022-10-12">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2022-10-12to2022-10-12">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-10-12to2022-10-12">2022-10-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-10-12to2022-10-12">SPRING VALLEY ACQUISITION CORP. II</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-10-12to2022-10-12">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-10-12to2022-10-12">001-41529</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-10-12to2022-10-12">98-1579063</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-10-12to2022-10-12">2100 McKinney Ave.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-10-12to2022-10-12">Suite 1675</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-10-12to2022-10-12">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-10-12to2022-10-12">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-10-12to2022-10-12">75201</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-10-12to2022-10-12">214</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-10-12to2022-10-12">308-5230</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-10-12to2022-10-12">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-10-12to2022-10-12">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-10-12to2022-10-12">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-10-12to2022-10-12">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-10-122022-10-12_custom_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember">Units, each consisting of one Class A ordinary share,     $0.0001 par value, one right and one-half of one redeemable public warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-10-122022-10-12_custom_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember">SVIIU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-10-122022-10-12_custom_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-10-122022-10-12_us-gaap_CommonClassAMember">Class A ordinary shares, par value $0.0001 per     share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-10-122022-10-12_us-gaap_CommonClassAMember">SVII</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-10-122022-10-12_us-gaap_CommonClassAMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-10-122022-10-12_custom_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember">Rights included as part of the units to acquire one-tenth     (1/10) of one share of Class A ordinary share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-10-122022-10-12_custom_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember">SVIIR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-10-122022-10-12_custom_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-10-122022-10-12_custom_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member">Redeemable     public warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-10-122022-10-12_custom_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member">SVIIW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-10-122022-10-12_custom_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-10-12to2022-10-12">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-10-12to2022-10-12">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>19
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MCU?HON+-&*:'0WXM^E=H(;DBU^-Q=?QJ]&K)'NT \ K]'[)(ZP+(:@%QV5I
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #2(455 6TV'[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #2(
M45697)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ -(A15;2%+<Q>!@  X!\  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #2(
M456?H!OPL0(  .(,   -              "  :$.  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ -(A159>*NQS     $P(   L              ( !?1$
M %]R96QS+RYR96QS4$L! A0#%     @ -(A15:K$(A8S 0  (@(   \
M         ( !9A(  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #2(454D
M'INBK0   /@!   :              "  <83  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( #2(455ED'F2&0$  ,\#   3
M      "  :L4  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
' /45      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>5</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm216731d39_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sv-ac.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm216731d39_8k.htm">tm216731d39_8k.htm</File>
    <File>svii-20221012.xsd</File>
    <File>svii-20221012_def.xml</File>
    <File>svii-20221012_lab.xml</File>
    <File>svii-20221012_pre.xml</File>
    <File>tm216731d39_ex1-1.htm</File>
    <File>tm216731d39_ex10-1.htm</File>
    <File>tm216731d39_ex10-2.htm</File>
    <File>tm216731d39_ex10-3.htm</File>
    <File>tm216731d39_ex10-4.htm</File>
    <File>tm216731d39_ex10-5.htm</File>
    <File>tm216731d39_ex10-6.htm</File>
    <File>tm216731d39_ex3-1.htm</File>
    <File>tm216731d39_ex4-1.htm</File>
    <File>tm216731d39_ex4-2.htm</File>
    <File>tm216731d39_ex4-3.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="34">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>24
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm216731d39_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 5,
   "dts": {
    "definitionLink": {
     "local": [
      "svii-20221012_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tm216731d39_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "svii-20221012_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "svii-20221012_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "svii-20221012.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 67,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 25,
   "memberCustom": 3,
   "memberStandard": 1,
   "nsprefix": "SVII",
   "nsuri": "http://sv-ac.com/20221012",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm216731d39_8k.htm",
      "contextRef": "From2022-10-12to2022-10-12",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://sv-ac.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm216731d39_8k.htm",
      "contextRef": "From2022-10-12to2022-10-12",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 4,
   "tag": {
    "SVII_RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable public warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50",
        "label": "Redeemable public warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]"
       }
      }
     },
     "localname": "RedeemablepublicwarrantsincludedaspartoftheunitseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar11.50Member",
     "nsuri": "http://sv-ac.com/20221012",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "SVII_Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights included as part of the units to acquire one-tenth (1/10) of one share of Class A ordinary share",
        "label": "Rights included as part of the units to acquire one-tenth (1/10) of one share of Class A ordinary share [Member]"
       }
      }
     },
     "localname": "Rightsincludedaspartoftheunitstoacquireonetenth110ofoneshareofClassAordinaryshareMember",
     "nsuri": "http://sv-ac.com/20221012",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "SVII_UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Units, each consisting of one Class A ordinary share, $0.0001 par value, one right and one-half of one redeemable public warrant",
        "label": "Units, each consisting of one Class A ordinary share, $0.0001 par value, one right and one-half of one redeemable public warrant [Member]"
       }
      }
     },
     "localname": "UnitseachconsistingofoneClassAordinarysharedollar00001parvalueonerightandonehalfofoneredeemablepublicwarrantMember",
     "nsuri": "http://sv-ac.com/20221012",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://sv-ac.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>25
<FILENAME>0001104659-22-109375-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-109375-xbrl.zip
M4$L#!!0    ( #2(456V3@R96P0  )01   1    <W9I:2TR,#(R,3 Q,BYX
M<V3-5]]3VS@0?KZ;N?_!Y]>.XS@4>J2A'0Z&3CKAVN/745XZLKQ.-,B2D>0D
MW%_?E6PG(3$AH65:/\G2]WW:7:U64N_]-./>&)1F4ASX4:OM>R"H3)@8'OB7
MY\'A^5&_[WOOW_WQNX=?[\\@\$X8\*3K'4L:]$4JWWK_D RZW@<0H(B1ZJUW
M17AA>^0)XZ"\(YGE' S@0#E3U]MM17O$"X(-=*] )%)=GO5GNB-C<MT-P\ED
MTA)R3"92W>H6E=EF@N>&F$+/U-K3=O5M1C]EFL[(K\CA[N3-](Q=#T'\50S(
MS@W]CY"/)/Z4_']S]@J^W$Y-]O=>_.66Q/=]$UU?1&\8A7[R;W9Y\_JDG+*G
MZ0@RXN%B"'W@6_\J]R8[+:F&8:?=CL+KT\&YP_DEL#OE3-PVP:/]_?W0C=;0
M%>0T5KR6W@GM<$PTS)1QE*W!,Z$-$?0!/C$SPB)X-RP''T!9(W2OA+(:FL 2
M3@-M#>4XQ '$=Z*[US6TT,&0D'P&3XF.G6PUX.!!.PIVHIJBE5F%8V<S-##W
M.>A&0CG40$N,6J(]B"0.AW;8,MN6V9DQSZ_Z_1E)CP-";7I;8"=J1QW<I!PR
M$.9$JNP84E)P].6N()RE#!+?,T0-P=A\U3FAL$ZJSG@BA,2-@;NSZK%]><XP
M\['CMYY-D:Z2'"[09,\V<$LV"-N1\$AB3?$]EASX9=-*H* 322!E@KF9JHT7
M>8'=9H5U"9N.T@N7P0L2A8;DDWCGVKD"C3QG^@ [*F(%>81$":<%WXXS-Z61
M4G74(9H'K=Y<9Y!Z;E-V[:H?^)K9LNA7?2,%*?:-&0OJM?F*KK4P(6J(E5ZS
M*5WDEZ-135Q+$$575%:*!HK(')1AF-4+E:$TG1E+_[PPC6?GT;X7_@B7.8FW
M=1DIP%_0UX'5_Z%.8B9MZ^3#Y'LA3X]GDRRZ6Q6#<%X-JO_EBM%#QZ4RGEBI
M.^M.D/+L&TCJI-90[%]0\P+;%40=++>MJ4[FEFYCQ#P,VQE1\YYAQ*/G6),%
M^G&";09E<].IUYZ):Z=O9(; C:Y[@KG6<\Q9/4&_PQXG]@R#GCZ<'S/J*:;[
MU\]*$2H+8=2]\W##)%FDU#\N'%NOS/)M:+-%J5GE@M@+TG<D1_/]ZKF&/)$:
MU:W*W5OL%>SK)59##82.J!2::8//(IE* 4><:'TH%;Z3B+K7(Z(@D9P3Y6XS
M.5%C^SQ H&+#$=:K!)LCPE-'1BR@]3&'O(@YHQ.B%!'F%++87IIL,/#M]1-F
M)K$VBE"\2AI58%$4#(5C>S"4_^Y5T,4SA,GDPAUU2:'<"N"-L_RO;[S=1&:$
MB;Z!S")QQ0H49Z:PZ ]*%GA5+^480M8MP9GU0S-!>9% 0C!-E)&I&4%A(V0D
MH7<%4]9C@[Q1%+6=JRXR,FT(U\,XOYC\KQG,Y@1XU'^;@),17BTJ($Q!4::M
M0"I5<SH2S+H*![G"MZY,RPR-HM9N>RGZOXP]/WFY>F%9TK#Y#5!+ P04
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MW;][TPWQ+44):KGOGF6X.>ZFP9T^:_U- F-Q_]XQW".S:9M<*,K/D@0T"_)
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MVCG,L2&%_>-@]#V&T:^'X3#'AA2>'@?CU&,8I_4P'&;:)85#_?%:W/$UL)X
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M U=]IB7*37?CQMMQ%+NC:1)[+2?=[DL&(B$)8PA0 5 ?_WX!?BB22(#7J3U
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MZLX>W=,P0'.H92&4ZD]6I<6Y-_T&3=WEH_ZT^L3\,'_02+_S?U!+ P04
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M<2#=467CALIVQ=3V9)?>\L>U1F9XK&<>C\]^_)@#1#%[VSB]O>!C_'>/=@$
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MEF$08+Q>EQP8E@*F@6?2'%(UU11K<=!K 9.VJ=X)*6K0/K5:>0U9Q:; 0 [
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M"[U^_(V*!.JARDB^6\,.H/&L]L3[1Y:7XEY (FX="-Z1@ELV6L\8$57NL0J
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MFLUPB+C/HE=+$'MYC:,JRAK6./H)1L.__?;@OV <(-%E12J4\5&R!*F-[YV
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MG3"A>Z3EG)[C7V8*._+@"L0HGD;X=UGA:A13UL3AW>U[T5E=J95AZZATIEV
MZG>^T*]^R<"7F?3I[Q<12!N0BQ?9!$.-?_R()LH?/YX7E^B#T <LBV$W54M<
M5_%1^E8;O21S6O3[.6@O5&AP2G23@M5>%7QS.@Y)N,V' _R-O9XV+<BZ,Y@]
MF%.P E'.)\YF0 NCF)+@6.+E;&.SAL0%4?G:-8DB8F6&=&?/BQ*.SW0Y@^'I
M+G>*?!_/"AS4>8K:"?Y3GN%!9 LQ%1D/TU%5H*<2[U'J)7H^8UBPHCQ+\NR?
M;CVK#&Q?V"I.G8_MQB7%@H<:KL0ANLM2DB,D'S)2\1?%[$*/F1R.&P].WHT7
M\6_^5O_7P4'T4Y;.)M]'[Y.S] 5<_X\E2!(<071P(#B$'UZ__9\PC\V1G..3
MCE#.<_QL1!K%??82E/ZGZ!@>7A6S; (#:.?%[?N^AQ'",SL>/RK3Y-/!* 4#
M#,:XH#';(3WO&!$.<]M'FHGY.\X,3\:_[))?)Z[ST5B!<-C(VTA+4EH<#'B;
M@S%,6BWZ-<EADNB?'TNT,8Q02T&ZD[^'JD_D-,EL%CI-^ZWQ^S >@L<7+3<X
MICG:X[/H0UW UOI(* 5-C?XMF2]>R$!</,)8B!\^-J(L8.;CQ6G+/?K('X>7
M9V@%CJH:)"THEMD5JR%R"<!.1V%;18*-X?$<'QT>J_#_'8S$JA;KY@-X%"U%
M[]P3JS<NSS$5X:QPIUHWM;'Y!RCW<1SX7]2UO5:]FF43\#$J\AWP\G,X#_CV
M"4\72.8QV,8M3YLF;3@XY6\#*QRC9GCQ*,WA9>M6Y* 9>G*^A.A,LL!8:77Y
M#0]$0'^%T[K"Z-CR?/;=J'U0T0-!?4^.A0T8\+=P#.GH230C @&"PVF>KFC-
MX7IZ^'3UV?('B0;")PD>SIL<S*W6(' ,8*?F*9EBWAE%)P4=:#0[_)/BJ!;I
M$QO;Q5N2[+:H*>;,5IV,A[5G@ZS/M7:Q=<RKJ+F+1<)MOXW#+>E,\5Z)"<:\
M>F^7NFW)X!;36AQ6N4_3>TH9&XB.]'0*GF))UN4D _>Z+C"B3K$-\#@J^!@C
M6.@83C'* Z.IG-M_P<!"PEM<%N4G%,WC9)&AXIL5L.E@-).T,8A6B$]^^$I^
MJ&_8"H]L\+[#06-H.--F)!T'!_9 FD\:#BNNCR@CYQ"F-F0WMJ'3\'W>X UY
M6KI>);YAZ?)LG>8FU6L%9-\>-:.,*/-2%V<INEY>PO1+Z<ZPK;^@&2MOVPZW
M*/$"@:=@H55GC;5#SSYU-H!;^(<F.S=SR$Y>2"ZL^A[O^X'7Z@4F7I?X]>WX
M:VT0:"N/M&FZW[RKOB58[5<+N,UIF8RR\8OHMV2>\DS\5N#[G02.F?X*O]DY
MC?\29JB)YW\ .3PN,Y881M*ATIZ($O\_2;Y,RBM^OY/G<71R='+<5 AK[]F0
MC23=>E$+3BTC;.&77UYA5.YU.DLN,? TR^;D#8&>'H&RKJ_ZX MRDP9\P0ME
M& 5)96L':%1KTDK[/XN_><:Y=HI_-9/MSNPP2=J7C21MU9.6'0XD;(VN6?!<
MET7TL>Z39S2(;94H^+_?K-:BA\/!VSSZ-8$GREH?G9S$@57#]AUE:#@(*(:0
MAOZ:YAV:5*OF U_H./[N^'G\_/DW\AE9YFPM:GPU,-0N\ZJU-M_ [^T]KK,V
MS=WS4T'XE>&@G0<_C/X@,,:Q@U_(Q9*E)8B$24' LDS3K%Z6Y,R+)29Q=3+-
MC(G0]+YE[*#!P=H[P&0F1WL$*I)5/L#,&>/NH9B-HL%9V0R-#'/4F4<F&R-=
M@/?6E3KI\_G$XJ"<R.NLPJP5SL%[4&PHF5>D+7V8^H&8%U\EG- ?:GJO<N,+
M8@R]=Q\.VK?OL/[-J=W>Y@=Q]61-2*'+P+:2(L&Q30(L1E-N')^X$^P<+@0S
M,-;J^$G\Y%GCVXSG+3R,<#C;IQ%?&5,O^Y+]O0S2GY3MWBC_N0& 1)8*UJ6U
M5FW W+\?@]ZA7&GO"K,@6;&]5@F5,+*R6IQT)F*O*4UVHF,+T1',,<Z<">IJ
M2K_''%PC-E;=>3AHWGJUV'!K6I"'#K83&9@UHT:O)51.W Y=%Z@,A8J-AYWA
MSDY]K,:ZY8Q[(T"'VD%]KK</G7B<94,7DR:?76G@9IWW'JK^>+4WWQ'"B5&\
M/9P<Z]<X.+.T1OQ&LM'9N-8._;9+[8$5&@2[S(%["XN(B_X+C6R# T7:J,=
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MQI&0>G8OML9 6?F[-F"--EGJERGG*R%(X66$=-1W6/8-/<0@,G%=Q@=)-"7
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MC;?A3]BE@%_!9[#QZF695TU_A^[L_ ]MTUXW&K.SN>M;:9)U=HF$B4&;=IL
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MV7X5!Q%()SA)%QZWB \7(]V  31^HSP1*R?1>G"MZ[L$<^/]&0TY3K.%(^O
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M9,S;R&S"4?_OWK%\X1FE6A4Y$DX2B@12_X+AF$VNJ1/W# X<QC[=H!UD.Z.
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MMSER]Y31+R!@]6@:L L]JO$B24A1Z:7\% ./M%/=6%WG2(GNXZN$OLAS-Y2
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MR4Q@2&/*XG<YR7@?CI(9H;BK\S2M.R)G^DG =%+[(K ?_OCQ%&\&SWLIM_J
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MQ4*PU<C9QIW&C-_DW4>EFZ F=I^>%Y?I15K2A[QV>Y\M2KUK9HACQ4T!7^R
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MB=;"<,#V[(W/Q.&0UJC,=990AX;LI ) 7<*-TO;8N*'"\PQ-FX4[2IC[@!=
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MW1V#:DV).G=D2Z$_LZ H/=EQV.F!J>?-\TR>^X'H\%N4G[/9/<*QO!;6E.$
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M@[A 8I*HF\\V^AT9_FIH]1E3#2^>6*KAQ3K5L$*6Y0()9JEVK8@Z(4N[<XQ
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M<,Q?P1>QE[(2FD=JT[G#[4DH;#;@2!4 HKJX9&DL]JR1A4["PH)FBK[IEF*
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ML)27W)H%];^WU5.N:1WX?]ML>1L^X8@T#;(92G@9\T2WTG_/#):S<'K$7F7
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MO+TB:N7!8S#[BXW!, 9M<^/$PLZ]97(C;\:RGB@1;D=<_K:Y%C<<=DZ(F,]
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MMNJ_'. OS$U =('&T \5 E>&>!V!(?:5P;.Y4P(N@T+I<!2H@= PZ$N%_N/
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M\G:[U2./B_2^1O$T5/Y0TQ^Y$0N+4((>Z#@/$06 5B X_=H\J=?(6A$, JB
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M0YGX.J)(P7XG'>T.5#I76(<]:7"B;)I$\XC)TM"!9BB4-OBW9*8&Y&,<!DV
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MB'% '@(-U3>1+3#OYHYTZH8B= (C(KXS% +QJHVQ$-N%5FCB,7SGUE$-RL
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MS WO-:W?PWG=-JQ5^7WR6S]X_;BSOX-Y718??M,P;HW"/H^"3#6058-BO=#
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MO(QNR:R]I"(\U356S6Z]$.G15+E>!9Z2'(E[Z>Z[+$CXKDDL"L_BRPT^826
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MM)L.5$6'Y6/#5[6?3/)L&D] L<![S+XV%H%ZG;38,$,V[1?Q08QL5F,5E8!
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MMV>M0ZZ1JC3]K]JP_K<&%('S[%PLE26??-L.N>#IND+HPHP9=!6W!8:-1HP
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M8?TH@A#-J5<6?P[.&99SLGW?=A_J59GKJL!:[TEPD^2IP(4,^S7<*$R<Z+"
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ME:AVDJGN]>@9O0MP]&!BKHHHJ[I>3916JF^Z$G;=G]-TCQ3]SG<PWT9VYY,
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M+R0',ZMDKUC>([4::Z^>*DJOYN)W,#L!>7+*4P3*TJ)K=.\1[/NMS'0>:5:
M<+62:D- \65&"#)/34L@X](RCH"N9 X6VB F\U9]G0#W8DHL/$NJW6,6&4$_
M0.X&=!I57#E20?^RO1< <J8(,4P2B+:,"TI(D&#@%6VN])=XDL(S^"^E^5+F
M2:XQ5NA6%QZY-V:V"6H5#P+4/KR%&9*80@%<\2#2LC N69>20SD&!>Q>3%DP
M!#=:3(WOM"#!"HO<9PYUU6*2[S8W+E)QG*&XJ=A%V<3\H#))2%RJ#&T1,E&)
M!CK7?H;")'H<8,YU(Z:YN=&$CA65U6S+FWJ?&&4BU[_BK"=B6T[NULRB)F?*
M\RHXEXE*8#:ADIROXMG?F-&#^!>%.6+BFKDZD,F7K)P4(;FG\C2^PU2)0 PS
M6<*LS*CNU(,DVS13:78K$Q=;'R,/P*3+L9>D8:2' ( ,7 =\.ID YC49W@!5
M/$B"7$C<BW^'@+PU)HO9[!V+NA(2,K8Y9,*"IHDYYZ&>Q+!<H)44=6[S0=A\
M1;=*&BH5<?2 WP5FS#8W8)2O=\2G">4#F?!SVV_!WJL)B$!<"@^D!9Z18;:B
M;50P$?E[',Q3S@SU*DJ8201-X36#"IP)HC,SZBE$N3:B99FVY@VB>R<XV/%J
M94>#M[]%= 2/S'IH8C?WIDT6,Y =B=DES,Y/H; #'9;Q$*B.4^2&=!G!1*SK
M[COH K4QK *H8R(AQ([FA<+\W@Q2 C1 %RO!0Z1L^J.3\L26-)XZH/XA2(R"
MNTXSH[29H0<DWDT#9B!!I>M)LP/3W^G<,$@@M@95PY:M)&SH4&*K!'O@H= \
M5'5&_G[HSLI;W.Y8*PS;<6([']N %XH ( %LPJTB+U@2EN-!1JM'>]+E_.3S
M$*&<:(S 5G#$#B=J#4>*.YW&=C0!OK.EW%.4%"LH@U/6$Z!PUB1Z0!##PL@X
M,*"1&LJ,U);.!0N78)?(L8Q9FV$LC5&+4@\N85(G[)D5CWAHI\P*FD(TUHFQ
M2I%*4LS8 Z9)QAQG'J01-8^^D_"A%40=*]0G8 *Q-L$\O#!FNPD6)P50UZ'Y
MQ!;*]1H$)&>FH4<4]56XQ!Y5<,X#HG,U(ZWC-8V74H\-[ 3%$2!H1C("C0A*
MDK> Z/2VC.U:M<WXS0V0$T;Y!K9=6:D&BB(& )RC6^9%6GY,)NQT"OB-J:^A
MFMA(P8/9HMSF2L-:#@N#[2/*=3.KPY!_J"+2K.B&QC,HEKS1D$-EOL(Z8;'@
M[OY+<'<=@[O.^;XDX^%&%YC" \Q5'51BN^%)8&%=.[;A(3=""J+NS)MR6,Q&
M9E!2@:@<@/$;^.J?QHO [[$X@!3SP,1_3'8U^@M07N4E.A P* KR6AHDFH"%
M3H8Q=N="9#9,WD0G\W#0O.&;K)3IX_<\_V2.H6,JNP.IA^+0CN9I-M5)SL?N
MZK03@%,WM?*X50<RR%]3.*I=."D(E+JN<.E<<J'PW:Q=&U*".\+$6,F,4H%Q
M!Q ;(1:+I1XSNO204&X1U!>-2?(,.HJ13*H4.1?V1425:>,DP05G/44+ZYQ4
M!K;8=3=G")P[Q2;K5QERW<W752!!\2X=Z-+M;&OUR=91'V8$C"<I+GU4NDBI
M]?HXH+&NB<NGRQ+(/WE@$7-?";<:D7R1HL=FK(L.0$M8R@>]%A_7T6LG>*T!
MU,J%IROP1 *Y*YBWB&=IKK68,C77,HS;+Q%Z-#PSU8/()+]VY-1;%CE=.SB^
MN7$J_LD>ZY N&)I2VHBA:K$3DTY$!]A".J7DC@@QQ:"*JYUN"RK);0\_!M71
M1]SA@4H4GD-"LO;BBB0+]G?_BH^ Z:-LTVE9.*]\)8<".C^!+O%,<XT),&)U
M;OSG=/#WCOP/6""B'"MR_M>,K&MGK+S=_<%9F*AAJZ42IU-/?:\P9;4C?0<K
M$.GS1?SQH9@7Z[,D.#?2UTRYJW! URFFCI2\.L!8+ 3H[.U% H!$YE,B@.(E
M -B659>>7YW)Z=I&F^R!MN*A"FI4FS<E1/5D<2D3S/!I<(7EP$J%G]9FF9;K
M2M=8_:,SR"47"G%Y<FM.>&-NC NAW#,$N<3",2Z7N;.,()>@&->Z4>'_643'
MRV2=&M-9,%12<P UF]_<B%*5N[ (*\HJ+M)2E8\+C'1/1HE6H,1DT3U[I$1T
M!DHV-URDI)UO7%'TTP1)YL5'B%*6'R 1"\9'*F=/:V5\204-1"DL*"&X.4$1
M\:B82!T/-"(DP5-$2"IRG1TBX=,"]#O5(5LD7M+=]N,B)F)FP 30[MI$3)[9
MQWX&>I7K+:&163,97C!233G5R%1B!<5L@9.?$IVICW3XSW"[H^N7I!\WM16F
M<<PQ__B!7YM2X*V5T$R^=_1EW"?V!'+ %QU%H(!#+RD\E)C( ZI!KDH%<ES=
MH^0#HS+*6:ZRQI,,_AH>.9:TID@B9U-@_2GT] [,86KFX14FN<6BF0<OT<QU
MC&8N!]YVB(ZDSJ/ ?&1TD+& K)=F#6:E4I48\T&,B$T X+.EF'R7X1X T:T#
MYS44;:<AA^KJ7L.N Z#HR.23ET_OS!1UM^\:.C.G$,YR*8?6B;S..;GFFDN&
MV4H#Q4>?AV1ZNIPN )$@/2+VF@LZFV(,(M0H$Q6BV[W*.<JK [^-0RR,O1C
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M[W=C;V@74&^S<*2$<7N!3_JY0A;3R]@S<3:A))T.,BE?Z"7E1AWP13\$BOF
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M<;"P\=%"*VMF?:P$7FU6?UYQQ%JGHA?PNMC6NZ*YS?(14W1X.C#[9K&9225
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M6459$96P0%4T2>;)!%87AM06N:KK"#Z&_0#OFE?E>9;"DEYDS5D$N^@_;=)
M1^#S!MK$#=&<565[>@;-U6V5%!.%;>LGHXR7#-Y*_8F2TP0>;.#SLDJS A^I
MLOHC;<U)GF2SFO9A,I'>R^/0H1ET"#8A[,JR;?!Q^"RK-C=P!F!,.!GZF^<\
M&'C=6)TE^12?KMO)F3<S-[?"=[1E\'"]*9,JQ>'MZ366F8GDI&UN] \A?:E[
M@F"CP4Z!O5?-L@(6O#E+FICV2)7"'L'9;9H*9I=FN5(-+$P$:YS#VL+CT%>8
M]A1^AS$Y[X>-D^?X510-FQO0S R^2%_&W8#_/2UQ4<=)G<%7$]@:31W59:Y
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M@]C9"CX ZSMKR">+?Z%OG*O<C,5^ 63F.1.@G8,8Q!0TC88"&W\*#7#6O*1
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M'?F&(2<B6B+4*5QW^#S[E3LN\6T- J'/G;[('<<5OQ*Z8TGR$0X%Y1]E1@D
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M*;$;Z*-;*=3XJOQE\]=TK:W?&*SO>0_6=SS<_7 T.OGC-H%\7]K@RX@NJ(S
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MJGG&1-C40M42E>"0Z?>ZF#3R-@=K&H8SM?HU39\MKFD:&Y:"*_W]W4PVEPZ
M?<ZVU,*E8/0PE96T!@P..[DI3@#"$FT3F853"*O##LGTD_W*H&&[4I?+*@LD
M/F -? \VQ072W.R24QV[Z"1WL&RC"J74DZE*"?+!'GAIXD-!A)^TV+3T RR\
M/DET-J]YV$U#;(NFNG22.G21!Z(#'\\R SVT7,^NC]^D%7?ZCW:MU'BNM=LQ
M,3RF7S:1+VT2!WD>A?B$D)%"V,$'@##'T"@8Y:W/;QGL2G E)&LD=5\8.U%Z
M8OPLHSE6B(V$6 -I6IFEG8C>[5Y:_&Z])<*[ :%$=(DYCR&SX Q:F!N"U+*
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M*-OB=)R79?J-+?XM]O\[7'V6F/OJ/"N^O7-_6YW_#M?]7SAIT?OR+/<=.M_
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M$HS;9_TN.^_V^Z-A^[QW>?&N5"^9ZV&[T\FN'ZUT*=UX3DOK+]91=,!J'FD
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M6;>B7>( @3OT?1P3O?;^^O1[\A!$,)4$D9;ED:(&8X=;PJ] 9M8I#3L4OQ;
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M"Z(0/Z DG)DY?^=\UM20=>F)==* _J9"2XX$/^))$2:3&N05.R6Q@45^98<
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MG&'3;H$V'KI=PE@@TLD%_!! >\-%1OL[_%TFAD8&0+8Q913\&<8G 3YJ]EK
M@SIA*[- 8S%"UIK6)JU6SAR)"P27SOEHLF6>+G$ ,/ Z&06NNV;8<J4F)HLR
M +$IVND>@^/F 6JE,HE)G;%%+I8*>GI*I"O"<8_!%QS4")I/=(1MN+F7S4!*
MSW(/!_!$@5D#*Q3D>@(0.O)+36_@= V&'\590*Z*3GLM6I8U\"/!<;1^/R[
M%+?0?*[G8[&>.N,DTQ@4X3Q/>-S6&4O,Z"T )AGLAW".K5=!(.N,3?E&; MX
MV:#=VAABH9?Y!YW<'^GM4>)30HG6ZZT"I[?Z-:^T=Y^?590F$<9)6*@@&$C$
M4@X$#QMP*!0"%!%QB,Q@U"* ).@A+5A,(Y^@3R11O6,2",06-CN017D[[P/#
M01::FV%#=0,TI(&*U#,-]0TB0>L/)7NW)4H+VKS(E\#Q[)NQT[&)!GW3HO!-
M1C8T"'3VJO (:9=LU@8L3P@A.^"'%V0)BTK"OQD+<&"FX;>$9E)R,V#+,Q:]
M0)5.TRAPHR6#&]9F&PVYK9_Y)810@)5@+_+^$L<ZP\!U).IK7D)NR((<K/]#
M$^SMMF_=[Z,4^)ZDP(^12>N"/!\GUJ,/S-)+W.?#0<.S#$8E.J+^DPU*%09.
M1QUOX[4BA&4'@TS0<\ZU& C,"5"?/'RQISVY_:_;0>R997%(7BO0ZR9/T$6(
MZ*J:V4[%S38*961WABPCJN@#RPCT#><916;*2B]X=.3D:QC%N8<S!-Y@W\'+
M^4*B\:2']8(&1"\NZL)ZQ*\,QP+K11BTA-V'+MX% 8O2#V.%+NG2X'C&8 ?C
MSJ8P*- R T9PX5"51*N2/</1!&>-5@=)@+W=W6];X8H+R5'BM!E=;$N4%J-T
M&,U<T?S%E3I"_S@LAJ!'']V+YK0+2(X33"#GN:5^8ZN,K-V!$S>4^ <_ZJC
M1  Q@AG%D73J:T)9P0;X?&DX&@=P45.N6-MGD>,D,&20HU<S^H@)>2G%EFW
MT:>LN>'(6XD!V)1R*C@",5"U&$9,S-($LCFK$90)7;-&D+=%9/9UX&+,%\+
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MR[W-VJS#4=Z3Y,TB4>,2];W%8 QYGJ_)#_A!_(#[)%2XSO\J<QXD@A82#OZ
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MI?[U^/7C9&,SB_5U4I'D^"*I%DG =E0&XFJ2IAMIC&0@A!J70H4'LR-%A5W
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MM(?!@&"0Z T6!<X,X:A[:7I%8J9H)Y2P[4*A[(E8TL&;%*[D@EJH^Q]'LF;
MLP6O2BA3J;JBL)<(?N#759FY0#@LG4SABU%'=!WW$I2827\=CA&-N(-65<>9
M!4XYT\X&Y<2IE5 0@JU"1/V_8:2OH"[%[B)&M:@60#"+$C>021C>#IZ(OZ6[
M:&FE$TQ0I1TV#,W1[G/W0!U;:+/![2) ,PG09/]D]( C'@6D[DN1?:U$.'B:
M@)O2<O$U&-75-7Z9NPH1T ?VRGJ</F.V3OC\.B6^0*2-( M]K?WA,KLM,>8J
M '\**WEO@^[CJKZP0T15FE5Q[:O+>FT"X&S,RTL877[.&"I]G!K\QT>]>K=:
MFK5S)NY$(&CD%E!<:^.H_>ODRAI"QL%<G#(X+=P'>!W(>SB-BRS/),O3,#<_
MT%(,A;G13,9(!D)/5-=]@7XL47TP1][&T=' LQ1U&)J*)#K!\B>A>J8'B'9&
MFCHP1Y0O-Q'UW1NWWVZ%N?;%[&OPY=!6(?ED^5L$;29!^W1:C=W0=N\;7RA@
MLE[.F*(\/E-<DE,OJL=I,=<>$76F+YWC^MGFO5;03<N7'1_=+6%V6]&&0*"Q
MI3"%A>"^+15R4:J2O ,LLQ(]#!,BC>E[VEJ9(9Q9[6-)[H!HQGJ5QT&OC6".
M(H1'5ED.U^FG,KKCHZ+*SJV/C_6'H(K&=SE==NHL 9?/#PFXO-'U< CT)=8R
MUUI\?K?*9+8/>R1@*:D=.6M1:[B-1"Z":*5-@D%0\5H(;8!TFFW=<803[ZF7
MN= I1V;(,-7O4*\5.9W]\^,1R($_4+_>$8_P.)$L@\P(J,7?.S2",9QNL;Y/
M#B6F$&7>6/P.7_O&*A(&F^^IB'"F$QKNM)@TQ^1@AO!TFNQ:@SU* T&OU,^,
M\RDZHH))8((][++@K&[UQLZ[8.(XLZ:IY/%N90E!8V.P([R;K_G5>7#3H+/P
MD660GSY94LCW/H7\],F#RR'/M@WB11@TLWL@!_/T(*(_/Y/P^!15RUHV3$%(
MVQ@UP3LX&0JN.]QN$;=,/)V$W#'\AW=WCH_$W_D/=6;DM=P=.1&S0TMC)#,2
MDWDS^ZDD7:A <&7ANPT;+<$A!U\2*<L@T]0X(O@T3. $]TIZM[+VU%%BK/2=
M+BCB5J?Z /]<<C?]M50XF'Q72.SKGU7'Q9UH&)05>F^8IDEQ$')/"AV;]07"
MZW,L7B/DJ.=HY5\$7!ZP:4J6-4\.:Y@/MI]2XED>@<4S+[^?/#?CGBBRMEA?
M$!2RA@Z;3Y:$+6K]-* -M8]5, 0"+"[%3.[=%X>5<F5V*X;;*^MJD%$>7VNF
M:G']YE^G+_XH*95N-!?Z^B/L4<='[_.\N(-S=GQ$:/$P .69 323C#X3A8R$
MRE84%B&",5Q(YT[O2XE/LZ\RB%!'\2;NI5*[#1(3G8(022SMUVX%HW:?^A.+
M2(98Z=%UHJUQ GV!_I"4*7QC.AU>8Q8=^0M>.5Q7&A1BL85*5^9*+!>,\W'R
M;_)6N;\+JW.<#-^2CC>](I#YJJ5=ZP=OUZH@MJN+BH[96+!(IN-P*X4J)%"^
M1TA=H#>OU]VV:3&% _9!Y@+H\KWRQ:+LK10/)V$*7C#&OBW,X1^\#>PH]5@$
M/- D"";&0@,NA)KT?H.A_+(B9$^>V5JKHDKB;:@>P0<F68%.:,9(U/#O7V R
M'IVYW,(O.X6)8O0*C-%Z38 D$*]-AT"@RE_ZCXJTO20.JZN2C=-W^998&(Z/
MGCW!%"%%#7JT;([V0@)KNC5<M@.I+4Y\QRB-=_G32RV<C!VL(>5%W'P^@%G!
MK4\7CO,_I:UNK B=?+NCB^7[RC":0&W6#1,O#M1?GZ1/=1]Q8=ZD_!8792;3
M=UIP93%]0]/7N6;$B@5*<\B"R?UFT+8CRY=_<#IF?MY@? 8$XQ0W.,=(AD_S
M:$:>C97'B=8.F\LJ9X (@BNJ;M6F@56"G%MNLTI@1P^GD-MJHK42[4VSPKB&
MA_!)C ?.G9K>CB,?IHB-_0\7;_A :8FG2UKB_J<EGCZXM,0#.]GN1G@HE;F*
MWR2V:/;616>%_ET=, 5N^J>!A-=9U1\?43OQMAT#2KE30WH6",'T4MPTJSQ,
MISSKA>N)<)"6S!V4HTZ;NCCH96$3BCQ;^O#,&T[_\C"TE#6P8-=+O'SFA?CR
M %:T'FW+3HDD6Z9>(-V9]G1J$R8[7.(V[3-O^=!:4 U&01B#R;YX^9<].-/2
MST";5DFAU6"1DK":;/CE"(WN->97?=>$P -+'9R*L,J&(_6DMO,BUMNGBW#,
MI:"?/CE$0_^7J7-W<KZ2OAU+?G/N=7GZY/ $9^36/W_\E.'\7.S/D(4+J\4>
MV@XE[MJ!Q5>Y%OQC*^5\0^WAV^,CHM&VP5JG/6 LEZU$'6F4!8 IN$^$2]J'
M;AQ$5JQK!\QU>;@ 6TI_&1W)*9]-VB"&++NV_RZ,L;^B@L1NE^)9<PGB:WU/
M':YJ*9L@5*Y4X_)G'"F70? ;'1]QS(PTW*7;%WGC5-48*H?&67%%JTDP9@\7
M%LQ^UFC6,TAP\IR^\-.6>@RJ>VAPFA)U Y63NZB3OF& GAJ^+(Y+N+Y-F;17
M>-[G=39E(I(3"811Q>95+UUJDBN37[)E,!Z(O"%%$S:'&0DI*X4]-@)D/C,<
MB,W=A-!$:$AK\ES@NOPFL<9;W_XTU3Y'',D+XF4&\]^.2X090 @V'MW_MIE'
MT@XDWFZH/,QXVN\>C59/<D?WS<T1QUA2L4R[OK1^9V/Q=XLOBJ%%:8XG^J6W
M!]!ZP-?:(^7'1RSF*57MKHAY51>&$5;QZX2O$@11Y8W>5'X(.B6X]N/"YL#C
M2G=/S01ZS<2:B,SDZY??;#LT1\ LZNC5X:1[^8U#,+C47&F1%@"%]_>NJKNM
MS[4$9<SX7AX\X&KA"9R(>;QK7&5D?6=$.\G"#6)H90\R([TLAX>9C?U4'HI[
M0,;$R#AZ.L>MP;87&OJJ>.]!C8=SID^SQ'N$HJ*2W+;G111)':/X:\$(;TF1
M*+5&5;L=X0]RUPG,4&T:(UI*O7^05>@C0?5X"WRZ_C5PZ&)FW4JK,)][:!#D
MB*E&.1C1":@:4\!IRIF<R,SGQ@01Z)5J[GA?R7MBA04> -'\A*;*(K]SR>_T
M^*R8@M+6Q6;#7BZ#8\J;BD$IJV\<V&\7J$=\B6WP!K:E?4<--(KK.UF9/(XT
MAO%Z\U'NM$;Y8^1'[>^FB3.Y(_C&;W%G@7#F9 )T;*-H@T3=9%->^6-+NCU;
MDF[W/^GV;$FZ?<Q:'2- 3P^BD// #?C_KZ4!T@<+ ,VLJ?B_.!5["K=ZR49J
M8MQ4R<8X:@1)"FJZ$!Z$O)"&*I)DHB00(M:V>#M1$@KKBK6CF7@'A!T1IDG?
M[.Q$8QYF19XE<HIQV[4LYT9M!9+>5%2!C-";X<WX"ZLWE::QDV[L2$,4'/V:
MK#_WIHT6^W =;!X4707T.F##72CJ)\)=<QH.QV[J5A)RC[J=>UH_\TL]-2HV
M#_->5W!'SKFJJ[<PT]BMV;CQ%>8*'O9XQA/OP6F-9X=HC9]AE;!+Q7F9J\B_
MJ>'[#QHS_J#*8H05C>KEL.GM=D><=<)UBY/26'5ST#DZL=@4@3J](8<M[J-3
M[NW]>Y=+(SW8F.@ PI9*8=]H@1MN'(RTY%0QUCCG2?)Q6-W'40N$*\,.,T0'
MO#\FZ\(ELE5%V9T&'IF8^C'LPA=O^M@@=700Y2(='MN*J^TP!E+;]IIM8S3.
M0V=AV:9_8)L^/V2;_IA;/M:7?,Z\OO/S.[<EDQCJ)J\Q  Q:!,,<6] GF";E
MU<*?*9Y53W&/:,$#E!,DIX[7 L]EV6):=FJTCLO= G:J& '*S<A.*W[9B"D
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M 0%IW!+YZ;,G*':VS SR.B+S9/!Z81I6KO]KW?S>52^H=.W=-3<_HKR6:RP
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MQJ0:AZZ9YHNL]H\-@?!T02#<?P3"TP>*0'AHA\DTJ++3ULJ#$^M*#GJ5F&Q
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M5M<TDM$)/G<$^Y274&S)E;EFJGY3YENL@\?:<7C($JQ]#Y[^\R<'M?LQGFE
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M=.M^Y?.847:)"GL\<.4_/&/P^9(QN/\9@\\?:,;@ 1U0GQZ4*["%]1SQ0>:
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M[N!+%E[\A6ZXH)3R>^E7#=>\QI91V'6>6@OR]G_MVT/A#?1+-I0:UD^"Y_>
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M(MZ)]!Z85VMOJK".RNEDHLC HL16?#XLM='OP0+[XA +[+4UQ6)LS:9IOCC
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M;3/WTJV4$L83".<FF-P-7/(X>2GA>VH'-E;6J8269MTV>JY0.6 (S0ML=4]
M%.UQ 9+2ZS)+%%Y3#C(#^,'6O+6CY! NN'=\M,G=N:K^ETP>'0OLU,B4J;&O
M>9UHIP2/N)).5Q1EXXYY>-\@'235GIR; 5&O.]L_4A(X^GTGU/ 0I?91:V*T
M/1V+A\=$1=Z%HJA.W/N,JD,VX;W)^O#=AT@.P JN+0TVZ3=Q"T *CDPJ7C!)
M!;4M[\$U"G[+$$O?SP<G3$4.\<3Z/"1DRI0JD!U3AQ7U52 D+U2:"=>O<M8R
M^.2BB+>K6C/^U%[*^.]Z3C\]Y)S^EMKB8!-?5NL+RG*NI?CDZ9VZ+(2MC"3!
ML=(UTJ,WZG? V767MDAQ2\.[FX)GFW8H<6 ?'RD&6^@UG(;4'F(*)KBLL.3U
M5')IU#.)U(LZ(VTUQ+'XQJ,,!"6"U*Q?Y>\Z*WB]$[HX'L0HP2!FT*,L"T'*
M6S@X&JX^8&188Y3C6#M4TI#.JRIK1A[.=0Z4X^:C#ELXYH5#.80Z*'F-&FHP
M^5M8-\Y((D4>,KU2J;ARHW@7:(.*[T8?J'64Y6##@4N)?1=_#=<\<A,CR"@M
M"A=VX/)+PV+ZM!D=-OI^]5@K-W(WA?P02?03(MA6E"7A0@<6JM+M2V 25JA
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MP$G%3*>D1G+NL)19TU[TUCR5  L2=[@,>EY*LU3NX,IA'[J?:5AJ\J+@6I0
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M#U]2[OW2^@EBZ?LC:T[6==S4;Q=3L74D^Q^T[JQ_:C@JD@Z +FYZC] ',3/
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MXR8CW&IL@S(!Y [>E=]3Y58/+BEO@SW*JA9;+),P@9L-K\. V\$*7$!QQRM
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MSD4AH))V!'Z0JU#OYY#*U^]Y:9.M!CO=6.):Z_C65B0\0LAT272U69HLO&1
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MRB*_4Z4+^XYIFHS1(BT?(?[@[A[C#]9Y_W\>/0)&&B7CE\$QZ$ZOX/?_7D9
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M,78(I\\&'^P8U;;@E\I<.T[\!<30*(L76IXZH^185UAY@9X.<(ODRB3PLFR
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M=20@J?@N()9!QL!?E6?F4)ZI;;04[]&[DULX3YVJ24XQ+#!]P5N;&4D+%IJ
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M]C*?A=),KK(:TTHM>)^.HX1+IA#5=P2#P#-=X&<PU#S8HW#V')Y.4_0 GCM
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M10C*G [/L%HT%.B%H6 'S:)BRL@/CN9NXE+8 ESB*0ZDD_O+.&?+J=FO!_+
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MV_9"$R%BNG!Q!V9CZ?BJ"^O'>7 1CD)&[\DL>3(2WRA<A","4,*RMW+^<K5
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M']X,L1;\91,NW2V>?Y,$KU-K;KK4M__F[R:F1PH=RNEC2:2O!*3_\?IQ_^9
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M/G8#CWF#1U#&[[K'9S!80QPT,M^.3^0674%:VE UNJ/(E*LM!=.,F0P"9I*
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MZ=]NC9>$D4-OF<V6&)%39^AR7HV)JMO:/52%R)L*["=1T25P\-S?2_F^G/\
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MVHRX"#^9MK62C35C[XS\/IZAGX5>8)N!2G,@'/K>$>2PQG=1;?5&35TH(ZW
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M[S686]0TS(8^WCW:_P.9U>-WP_<';_X_4$L#!!0    ( #2(454>U>NID30
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MF6@XUN8H9_A]R[N=+7]YVP@FY2(H4@'G9W;@,(H(0@%V:*Q SVAG)>PZN\H
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M:#M2,W3&H1L5* $0J./4#U^L./><&+((-8L@9HG.VP3\@^PD_FHO--P&\B7
M2T3#>L"*F$CMXN!8:'4L1KI(/*""4PX;(/)2'\9:7G4RC<N(K>TK!K"$M(4D
M>_0.SP6V\7NI,S:#)JH(IF&.M*TPUR0[Q\V1TC?+PJF<W_TQH-T",=9F):U>
M/\MCO:3*8:L 7&.P J'I%'BGPP&Y2XFXS1O!BF%BE7PKM, [$]&S@>6'J#T3
MHAB0JH_9DV@O)(I#E1?DL3A2\Q0TNZAD!:T'^L<T9GV_E^?I5-/X]SV&6Z!B
M788X!Q4;Q6,,QUZ[/6X@=BLZOT8(-Z%8'N0I4F",ED'2-:7H08L_A$Z9$MM7
M@XE4!421GH%>3HOV "DR/V4*5)-$A#,AH)Z"G@<M)BH@U;.:,$K:#XG+97:I
M+RE2'!DH^<["5G3N>JS5#Y.88RH'Z-<Z0\IPB<H("+=3\J]PAD::7'*ZDLBN
MQ-X6!1T*AQ2U[*3M=)A-F!TV#$A5.\EV[JF023F?\ .8$=#@@# DZW(7JDM^
M/&*XG$E!8D74]4T^QJI(YB%4Z<@:&<(-B<^0KY'-#1=Z[C%Q#IHS^^#5ULU"
M=N5A,/5L+^A;3M//CV!)L/)%*MD\EJWGS"I!$JD8?E@Y1A_)>6K40'(4&W>W
M"RUJQG_4+204N;22ZP?7,WW?D%N-J>'K19AL2 *Y)^JHAM3<<#2'!6U.Q*NK
MM(Q]4R\ZZN1""9LH'*<VUZJINL:%6^CY31":(_7%D-PT35VD5P$)2JR(\ZKF
M]E319A5%J"NJ",Z*;P%A%W@D+*X@%0P5[:)P?LX_PUP)I3WN6MD+6A>S2\5B
MI4U4B12<&=G+Z0YQ']YA^EN2DT.M]Y)<K[H]1(F3T3I;)ALM#J^Z@IE\E2*A
M\FB@.)-V'*57B;$ ^[-ZDG0+PA-94/BI0&LOQB)PC@IA:")^WLX6'#9,4NK\
MPEA1VS?YL&OLG@)\$V7):LSX@#\$?)[HP<&?5QS8-AY'6C(PT[I0HL87.!SA
MH8VJM/D>-O3+WLBLI,"*%5-XIR,X5A71Q*'N;<@CA\*+^/50SH^)+(J>R]KE
M<.BV.<>Y,<$CI40EC%8,A^=O&A83:U4R_5@ 7% FA+%4HQU");G(F7PR9)NN
MA.X[!Y' G<%D@E4B%IS+)3NA2-KV$'.S7J/8*8Q\S7-G&Z*!D,()K*^@0.K+
M0GBCS'F'Y;&;Q0;L_H@-V)S8 "==K]/]YX3L7U'Z0WK/LK;(U2T2FD1AU2T>
M8H[A^&@,]D,15D*U*G*,-<&0O!DO;: 7\M0E&6;8,I< H02FF^<HR]]AY+SE
M=:Y%RVRZB( 1D2!1O5 RUK7Z5JW@<$-!MPD6!C+X@HW;T/@+R0Z%GEYAP)Q[
M =Q#U=@$4&,@15:#$(XH8I!OX*^+?#KSP@_D&?.\E]4@<EYMF[Q#>-)L<G,
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M5]8DT3@>4C[/4XS.=)7=(LQLH.S  DU) #!Z@6H;H:+15M^G65J>4ZCR49B
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ML88C]J%HRR'RA[+^H9M<#*;IAV54O9^-0:;O8S?I?R'Z#93I>FRBLEV<)+O
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MOQ.:FKJ2\T%UX;P,$NJ9C5 PIK@"@$LDP$&CMT184$TQ[(HY2-"A2B!V%"8
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M"[O_CC&MVZZ$61FK7/J*DB/^O(PEOM09H^EB&1JJP06[KQKM1WH8[L,;R'T
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MV],Q*"J8^:=.4E+ _QBCD\Y_B3 ,V_I4/&&&(FNOVP1?OD>C+2QA'IT%IFV
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MC!F>S<M2&%V(>H/:&X%2L!H?1.LCG2Q:%=D$!*KE?*+/2_(Y$*1D6 3=&(A
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M,BYX<V102P$"% ,4    "  TB%%5-RLGX*\)  "2<   %0
M@ &*!   <W9I:2TR,#(R,3 Q,E]D968N>&UL4$L! A0#%     @ -(A156O3
M@9U^#@  ":0  !4              ( !; X  '-V:6DM,C R,C$P,3)?;&%B
M+GAM;%!+ 0(4 Q0    ( #2(455L QDQ^@@  ")K   5              "
M 1T=  !S=FEI+3(P,C(Q,#$R7W!R92YX;6Q02P$"% ,4    "  TB%%5]O?E
M%>DB   \V0  $@              @ %*)@  =&TR,38W,S%D,SE?.&LN:'1M
M4$L! A0#%     @ -(A150+.%^Y]K0  JFP$ !4              ( !8TD
M '1M,C$V-S,Q9#,Y7V5X,2TQ+FAT;5!+ 0(4 Q0    ( #2(454WZ)F@#C8
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M P!T;3(Q-C<S,60S.5]E>#0M,RYH=&U02P4&     !  $  O!   >Z$#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
